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Abstract 
Porous strontium-doped apatite-wollastonite scaffolds were evaluated as potential 
substitutes for enhanced bone regeneration and the prevention of peri-prosthetic 
infections.  
Parent glasses of composition 35.5SiO2-7.1MgO-0.4CaF2-7.1P2O5-(49.9-x)CaO-xSrO 
mol%, where x = 0, 6.2, 12.5, 18.7, 24.9 or 37.4, were produced via the melt-quench 
route, ground and sieved <45 µm. Porous scaffolds were obtained following the foam-
replication method and heat-treated at 1050 °C for 2 h for controlled nucleation and 
growth of the crystal phases. 
All six glasses produced were amorphous. Differential scanning calorimetry showed 
that the formation of the calcium silicate phase strongly depended on the amount of 
strontium contained in the parent glass, linearly moving to higher temperatures with 
increasing strontium. 
Morphological evaluation (scanning electron microscopy and micro-computed 
tomography) proved that the obtained scaffold porosity, about 55 vol%, did not depend 
on the strontium content. X-ray diffraction showed that strontium preferentially 
substituted in apatite, while only higher strontium compositions formed a strontium 
magnesium calcium silicate phase. Compressive and biaxial flexural strength were 
both comparable to cancellous bone. Compositions containing 0 %, 6.2 % and 12.5 % 
strontium showed excellent apatite forming ability when submerged in simulated body 
fluid, which then decreased with increasing strontium for the three higher-strontium 
compositions.  
Microbiological tests carried out on strontium-containing salts showed no effective 
antibacterial properties for strontium as a free element. Amongst the six strontium-
containing glasses, only the 37.4 % strontium oxide glass showed antimicrobial effects 
against Pseudomonas aeruginosa in broth dilution tests.  
Proliferation and osteogenic differentiation of porous scaffolds were tested on human 
bone cells. No conclusive results were obtained for the G292 cell line. When scaffolds 
were tested with human primary mesenchymal stromal cells, an increase in DNA 
content was observed with increasing strontium, while enhanced alkaline phosphatase 
activity and increased collagen production were found for low strontium compositions.
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Chapter 1  
Introduction 
1.1 Background to the project 
Bone defects can derive from trauma, diseases such as osteoporosis and 
osteoarthritis, surgery (for example after the removal of a tumour) or infections. They 
represent one of the major clinical challenges in orthopaedics, especially those defects 
that are above a critical size, i.e. more than 2 cm long with more than 50 % of lost 
bone (1, 2). Non-unions, which are fractures that do not present signs of healing after 
6 months, occur in 5-20 % of all traumatic fractures (3, 4). About 1 million bone 
reconstructions are performed in Europe every year (5) and this number is constantly 
increasing due to the ageing of population. In fact, bone is already the second most 
transplanted tissue after blood (6), with musculoskeletal grafts representing the 71 % 
of total grafts distributed in the U.S. in 2015 (7). 
The current gold standard for the treatment of large bone defects and non-unions is 
the use of autografts, followed by allografts and xenografts. However, all these present 
relevant drawbacks such as donor site morbidity, lack of donor tissue and disease 
transmission (8-10). In addition, the incidence of infections in the orthopaedic field is 
becoming a growing issue, further aggravated by the increasing antibiotic resistance of 
pathogenic bacteria, with heavy economic consequences. For this reason, extensive 
research has been carried out since the 1970s around the design of synthetic 
substitutes that could support, guide and stimulate bone regeneration and, more 
recently, also present antimicrobial properties (11). 
 
The work presented in this thesis concerns the production and characterisation of 
porous scaffolds for enhanced bone regeneration. The material chosen for the 
scaffolds is the apatite-wollastonite glass-ceramic (AWGC), which has improved 
mechanical properties in comparison to other bioactive glass or glass-ceramic 
materials, making it a good candidate for load-bearing sites (12, 13). Its composition 
was then modified so that strontium oxide was substituted for calcium oxide. In fact, 
strontium is a chemical element well known for its ability to induce bone regeneration 
and it is used in clinic for the treatment of severe osteoporosis (14-16). In addition, 
interest is growing on whether this element could possess antibacterial features that 
could thus be imparted to the material that contains it (17, 18). 
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The present Chapter will provide some background to the work reported in this thesis: 
a summary on bone tissue and its characteristics (Section 1.2) and an overview on 
bone grafts (Section 1.3) and on bioactive glass and glass-ceramic materials (Section 
1.4) will be provided, before focussing on the AWGC system used for the work 
presented here (Section 1.5); then orthopaedic post-operative infections will be 
introduced (Section 1.6) and finally the use of strontium as a therapeutic agent and in 
bone substitutes will be described (Section 1.7). The aim and objectives of the 
research presented in this thesis will also be presented (Section 1.8). 
1.2 Bone tissue 
The human body is composed of 206 bones that form the skeleton, which provides 
mechanical stability, protects the internal organs, takes part in the formation of blood 
cells (haematopoiesis) and maintains ion homeostasis, in particular calcium and 
phosphorus (19, 20). 
When designing artificial constructs for the repair of a portion of the body, it is 
important that the architecture and biology of the original sound tissue and organs are 
known and understood, so that properties of the new implant can match those of the 
surrounding tissue once implanted.  
In the following Sections, bone tissue characteristics will be presented and described: 
composition and structure (Section 1.2.1), mechanical properties (Section 1.2.2) and 
the mechanisms of bone remodelling and healing (Section 1.2.3). 
 
1.2.1 Bone composition and structure 
Bone is essentially a composite material, made of an organic collagen-based matrix 
(25 wt%), a mineral apatite dispersed phase (65 wt%) and about 10 wt% of water (21). 
These phases are organised in ordered structures, with the apatite crystals disposed 
along the collagen fibrils. 
The molecule of collagen consists of a repetitive sequence of aminoacids –(Glycine-X-
Y)n–, where usually X is proline and Y is hydroxyproline, which allows the protein to 
form a triple helix called tropocollagen (21), about 300 nm long (20). Molecules of 
tropocollagen are then organised in staggered arrays, where molecules are parallel, 
but offset by about 67 nm in respect from the next molecule and disconnected from the 
following molecule by a gap of approximately 40 nm (20-22); this structure gives fibrils, 
which are then organised in fibres. Each fibril is filled and surrounded by nanocrystals 
that constitute the mineral phase of bone (23, 24). Bone mineral crystals nucleate 
within the gaps of the collagen fibrils, as represented in Figure 1.1, giving platelets that 
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are 15-200 nm long, 10-80 nm wide and 2-10 nm thick (21, 23). It is a form of 
hydroxyapatite (HAp), Ca10(PO4)6(OH)2, with a Ca:P ratio lower than the stoichiometric 
value of 1.67 because of the presence of impurities such as carbonate, fluorine, 
sodium and magnesium (21, 23). It crystallises in the hexagonal system, with Ca2+ 
ions and PO43- tetrahedrons arranged around a column of OH- ions along the c-axis 
(Figure 1.2). 
 
 
Figure 1.1: Schematic representation, not in scale, of the structure of bone at the 
nanoscale, with molecules of tropocollagen (the collagen molecules) 
organised in a staggered array and thin mineral crystals (mineral particles) 
nucleating within the 67 nm gap between tropocollagen molecules and 
growing along the fibril axis. Reproduced with permission from (23). 
 
 
Figure 1.2: Simplified representation of the crystal structure of hydroxyapatite. 
Drawn using Servier Medical Art, https://smart.servier.com/. 
 
Four main types of cells can be found in bone tissue: osteoclasts, osteoblasts, 
osteocytes and osteoprogenitors. Osteoclasts are large, multinucleated cells that 
resorb bone through the production of acids and enzymes. Osteoblasts are the bone-
producing cells: they deposit new bone matrix and control mineralisation during 
remodelling, until they remain embedded in the tissue and enter a quiescent status, 
becoming osteocytes. Osteocytes maintain the mineral homeostasis and act as 
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mechano-transducers. Osteoprogenitor cells derive from the differentiation of 
mesenchymal stromal cells (MSCs) and will mature into osteoblasts (25). All these 
cells take part into bone formation and regeneration, the mechanisms of which will be 
explained in Section 1.2.3. 
 
At the macroscale, bone can be divided into two types: cortical (or compact) and 
cancellous (or spongious or trabecular) bone. Cortical bone is found on the outside of 
long bones and in flat bones; it is dense and formed by regular, cylindrical lamellae 
that form the Haversian system: a cylindrical structure with blood vessels in the middle 
and osteocytes in between layers (22, 26). Cancellous bone is a porous structure that 
is usually found within the epiphysis of long bones, within short bones and a small 
amount in flat bones and it is filled with bone marrow. Its porosity is higher than 50 % 
and it is formed by interconnected lamellar plates and cylindrical trabecular struts. In 
general, it consists of struts, about 100 µm in diameter, which extend for about 1 mm 
before making a connection (27). Where high loads are involved, trabeculae tend to 
orient along the lines of principal stress so that loads are transferred to cortical bone 
(28).  
 
1.2.2 Bone properties 
The two types of bone described in Section 1.2.1 differ not only in their 
macrostructure, but also in their porosity and mechanical behaviour. When designing 
artificial constructs, it is important to match the characteristics of the native tissue as 
much as possible, so that the optimal integration of the implant can be achieved. 
However, it is also important to note that, when it comes to living tissues, variability in 
their properties is very high and therefore only ranges of values can be given when 
describing them. 
As mentioned before, cortical and cancellous bone can be distinguished by eye by 
their porosity. While the porosity of cortical bone has been estimated as 3-12 % (29), 
that of trabecular bone can range between 50 % to 90 % (30), with pore size at the 
order of 1 mm, depending on species, anatomical site considered, age and health of 
the subject and, partially, also on method of measurement used.  
Like any other material, bone can be characterised for its elastic properties, strength, 
fracture mechanism, creep and fatigue resistance. However, since bone structure 
depends on the function it exerts in a specific anatomical region of the body, its 
architecture is optimised to obtain the best mechanical properties with the least 
amount of material; as a consequence, the mechanical properties of bone are highly 
anisotropic, i.e. they highly depend on the direction in which they are tested. An 
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example is given in Table 1.1, where properties of human cortical bone are listed. 
Average Young’s modulus for cortical bone is 19.3 GPa (31). 
Table 1.1: Mechanical properties of Haversian cortical bone, measured 
longitudinally and circumferentially (22). All strength values are in MPa ± 
standard deviation.  
 Longitudinal Circumferential 
Tension   
   Strength 133 ± 15.6 53 ± 10.7 
   Yield stress 114 ± 7.1 - 
   Ultimate strain 0.031 ± 0.006 0.007 ± 0.0014 
Compression   
   Strength 205 ± 17.3 131 ± 20.7 
   Ultimate strain 0.019 ± 0.003 0.050 ± 0.011 
Shear   
   Strength 67 ± 3.5 
 
For human cancellous bone, its mechanical properties highly depend on its porosity. 
Its compressive strength can vary between 2 and 12 MPa and Young’s modulus 
between 50 and 500 MPa (32-35), with power law relationships to apparent density for 
both parameters (22). 
Toughness has been estimated as 2-12 MPa·m1/2 for cortical bone and 0.1-0.8 
MPa·m1/2 for cancellous bone (35). Cortical bone has also been shown to be more 
fatigue-resistant than cancellous bone, although the latter can undergo much higher 
deformations before fracture (36). 
 
1.2.3 Bone remodelling and healing 
In 1892, Wolff published a treatise on the influence of mechanical stress on bone 
structure, in particular trabecular bone, known as “Wolff’s Law” (37). Now generally 
summarised as “bone functional adaptation”, it provided a mathematical model for 
bone remodelling in cancellous bone trabeculae as a function of their loading history. 
Although some of the premises for his theory have now been disproved, the general 
conclusion that bone adapts to the direction and pattern of the applied mechanical 
load is still valid. This is particularly evident, as displayed in Figure 1.3, in the proximal 
portion of the femur, where trabeculae are oriented along the axis of principal stresses, 
thus resembling, as Wolff showed, the stress trajectories derived by Culmann in a 
curved crane (38). 
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Figure 1.3: Comparison between the principal stress trajectories in Culmann’s 
crane (left) and the orientation of trabeculae of cancellous bone of the 
proximal femur (right). Drawing based on (38, 39) . 
 
At the cellular level, bone remodelling is controlled and managed by the four types of 
cells described in Section 1.2.1. It is a continuous process that develops in a cycle, 
displayed in Figure 1.4. The cycle is initiated by microdamage of the matrix and 
osteocyte apoptosis. First, osteoclast precursors are recruited from the blood stream 
to the site of remodelling, where they differentiate into mature osteoclasts, adhere to 
the bone surface and excrete acids and enzymes that degrade the matrix. 
Macrophages clear the area from debris before osteoblasts, differentiated from 
mesenchymal stromal cells, deposit new collagen and induce its mineralisation. 
Osteoblasts then either mature into osteocytes or bone lining cells, which reside 
embedded in the bone matrix or on its surface, respectively (40-42). 
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Figure 1.4: Stages of bone remodelling. Activation: osteoclast precursors are 
recruited. Resorption: osteoclasts demolish old bone matrix. Reversal: 
macrophages process the debris left by the osteoclasts. Formation: 
osteoblast precursors are recruited, mature into osteoblasts and deposit 
new bone matrix, inducing its mineralisation. Termination: osteoblasts 
mature into osteocytes or bone-lining cells and new bone tissue is formed. 
Drawn using Servier Medical Art, https://smart.servier.com/. 
 
Bone healing is the process of repairing fractured bones. Depending on the type of 
fracture, it can happen as primary healing or secondary healing. Primary healing 
occurs when the two fractured surfaces are maintained in contact; osteoclasts resorb 
the fractured tissue, osteoblasts deposit new matrix and the fracture is repaired 
through bone remodelling. Secondary healing occurs when a gap is created between 
the two fracture surfaces. The process takes longer and involves, in chronological 
sequence, hematoma formation and inflammation, granulation (formation of a soft 
callus), callus mineralisation, callus remodelling and bone remodelling (43-46). 
1.3 Bone substitutes 
When repairing a non-healing fracture or filling a bone defect, it is necessary to implant 
some material (a graft or a scaffold) that can provide mechanical support to the 
regenerating tissue, integrate with the native tissue (bioactivity) and, ideally, undergo 
remodelling, so that the defect can be filled and repaired by the body. The way and 
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extent at which this happens depends on which of these characteristics the construct 
presents (47, 48): 
- Osteconduction describes the ability of a material to bind to native bone and guide 
bone regeneration, without the formation of fibrous tissue at the interface. 
- Osteoinduction is the formation of new bone through the recruitment of 
mesenchymal stromal cells and their differentiation into osteoblasts, even in 
heterotopic tissues; growth factors are required for this process. 
- Osteogenicity is the capacity of the construct itself to form new bone tissue, 
deposited by osteoblastic cells. 
The various options of materials and constructs that are now available for surgeons 
will be illustrated in the following Sections. One category of these grafts is represented 
by bone tissue-derived grafts, described in Section 1.3.1, while a second option is the 
use of synthetic materials for the production of fillers, granules, cements or solid 
scaffolds and is illustrated in Section 1.3.2. The requirements for the ideal bone 
scaffold will then be presented in Section 1.3.3. 
 
1.3.1 Bone grafts 
Currently, the gold standard for the repair of bone defects is the use of autografts: 
pieces of bone removed from one site and implanted in another site of the same 
patient’s body. Usually, they are harvested from the iliac crest, they provide immediate 
stability and perfectly integrate with the native tissue. However, they have limited 
availability, require longer surgery time, cause donor site morbidity and increase the 
risk of infections (47-49). 
The second option is the use of allografts: bone pieces taken from a different donor or 
a cadaver, processed and then implanted. Although they eliminate the risk of second 
site morbidity and are readily available during surgery, often they lose their mechanical 
stability through sterilisation; they are also not osteogenic and they can cause an 
immune response or, rarely, transmit diseases to the recipient (48, 49). 
Xenogenic scaffolds are mainly used in dentistry and maxillofacial surgery in the form 
of granules; they usually derive from bovine bone tissue that has been treated to 
remove all its organic components. Also in this case, the material is always available 
at the time of surgery, but presents reduced mechanical stability, is not osteogenic and 
has reduced osteoinductivity (50). 
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1.3.2 Synthetic bone substitutes 
Because of the risks and drawbacks associated with the use of natural bone grafts, 
grafts based on synthetic materials represent an appealing alternative for repairing 
large defects. In this case, apatite or calcium phosphate substitutes are the most 
obvious choice, due to their similarity with the native bone mineral phase. They are 
often used as granules or powder fillers or, sometimes, as 3D constructs. The most 
common are hydroxyapatite (HAp) and β-tricalcium phosphate (β-TCP). HAp is the 
closest to the original bone apatite, it is osteoconductive and integrates very well with 
the native tissue. β-TCP is also resorbable, but at a higher rate than HAp; resorption 
rate can be controlled by mixing HAp and β-TCP (8, 49, 51).  
Another class of materials that can be used to fill bone gaps is cements. Inorganic 
cements are obtained from either calcium phosphates, which give a carbonated 
apatite once cured in vivo, or calcium sulphates (gypsum). Both are implanted, or 
sometimes injected, as a paste, they solidify in the body within few minutes and then 
slowly resorb while new bone tissue forms (9, 52). 
A different material commonly used to fill bone voids is PMMA (poly-
methylmethacrylate) cement. It is mainly used in combination with joint replacement 
implants, to fix them in place and provide immediate stability. It is often used also in 
the case of prosthetic revisions due to peri-prosthetic infections: a temporary spacer is 
created with antibiotic-loaded PMMA and implanted to maintain the functionality of the 
treated bone or joint, until the infection is under control and the final revision implant 
can be placed (53, 54).  
One more class of materials suitable for bone implants is represented by bioactive 
glasses and glass-ceramics, which will be more extensively described in Section 1.4.4. 
A summary of the characteristics of the different types of graft is reported in Table 1.2. 
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Table 1.2: Properties of bone grafts and substitutes. Adapted from (8, 9, 52). 
Grafting 
material 
Osteo-
conduction 
Osteo-
induction 
Osteo-
genicity 
Immuno-
genicity 
Donor site 
morbidity Comments 
Autograft ++++ ++ +++ - + Gold standard 
Allograft + +/- - + - 
Available in 
many forms 
Xenograft + +/- - + - 
Different 
resorption 
HAp + - - - - Biocompatible 
β-TCP + - - - - Resorbable 
Inorganic 
cements 
+ - - - - 
Initial support; 
resorbable 
PMMA - - - - - 
Primary 
stability 
Bioactive 
glasses 
+ +/- - - - 
Anti-infective 
potential 
 
1.3.3 The diamond concept and the ideal scaffold 
To obtain bone repair, four factors are considered fundamental for the healing of a 
fracture or a defect. These have been combined in the so-called diamond concept, 
where each of them builds one side of a diamond, as shown in Figure 1.5. These four 
requirements are (55, 56): 
- The recruitment and action of osteogenic cells, in particular mesenchymal stromal 
cells. 
- The presence of growth factors and proteins, which control the different stages of 
tissue repair. 
- The presence of a structure (a scaffold) that can provide mechanical support and 
guide the healing process. 
- The transmission of mechanical loads and stresses from the surrounding tissues to 
the healing region, to provide the required mechanical stimulation. 
Once these four factors are in place, the success of an implant will also depend on its 
vascularisation and the general health condition of the host (57). 
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Figure 1.5: The diamond concept for bone repair. The four sides correspond to 
the fundamental requirements necessary to obtain bone regeneration, 
which is also influenced by the factors in the black boxes. Reproduced 
with permission from (57).  
 
This diamond concept thus provides the general requirements for the success of a 
bone implant aimed at bone regeneration. It therefore follows that the ideal bone 
scaffold possesses numerous properties (9, 34, 58): 
- It is biocompatible, so it does not induce an inflammatory response; 
- It is bioactive, connecting to the surrounding tissues (osteoconduction) and 
stimulating the differentiation of osteoprogenitor cells (osteoinduction); 
- It guides the formation of new sound tissue; 
- Its mechanical properties match those of the host tissue; 
- Its nanotopography supports cell attachment, while its porosity, with at least 
100 µm pore size (30), favours bone ingrowth and angiogenesis for better 
integration of the construct within the tissue; 
- Its resorption rate matches the rate of new tissue formation and its degradation 
products are not toxic nor cause any inflammatory response; 
- It is easy to sterilise, its shape can be tailored to the defect shape and is cost-
effective; 
- It allows and promotes angiogenesis. 
Although a construct that presents all these characteristics does not exist yet, some 
materials can be tailored and used to design implants that cover most of the 
requirements listed above, thus giving scaffolds that possess great potential for a 
future clinical use. Amongst these are bioactive glasses and glass-ceramics, which will 
be described later in Sections 1.4.4 and 1.5. 
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1.4 Glasses and glass-ceramics 
The concept of bioglass was first introduced by Larry Hench in 1971, when he 
described a glass composition that could interact and bond to living bone (59). Since 
then, many other compositions have been proposed with the intent of designing the 
optimal material for bone regenerating constructs, which include the apatite-
wollastonite glass-ceramic (AWGC) chosen for the present thesis. 
In order to better understand what a glass and a glass-ceramic material is, Section 
1.4.1 will describe the structure of a glass and its formation, Section 1.4.2 will describe 
the crystallisation process in glass-ceramics and Section 1.4.3 will explain the 
mechanisms of sintering of glass powders. Section 1.4.4 will then present the most 
common bioglass and bioglass-ceramic compositions, while the AWGC will be more 
extensively presented in Section 1.5. 
 
1.4.1 Glass formation 
A glass can be defined as an amorphous solid that lacks long-range, periodic atomic 
structure and exhibits a temperature region of glass transformation (60). Its 
characteristics can be described in terms of enthalpy (or volume) to temperature 
relation, as represented in Figure 1.6, as the final atomic structure of the material 
depends on the cooling rate used after melting. When a small volume of material is 
brought to a temperature well above the melting temperature Tm, it will be in its liquid 
state. If the material is then cooled down slowly, its atomic structure will re-arrange to 
form crystals, which causes the enthalpy of the system to drop. However, if the molten 
glass is cooled down quickly, crystals will not form and a supercooled liquid will be 
obtained; its enthalpy will gradually decrease, while its viscosity will increase until 
atoms will not be able to rearrange to the equilibrium order. The range of temperature 
between the deviation from the supercooled liquid to the frozen liquid represents the 
glass transformation region. If a lower cooling rate is used, the conversion from 
supecooled to frozen liquid will begin at a lower temperature. The atomic structure of 
the final glass will be the one of the equilibrium liquid at the fictive temperature Tf, 
which is the temperature where the lines of the supercooled liquid and frozen liquid 
intersect (60). 
Since this change of state, from liquid to frozen liquid, happens over a range of 
temperatures, the glass transition temperature Tg cannot be uniquely defined and 
depends on the measurement method. However, it is used as an indication for the 
change in behaviour of the material: below Tg, the glass behaves as a solid, above Tg 
it behaves as a liquid (60). 
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Figure 1.6: Effect of temperature on the enthalpy of a glass forming from its 
liquid molten state. Reproduced with permission of The Royal Society of 
Chemistry, http://dx.doi.org/10.1039/9781847551160-00001 (60). 
 
The atomic structure of a glass can be easily exemplified with silica, which is the most 
common glass former for bioactive glasses used in bone applications. Silica tends to 
form tetrahedrons where the silicon atom is in the centre, surrounded by four oxygen 
atoms. As shown in Figure 1.7, in the case of a crystalline structure (quartz) all the 
tetrahedrons are connected in an ordered regular structure. For an amorphous silica 
glass, the tetrahedral unit is still present, but the long-range order is lost. This irregular 
network can be further modified by the introduction of other elements, for example 
calcium, sodium and potassium, that interrupt the silica network by creating non-
bridging oxygens (NBO). While silicon, boron and phosphorus are glass network 
formers, ions such as sodium, potassium, calcium, strontium and barium are 
considered network modifiers, whereas aluminium, magnesium and titanium are 
intermediate oxides, because their role in the structure depends on the overall 
composition of the glass (61). 
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Figure 1.7: Schematic representation of the atomic structure of a) crystalline 
silica, b) glassy silica and c) silicate glass with calcium as network modifier 
and non-bridging oxygens. Adapted with permission from (61).  
 
A measure of the amount of non-bridging oxygens is given by a parameter called 
network connectivity (NC). It describes the average number of bridging oxygens per 
[SiO4] tetrahedron and, consequently, the mobility of ions and solubility of the glass: 
the higher the NC, the more the network modifier ions are locked within the glass 
structure and therefore the less they are likely to be released when in solution (62). 
The formula for calculating NC, displayed in Equation 1.1, depends on the 
concentration of network formers present in the glass (63). In the case of a silico-
phosphate glass like the composition chosen for this thesis, where phosphorus acts as 
a modifier and silicon is the only network former (Hollings, personal communication), 
the formula for calculating NC is (64): 
 
𝑁𝐶 = 4 − 2 ∗ (
𝐶𝑂 − 4𝐶𝑃
𝐶𝑆𝑖
− 2) 
Equation 1.1: General formula for the network connectivity of a glass (64). 
 
Where CO, CP and CSi are the atomic concentrations of oxygen, phosphorus and 
silicon, respectively. It has been shown that, for most bioactive glasses, the NC is 
below or close to 2 (65, 66). In the case of the strontium AW parent glasses described 
in this thesis, it was calculated to be 1.98 (Hollings, personal communication). 
 
1.4.2 Crystallisation 
Glass-ceramics derive from glasses that have undergone a controlled thermal 
treatment, which induced the formation of crystal phases (crystallisation or 
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devitrification). Through this process, a specific microstructure is created and desired 
properties are imparted to the initial glass such as mechanical strength and controlled 
solubility (13, 67). The crystallisation of a glass takes place in two stages: nucleation, 
described in Section 1.4.2.1, and crystal growth, explained in Section 1.4.2.2. 
 
1.4.2.1 Nucleation 
A nucleus is an entity that belongs to the crystal phase, but is in unstable equilibrium 
with respect to the parent glass (13). Nucleation is regulated by the difference in free 
energy (enthalpy) between the glass and the crystal; it is called homogenous 
nucleation if the development of a new crystal phase happens without foreign 
boundaries, while if boundaries are involved, for example in the presence of substrates 
or grain boundaries, it is referred to as heterogeneous nucleation. In the case of 
homogenous nucleation, if spherical particles with radius r are considered, the free 
enthalpy of the system ΔG can be modelled as shown in Equation 1.2: 
 
∆𝐺 =  −
4
3
𝜋𝑟3∆𝐺𝑉 + 4𝜋𝑟
2𝛾 + ∆𝐺𝐸 
Equation 1.2: Free enthalpy of phase transition in a glass (13). 
 
Where ΔGV is the change in free enthalpy per unit volume caused by the formation of 
crystal nuclei, 𝛾 is the required energy for the formation of the surface of the new 
nucleus and ΔGE represents the energy of the elastic distortion caused in the system, 
which can usually be neglected in the case of crystallisation of glasses (13). 
Nucleation occurs if the thermodynamic barrier ΔG* (Equation 1.3) is overcome and 
the variation in ΔG becomes negative, which happens if the radius of the forming 
crystal is larger than the size of the critical radius r* (Equation 1.4) (13, 68, 69): 
 
∆𝐺∗ =
16𝜋𝛾3
3(∆𝐺𝑉)2
 
Equation 1.3: Critical free energy required for the nucleation of stable crystals in 
a glass (13). 
 
𝑟∗ =
2𝛾
∆𝐺𝑉
 
Equation 1.4: Minimum critical radius of a crystal nucleus required for the 
formation of stable crystals in a glass (13). 
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For heterogeneous nucleation, the critical enthalpy ΔGH* depends on the interaction 
between the substrate and the material, in particular their contact angle θ (13, 70), as 
shown in Figure 1.8 and Equation 1.5. 
 
 
Figure 1.8: Heterogeneous nucleation of a crystal on a substrate, with contact 
angle θ. Drawn based on (13) and (70). 
 
∆𝐺𝐻
∗ = ∆𝐺∗
(2 + 𝑐𝑜𝑠𝜃)(1 − 𝑐𝑜𝑠𝜃)2
4
 
Equation 1.5: Critical enthalpy in heterogeneous nucleation of crystals in a glass 
(13, 70). 
 
The theory of kinetics for crystal nucleation and growth was developed by Johnson, 
Mehl and Avrami and Kolmogorov and is known as the JMAK theory or the Avrami 
theory (71). Their equation for describing an isothermal transformation, reported in 
Equation 1.6, can be applied also to glass-ceramics: 
 
𝑋(𝑡) = 1 − exp[−𝑋𝑒(𝑡)] ,   𝑋𝑒(𝑡) = 𝑘𝑡
𝑛 
Equation 1.6: The JMAK equation for crystal nucleation and growth kinetics. 
 
Where t is time, X is the volume fraction of transformed material, Xe is the extended 
volume fraction (the theoretical fraction of new phase that would form if the different 
growing crystals would not affect each other), k is a constant and n is the Avrami 
coefficient; for continuous, homogenous nucleation and spherical crystal growth, k 
equals 𝜋/3 and n equals 4, while for fast, heterogeneous nucleation n equals 3 (13, 71, 
72). 
Depending on the composition of the glass, the thermal treatment and the time, 
nucleation can happen homogenously in the bulk of the material or on its surface. In 
the first case, a neat sharp exothermal peak is found when the thermal characteristics 
of the material are tested, for instance using differential thermal analysis or differential 
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scanning calorimetry. In the case of surface nucleation, a broad and smaller peak is 
generated (73).  
 
1.4.2.2 Crystal growth 
Once the nuclei have reached their critical value r*, crystals start to grow. The rate of 
crystal growth depends on the material transport from the glass matrix to the interface 
with the new crystal, where the driving force is the entropy change at this interface 
(13). For a microscopically rough interface, the growth rate V deriving from continuous 
crystal growth is given by Equation 1.7 (13, 74). 
 
𝑉 = 𝜈𝑎 (1 − exp (
−Δ𝐺
𝜅𝑇
)) 
Equation 1.7: Growth rate for continuous crystal growth (13, 74). 
 
Where 𝜈 is the frequency factor for material transport to the interface, 𝑎 is a distance 
factor, ΔG is the change in free enthalpy at the interface, κ is the Boltzmann’s constant 
and T is the temperature. 
In the case of surface crystallisation, the model is based on a smooth surface and V is 
obtained according to Equation 1.8 (13): 
 
𝑉 = (𝐶𝜈 ∙ exp (
−𝐵
𝑇 ∙ ∆𝑇
)) 
Equation 1.8: Crystal growth rate for surface crystallisation (13). 
 
Where C and B are parameters that depend on the time necessary for the formation of 
a nucleus and on that necessary for its growth at the interface. 
Crystal growth can be classified as primary growth, anisotropic growth, surface growth 
and secondary growth. In primary growth, crystals grow through an isotropic process 
from the nucleus until secondary growth starts. In anisotropic growth, crystals grow 
preferentially in certain directions through diffusion processes, imparting distinct 
properties to the material. Surface growth derives from surface nucleation; it begins at 
the surface and then continues into the volume of crystal. Secondary grain growth 
occurs after the maximum crystallinity has been reached and leads to an increase in 
crystal size; it is due to a reduction in energy deriving from the reduction in surface 
area and may cause a deterioration of the material properties (13). 
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1.4.3 Sintering 
Sintering (or firing) is a processing technique that uses powders to produce dense 
bodies with controlled microstructure through temperature. Powder is first compacted 
into a green body, shaped and then an appropriate thermal treatment is applied. There 
are four categories of sintering (75, 76): 
- Solid-state sintering: the green body is densified only in the solid state, through 
atomic diffusion at a temperature of 0.5 to 0.9 times the melting temperature. 
- Liquid-phase sintering: a liquid phase is formed during heating, although not 
enough to fill all the pores so other processes are necessary to reach complete 
densification. 
- Vitrification: a liquid phase is formed that is sufficient to fill all the pores, after which 
either crystallisation or vitrification of this liquid phase occurs. 
- Viscous flow sintering: glass particles are heated above or near their softening 
temperature and densification is caused by surface tension forces. 
The main two mechanisms are solid-state sintering and liquid-phase sintering. 
Solid-state sintering can be divided into three stages. During the initial stage, necks 
form between particles through atom diffusion mechanisms and about 5 vol% 
shrinkage is obtained. At the intermediate stage, the body has become a three-
dimensional network of interpenetrating particles and continuous porosity, with grain 
growth becoming significant. At the final stage, grain growth becomes more important 
and the network of pores is converted into isolated closed voids. The sintering rate 
increases with decreasing particle size and with increasing sintering temperature and 
time (75, 76). 
Liquid-phase sintering is usually achieved through the use of additives that induce the 
formation of a liquid phase and increase the degree of densification of the initial 
particles. In this case, the processing factors are the heating rate, holding time, peak 
temperature, cooling rate, green density and particle size. Material transport is 
facilitated by capillary forces that induce a liquid flow. However, some properties such 
as creep or fatigue resistance may be reduced in the final solid (75-77). 
 
1.4.3.1 Foam replication method 
A particular technology that makes use of sintering is the foam (or sponge) replication 
method, through which 3D highly porous structures can be produced. The process 
requires the preparation of a ceramic slurry, which usually contains a polymeric binder; 
an open-cell polymeric (normally polyurethane) sponge is then impregnated through 
cyclic soaking and removal of the excess slurry, before it is let dry and finally thermally 
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treated so that the polymers are burnt out and the ceramic particles sinter, leaving a 
positive replica of the initial template. 
This technique was first described in 1963 (78), but it is only in more recent years that 
it has been applied to medical materials, hydroxyapatite first in 2001 (79) and bioactive 
glasses later in 2006 (80, 81), due to the similarity between the foam porous structure 
and cancellous bone.  
With this method, it is possible to tailor the shape of the scaffold, for example to the 
shape of a bone defect, and the porosity and pore size can be controlled through the 
choice of the initial template. An adequate thermal treatment, which is highly 
dependent on the material used and the particle size of the initial slurry, is then 
necessary to control the densification of the material and the formation of crystal 
phases. For example, hydroxyapatite with average particle size around 1-5 µm is 
sintered at 1200 °C for 1 h, with a step at 600 °C for 1 h to burn the polymers (79, 82). 
Bioglass 45S5 scaffolds prepared with <5 µm particles are either sintered at 1000 °C 
for 5 h or 1100 for 1 h and combeite Na2CaSi2O6 crystallises (80, 83). Apatite-
wollastonite is sintered at 1050 °C for 30 min on hydroxyapatite foam-replicated 
scaffolds (84), which is the same temperature used to crystallise apatite-wollastonite in 
<45 µm compacted powder (85). 
Because of the similarity of the final product with trabecular bone, the possibility of 
tailoring the final shape of the implant and the low costs of production, foam replication 
was the method of choice for the porous strontium-containing apatite-wollastonite 
scaffolds studied in this thesis. 
 
1.4.4 Bioactive glasses and glass-ceramics 
As explained in Section 1.3.3, a material is defined as bioactive if, once implanted in 
vivo, it reacts with surrounding fluids and tissues; in the case of materials for bone 
regeneration, this reaction leads to the spontaneous precipitation of apatite and the 
formation of a chemical bond between the implant and bone. 
The first bioactive glass composition was invented by Larry Hench in 1971; it is known 
as Bioglass 45S5 and it is a sodium-calcium-phosphorus-silicate glass with 
composition 45SiO2-24.5CaO-24.5Na2O-6P2O5 wt% (59). The proposed mechanism of 
Bioglass bioactivity, summarised in Figure 1.9, is composed of 12 steps: the first 5 are 
inorganic reactions that occur between the glass surface and the surrounding fluids, 
while the remaining 7 steps describe the interactions with cells up to the formation of 
new bone tissue. First, Na+ ions go in solution and are exchanged with H+ ions; this 
leads to the formation of Si-OH (silanol) groups on the glass surface, which condense 
and form a layer of hydrated silica gel. This silica gel is then enriched with other ionic 
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species, forming an amorphous CaO-P2O5-rich film that subsequently crystallises in 
hydroxyl-carbonate-apatite (HCA). The regeneration of bone tissue is then initiated 
with the adsorption of proteins, which then triggers, along with other cellular 
processes, osteogenesis and osteoblast differentiation so that new bone tissue is 
formed (86-88). This bioactive response is controlled genetically: seven families of 
genes are activated and up-regulated in osteoprogenitor cells, thus inducing 
osteostimulation through the rapid proliferation and differentiation of osteoblasts (89-
92). Bioglass 45S5 products are now commercially available under the brand name of 
NovaBone for bone grafts and NovaMin as an additive in toothpaste (93). 
 
 
Figure 1.9: Sequence of reactions in the bioactivity mechanism of Bioglass 
45S5. Reproduced with permission from (88). 
 
After Bioglass 45S5, many other compositions of bioactive glasses and glass-ceramics 
have been introduced and studied over the last 40 years, based on the phase diagram 
shown in Figure 1.10. One example is the bioactive glass S53P4, a variation of 
Bioglass 45S5 that proved good osseointegration and antimicrobial properties, now 
sold with the brand name of BonAlive (93, 94). BioMin also derives from Bioglass 
45S5; it contains CaF2 and higher phosphate and it is also used in toothpaste (93). 13-
93 is another silica-based bioactive glass, specifically designed to undergo sintering 
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without forming crystal phases (95, 96). Bioverit I and Bioverit II are machinable 
bioactive glass-ceramics (13, 97), while CEL2 and ICEL2 are a silica-based and a 
phosphate-based glass-ceramics, respectively; the former contains combeite and 
akemanite, while the latter contains sodium/magnesium phosphate and calcium 
pyrophosphate and they both have been studied as materials for porous bone 
substitutes (98, 99). Apatite-wollastonite is a high strength bioactive glass-ceramic, 
commercially sold as Cerabone (13, 97); it is the base material chosen for the work 
described in the present thesis and will be fully described in Section 1.5.  
Table 1.3 compares the composition of some of the glasses and glass-ceramics 
described above. 
 
 
Figure 1.10: Diagram showing the bone bonding ability of different glass 
compositions, amounts in wt%. Bioglass 45S5 is in region E, glasses in 
region S are osteoinductive (they also bond to soft tissues and are gene 
activating), glasses in region A are osteoconductive (they bond to bone 
tissue), compositions in regions B, C and D are non-bonding. AWGC has a 
higher amount of P2O5 and no Na2O. Reproduced with permission from 
(100). 
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Table 1.3: Molar composition of some bioactive glasses and glass-ceramics 
described in the literature and commercially available (all values in mol%). 
 SiO2 CaO Na2O P2O5 MgO K2O CaF2 
Bioglass 45S5 46.1 26.9 24.4 2.6    
BonAlive S53P4 53.8 21.8 22.7 1.7    
13-93 54.6 22.1 6.0 1.7 7.7 7.9  
CEL2 45 26 15 3 7 4  
ICEL2 3 26 15 45 7 4  
Cerabone AW 35.5 49.9  7.1 7.1  0.4 
 
1.5 The apatite-wollastonite system 
The apatite-wollastonite glass-ceramic (AWGC) material was first described by 
Kokubo and co-workers in 1982 (85). Thanks to the controlled crystallisation of fine-
grained apatite and fibrous β-wollastonite, it proved to have superior mechanical 
properties compared to other bioactive glass and glass-ceramic compositions, while 
still retaining excellent apatite-forming and bone-bonding ability (12, 101, 102). For 
these properties, AWGC was chosen as the reference material for the addition of 
strontium and the production of foam-replicated scaffolds presented in this thesis. Its 
production is described in Section 1.5.1, before its mechanical properties are 
presented in section 1.5.2 and apatite-forming ability in Section 1.5.3; its commercial 
form Cerabone is described in Section 1.5.4. 
 
1.5.1 Production 
AWGC is prepared by melting its precursors and then either pouring the melt on 
platinum or quenching it in cold water. Its molar composition is listed in Table 1.3. The 
reagents used for its preparation are MgO, CaCO3, SiO2, CaHPO5•2H2O (or P2O5) and 
CaF2, which are mixed and then melted at 1450 °C for 2 h (85, 103). In order to better 
control the nucleation and growth of wollastonite, the glass obtained is ground and its 
powder compacted, before being treated at 1050 °C for 2h (usual heating rate 5 
°C/min) (104). A glass-ceramic is thus formed that contains 36 wt% of 3CaO•P2O5, 40 
wt% of CaO•SiO2 and 24 wt% of CaO•MgO•2SiO2. As shown in Figure 1.11, the 
3CaO•P2O5–CaO•SiO2 system has a eutectic point at 36 wt% 3CaO•P2O5 – 64 wt% 
CaO•SiO2 at a temperature of 1420 °C, which is decreased through the partial 
substitution of CaO•SiO2 with CaO•MgO•2SiO2 in the AWGC system (103).  
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Figure 1.11: Pseudo-ternary system of 3CaO•P2O5 – 64 wt% CaO•SiO2 – 
CaO•MgO•2SiO2 , where a small circle indicates the base composition of 
AWGC. Reproduced with permission from (103). 
 
The system can precipitate three crystal phases, depending on the temperature at 
which the powder compact is treated: as summarised in Table 1.4, apatite forms first, 
at about 870 °C, then wollastonite precipitates at about 900 °C; if the material is 
heated above 1050 °C (the temperature used to obtain AWGC), the apatite crystals 
disappear and whitlockite (β-3CaO•P2O5) forms at about 1100 °C (85).  
Table 1.4: Crystalline phases found in AWGC, depending on the temperature of 
the applied thermal treatment (85). 
Crystalline phase Temperature (°C) Composition 
Oxyfluoroapatite 870 Ca10(PO4)6(O,F2) 
β-Wollastonite 900 CaO·SiO2 
Whitlockite 1100 β-3CaO·P2O5 
 
1.5.2 Mechanical properties 
The composition of AWGC was specifically designed to improve the mechanical 
properties of Bioglass. This was obtained by producing a material that contained fine-
grained apatite and wollastonite, homogenously dispersed in the glass matrix (105). 
Kokubo and co-workers showed how the precipitation of wollastonite in particular 
brought a significant improvement in the bending strength and fracture toughness of 
the material, making it comparable to human bone (Figure 1.12) (106). 
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Figure 1.12: Comparison of the mechanical properties of AWGC (AW) with its 
parent glass (G), its glass with only apatite (A), sintered hydroxyapatite 
(HAp) and human bone. a: apatite, g: glass, W: wollastonite. Reproduced 
with permission from (106). 
 
AWGC also showed improved compressive strength, compared to sintered HAp, and 
Young’s modulus, compared to both Bioglass 45S5 and sintered HAp (12, 13, 107), as 
summarised in Table 1.5.  
Table 1.5: Comparison of the mechanical properties of AWGC, Bioglass 45S5, 
sintered hydroxyapatite and human cortical bone (107). 
Property AWGC Bioglass HAp Bone 
Density (g/cm3) 3.07 2.66 3.16 1.6-2.1 
Flexural strength (MPa) 220 42 (tensile) 115-200 50-160 
Compressive strength (MPa) 1060  500-1000 100-230 
Young’s modulus (GPa) 118 35 80-110 7-30 
Hardness (Vickers) 680 458 600  
Fracture toughness (MPa•m1/2) 2.0  1.0 2-6 
 
In terms of fatigue strength, it was estimated a life-time of 10 years when AWGC was 
subjected to a bending stress of 65 MPa in simulated body fluid (SBF) at 36.5 °C, with 
the lowest dependence on the stress rate compared to its parent glass and the same 
glass with only apatite (108). 
 
1.5.3 Apatite forming mechanism and in vivo behaviour 
Kokubo and co-workers also studied the apatite forming ability of AWGC and they 
observed that it did not form an intermediate silica-gel layer between the sample and 
the deposited apatite, thus differing from the bioactivity mechanism of Bioglass 45S5 
proposed by Hench (86) and summarised in Section 1.4.4. As displayed in Figure 
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1.13, when AWGC is put in contact with SBF, calcium and silicon ions are released 
from wollastonite and from the glassy phase; calcium induces a local supersaturation 
of the solution for apatite, while on the AWGC surface silanol groups are formed that 
provide nucleation sites for the precipitation of apatite. The preferential dissolution of 
wollastonite and of the glassy phase also causes the formation of a rough surface, 
mainly composed of the remaining apatite crystals, which provides further nucleation 
sites for the deposition of HAp (109). The precipitated apatite is a calcium-deficient, 
carbonated hydroxyapatite (Ca/P ratio 1.46), which incorporates also small amounts of 
magnesium and silicon and is composed of needle-like nano-crystals, randomly 
oriented (105, 106). The absence of the silica gel allows AWGC to get in direct contact 
with bone when implanted in vivo (105), thus giving a very high bonding strength with 
bone tissue (101). 
Animal testing of AWGC samples demonstrated the excellent ability of the material to 
bond to bone, with the apatite layer precipitated on the surface of the implanted 
samples providing the substrate for its integration with the newly formed bone tissue 
(110). AWGC showed the highest failure load 8 weeks after implantation when 
compared to alumina, Bioglass 45S5 and hydroxyapatite, with samples fracturing 
either at the interface with bone or within the bone (85, 101). AWGC porous 
intramedullary plugs (70 % porosity, 200 µm mean pore size) were tested in dogs and 
rabbits and showed bone-bonding at 1 month and bone remodelling at 24 months 
(111, 112). AWGC granules were used during arthroplasty in humans, as bone fillers 
during total hip replacements, with excellent outcomes: direct bonding with bone and 
bone tissue remodelling were observed in all patients, when followed-up for up to 9 
years (113). 
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Figure 1.13: Scheme of the bioactivity mechanism for apatite-wollastonite glass-
ceramic, as proposed by Kokubo. Adapted with permission from (109). 
 
1.5.4 Cerabone® and recent studies 
Thanks to its excellent mechanical properties and bone-bonding ability, AWGC has 
been made into a commercial product called Cerabone®, produced by Nippon Electric 
Glass Co Ltd and sold in Japan as granules and porous or solid spacers until 
December 2000 (Figure 1.14) (97, 114). It has been estimated that, in Japan, more 
than 60,000 patients have been treated with AWGC bone substitutes between 1990 
and 2000 (115). 
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Figure 1.14: Examples of Cerabone® products: (A) intervertebral disc spacers, 
(B) artificial vertebrae, (C) spinous process spacers, (D) iliac crest spacers, 
(E) porous spacers and (F) granular bone filler. Reproduced with 
permission from (116). 
 
Improvements for the AWGC material have also been proposed in the literature. Ono 
et al. studied the mechanical properties of implanted AWGC-fibrin mixtures in rats and 
observed that the fracture toughness was comparable to that of cancellous bone after 
24 weeks (117). Magallanes-Perdomo et al. proved the citocompatibility of an AW 
glass-ceramic composition, crystallised with a different thermal treatment than that of 
Kokubo’s AWGC, by studying its effect on human bone-marrow mesenchymal stromal 
cells (hBM-MSCs) (118). Xiao et al. produced AWGC porous scaffolds using selective 
laser sintering, which maintained excellent mechanical properties and apatite-forming 
ability (119); Dyson et al. showed that the same scaffolds were also biocompatible and 
osteo-supportive when tested with hBM-MSCs (120). Serna proved the feasibility of 
foam-replication for the production of porous AWGC scaffolds, which showed 
mechanical properties similar to cancellous bone (121). 
1.6 Post-operative and peri-prosthetic bone infections  
One of the reasons for a fracture or a bone defect to not heal is represented by the 
presence of an infection at the site, one of the current major orthopaedic challenges. 
They are often the consequence of an open traumatic fracture or a surgical 
intervention; especially when an implant is inserted inside the body, for instance a joint 
replacement implant or a plate or a nail for reducing a fracture, it provides a surface 
onto which bacteria can attach and proliferate, making the infection more difficult to 
eradicate. Some background on bacterial growth and biofilm formation is provided in 
Section 1.6.1, before the impact of infections in the orthopaedic field is discussed in 
Section 1.6.2. 
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1.6.1 Bacterial proliferation 
Bacteria are prokaryotic, mono-cellular organisms; they do not possess a contained 
nucleus and present a cell wall around their cell membrane. Their size ranges in 
general between 1 and 10 µm and they come in different shapes: for example, cocci 
are spherical, while bacilli are rod-shaped. Depending on the type of cell wall they 
present, they can be divided into two main groups: Gram-positive and Gram-negative. 
Gram-positive bacteria present a thick cell wall, mainly composed of peptidoglycans, 
while Gram-negative bacteria have a thinner peptidoglycan layer and a further outer 
membrane that contains liposaccharides, proteins and phospholipids (122, 123). This 
classification derives from the outcome of Gram staining: Gram-positive bacteria retain 
the stain within their thick wall, while the outer membrane of Gram-negative bacteria 
prevents the staining from interacting with the peptidoglycan membrane. This 
difference in wall morphology, along with allowing for a simple morphological 
identification, is also the reason for Gram-negative bacteria to be more resistant to 
antibiotics and antimicrobial agents (124). 
When cultured in vitro in liquid media, a typical bacterial growth curve is composed of 
four different phases, although the time-scale for the growth is species-specific. These 
four phases are represented in Figure 1.15 and are (122): 
- Lag phase: when few bacterial cells are added to the media, they initially adapt to 
the new environment without increasing in number. 
- Log phase: the cell number increases quickly because of their exponential 
proliferation; the media turns from clear to cloudy. 
- Stationary phase: the cell number stops increasing because nutrients become 
exhausted or the pH has decreased due to the high concentration of metabolic 
waste products. 
- Decline phase: the media does not contain enough nutrients to sustain cell survival 
and cells die; while the optical density of the culture does not change at this stage, 
the viable count decreases. 
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Figure 1.15: Typical bacterial growth curve. Reproduced from (125).  
 
In the presence of a surface, bacteria usually adhere and form a thick layer of cells 
called biofilm. Biofilms contain a high concentration of cells of one or more species, 
which are embedded in a self-produced extracellular polymeric substance (EPS) that 
is made of polysaccharides, proteins, lipids and extracellular DNA (126). It protects 
bacteria from antimicrobial agents and mechanical stresses, thus making them more 
difficult to eradicate and therefore representing a major issue for the treatment of 
infections (127), as it will be discussed in Section 1.6.2. 
The formation of a biofilm, shown in Figure 1.16, begins with bacterial cells attaching 
to the surface and starting to produce the EPS. At this point, cells begin to proliferate 
and aggregate, forming microcolonies first, which then develop into a mature biofilm. 
The biofilm is then maintained and evolves by releasing cells and fragments of EPS 
into the medium or surrounding environment, while the EPS matrix is constantly 
remodelled (123, 127).  
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Figure 1.16: Phases of biofilm formation on a surface. Source: Montana State 
University Center for Biofilm Engineering, http://www.biofilm.montana.edu. 
 
Both Gram-positive and Gram-negative bacteria can form biofilms on various surfaces, 
including surgical sutures, catheters and orthopaedic implants and this causes the 
development of post-operative and peri-prosthetic infections, which are presented in 
the following Section 1.6.2. 
 
1.6.2 Impact of orthopaedic infections 
Bone implant-related infections generally occur in 1-2 % of primary joint replacement 
procedures (128, 129), but numbers can increase to 4-5 % for secondary procedures 
and depending on the hospital and the inclusion criteria considered (127, 130), or even 
up to 30 % in the case of treatment of open traumatic fractures (131). They 
tremendously hinder the quality of life of patients and have very high associated costs 
for their treatment. It has been shown that a septic revision can cost 2-4 times more 
than a primary procedure and 1.5-3 times more than an aseptic revision surgery (132). 
In the U.S., it has been calculated that in 2009 the average cost for the revision of an 
infected hip prosthesis was $ 93,600 and $ 74,900 for an infected knee (133); if 
explant surgery, medical treatment and re-implantation procedure are considered, 
costs can even exceed $ 500,000 per patient (127). In the case of traumatic fractures, 
it has been estimated that the total cost of treatment for a fracture that becomes 
infected is twice the cost of the initial treatment, estimated as about $ 109,000 per 
infected patient compared to about $ 57,000 per patient without infection (134). In a 
recent study carried out in Belgium, the average cost for a deep infection after tibial 
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fracture was calculated to be about 6.5 times higher than uninfected cases, with about 
€ 44,500 spent compared to about € 7,000 without infection (135). 
The presence of biofilms can further complicate the detection of infections. In fact, 
current diagnostic methods rely on the collection of planktonic microbes in the tissue, 
blood or synovial fluid, while when pathogens are embedded in the EPS of a biofilm 
they are more difficult to retrieve, they tend to not grow using standard laboratory 
techniques and are more resistant to antibiotics; in addition, bacteria can also colonise 
cells, especially osteoblasts, which protects them from antimicrobial agents and further 
complicates their detection (136, 137). Because of all these reasons, it has been 
argued that, of all the revisions of orthopaedic implants that are ascribed to aseptic 
loosening, about 20 % are actually due to infections that could not be diagnosed (128, 
138, 139), making the actual rate of post-operative infection increase dramatically. 
The bacterial species usually detected in orthopaedic peri-prosthetic joint infections 
(PJI) and their incidence are summarised in Table 1.6. Aerobic Gram-positive cocci 
account for 65-78 % of infections, with Staphylococcus aureus and Staphylococcus 
epidermidis being the most frequently detected. Aerobic Gram-negative bacilli are 
found in less than 10 % of cases, while anaerobic bacteria are involved in 7 % of 
infections (133, 140). Depending on the timing and type of infection, the most 
commonly species found are (133, 141): 
- S. aureus (36 %), S. epidermidis (16 %), E. coli (15 %) and P. aeruginosa (15 %) in 
early post-operative infections; 
- S. epidermidis (33 %), S. aureus (20 %), other Staphylococci (17 %) and P. acnes 
(5 %) in chronic infections;  
- S. aureus (39 %), E. coli (13 %), S. agalactiae (11 %) and other Streptococci (5 %) 
in acute haematogenous infections. 
Most infections involve only one species, although about 20 % of infections are 
polymicrobial, i.e. are caused by more than one species.  
Currently, treatments include the use of antibiotics, irrigation and debridement of the 
affected site and revision of the implant, either in one stage or two stages with the use 
of a temporary antibiotic-loaded cement spacer (133, 142, 143). However, concerns 
around antibiotic resistance are constantly increasing: multidrug-resistant species are 
found in 14 % of PJI, where 8 % are due to methicillin-resistant S. aureus and 6 % to 
multidrug-resistant Gram-negative bacilli (133). In addition, in 4-12 % of cases no 
pathogens are detected despite some of the symptoms being present (133). 
It is therefore of primary importance that new ways of preventing and treating 
infections, especially alternatives to antibiotics, become available. 
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Table 1.6: Bacterial species identified in culture-positive peri-prosthetic joint 
infections. Adapted from (141). 
Microorganism or group % of infections 
Aerobic Gram-positive cocci 77.7 
Coagulase-negative staphylococci 39.6 
   Staphylococcus epidermidis    23.3 
   S. lugdunensis    1.9 
   S. capitis    1.5 
   S. hominis    1.3 
Staphylococcus aureus 28.1 
   Methicillin-resistant S. aureus    7.9 
Streptococcus species 9 
   S. agalactiae    2.8 
   Viridans group    2 
   S. mitis group    1.4 
   S. anginosus group    1 
Enterococcus species 8 
   E. faecalis    6.9 
Aerobic Gram-negative bacilli (GNB) 27.6 
Enterobacteriaceae  20.4 
   Escherichia coli    9.1 
   Proteus species    4.8 
   Enterobacter species     4.2 
   Klebsiella species    2.5 
   Morganella morganii     1.9 
Non-fermenting GNB 9.5 
   Pseudomonas species    8.8 
Aerobic Gram-positive bacilli 2.4 
Corynebacterium species 2.2 
Anaerobic bacteria 6.8 
Anaerobic Gram-positive bacilli 5.1 
   Cutibacterium species 4.9 
Anaerobic Gram-positive cocci 1.4 
Mycobacterium species 0.4 
Fungi 1.3 
   Candida species    1.2 
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1.7 Strontium 
Strontium, symbol Sr and atomic number 38, is the fourth alkaline-earth metal in the 
periodic table of chemical elements, between barium and calcium. Its atomic weight is 
87.62 u (144), 2.2 times that of calcium, and its ionic radius is 1.13 Å, 1.14 times that 
of calcium (145). 
Traces of strontium are found in the human body, 98 % of which deposited in bone 
and teeth where it substitutes for calcium in the atomic structure of hydroxyapatite 
(146). Normally, the strontium/calcium ratio in bones and serum varies between 
1:1000 and 1:2000, with the highest concentration of strontium being found in newly 
formed bone and in calcified bone near the mineralisation front (147-149). 
Oral administration of this element has been shown to induce higher bone formation 
rate and higher density in trabecular bone and is therefore used in clinic to treat 
osteoporosis. The following Sections will provide an overview on its effects on bone 
cells (Section 1.7.1), the use of strontium ranelate as a drug for treating osteoporosis 
(Section 1.7.2), its use as a doping agent in bioactive glasses and glass-ceramics for 
bone substitutes (Section 1.7.3) and more recent investigations on its potential 
antimicrobial effect (Section 1.7.4). 
 
1.7.1 Effect of strontium on bone cells 
Strontium has been shown to enhance bone deposition and, at the same time, inhibit 
bone resorption (15, 150, 151). This is due to the fact that strontium can be considered 
an uncoupling agent, for its dual action on osteoblasts and osteoclasts (14, 15), as it 
can be seen in Figure 1.17. 
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Figure 1.17: Action of strontium as an uncoupling agent for osteoblasts and 
osteoclasts. Through the calcium sensing receptor (CaSR), osteoblasts 
and their precursors are induced to increase their proliferation, 
differentiation and survival, thus enhancing bone formation, while 
osteoclast activity is inhibited so that bone resorption is reduced and 
apoptosis is increased. Reproduced with permission from (152). 
 
It has been shown that strontium can interact with both osteoblasts and osteoclasts 
through their calcium sensing receptors (CaSRs), although the whole mechanism of 
action of strontium on bone cells and the way it can be distinguished from calcium is 
still not fully understood. 
In osteoblasts, strontium can enhance the differentiation of osteoblast precursors, their 
proliferation and the production of osteoblast markers such as alkaline phosphatase 
(ALP), bone sialoprotein (BSP) and osteocalcin (OCN), which altogether can increase 
bone deposition (153-156). CaSRs control the activation of the ERK1/2-MAPK 
pathway (extracellular signal-regulated kinase – mitogen-activated protein kinase), 
which regulates proliferation, and of the Wnt pathways, which regulate differentiation 
(157, 158). 
In osteoclasts, strontium has been shown to disrupt the actin network that allows these 
cells to attach to bone and resorb it (16) and to modulate the NF-κB (the nuclear factor 
kappa-light-chain-enhancer of activated B cells) and the PKCβII (protein kinase C βII) 
signalling pathways, thus reducing their differentiation and inducing their apoptosis, 
respectively (159, 160). 
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1.7.2 Use of strontium in medicine: Strontium ranelate 
After the discovery of the bone regenerative properties of strontium described above in 
Section 1.7.1, Marie and co-workers developed an organic divalent strontium salt that 
could be used to treat osteoporosis: strontium ranelate, S12911 (15). It was shown 
that, like other strontium salts, strontium ranelate could promote bone formation, 
increase trabecular bone volume and decrease bone resorption (14, 16, 161). Clinical 
trials in humans proved its efficacy at preventing vertebral and non-vertebral fractures 
and bone loss in postmenopausal women and osteoporotic men (162-167). 
The use of strontium ranelate as a drug was approved in Europe in 2004 and is 
currently utilised in 70 countries as a drug for the treatment of osteoporosis and the 
prevention of fractures, with the commercial names of Protelos and Osseor (145, 168). 
However, concerns increased in 2012 about the potential cardiovascular side effects 
of this drug (169-171). As a result, in 2013 and again in 2014 the European Medicines 
Agency (EMA) set stricter recommendations and new contraindications for its systemic 
use (172-175), so that it is now prescribed only to patients who do not have a history 
of heart or circulatory conditions and are unable to take any other medication for 
severe osteoporosis (168, 176). It is therefore clear that the systemic delivery of this 
drug is not advisable and other routes of administration would be preferable to avoid 
its contraindications. The use of bioactive glasses and glass-ceramics for the local 
delivery of low doses of strontium, as investigated in the work presented in this thesis, 
would be therefore ideal for the safe treatment of a larger number of patients that 
would benefit from the bone regenerative properties of this element. 
 
1.7.3 Use of strontium as a doping agent in bone substitutes 
With the increase in interest for the bone regenerative properties of strontium, 
numerous solutions have been proposed for the addition of this element into the glass 
network of bone scaffolds, so that their bioactivity could be improved.  
The first composition that was modified, as it is also the most studied, was Bioglass 
45S5. 0 to 100 mol% of its CaO has been substituted with SrO and the dual action of 
strontium in inhibiting osteoclasts and promoting osteoblast activity in vitro was further 
confirmed, with the best results obtained for the 10 mol% SrO composition (151, 177). 
In vivo tests then proved the osteoconductivity of the material (178). In sol-gel glass 
systems, the dissolution rate of strontium-doped bioactive glasses showed faster 
dissolution kinetics (179), while still promoting osteoblast differentiation (180, 181). 
Similar results were also observed when strontium was added to glass-ceramics such 
as calcium silicates, calcium phosphates and hydroxyapatite, where changes in the 
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dissolution rate and an increase in osteoblast proliferation and differentiation were 
found, with the optimal amount of strontium depending on the initial composition of the 
starting material (182-185). In particular, Vickers first developed the strontium AWGC 
compositions studied in this thesis and found that the best composition in terms of 
bioactivity and osteogenic properties was the one containing 6.2 mol% of SrO (186) for 
samples prepared from compacted powders. 
3D porous scaffolds containing strontium were also described in the literature, 
produced following different techniques such as the use of a polymeric porogen (183, 
187), foam replication (188, 189), foam replication combined with sol-gel (190-192), 
electrophoretic deposition of strontium-containing glass particles (193) and 3D printing 
(194). In the case of the work described in present thesis, the strontium-doped AW 
glass was produced via melting and quenching, then the porous scaffolds were 
fabricated following the foam replication technique utilising a single thermal treatment 
to obtain both sintering of the glass particles and controlled nucleation and growth of 
the crystal phases. 
 
1.7.4 Antibacterial activity of strontium 
In more recent years, interest has increased around the possibility that strontium could 
have some antimicrobial properties. Investigations started in 2003, when Guida et al. 
hypothesised a synergistic effect of strontium and fluoride when combined in glass 
ionomer cements for dental applications (17), later observed also by Dabsie et al. 
(195). Afterwards, further studies described the improved loading and release of 
antibiotics from a strontium-substituted calcium phosphate cement (196), the 
bactericidal effect of a strontium-doped bioactive glass in a composite cement (197), 
the antibacterial properties of strontium-modified bioactive glasses against sub-
gingival bacteria (18) or of borosilicate bioactive glasses against common bone 
pathogens (198) and the antimicrobial properties of strontium-substituted 
hydroxyapatite nanoparticles (199). Some authors combined strontium with silver in 
antibacterial glasses and glass-ceramics; although generally no enhancement was 
found in their antimicrobial action when strontium was added to silver, a reduction in 
cytotoxicity was observed, therefore allowing enhanced bone regeneration while 
maintaining the same antimicrobial effect (200-202). 
Whether strontium can be considered a bactericidal or bacteriostatic agent is still not 
clear, as well as its interaction and mode of action with bacterial cells is still under 
investigation. It must be noted that it has been observed that not only strontium 
glasses can present an antibacterial behaviour, but also Bioglass 45S5 itself (203, 
204) and, more distinctively, Bioglass S53P4 (BonAlive) (94, 205-207). In addition, 
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two publications studied different compositions of bioactive glasses against numerous 
aerobic and anaerobic bacterial species, observing growth inhibition for all samples 
(208, 209). Some authors ascribed the observed antibacterial effect to the presence of 
calcium (210, 211), while others to phosphorus (212, 213). Proposed mechanisms of 
action include the decrease in zeta potential when strontium is added (199), the 
increase in local pH and osmolarity caused by the dissolution of the glass (94, 206-
208), the formation of debris that can damage the bacterial cell membrane (204) and 
disturbance to the membrane potential by the increase of calcium ions (208, 209). 
Certainly, the induction of antimicrobial properties adds very high value to materials 
designed for bone repair, turning them into potential tools for the prevention and 
treatment of post-operative and peri-prosthetic infections. 
1.8 Thesis aim and objectives 
The overall aim of the work presented in this thesis was to investigate the feasibility of 
the production of bone porous substitutes that, through the addition of strontium to 
AWGC, could enhance bone tissue regeneration and, at the same time, provide 
antibacterial features for the prevention and treatment of infections.  
The investigation was therefore divided into different objectives, which will be 
addressed in the following Chapters 2 to 5: 
- Production and characterisation of the glass powders used for the fabrication of 
the porous scaffolds. 
- Production of porous scaffolds through the foam replication method and their 
characterisation, including the assessment of their crystallinity, morphology, 
mechanical properties, in vitro apatite forming ability and radiopacity. 
- Investigation of the antibacterial properties of strontium and of the strontium-
containing glass powders produced. 
- Investigation of the in vitro biological properties of the porous scaffolds, in terms of 
effect on proliferation and osteogenic differentiation of bone cell precursors.
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Chapter 2  
Production and characterisation of strontium glasses 
2.1 Introduction 
Substitution of strontium for calcium in bioactive glasses and glass-ceramics has been 
widely described in the literature, based on different glass compositions: from Bioglass 
45S5 (151, 177), to boron-containing 13-93 (214), to hydroxyapatite (184). Vickers first 
studied the substitution of strontium for calcium in the apatite-wollastonite glass-
ceramic (AWGC) system: substitutions up to 50 mol% of the initial calcium oxide 
amount were described and 45-90 µm powders were used to produce microporous 
scaffolds from compacted powders (186). 
In the work presented in this thesis, substitutions up to 75 mol% of calcium oxide were 
produced and powders <45 µm were used for the fabrication of macroporous 
scaffolds, as it will be described in Chapter 3. Before the strontium-containing glass-
ceramic porous scaffolds under study could be produced, parent glasses of the 
desired composition were prepared. These glasses were produced via the melt-
quench route and then processed in order to obtain glass powders in the desired 
range of particle size. Powders were also characterised to ensure that strontium had 
been substituted for calcium in the desired proportion for each desired composition 
and to study the thermodynamic effects of this substitution. 
The aim of this chapter was therefore to describe the six strontium glasses produced, 
assess the strontium substitution and study the effects of this substitution. In this 
chapter, the methods used for producing the six strontium glasses will be presented, 
along with their processing steps and their characterisation in terms of density, 
morphology, composition, particle size distribution, thermal behaviour and atomic 
structure. 
2.2 Materials and methods 
2.2.1 Production of strontium-containing AW parent glasses 
Basing on the original AWGC composition first described by Kokubo and co-workers 
(85) and later studied by Xiao and co-workers (119), six different glass compositions 
were produced by substituting an increasing amount of strontium oxide for calcium 
oxide on a molar basis. The general formula for the six compositions under study is: 
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35.5 SiO2 – 7.1 MgO – 0.4 CaF2 – 7.1 P2O5 – (49.9-x) CaO – x SrO mol %, 
 
where x = 0, 6.2, 12.5, 18.7, 24.9, 37.4. 
The six compositions were named after the molar amount of SrO they contained and 
are listed in Table 2.1. 
Table 2.1: Composition of the six strontium AW glasses under study. Amounts 
in mol%. 
Glass SiO2 MgO CaF2 P2O5 CaO SrO 
AW 0% 35.5 7.1 0.4 7.1 49.9 0 
AW 6.2% 35.5 7.1 0.4 7.1 43.7 6.2 
AW 12.5% 35.5 7.1 0.4 7.1 37.4 12.5 
AW 18.7% 35.5 7.1 0.4 7.1 31.2 18.7 
AW 24.9% 35.5 7.1 0.4 7.1 25.0 24.9 
AW 37.4% 35.5 7.1 0.4 7.1 12.5 37.4 
 
All glasses were produced through melting and quenching. The reagents listed in 
Table 2.2 were first weighed in the specified amounts and then mixed for 1 hour on a 
roller mixer, then carefully packed in alumina crucibles (Almath Crucibles Ltd). These 
were placed inside bigger mullite crucibles (Magma Ceramics & Catalysts) containing 
calcined alumina powder and, with their lid on, placed in a furnace (Elite, BCF13/12-
2416); temperature was brought to 500 °C and held for 15 min. The big crucibles were 
then transferred to a Pyro Therm furnace, pre-heated at 1400 °C, and its temperature 
was further raised to 1450 °C. After 2 h, the big crucibles were taken out of the 
furnace, the alumina crucibles extracted and the molten glass poured in cold tap 
water. The frit obtained was then rinsed under running water and dried overnight in a 
drying cabinet. Table 2.2 lists the amounts necessary for making 100 g of glass frit. 
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Table 2.2: Details of the reagents and relative amounts necessary for producing 
100 g of glass frit for the six compositions under study. All data in g. 
 SiO2 
Tilcon 
Sands 
MgO 
Sigma 
Aldrich 
CaF2 
VWR 
Int. 
P2O5 
Fisher 
Scientific 
CaCO3 
Fisher 
Scientific 
SrCO3 
Fisher 
Scientific 
AW 0% 34.1 4.6 0.5 16.1 79.8 0.0 
AW 6.2% 32.6 4.4 0.5 15.4 66.8 14.0 
AW 12.5% 31.1 4.2 0.5 14.7 54.6 26.9 
AW 18.7% 29.9 4.0 0.4 14.1 43.7 38.6 
AW 24.9% 28.7 3.8 0.4 13.5 33.6 49.4 
AW 37.4% 26.5 3.6 0.4 12.5 15.6 68.7 
 
After drying, the glass frit was ground for 15 min with a Gyro-mill percussion mill (Glen 
Creston Ltd), using a small puck with 20 g of frit at a time. The powder so obtained 
was then sieved with an automatic siever (Octagon Digital, Endecotts), run for 30 min 
at intermittent mode and amplitude 9 and fitted with the following stack of sieves: 45 
µm, 90 µm, 125 µm, 1 mm, 2 mm. Glass powders were collected separately for the 
different size ranges and the fraction <45 µm (about 50% of the starting load) was 
used for producing porous scaffolds, following the methods described in Chapter 3. 
 
2.2.2 Characterisation of the strontium-containing AW parent glass 
powders 
2.2.2.1 Density of strontium AW glass powders 
The density of the six glass powders was measured using a Micromeritics AccuPyc 
1330 pycnometer. Given the weight of the sample, the machine used helium to 
measure the volume occupied by the powder and calculate its density; the machine 
performed up to 50 measurements until five of them had a standard deviation below 
0.005 % of their average. 
About 1.4 g of glass powder <45 µm were tested for each composition; the exact 
weight was recorded, as well as their single measurements, average and standard 
deviation. 
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2.2.2.2 Morphology and composition of ground strontium AW glass 
powders 
Glass powder particles sieved <45 µm were checked for their morphology and 
composition using a Hitachi S-3400N scanning electron microscope (SEM), coupled 
with a Bruker XFlash detector for energy dispersive x-ray spectroscopy (EDS). 
Powders were attached to aluminium stubs using adhesive carbon tape, sputtered with 
gold to enhance their conductivity and analysed at 30 kV to allow for a better detection 
of strontium, whose Kα signal is at 14.16 keV. Micrographs were taken at about 5 mm 
working distance, while EDS data were collected at 10 mm from areas magnified 200 
times. 
Elemental analyses were performed with Quantax Esprit 1.9.4 analysis software, on 
three different batches of glass for each composition. 
 
2.2.2.3 Particle size distribution of ground strontium AW glass powders 
After grinding and sieving the glass frit as described in Section 2.2.1, the particle 
fraction <45 µm was analysed for particle size distribution via laser light scattering 
using a Malvern Mastersizer 2000, to verify that the powders produced were 
consistent across compositions. Powders were dispersed in ultrapure water and 
modelled as glass beads; the refractive index was set to 1.33 for water and to 1.52 for 
the glass particles. Before each sample was suspended in water, a background 
measurement was recorded. The glass powders were kept suspended in the 
dispersant by maintaining a stirring speed around 2000 revolutions per minute (rpm) 
on the dispersion unit. For each sample, 10 measurements were taken and 
automatically averaged by the Mastersizer 2000 software. 
 
2.2.2.4 Thermal behaviour of the strontium AW parent glasses 
The thermal behaviour of all six glass compositions was tested using a Netzsch DSC 
404 F3 Pegasus differential scanning calorimetry (DSC) machine. 
20 mg of sample (fraction tested <45 µm) were placed in a platinum-rhodium crucible 
with a lid and the measurement was conducted against an empty crucible, upon 
recording of the baseline signal using the same two crucibles, both empty. During the 
analysis, the glass powder was heated at 10 °C/min from room temperature to melting, 
maximum temperature 1300 °C, and the signal produced by the sample recorded in a 
graph. 
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After the measurement, Proteus Analysis software was used to identify the 
characteristic temperatures: glass transition temperature (Tg), onset of peak 
temperature (Ton), top of peak temperature (Tp) and melting temperature (Tm). 
For each glass composition, three batches were tested and averaged using OriginPro 
2015 to verify the consistency of production.  
 
2.2.2.5 Verification of the amorphous nature of strontium AW glass 
powders 
The amorphous nature of the six compositions was verified by means of x-ray 
diffraction (XRD): if a sample was amorphous, it did not produce any XRD peak, but 
gave a broad halo instead. In general, for silicon-based glasses, the characteristic halo 
has a broad hump centred at about 2θ = 30 °. 
All six strontium glasses were tested with a Bruker D8 Advance diffractometer, working 
with Bragg-Brentano geometry and copper-K alpha radiation. The diffractometer was 
set to 40 kV and 40 mA, the required amount of <45 µm powder was compacted in the 
sample holder and the analysis run from 10 ° to 70 ° 2θ, step size 0.033 °, time/step 
0.6 s. 
2.3 Results  
2.3.1 Strontium increases the density of AW glass powders 
The density measured for the six glasses is reported in Table 2.3 and shown in Figure 
2.1. Average and standard deviation were given as output from the Micromeritics 
AccuPyc 1330 pycnometer measurements. 
Table 2.3: Density of the six strontium-containing AW glasses. 
 Average 
(g/cm3) 
Standard deviation 
(g/cm3) 
AW 0% 2.9372 0.0065 
AW 6.2% 3.0915 0.0103 
AW 12.5% 3.1925 0.0042 
AW 18.7% 3.2849 0.0082 
AW 24.9% 3.3538 0.0139 
AW 37.4% 3.5796 0.0102 
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Figure 2.1. Density of the six strontium-containing AW glasses, with fitting 
trendline. Error bars indicate the standard deviation from 5 measurements 
performed by the Micrometrics AccuPyc 1330 helium pycnometer for each 
sample. 
 
As expected from the substitution, on a molar basis, of a heavier element for a lighter 
element, it was found that the density of the six glasses linearly increased with the 
increasing amount of strontium. 
These results were used, as described in Chapter 3, to calculate the (water + PVA)-to-
glass ratio of the slurry used for the production of solid discs and porous scaffolds. 
 
2.3.2 Effect of strontium on morphology and composition of ground 
AW glass powders 
SEM micrographs of particles of the six strontium AW glasses, ground and sieved <45 
µm, are shown in Figure 2.2 and Figure 2.3. 
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Figure 2.2: SEM micrographs at low magnification of the glass powders sieved 
<45 µm, imaged from secondary electrons. (a) AW 0%, (b) AW 6.2%, (c) AW 
12.5%, (d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. Scale bars represent 100 
µm. 
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Figure 2.3: SEM micrographs, at higher magnification and imaged from 
secondary electrons, of the glass powders sieved <45 µm shown in Figure 
2.2. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5%, (d) AW 18.7%, (e) AW 24.9%, (f) 
AW 37.4%. Scale bars represent 10 µm. 
 
All samples presented particles with an irregular shape, as expected from the grinding 
process of a glass frit. For all compositions, most particles were within the required 
size, with few particles bigger than 45 µm in only one of their dimensions, which let 
them still pass through the mesh of the sieve. As better shown in Figure 2.3, all 
samples contained an important fraction of small particles, about 1 µm large or less. 
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EDS data were taken in order to confirm the composition of powders, from areas of the 
samples magnified 200 times. 
Table 2.4 shows the expected theoretical values for the elements of interest, while 
Table 2.5 reports the results of the quantitative analysis of the powder samples, 
expressed as average ± standard deviation of three batches of glass for each 
composition. 
Table 2.4: Theoretical atomic percentages of the elements of interest for the 
glass and glass-ceramic samples, which correspond to the expected EDS 
values. 
Elem. AW 0% AW 6.2% AW 12.5% AW 18.7% AW 24.9% AW 37.4% 
Si 32.90 32.90 32.90 32.90 32.90 32.90 
Mg 6.58 6.58 6.58 6.58 6.58 6.58 
F 0.74 0.74 0.74 0.74 0.74 0.74 
Ca 46.62 40.87 35.03 29.29 23.54 11.96 
P 13.16 13.16 13.16 13.16 13.16 13.16 
Sr 0.00 5.75 11.59 17.33 23.08 34.66 
 
Table 2.5: Average atomic percentage and standard deviation of the elements of 
interest in the glass powder samples, as measured by EDS from three 
batches for each composition. 
Elem. AW 0% AW 6.2% AW 12.5% AW 18.7% AW 24.9% AW 37.4% 
Si 30.50 ± 
0.73 
28.35 ± 
0.85 
27.79 ± 
1.49 
26.63 ± 
1.72 
25.71 ± 
1.39 
26.17 ± 
2.66 
Mg 4.84 ± 
0.08 
4.76 ± 
0.02 
5.04 ± 
0.23 
5.44 ± 
0.90 
5.06 ± 
0.24 
5.11 ± 
0.37 
F 2.29 ± 
2.12 
2.41 ± 
1.64 
2.28 ± 
2.37 
2.86 ± 
2.52 
5.06 ± 
1.48 
5.53 ± 
0.28 
Ca 47.59 ± 
0.80 
42.65 ± 
0.63 
36.69 ± 
0.29 
30.36 ± 
0.75 
24.47 ± 
1.08 
12.45 ± 
0.77 
P 14.33 ± 
0.44 
13.64 ± 
0.39 
13.68 ± 
0.32 
13.50 ± 
0.67 
12.83 ± 
0.39 
12.04 ± 
0.80 
Sr 0.00 ± 
0.00 
7.12 ± 
0.34 
13.62 ± 
0.28 
19.97 ± 
1.05 
26.05 ± 
1.71 
38.27 ± 
2.07 
Al 0.45 ± 
0.16 
1.07 ± 
0.35 
0.91 ± 
0.20 
1.25 ± 
0.50 
0.83 ± 
0.09 
0.42 ± 
0.57 
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For all compositions, the atomic percentage of calcium, phosphorus and strontium was 
very close to the theoretical values, within the limits of the technique. The element that 
presented the highest deviation from its theoretical value was fluorine, which was 
found higher in all compositions: about 2 at% for compositions AW 0%, AW 6.2%, AW 
12.5% and AW 18.7%, while about 5 at% for compositions AW 24.9% and AW 37.4%. 
This was likely due to the intrinsic error of the analysis, for which it was not possible to 
precisely detect amounts below 1 at% (the theoretical value is 0.74 at%) and, in fact, 
the standard deviations for fluorine were the highest amongst all the elements. The 
higher fluorine was compensated by lower amounts of silicon and magnesium. A small 
amount of aluminium (around 1 at%) was detected in all samples, which was likely due 
to an ionic exchange, occurring at high temperature, with the alumina crucibles used to 
produce the glass samples. 
 
2.3.3 Particle size distribution of strontium AW glass powders for 
scaffold production 
Laser light scattering was used for the six strontium AW glasses, <45 µm fraction, in 
order to ensure that the powders used for producing the scaffolds presented 
comparable particle size distributions. Results are displayed in Figure 2.4. 
 
 
Figure 2.4: Particle size distribution of the six strontium AW glass powers, 
ground and sieved <45 µm. 
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All six samples gave very similar results. Each particle size distribution presented two 
main peaks: the first peak centred around 250 nm and the second peak at about 25 
µm; for all glasses, the second peak also showed a hump around 6 µm. The minimum 
detected size was 100 nm, while the maximum detected size was 100 µm, thus 
indicating that some larger particles passed through the sieve. Because all 
compositions showed the same distribution, particle size was not considered a 
variable in the foam replication production of porous scaffolds, described in Chapter 3. 
 
2.3.4 Effect of strontium on the thermal characteristics of AW glass 
powders 
Thermal analyses were run at 10 °C/min on three batches of <45 µm glass powder per 
each composition. Average graphs for the whole range of tested temperatures are 
shown in Figure 2.5, then reproduced with their standard deviations represented in 
grey and within the temperatures of interest in Figure 2.6. 
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Figure 2.5: DSC average traces of the strontium AW glass compositions, for powders <45 µm heated at 10 °C/min. 
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Figure 2.6: Average DSC traces of the <45 µm powders heated at 10 °C/min, with 
standard deviations in grey (n=3). (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, 
(d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. 
 
The thermal trace for all compositions presented an inflection between 700 and 750 
°C, representing their glass transition temperature Tg. Two exothermic peaks followed 
at higher temperature. The first peak appeared around 850 °C for all glasses, 
indicating the formation of apatite as described in the literature (85, 104, 186). The 
temperature of the second peak varied from about 950 °C for AW 0% to 1020 °C for 
AW 37.4%, representing the formation of the wollastonite phase according to the 
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literature (85, 104, 186). It was therefore evident that the formation of the calcium 
silicate phase strongly depended on the strontium content.  
 
To better visualise the temperatures of interest across the glass compositions, Figure 
2.7 summarises the behaviour of the characteristic temperatures depending on the 
strontium content: glass transition (Tg), onset of peaks (Ton), top of peaks (Tp) and 
melting (Tm). 
 
 
Figure 2.7: Characteristic temperatures of the strontium glasses depending on 
their strontium content, with fitting trendlines. Tg: glass transition 
temperature; Ton1: onset of the first exothermic peak; Tp1: first exothermic 
peak temperature; Ton2: onset of the second exothermic peak; Tp2: second 
exothermic peak temperature; Tm: melting temperature. Error bars indicate 
standard deviations (n=3). 
 
The graph in Figure 2.7 confirmed that the glass transition temperature (Tg) did not 
change considerably with the amount of strontium, while the position of the first 
exothermic peak was slightly shifted towards lower temperatures with increasing 
strontium. On the contrary, the nucleation and growth of the second crystal phase was 
directly proportional to the strontium content. The melting temperature followed a 
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second order curve with AW 24.9% melting at the lowest temperature. Data are 
summarised in Table 2.6, reported as mean ± standard deviation.  
Table 2.6: Average ± standard deviation of the characteristic temperatures of the 
strontium glasses. Tg: glass transition temperature; Ton1: onset of the first 
exothermic peak; Tp1: first exothermic peak temperature; Ton2: onset of the 
second exothermic peak; Tp2: second exothermic peak temperature; Tm: 
melting temperature. All data in °C. 
 Tg Ton1 Tp1 Ton2 Tp2 Tm 
AW 0% 754.8 ± 
9.3 
854.0 ±  
3.8 
887.2 ±  
4.2 
927.0 ±  
6.2 
944.3 ±  
8.7 
1210.3 ±  
14.2 
AW 6.2% 748.9 ±  
3.3 
867.1 ±  
4.2 
889.2 ±  
1.8 
936.2 ±  
13.5 
961.2 ±  
14.9 
1184.0 ±  
8.2 
AW 12.5% 743.7 ±  
1.8 
863.7±  
3.7 
884.4 ±  
2.2 
954.7 ±  
13.5 
984.4 ±  
15.1 
1162.3 ±  
13.0 
AW 18.7% 747.5 ±  
4.8 
859.2 ±  
0.9 
879.0 ±  
1.1 
961.6 ±  
20.8 
1006.4 ±  
21.7 
1149.3 ±  
12.9 
AW 24.9% 741.3 ±  
3.1 
853.9 ±  
5.8 
874.9 ±  
3.7 
980.6 ±  
11.4 
1020.9 ±  
11.8 
1140.0 ±  
2.0 
AW 37.4% 744.7 ±  
9.3 
838.3 ±  
2.7 
857.9 ±  
3.0 
986.0 ±  
11.5 
1021.6 ±  
12.3 
1216.7±  
7.4 
 
All fitting curves shown in Figure 2.7, described by Equation 2.1 to Equation 2.6, were 
obtained using Origin Pro 2015. 
 
𝑇𝑔 = 748.52 − 0.27 ∗ 𝑆𝑟𝑂% 
Equation 2.1: First order regression curve for the glass transition temperature. 
 
𝑇𝑜𝑛1 = 869.75 − 0.64 ∗ 𝑆𝑟𝑂%  
Equation 2.2: First order regression curve for the onset temperature of the first 
crystal phase. 
 
𝑇𝑝1 = 894.72 − 0.88 ∗ 𝑆𝑟𝑂% 
Equation 2.3: First order regression curve for the peak temperature of the first 
crystal phase. 
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𝑇𝑜𝑛2 = 928.15 + 1.74 ∗ 𝑆𝑟𝑂% 
Equation 2.4: First order regression curve for the onset temperature of the 
second crystal phase. 
 
𝑇𝑝2 = 948.95 + 2.31 ∗ 𝑆𝑟𝑂% 
Equation 2.5: First order regression curve for the peak temperature of the 
second crystal phase. 
 
𝑇𝑚 = 1229.26 − 9.72 ∗ 𝑆𝑟𝑂% + 0.25 ∗ (𝑆𝑟𝑂%)
2 
Equation 2.6: Second order regression curve for the melting temperature. 
 
While the glass transition temperature only slightly decreased with the increase of 
strontium, the formation of the first crystal phase (apatite) linearly tended to lower 
temperatures with a shift of about 30 °C between AW 0% and AW 37.4%; this 
difference was not detected from the qualitative assessment of the DSC graphs shown 
in Figure 2.5 and Figure 2.6. The formation of the second crystal phase (calcium 
silicate) also depended linearly on the amount of strontium oxide in the starting glass 
powder, but its onset and peak temperature increased with increasing strontium, with a 
shift of about 80 °C between the lowest and the highest strontium composition. The 
melting temperature, however, presented a minimum for the AW 24.9% composition, 
while AW 0% and 37.4% melted at about the same temperature, around 1200 °C. 
 
2.3.5 Amorphous nature of the strontium AW glass powders 
Glass powders sieved <45 µm were tested to verify that no crystalline phases formed 
during the melting and quenching of the six glasses; in fact, the starting materials had 
to be amorphous glasses, so that the formation of crystal phases could be controlled 
through appropriate thermal treatments. 
Figure 2.8 shows the resulting XRD spectra for the six samples. 
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Figure 2.8: XRD traces of the six strontium AW parent glass compositions, 
ground and sieved <45 µm before sintering and controlled devitrification. 
 
All samples presented only the amorphous hump expected for silica-based glasses 
and no peaks could be detected. This confirmed that the six starting materials were 
amorphous, thus the formation of crystals in the final scaffolds could be induced by 
subsequently applying an appropriate thermal treatment. The peak of the hump 
progressively moved towards lower angles with increasing strontium, from around 2θ = 
30 ° for AW 0%, to around 2θ =  27 ° for AW 37.4%. 
2.4 Discussion 
This chapter investigated the six strontium apatite-wollastonite parent glasses, which 
will be used for producing the porous scaffolds described in Chapter 3, and showed 
that the substitution was feasible via a melt-quench route. 
 
Similar substitutions were widely described in the literature for other bioactive glasses 
and glass-ceramics: Bioglass 45S5 has been modified via a melt-quench route by 
different authors so that up to 100 % of its calcium oxide was substituted with 
strontium oxide (177, 178), as well as other glasses belonging to the same SiO2-CaO-
Na2O-P2O5 system (18, 63, 151); Lao et al. substituted up to 5 wt% of calcium oxide 
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with strontium oxide in sol-gel SiO2-CaO-SrO and SiO2-CaO-P2O5-SrO glasses (215); 
Kargozar et al. produced melt-quenched glasses in the system SiO2-P2O5-CaO-SrO-
Na2O-MgO-K2O-CoO by replacing 6 mol% of CaO with SrO (216); Yin et al. studied 
the effect of strontium substitution on foam-replicated scaffolds in the borate glass 13-
93B2 (214). Strobel et al. obtained strontium-doped nanoparticles (5 wt%) by flame-
spraying (217); Wu et al. produced strontium-containing mesoporous scaffolds with 5 
and 10 mol% strontium oxide (191); strontium hydroxyapatite was studied in the form 
of microspheres (184), nanowires (218), powder (185) and single-crystal nanorods 
(219). In addition, the same substitution in apatite-wollastonite presented in this thesis 
was described by Vickers in previous work (186): compositions up to AW 24.9%, 
which corresponds to 50 mol% of calcium oxide being substituted with strontium oxide, 
were produced and fraction 45-90 µm was used to obtain microporous scaffolds from 
compacted powders. In this work, the <45 µm fraction was studied for the fabrication 
of foam-replicated macroporous scaffolds. 
 
2.4.1 Strontium determines the density of AW glasses 
As expected from the substitution of a heavier element (strontium) for a lighter element 
(calcium), not only the molecular weight of the glasses increased with increasing 
strontium, but also their density. As highlighted in Table 2.7, where the theoretical 
molecular weight ratio of the glasses is compared with the ratio of the measured 
densities (derived from Table 2.3), the density of the glass powders increased with the 
increase of strontium content. However, the increase in density was smaller than the 
increase in weight and this was due to the fact that strontium is 2.2 times heavier than 
calcium, but only 1.14 times bigger (144, 145). Hence, not only the molar weight of the 
strontium glasses is higher, but also the molar volume, which consequently slows 
down the increase in density. The effect of the enlarged glass network is also evident 
in the XRD results of the tested glasses (Figure 2.8) and it has been reported in the 
literature (220), as it will be further discussed in Section 2.4.4 and in Chapter 3. 
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Table 2.7: Comparison between the molecular weight ratio and the density ratio 
of the strontium glasses compared to the no-strontium control AW 0%. 
 Mol. weight 
(g/mol) Weight ratio Density ratio 
AW 0% 62.5645 1.0000 1.0000 
AW 6.2% 65.5121 1.0471 1.0525 
AW 12.5% 68.5073 1.0950 1.0869 
AW 18.7% 71.4549 1.1421 1.1184 
AW 24.9% 74.4025 1.1892 1.1418 
AW 37.4% 80.3452 1.2842 1.2187 
 
2.4.2 Final morphology and composition of the strontium AW glass 
powders 
The glass particles produced by grinding and sieving the glass frit presented sharp 
edges and a broad range of dimensions, from 45 µm to less than 1 µm, as assessed 
with SEM imaging. Particle size distributions were found similar for all compositions, 
with two main peaks at about 250 nm and 25 µm. The smaller fraction around 250 nm 
is of particular interest for the foam replication method of scaffold production and their 
subsequent treatment. In fact, it has been shown that the particles size distribution can 
affect the final sintering process of ceramic materials, for which broader distributions 
tend to lead to higher bulk densities, reduce the shrinkage needed to reach the desired 
density and present a higher densification rate at the initial stages of sintering (221-
223). This is due to the smaller particles filling the bigger pores left by larger particles; 
as a consequence, it provides better mechanical properties, for example in the case of 
3D printed scaffolds (224). 
 
The EDS analysis of the sieved powders confirmed that the substitution was effective 
and all six glasses reached the expected composition. About 1 at% of aluminium was 
detected in all samples; this could be explained by the use of alumina crucibles for the 
production of the glasses, causing an ionic exchange from container to molten glass at 
high temperatures. Although aluminium has been proven in the literature to be 
cytotoxic (225-228), the amount found in the samples is very low and similar materials 
have been successfully used in cell culture in previous work (186) and in the work 
presented in this thesis, as it will be presented in Chapter 5. In addition, Ohgushi et al. 
reported that an alumina-containing apatite-wollastonite glass ceramic better 
stimulated the osteogenic differentiation of rat bone-marrow derived stem cells 
compared to standard apatite wollastonite and hydroxyapatite-coated apatite-
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wollastonite (229), thus confirming that the amount found in the samples prepared in 
the present work did not reach concerning levels. 
 
2.4.3 Dependence of characteristic temperatures of AW glass 
powders on the strontium content 
The DSC results showed that the thermal properties of the six produced glasses 
varied with their composition: with increasing strontium, the glass transition 
temperature and the formation of the first crystal phase moved slightly towards lower 
temperatures, while the formation of the second crystal phase moved more 
significantly towards higher temperatures, thus the two main peaks moved apart. The 
crystal phases formed in the strontium glasses were tested and results are presented 
and discussed in Chapter 3. 
 
The effect on the glass transition temperature can be explained by the fact that the 
glass network expands in order to accommodate a bigger ion. This has been shown 
already by O’Donnell et al. (177), Fredholm et al. (230) and Yin et al. (214) when 
doping Bioglass, a Bioglass-derived glass and a borate-based glass with strontium, 
respectively, as well as by Vickers for apatite-wollastonite parent glasses (186). The 
same effect has also been described by Brink for bioglasses in the system Na2O-K2O-
MgO-CaO-B2O3-P2O5-SiO2 when doped with magnesium (231); as later explained by 
Watts et al. using magic angle spinning nuclear magnetic resonance (MAS NMR), 
although magnesium is a smaller ion than calcium, it partially behaves as an 
intermediate oxide instead of a network modifier, leading to the formation of Mg-O 
bonds that are weaker than Si-O bonds (66). This has also been observed by Linati et 
al. when adding zinc, which caused Tg to decrease for compositions containing up to 
15 mol%, while higher percentages made Tg increase due to the polymerisation of the 
glass network with the increasing amount of interconnected Si-Zn-P tetrahedra (232).  
The other two thermal events evidenced by the DSC analysis are two exothermic 
peaks, which correspond to the nucleation and growth of two crystal phases. As 
described in the literature for composition AW 0%, the first peak corresponds to the 
formation of fluoro/oxyapatite and the second peak to wollastonite (85, 104, 186, 233, 
234). In the present thesis, it was found that apatite precipitated at (887.2 ± 4.2) °C, 
while wollastonite precipitated at (944.3 ± 8.7) °C. This is close to what described in 
the literature: Kokubo et al., when they first described the material, found that apatite 
formed at 870 °C and wollastonite at 900 °C (85, 104) for particles <44 µm heated at 5 
°C/min. Cannillo et al. found that particles <38 µm gave apatite at 887 °C and 
wollastonite at 927 °C for a heating rate of 10 °C/min (233). Likitvanichkul and 
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Lacourse described crystallisation peaks for apatite and wollastonite at 880 °C and 
1008 °C, respectively, for glass particles in the range 1-2 mm and heated at 5 °C/min 
(234). Vickers observed that apatite precipitated at 892.7 °C and wollastonite at 955.2 
°C, when particles were <45 µm and heated at 10 °C/min (186). While the formation 
temperature of apatite is comparable across the literature, differences in the formation 
temperature of wollastonite can be found. This is due to the different formation 
mechanism of the two crystal phases: in fact, while apatite follows a bulk nucleation 
mechanism, wollastonite has a surface nucleation mechanism that makes it strongly 
dependent on the particle size and the particle size distribution of the powders chosen 
for the analysis (186). 
The effect of the substitution of strontium for calcium on the formation of the crystal 
phases can therefore be due to a combination of factors. First of all, as it will be shown 
in Chapter 3, the crystal phases that formed in each sample changed with the increase 
of strontium, eventually becoming strontium-apatite and strontium-wollastonite, which 
likely require different energies for initiating their transformation. Secondly, the 
expansion of the glass network could facilitate the migration of ions, so the energy 
barrier necessary for initiating the phase transformation was reduced; this in particular 
could be the case for apatite, for which calcium ions could have been more easily 
available, thus explaining the decrease of its peak temperature with the increase in 
strontium. Hill et al. suggested that the substitution of strontium for calcium in a SiO2-
Al2O3-P2O5-CaO-CaF2 glass caused the apatite to turn from bulk nucleation to a 
surface nucleation mechanism (235). However, this was not observed by Vickers for 
the strontium apatite-wollastonite parent glasses up to composition AW 24.9%, where 
the peak temperature for apatite remained constant with varying particle size, within 
the same composition (186). Thirdly, it is possible that the facilitated formation of 
apatite depleted the remaining material of most of the calcium and strontium ions, so 
the wollastonite phase presented a higher energy barrier, i.e. required a higher 
temperature, to gather all the necessary atoms before the phase could precipitate. 
 
The melting temperature of the glasses under study was the only characteristic with a 
clear non-linear behaviour: as shown in Figure 2.7, the melting temperature decreased 
with increasing strontium until composition AW 24.9%, but for composition AW 37.4% 
it was as high as for the starting AW 0%, so that the fitting curve became a second-
order equation. This could mean that substituting 50 mol% of calcium with strontium, 
or an amount around 50%, might give a eutectic composition for the class of glasses 
under study. Since this is the first time that composition AW 37.4% is produced and 
studied, it is also the first time that this behaviour is observed and therefore further 
studies are required to confirm this hypothesis. 
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It is important to note that all compositions formed both crystal phases before the 
temperature of 1050 °C, which was the temperature chosen for treating all samples 
and producing the porous scaffolds described in Chapter 3. 
  
2.4.4 Atomic organisation of the strontium AW glasses 
The XRD analysis showed that all the produced powder samples were amorphous 
glasses, as their traces gave only the broad hump typical of silicate-based glasses. 
The amorphous hump moved towards lower angles with the increasing amount of 
strontium in the glass. This effect of strontium substitution in bioactive glasses has 
been observed in previous work (186) and in the literature (63, 236, 237) and it is due 
to strontium atoms expanding the glass network, thus increasing its d-spacing. In fact, 
according to Bragg’s law (Equation 2.7), when the interatomic distance d increases the 
incident angle θ decreases, for a constant wavelength: 
 
𝑛𝜆 = 2𝑑 ∗ 𝑠𝑖𝑛𝜃 
Equation 2.7: Bragg’s law for x-ray diffraction. 
 
Where n is an integer number and λ is the wavelength of the x-ray radiation used for 
the analysis: 0.154056 nm for Cu-K alpha radiation. This effect was also confirmed 
with other techniques by Hollings et al. (personal communication), who drew the same 
conclusion from the results of neutron diffraction and Raman spectroscopy analyses 
run on the same glasses. 
These results therefore confirmed that the starting glasses were amorphous, which 
was essential for the purposes of the work presented in this thesis: in fact, only if the 
starting glasses were amorphous, their crystallisation could then be controlled by the 
thermal treatments applied when producing the scaffolds, as described in Chapter 3.
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Chapter 3  
Production and characterisation of strontium AW scaffolds  
3.1 Introduction  
When materials are developed to support bone repair, it is important to consider the 
form in which these materials are intended to be used, for instance granules, putty or 
solid and porous scaffolds. If the implant is to be used in load-bearing regions, then its 
structural and mechanical properties are key to the success of the implant integration 
in the native bone tissue for an effective repair of the defect. Different methods have 
been described in the literature for the fabrication of 3D porous scaffolds, from the use 
of organic porogens (238-241) to freeze-casting (242, 243), sol-gel foaming (244-247) 
or 3D printing (119, 248-250). For the strontium-doped AW porous scaffolds produced 
in the present thesis, the foam (or sponge) replication method was chosen, which was 
first applied to hydroxyapatite in 2001 by Tian and Tian (79) and then developed for 
bioactive glasses in 2006 by Chen et al. (80) and Park et al. (81). 
Chapter 2 presented the production and characterisation of the strontium-containing 
glass powders used for the scaffold production. The present chapter will first describe 
the steps of the sponge replication method followed for the production of the strontium 
AW scaffolds. Then the glass-ceramic samples, in the form of solid discs and porous 
scaffolds, will be characterised in terms of volumetric shrinkage upon treatment, 
crystal phases, morphology, mechanical properties, apatite-forming ability and 
radiopacity. 
The aim of this chapter was therefore to assess the effects of substituting strontium for 
calcium in apatite-wollastonite when 3D porous construct, intended as bone 
substitutes for large bone defects, are produced by the foam replication method. 
3.2 Materials and methods 
3.2.1 Glass-ceramic scaffold production 
Porous scaffolds were produced following the sponge/foam replication method (80, 
81). 
A slurry was prepared using ultrapure water, high molecular weight poly-vinyl alcohol 
(PVA, Mowiol® 56-98, Mw 195000, Aldrich) and the <45 µm glass powder produced 
as described in Chapter 2. The composition of the slurry used in this work was based 
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on the results of Serna, who optimised it for the AW 0% glass as 55:3:42 wt% 
water:PVA:glass powder (121). As shown in Chapter 2, the different strontium glasses 
had different densities. To take this into account when preparing the slurry, the 
water:PVA:volume of glass (instead of mass) ratio was kept constant. Table 3.1 shows 
the resulting slurry compositions for the six glasses under study. 
Table 3.1: Composition of the slurry for the fabrication of foam-replicated 
scaffolds, depending on the glass used and starting from 10 mL of 
ultrapure water. 
 Water (mL) PVA (g) Glass powder (g) 
AW 0% 10.0 0.53 7.88 
AW 6.2% 10.0 0.53 8.30 
AW 12.5% 10.0 0.53 8.57 
AW 18.7% 10.0 0.53 8.82 
AW 24.9% 10.0 0.53 9.00 
AW 37.4% 10.0 0.53 9.61 
 
To prepare the slurry, the first step was to dissolve the PVA in ultrapure water. As all 
the glasses required the same water-to-PVA ratio, stocks of 500 mL of water (26.70 g 
of PVA) were prepared and the required amount was weighed out at the time of 
making the samples. For dissolving the PVA, first the required amount of ultrapure 
water was heated up to 92°C in a water bath on a stirring hot plate. Then the PVA 
flakes were added to the water and kept stirring until the polymer was completely 
dissolved. 
Once the polymer solution was cooled down to room temperature, the required 
amount was weighed in a beaker and the corresponding amount of glass powder was 
added. The mixture was then vigorously stirred for 1 h so that a stable suspension, the 
slurry, was obtained. 
Polyurethane foams with porosity of 90 pores-per-inch (PPI) were used. The shape 
and dimensions of the foams, manually cut, differed depending on the application and 
will be specified case by case in this thesis. Each foam was soaked and squeezed in 
the slurry for 1 minute, in order to ensure the complete coating of the porous structure 
and, at the same time, avoid the occlusion of pores. All coated foams were then let dry 
overnight on a bench, periodically turning them for the first hour to remove the excess 
slurry and maintain the slurry evenly distributed. For making solid discs, the same 
slurry was used, but poured on greased 96 well-plates lids using a micropipette, 83 µL 
of slurry per sample, and then dried overnight. 
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All samples were finally treated in a furnace at 1050°C for 2 hours, heating rate 
10°C/min (186), in order to burn all the polymers (PVA and foams), sinter the glass 
particles and induce the nucleation and growth of the crystal phases. The final 
samples were thus obtained, the porous ones being a replica of the polyurethane 
template. 
 
3.2.2 Glass-ceramic sample characterisation 
3.2.2.1 Shrinkage of 3D porous scaffolds 
The sintering of glass particles and densification of the material during thermal 
treatment caused the samples to shrink, so their dimensions decreased after the 
treatment and the final samples were smaller replicas of the original template. 
In order to measure this shrinkage, dimensions were taken of specimens produced 
with cubic foams, 5.0 mm side. The three dimensions were measured using a digital 
calliper and volumes calculated. Measurements were performed before the thermal 
treatment, on air-dried coated foams, and after it. The shrinkage was calculated as a 
percentage of the initial volume, according to Equation 3.1: 
 
𝑆% =  
(𝑉𝑜𝑙𝑖 − 𝑉𝑜𝑙𝑓)
𝑉𝑜𝑙𝑖
∗ 100 
Equation 3.1: Volume shrinkage of porous scaffolds. 
 
where S% is the percentage of volume shrinkage, while Voli and Volf are the initial and 
the final volume, respectively. 30 samples per composition were tested and the 
average and standard deviation of their shrinkage were calculated. 
 
3.2.2.2 Density of strontium AW glass-ceramics 
Fragments of the porous scaffolds tested for compression (Section 3.2.2.6.1) were 
ground for 2 min using a Gyro-mill percussion mill, Glen Creston Ltd, and the powders 
obtained were used to measure the density of the final glass-ceramic materials. 
About 4.5 g of glass-ceramic powder were poured in the measuring vessel, previously 
tared, and a Thermo Scientific Pycnomatic ATC helium pycnometer was used to 
measure the density. After 3 cleansing cycles, the machine automatically performed 
up to 20 measurements until the standard deviation of 3 measurements was 0.400 % 
of their average density. The result of the measurements was provided as the average 
density and the standard deviation of the sample. 
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3.2.2.3 X-ray diffraction for crystal phase identification 
In order to detect the crystal phases nucleated in the samples, porous scaffolds were 
ground using the Gyro-mill percussion mill (Glen Creston Ltd) using a small puck for 
15 min. These were tested using a Bruker D8 Advance diffractometer, set on the same 
parameters used for the glass powders (Section 2.2.2.5), i.e. from 10 ° to 70 ° 2θ, step 
size 0.033 °, time/step 0.6 s and run at 40 kV and 40 mA. 
The collected data were analysed using the software X’Pert Highscore Plus and 
crystal phases checked against the last updated International Centre for Diffraction 
Data (ICDD) database. 
 
3.2.2.4 Scanning Electron Microscopy and Electron Dispersive x-ray 
Spectroscopy for assessing scaffold morphology and 
composition 
Solid discs and porous scaffolds were observed under a Hitachi S-3400N SEM for a 
qualitative assessment of their morphology, after sputtering them with gold. In order to 
improve sample conductivity, solid discs were fitted to aluminium stubs using a silver 
paint (Agar Scientific), while the top and bottom surfaces of porous scaffolds (derived 
from 5.0 mm-side foams) were manually polished before fitting them to stubs with 
conductive carbon tape. 
The composition of samples was verified using EDS quantitative analysis, performed 
using a Bruker XFlash detector and Quantax Esprit 1.9.4 analysis software. 
 
3.2.2.5 Micro Computed Tomography for assessing the 3D scaffold 
architecture 
For each composition, four scaffolds, derived from 5 mm side cubic foams, were 
tested using the micro computed tomography (CT) system Bruker Skyscan 1172 
scanner. A 0.5 mm aluminium filter was used, 9 µm resolution was set, which gave a 
pixel size of 8.88 µm, and scans were performed at 100 kV and 100 µA. Before each 
scan, the flat field was recorded and then applied. The four samples were scanned 
together setting an automated oversize scan, averaging was set to 3, rotation step to 
0.6 ° and random movement to 1 to reduce the ring artifact. Reconstruction of slices 
was performed using the Bruker NRecon software: after previewing a slice, the 
greyscale histogram was set between 0 and 10 % above the value of the last bar, then 
the beam hardening artifact was reduced using the fine tuning function. 
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3D rendered pictures of the scanned samples were created using the software CTvox, 
after adapting the opacity and luminance of the object basing on its intensity 
histogram.  
3.2.2.5.1 Scaffold porosity evaluation 
Micro CT images of the strontium AW scaffolds, collected as described in Section 
3.2.2.5, were analysed for porosity using the Bruker CT-Analyser (CTAn) software. For 
the analysis of the open and closed porosity of samples, at first a cylindrical volume of 
interest (VOI) was created by selecting its top and bottom slice and then applying a 
circular region of interest (ROI) to all the slices in the selected stack. The images of 
the VOI were binarised by selecting the threshold automatically calculated by CTAn on 
the base of the entire dataset. Then an automated task list was set up, as shown in 
Figure 3.1, by using CTAn plugin functions so that the general, open and closed 
porosity of each sample could be calculated, along with their pore size distributions. 
Porosity P% was defined, according to Equation 3.2, as the portion of the total volume 
of sample VTot that was due to voids, Vp: 
 
𝑃% =
𝑉𝑝
𝑉𝑇𝑜𝑡
∗ 100 
Equation 3.2: Definition of porosity for a scaffold. 
 
 
Figure 3.1: Task list used for the calculation of sample porosity in CTAn. 
 
In the task list, first the chosen threshold was applied to all slices. Then, Despeckle 
was performed twice: the first time to remove the black noise (volumes of less than 10 
voxels) and making it white, the second time to remove the white noise by sweeping 
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every white voxel except the largest object (the scaffold). This was followed by the 3D 
analysis of the object for calculating the general porosity. 
The following Bitwise operation saved the stack before performing a further Despeckle 
that deleted all the closed pores in the VOI, so that the next 3D analysis calculated the 
open porosity. 
Finally, with the last Bitwise operation, the saved VOI was loaded back, the open 
pores were removed with the Despeckle function and the closed porosity calculated 
with the last 3D analysis. All the results were automatically recorded in the same Excel 
file.  
Results for the open porosity were summarised as average ± standard deviation and 
tested with ANOVA using OriginPro 2015. 
Pore size distributions were also plotted, represented as volume percentage against 
pore range.  
3.2.2.5.2 Comparison with experimental porosity 
Porosity could also be calculated from the volume and mass of samples after thermal 
treatment. In fact, using data collected from the samples tested for shrinkage (Section 
3.2.2.1), knowing the final density of the glass-ceramic materials (Section 3.3.2) and 
starting from the definition of porosity represented in Equation 3.2, the porosity P% of 
scaffolds could be calculated as shown in Equation 3.3: 
 
𝑃% = (1 −
𝑉𝑜𝑙𝑚𝑎𝑡
𝑉𝑜𝑙𝑇𝑜𝑡
) ∗ 100 = (1 −
𝑚𝑚𝑎𝑡
𝑑 ∗ 𝑉𝑜𝑙𝑇𝑜𝑡
) ∗ 100 
Equation 3.3: Formula for calculating the porosity of scaffolds from their 
experimental mass, volume and density. 
 
where Volmat is the volume of the actual material that makes the scaffold, VolTot is the 
total volume of the scaffold (in cm3), mmat is the experimental mass of the sample (in g) 
and d is the measured density of the material (in g/cm3). 
 
3.2.2.6 Mechanical testing of porous scaffolds 
Cylindrical porous scaffolds were prepared using 90 PPI foams, diameter 20 mm and 
height 15 mm, and tested for compressive strength (Section 3.2.2.6.1) and biaxial 
flexural strength (Section 3.2.2.6.2). 
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3.2.2.6.1 Measurement of scaffold compressive strength 
Eight samples for each composition were tested for compression using an Instron 
3365 universal testing machine, fitted with a 5 kN load cell and controlled via the 
Instron Bluehill 3 software. Height and diameter of each sample were manually added 
to the software, then the load was applied at 1.0 mm/min and recorded, along with the 
displacement of the loading head. 
After the measurement, the compressive strength was calculated from the maximum 
load reached according to Equation 3.4: 
 
𝜎𝑐 =  
𝐿𝑚𝑎𝑥
𝐴
=  
𝐿𝑚𝑎𝑥
𝜋(𝑑 2⁄ )
2 
Equation 3.4: Compressive stress of cylindrical porous scaffolds. 
 
where Lmax is the maximum load recorded for the sample, A is its resisting area and d 
its mid-height diameter. The Young’s elastic modulus, E, was derived as the slope of 
the linear region of the stress-strain curve, using the Linest function in Microsoft Excel. 
For each set of eight samples, average and standard deviation were calculated and 
results compared using the ANOVA test in OriginPro 2015, upon checking for the 
normality of distributions of values. 
 
Fracture surfaces were observed by performing SEM imaging on fragments of tested 
samples, attaching them to aluminium stubs using carbon tape and silver paint and 
sputtering them with gold to increase their conductivity. 
3.2.2.6.2 Measurement of scaffold biaxial flexural strength 
The biaxial flexural strength of porous scaffolds was tested on thin circular slices 
obtained from cylindrical samples like those described above in Section 3.2.2.6.1. 
Samples were cut using a Struer Accutom-5 cutting machine, fitted with a 350 µm 
diamond-coated blade fed at 0.1 mm/min; the obtained slices were 1.5 mm thick. Each 
slice was measured prior to testing using a digital calliper. The Instron 3365 universal 
testing machine, fitted with a 500 N load cell, was used to perform the piston-on-three-
ball test described in the standard BS EN ISO 6872 (251). The apparatus consisted of 
three stainless steel balls, diameter (4.5 ± 2) mm, positioned at 120 ° on a support 
circle of (11 ± 1) mm diameter. As shown in Figure 3.2, during the test samples were 
positioned concentrically to the circle, then a flat punching pin, diameter (1.4 ± 0.2) 
mm, was lowered in the middle of the sample at 1.0 mm/min and the load recorded 
until failure. For each composition of scaffold, 15 slices were tested. 
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Figure 3.2: Apparatus used for the biaxial flexural strength test of slices of 
porous scaffolds. 
 
The biaxial flexural strength was calculated according to the standard BS EN ISO 
6872, following Equation 3.5 (251). 
 
𝜎 =  −0.2387𝑃
(𝑋 − 𝑌)
𝑏2
 
Equation 3.5: Formula for calculating the biaxial flexural strength (251). 
 
where σ is the biaxial flexural strength of the sample, in MPa, P is the maximum load 
at fracture, b is the specimen thickness and X and Y are described by Equation 3.6 
and Equation 3.7, respectively: 
 
𝑋 = (1 + 𝜈)𝑙𝑛 (
𝑟2
𝑟3
)
2
+ 
(1 − 𝜈)
2
(
𝑟2
𝑟3
)
2
 
Equation 3.6: Formula for the calculation of X in Equation 3.5 (251). 
 
𝑌 = (1 + 𝜈) [1 + 𝑙𝑛 (
𝑟1
𝑟3
)
2
] + (1 − 𝜈) (
𝑟1
𝑟3
)
2
 
Equation 3.7: Formula for the calculation of Y in Equation 3.5 (251). 
Sample
Balls
Punching pin
Sample 
holder
Precision rod
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where ν is the Poisson’s ratio of the material, estimated as 0.25, r1 is the radius of the 
support circle, r2 is the radius of the loaded area (i.e. the radius of the punching pin) 
and r3 is the radius of the specimen. 
Results were reported as average ± standard deviation and tested for ANOVA using 
OriginPro 2015. 
 
As 15 samples for each composition were tested, the Weibull statistics could also be 
calculated, according to the standard BS EN ISO 6872 (251). The Weibull distribution 
is a two-parameter statistical distribution frequently used to describe the dispersion in 
fracture strength of brittle materials; it links the cumulative probability of failure Pf to the 
tensile stress σ as described in Equation 3.8 (251-253). 
 
𝑃𝑓 = 1 − 𝑒𝑥𝑝 [− (
𝜎
𝜎0
)
𝑚
] 
Equation 3.8: Weibull distribution (251-253). 
 
where m and σ0 are the two Weibull parameters: the Weibull modulus and the Weibull 
characteristic strength, respectively. The Weibull modulus m is a shape parameter and 
describes how steep the function is, thus how dispersed the fracture stresses are, 
while the Weibull characteristic σ0 determines the location of the distribution; σ0 is 
related to the mean fracture stress and represents the strength that has 63.2 % 
probability of causing failure (251, 252). 
In order to calculate the Weibull parameters for the biaxial flexural strength of the six 
compositions of scaffolds, first the flexural strengths that were calculated according to 
Equation 3.5 were ranked in ascending order and their probability of failure Pf 
assigned as per Equation 3.9: 
 
𝑃𝑓 =
𝑖 − 0.5
𝑁
 
Equation 3.9: Probability of failure of the ith sample. 
 
where i is the rank of the specimen and N the total number of tested specimens in the 
batch. Variables Pf and σ were then transformed in lnln[1/(1-Pf)] and lnσ and plotted as 
the y and x axis, respectively. The linear regression parameters were calculated using 
the function Linest in Excel: if the linear fit was represented as y = mx + constant, the 
Weibull modulus corresponded to the slope m of the fitting line, while the Weibull 
characteristic strength σ0 was obtained by setting y = 0 and calculating the natural 
exponential of the so-derived x0, σ0 = 𝑒𝑥0, which corresponded to Pf = 63.2 %.  
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SEM micrographs of fracture surfaces were obtained by attaching the slices to 
aluminium stubs using carbon tape and silver paint so that the fractured side was 
exposed, then samples were sputtered with gold to increase their conductivity. 
 
3.2.2.7 Apatite-forming ability of strontium AW glass-ceramic samples 
An important requirement for a biomaterial for bone regeneration is its ability to induce 
the formation, when in contact with body fluids, of hydroxyapatite (HAp), a crystal 
phase very close to the natural mineral phase found in bone tissue (see Chapter 1). 
In this thesis, both solid discs and porous scaffolds were used to test the bioactivity of 
the six materials under study. Following the ISO standard 23317 (254), specimens 
were immersed in simulated body fluid (SBF) solution: this is a solution, as described 
by Kokubo and Takadama (255), that simulates the inorganic composition of human 
blood plasma. Table 3.2 compares the ion composition of SBF with human plasma. 
Table 3.2: Comparison of the ion concentration in SBF and in human blood 
plasma (255). 
Ion 
Concentration (mM) 
SBF (pH 7.40) 
Blood plasma 
(pH 7.2 to 7.4) 
Na+ 142.0 142.0 
K+ 5.0 5.0 
Mg2+ 1.5 1.5 
Ca2+ 2.5 2.5 
Cl- 147.8 103.0 
HCO3- 4.2 27.0 
HPO42- 1.0 1.0 
SO42- 0.5 0.5 
 
SBF was prepared following the above mentioned standard (254). First, 700 mL of 
ultrapure water were heated in a water bath and temperature was brought to (36.5 ± 
1.5) °C. Then the reagents listed in Table 3.3 were added. The first eight reagents 
were dissolved one by one, and granule by granule if necessary, ensuring that 
temperature was always in the range (36.5 ± 1.5) °C, rinsing every weighing container 
with ultrapure water and adding the washings to the solution. A pH meter was then 
inserted and the pH checked, which was expected to be in the range of 2.0 ± 1.0; then 
the volume of water was brought to 900 mL and its temperature kept at (36.5 ± 1.5) 
°C. While measuring the pH and keeping the temperature of the solution always at 
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(36.5 ± 0.5) °C, TRIS was slowly added until the pH raised to 7.45 ± 0.01. At this point, 
HCl 1 M was added dropwise until the pH decreased to 7.42 ± 0.01 and this process 
was repeated until all the TRIS was completely dissolved. The pH was finally adjusted 
to 7.40 at exactly 36.5°C, the pH probe was removed, rinsed with ultrapure water and 
the washing added to the solution. Once at room temperature, the final volume of SBF 
was brought to 1 L and the solution stored at 4 °C until use for up to 30 days. 
Table 3.3: Reagents used for preparing SBF. 
Reagent Formula Amount 
Sodium chloride NaCl 8.035 g 
Sodium hydrogen carbonate NaHCO3 0.355 g 
Potassium chloride KCl 0.225 g 
Di-potassium hydrogen phosphate trihydrate K2HPO4∙3H2O 0.231 g 
Magnesium chloride MgCl2 0.143 g 
Hydrochloric acid, 1 M HCl 39 mL 
Calcium chloride CaCl2 0.292 g 
Sodium sulphate NaSO4 0.072 g 
Tris-hydroxymethyl aminomethane TRIS 6.118 g 
Hydrochloric acid, 1 M HCl 0 to 5 mL 
 
The minimum required volume of SBF per each sample was calculated according to 
Kokubo and Takadama (255), with Equation 3.10: 
 
𝑣𝑠 = 𝑆𝑎/10 
Equation 3.10: Volume of SBF required for testing one sample. 
 
where vs is the volume of SBF (mL) and Sa is the apparent surface of the sample 
(mm2).  
 
When testing the thin solid discs, the required volume of SBF was calculated from their 
average diameter of 6.4 mm: considering their exposed surface as twice their area, the 
minimum required volume was found to be 6.4 mL. However, as samples had some 
residual porosity and their surface presented some degree of roughness (see SEM 
results in Section 3.3.4), the volume of SBF used was 10 mL per sample. Specimens, 
marked on their top surface, were placed at the bottom of 15 mL Falcon tubes 
(Corning) as shown in Figure 3.3a, SBF was added and then all the tubes were placed 
in an oven kept at 37 °C. Samples were collected after 1 day, 3 days, 7 days and 14 
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days, in triplicate. At the time of collection, the final pH of the solution was recorded, 1 
mL was taken for ion release testing and the sample was carefully extracted, rinsed 
with ultrapure water and placed in a desiccator for drying.  
 
When the porous scaffolds were tested, samples were put in 50 mL Falcon vials as 
shown in Figure 3.3b and 30 mL of 37 °C SBF added, according to literature (256-
258). Vials were kept in a 37 °C oven for 1 day, 7 days and 14 days. At collection, the 
pH of the solution was measured and samples were extracted, rinsed with ultrapure 
and left drying in a desiccator until analysed. 
 
Once dried, as shown in Figure 3.3 and described in the standard ISO 23317 (254), 
the bottom side of solid discs was analysed with SEM and EDS (see details of the 
machine in Section 3.2.2.4), fixed to the stubs using conductive silver paint and 
sputtered with gold. The ion release of samples was tested at the School of 
Geography (University of Leeds) using a Thermo Scientific iCAP7600 Inductively 
Coupled Plasma – Optical Emission Spectrophotometer (ICP-OES) equipped with a 
240-position Cetac auto-sampler, which is a simultaneous analyser with the capability 
to view in axial or radial mode. The 1 mL of sample that was collected at each time-
point was diluted in 9 mL of ultrapure water and then frozen until the day of the 
analysis. All samples were tested for Si, Mg, P, Ca and Sr and standards were run 
with the samples for calibration. The wavelength, revolutions per minute (rpm) and 
mode used for the final calculations were chosen basing on the best calibration. 
 
Porous scaffolds extracted from SBF and dried were fitted, prior to testing, to SEM 
stubs using carbon tape and sputtered with gold. As the apatite found was only inside 
their pores and not on their surface (see results in Section 3.3.7.2), EDS analysis was 
not feasible and therefore only SEM imaging was performed on one of their lateral 
sides, as required by the ISO standard 23317 (254) and depicted in Figure 3.3b. 
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Figure 3.3: Sample configuration for SBF testing, as specified in the ISO 
standard 23317 (254); (a) solid disc, in a 15 mL Falcon tube and (b) porous 
scaffold, in a 50 mL Falcon tube. Red arrows indicate the surfaces 
investigated for apatite deposition. 
 
3.2.2.8 Radiopacity assessment through x-ray imaging of porous 
scaffolds 
As strontium is known to be a radiopaque agent for glasses and cements (259), 
porous samples produced using the six strontium compositions studied in this work 
were pictured using x-rays and the obtained radiographs analysed for radio-density.  
X-ray pictures were taken using the dental radiography system Carestream CS 2200, 
coupled with CS 7600 film reader for the digitalisation of images. The machine was 
operated at 70 kV, 7 mA, large-adult and molar tooth mode. Two sets of samples were 
tested, in triplicate: pieces of circular slices previously tested for biaxial flexural 
strength (Section 3.2.2.6.2), all 1.5 mm thick, and small cubic scaffolds obtained from 
5 mm-side foams. Pictures were automatically saved as DICOM and were then 
converted to TIFF using the software ImageJ. 
ImageJ was also used to calculate the average optical density of samples: polygonal 
and square regions of interest (ROI) were drawn for the slices and the cubic samples, 
respectively, as shown in Figure 3.4. Exactly the same ROI shape was used for all the 
samples in each picture and radiopacity was measured using the function “Measure”, 
which provides the average intensity of the selected area, where 0 = black and 255 = 
white. Three pictures per set were tested and the average and standard deviation 
were calculated for each composition of sample. 
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Figure 3.4: Example of regions of interest (ROIs) selected for (a) the scaffold 
slices and (b) the cubic scaffolds. 
 
3.3 Results  
3.3.1 Effect of strontium addition to AW on scaffold shrinkage 
The shrinkage of samples upon thermal treatment was measured for cubic samples 
and results, averaged from 30 samples for each composition, are reported in Table 
3.4. 
Table 3.4: Average and standard deviation of volume shrinkage of porous 
scaffolds. 
 
Shrinkage (%) 
Standard 
deviation (%) 
AW 0% 58.2 2.7 
AW 6.2% 56.8 2.8 
AW 12.5% 54.5 3.0 
AW 18.7% 53.4 3.0 
AW 24.9% 50.5 2.6 
AW 37.4% 48.5 2.5 
 
As better shown in Figure 3.5, shrinkage of cubic porous scaffolds decreased with 
increasing strontium, with a difference of about 10 % between sample AW 0% and 
sample AW 37.4%. 
 
75 
 
 
 
Figure 3.5: Volumetric shrinkage of cubic porous scaffolds, with trendline 
dashed in red, y = -0.27x + 58.13, R2 = 0.98. Error bars indicate the standard 
deviation (n=30). 
 
Using OriginPro 2015, data could be fit to a line with slope -0.27, R2 0.98. This meant 
that the addition of strontium reduced the degree of sintering of glass particles, or that 
the different compositions followed different sintering mechanisms, or that the crystal 
phases forming in strontium-containing samples had a bigger volume, or a 
combination of these effects. 
 
3.3.2 Effect of strontium addition to AW scaffolds on material 
density 
Glass-ceramic samples were ground and tested for density using a helium pycnometer 
(Thermo Scientific Pycnomatic ATC). Results of the measurements are presented in 
Table 3.5, along with the standard deviations calculated by the machine, and 
summarised in Figure 3.6. 
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Table 3.5: Density of ground glass-ceramic scaffolds. 
 Density 
(g/cm3) 
Standard deviation 
(g/cm3) 
AW 0% 3.00157 0.00405 
AW 6.2% 3.10460 0.00235 
AW 12.5% 3.23409 0.00439 
AW 18.7% 3.29850 0.00211 
AW 24.9% 3.32916 0.00099 
AW 37.4% 3.47934 0.00129 
 
 
Figure 3.6: Density of the six strontium-containing AW porous scaffolds, with 
fitting trendline. Error bars indicate the standard deviations, as calculated 
by the Thermo Scientific Pycnomatic ATC helium pycnometer. 
 
As expected, the density of the glass-ceramic materials that constituted the porous 
scaffolds increased with the increasing amount of strontium, as strontium is a heavier 
ion than calcium. In particular, the increase was found to be linear, with a slope of 
0.012 and R2 of 0.976 for the fitting line. The same trend was already observed with 
the parent glasses, as shown in Chapter 2, and results were similar for each 
composition. Therefore, despite the rearrangement of ions during crystallisation, the 
overall density of the material did not change significantly with the thermal treatment.  
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3.3.3 Identification of crystal phases formed in strontium-
containing AW porous scaffolds 
XRD traces of ground porous scaffolds are compared in Figure 3.7, with their peaks 
assigned to ICDD crystal phases. Each trace is then shown individually in Figure 3.8 to 
Figure 3.13, where the stick patterns of the selected phases are also displayed. 
 
 
Figure 3.7: XRD traces of ground porous scaffolds, with peaks assigned to 
matching ICDD crystal phases. ● 00-064-0738 Hydroxyapatite, ♦ 00-066-
0271 Wollastonite 2M, * 01-089-5632 Strontium hydroxyapatite 
(Ca7.7Sr2.3)(PO4)6(OH)2, + 01-089-5633 Strontium hydroxyapatite 
(Ca3.6Sr6.4)(PO4)6(OH)2, ■ 04-011-6810 Calcium magnesium silicate 
CaMgSi2O6, ▼ 04-012-1764 Pseudowollastonite, ▲ 01-083-5061 Calcium 
magnesium strontium silicate (CaSr)Mg(Si2O7). 
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Figure 3.8: Detail of the XRD trace derived from ground AW 0% porous scaffolds 
shown in Figure 3.7, with corresponding peak assignment: ● 00-064-0738 
Hydroxyapatite, ♦ 00-066-0271 Wollastonite 2M (upper panel). Stick patterns 
of the selected crystal phases as provided by the ICDD database (middle 
and lower panel). 
 
 
Figure 3.9: Detail of the XRD trace derived from ground AW 6.2% porous 
scaffolds shown in Figure 3.7, with corresponding peak assignment: * 01-
089-5632 Strontium hydroxyapatite (Ca7.7Sr2.3)(PO4)6(OH)2, ♦ 00-066-0271 
Wollastonite 2M (upper panel). Stick patterns of the selected crystal phases 
as provided by the ICDD database (middle and lower panel). 
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Figure 3.10: Detail of the XRD trace derived from ground AW 12.5% porous 
scaffolds shown in Figure 3.7, with corresponding peak assignment: + 01-
089-5633 Strontium hydroxyapatite (Ca3.6Sr6.4)(PO4)6(OH)2, ■ 04-011-6810 
Calcium magnesium silicate CaMgSi2O6 (upper panel). Stick patterns of the 
selected crystal phases as provided by the ICDD database (middle and 
lower panel). 
 
 
Figure 3.11: Detail of the XRD trace derived from ground AW 18.7% porous 
scaffolds shown in Figure 3.7, with corresponding peak assignment: + 01-
089-5633 Strontium hydroxyapatite (Ca3.6Sr6.4)(PO4)6(OH)2, ▼ 04-012-1764 
Pseudowollastonite (upper panel). Stick patterns of the selected crystal 
phases as provided by the ICDD database (middle and lower panel). 
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Figure 3.12: Detail of the XRD trace derived from ground AW 24.9% porous 
scaffolds shown in Figure 3.7, with corresponding peak assignment: ▲ 01-
083-5061 Calcium magnesium strontium silicate (CaSr)Mg(Si2O7) (upper 
panel). Stick patterns of the selected crystal phases as provided by the 
ICDD database (middle and lower panel). 
 
 
Figure 3.13: Detail of the XRD trace derived from ground AW 37.4% porous 
scaffolds shown in Figure 3.7, with corresponding peak assignment: ▲ 01-
083-5061 Calcium magnesium strontium silicate (CaSr)Mg(Si2O7) (upper 
panel). Stick patterns of the selected crystal phases as provided by the 
ICDD database (middle and lower panel). 
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From the comparison between compositions summarised in Figure 3.7, it was 
observed that the main apatite peak moved towards lower angles with the increase in 
strontium in the sample composition, as a consequence of its crystal lattice being 
enlarged by the presence of the bigger ion. In addition, the main peaks, in particular 
the two apatite peaks around 32 °, became higher and narrower with the increase in 
strontium. 
All scaffold compositions matched two phases: an apatite and a calcium silicate. AW 
0% samples contained the two expected phases described in the literature (85), 
hydroxyapatite (ICDD: 00-064-0738) and wollastonite 2M (ICDD: 00-066-0271). With 
the increase in strontium content in the samples, apatite prevalently acquired strontium 
in respect to wollastonite. In fact, strontium-apatite, with chemical formula 
(Ca7.7Sr2.3)(PO4)6(OH)2 (ICDD: 00-066-0271), was matched for scaffolds AW 6.2% and 
a different strontium-apatite with a higher strontium content, chemical formula 
(Ca3.6Sr6.4)(PO4)6(OH)2 (ICDD: 01-089-5633), was then matched for compositions AW 
12.5% and higher. On the contrary, the wollastonite phase maintained the same 2M 
structure (ICDD: 00-066-0271) for samples AW 0% and AW 6.2% and then evolved 
into different phases with the increase of strontium: it was found to contain magnesium 
in composition AW 12.5 %, matching diopside CaMgSi2O6 (ICDD: 04-011-6810), then 
it became pseudowollastonite for AW 18.7% scaffolds and acquired strontium only 
with samples AW 24.9% and 37.4%, matching with a calcium magnesium strontium 
silicate (ICDD: 01-083-5061). 
 
3.3.4 Effect of strontium addition to AW glass-ceramic samples on 
surface morphology and elemental composition  
Both solid discs and porous scaffolds were observed under the SEM to investigate 
their surface morphology.  
Micrographs of the surface of discs were taken at 5 mm working distance and two 
different magnifications, 1000x shown in Figure 3.14 and 5000x shown in Figure 3.15. 
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Figure 3.14: SEM micrographs, imaged from secondary electrons, of the surface 
of solid discs at lower magnification, 1000x. (a) AW 0%, (b) AW 6.2%, (c) 
AW 12.5 %, (d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. Scale bars represent 
50 µm. 
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Figure 3.15: SEM micrographs, imaged from secondary electrons, showing 
details of the solid discs displayed in Figure 3.14 at higher magnification, 
5000x. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, (d) AW 18.7%, (e) AW 24.9%, 
(f) AW 37.4%. Scale bars represent 10 µm. 
 
As seen in Figure 3.14, all samples appeared well sintered, with the presence of 
rounded protrusions only for discs AW 24.9% and AW 37.4% deriving from the original 
glass particles, thus indicating a lower degree of sintering for these two phases. 
In Figure 3.15, areas with different morphologies and bigger crystals were observed 
for samples containing 12.5 mol% strontium oxide and higher, signifying a different 
distribution and growth of the crystal phases. 
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Figure 3.16 and Figure 3.17 show micrographs of the porous scaffolds and details of 
the sintered struts, respectively, taken at different magnifications. 
 
 
Figure 3.16: SEM micrographs, imaged from secondary electrons, of porous 
scaffolds taken at magnification 100x. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 
%, (d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. Scale bars represent 500 µm. 
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Figure 3.17: SEM micrographs, imaged from secondary electrons, of the porous 
scaffolds displayed in Figure 3.16 at higher magnification (200x), showing 
details of the struts. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, (d) AW 18.7%, 
(e) AW 24.9%, (f) AW 37.4%. Scale bars represent 200 µm. 
 
After their thermal treatment, scaffolds maintained the porous structure of the 
template, with struts forming an interconnected network of pores for all the 
compositions. All scaffolds presented a residual microporosity where sintered glass 
particles did not fuse completely. It could also be observed that samples sintered 
differently, especially compositions AW 24.9% and 37.4% where the trace of the 
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original glass particles remained evident. Sintering defects were also present for all the 
compositions, with hollow struts that derived from the templating polyurethane foam. 
 
3.3.4.1 Effect of strontium addition on the elemental composition of discs 
and porous scaffolds 
The composition of discs and scaffolds was verified using EDS from the same 
samples observed under SEM. 
Table 3.6 reports the results of data collected at 30 kV, magnification 1000x for discs 
and 200x for scaffolds. Figure 3.18 to Figure 3.23 show, for each composition, 
selected EDS points and their corresponding spectra for solid discs; data were 
collected at 5000x magnification and 10 kV, as a lower voltage allowed for a better 
identification of the sample topography.  
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Table 3.6: EDS quantification of relevant atoms for solid discs (D.) and porous scaffolds (Sc.), compared to the theoretical values (Th.). All data in at%. 
 AW 0% AW 6.2% AW 12.5% AW 18.7% AW 24.0% AW 37.4% 
Atom Th. D. Sc. Th. D. Sc. Th. D. Sc. Th. D. Sc. Th. D. Sc. Th. D. Sc. 
Si 32.90 29.30 29.65 32.90 24.15 25.01 32.90 24.93 24.01 32.90 24.83 23.42 32.90 23.46 22.03 32.90 23.96 20.25 
Mg 6.58 4.67 4.32 6.58 4.29 3.77 6.58 4.35 4.07 6.58 5.17 4.30 6.58 4.68 4.56 6.58 5.34 4.21 
F 0.74 2.12 4.22 0.74 2.65 4.62 0.74 2.52 4.91 0.74 0.80 4.20 0.74 2.19 3.84 0.74 0.26 4.62 
Ca 46.62 50.65 47.84 40.87 46.54 41.84 35.03 38.79 35.38 29.29 31.54 30.09 23.54 26.02 22.98 11.96 14.23 11.84 
P 13.16 13.25 13.97 13.16 12.82 13.47 13.16 14.11 13.39 13.16 14.98 12.74 13.16 13.90 12.60 13.16 14.10 11.48 
Sr 0.00 0.01 0.00 5.75 9.55 11.29 11.58 15.30 18.24 17.33 22.68 25.25 13.08 29.75 33.99 34.66 42.11 47.60 
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Figure 3.18: EDS results of three point areas on an AW 0% disc. Secondary 
electron image of the analysed area (top left). EDS spectrum of Point 1 (top 
right), Point 2 (bottom left) and Point 3 (Bottom right). 
 
 
Figure 3.19: EDS results of three point areas on an AW 6.2% disc. Secondary 
electron image of the analysed area (top left). EDS spectrum of Point 1 (top 
right), Point 2 (bottom left) and Point 3 (Bottom right). 
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Figure 3.20: EDS results of three point areas on an AW 12.5% disc. Secondary 
electron image of the analysed area (top left). EDS spectrum of Point 1 (top 
right), Point 2 (bottom left) and Point 3 (Bottom right). 
 
 
Figure 3.21: EDS results of three point areas on an AW 18.7% disc. Secondary 
electron image of the analysed area (top left). EDS spectrum of Point 1 (top 
right), Point 2 (bottom left) and Point 3 (Bottom right). 
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Figure 3.22: EDS results of three point areas on an AW 24.9% disc. Secondary 
electron image of the analysed area (top left). EDS spectrum of Point 1 (top 
right), Point 2 (bottom left) and Point 3 (Bottom right). 
 
 
Figure 3.23: EDS results of three point areas on an AW 37.4% disc. Secondary 
electron image of the analysed area (top left). EDS spectrum of Point 1 (top 
right), Point 2 (bottom left) and Point 3 (Bottom right). 
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Table 3.6 showed that both forms of glass-ceramic samples, solid discs and porous 
scaffolds, maintained all the atomic elements they contained before their thermal 
treatment. However, both discs and even more the porous scaffolds had a higher 
percentage of strontium compared to the theoretical values, always balanced by a 
lower amount of silicon. Since this result was not found for the parent glasses (Chapter 
2), it is likely that this change in composition was an effect of the thermal treatment 
and the formation of crystal phases in the samples. In particular, it is possible that the 
apatite phase (more specifically, a strontium-substituted apatite) tended to emerge to 
the outer surface of samples, thus segregating the silicate phase deeper in the bulk. 
Therefore, a surface investigation of samples such as the EDS described here would 
preferentially detect only the outer apatite phase, but an analysis of ground or 
sectioned samples would be necessary to confirm this hypothesis. Fluorine was also 
found to be higher than its theoretical values by a few percent units in all samples, as 
already observed with the parent glasses, and higher in scaffolds than discs. As 
explained in Chapter 2, this result could derive from the intrinsic error of the machine 
and probably did not represent an actual increase in fluorine. 
 
As far as the sample topography was concerned, as also shown previously in Figure 
3.14 and Figure 3.15, different crystal phases could not be clearly identified in discs 
AW 0% and AW 6.2%. This was confirmed by the EDS spectra taken in different areas 
of these samples, which appeared similar in the three selected points. For composition 
AW 12.5% and above, the morphology of the surface of discs indicated the formation 
of areas with different crystal compositions. In particular, smoother areas tended to be 
richer in magnesium and poorer in phosphorus, indicating that the specific crystal 
phase could be the magnesium-calcium silicate identified during the XRD analysis 
(Section 3.3.3). On the contrary, dotted areas were identified as apatite. It was not 
possible to visualise the increase in strontium in these spectra, as its Kα and Kβ signals 
are at about 14 and 16 keV, respectively, and therefore a higher voltage would have 
been required that, however, would have hindered the quality of the topography 
investigation. However, the silicon+strontium peak at about 1.8 keV increased with the 
increase in strontium; since silicon was constant throughout the six sample 
compositions, the increase was therefore due to the increased amount of strontium. 
 
3.3.5 Effect of strontium addition to AW glass-ceramic on the 3D 
architecture and porosity of porous scaffolds 
Micro CT data were used to reconstruct 3D models of the scanned scaffolds. Images 
were created using the software CTvox and Figure 3.24 shows pictures of one sample 
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per composition, where their front side was virtually cut with a plane so that the 
internal structure could be seen. 
 
 
Figure 3.24: Micro CT images of porous samples, sectioned with a cutting-
through plane for visualising their internal structure. (a) AW 0%, (b) AW 
6.2%, (c) AW 12.5 %, (d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. Marks on 
the axes of purple boxes indicate 500 µm. 
 
All samples maintained their porous structure throughout their volume. Pores looked 
interconnected, with the presence of some bigger pores where struts failed to form due 
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to incomplete coating from the slurry. Struts of varying thickness could be observed for 
all samples. No difference could be observed between compositions. 
 
3.3.5.1 Effect of strontium addition to AW scaffolds on porosity from 
micro CT imaging 
Micro CT post-processing analysis was then used to study the porosity of the 
scaffolds. Table 3.7, Table 3.8 and Table 3.9 report the resulting general, open and 
closed porosity, respectively, calculated from 4 scaffolds for each composition. 
Table 3.7: General porosity of scaffolds as measured by µCT, n=4. 
 Average 
(%) 
Standard 
deviation (%) 
AW 0% 63.07 3.50 
AW 6.2% 57.15 2.13 
AW 12.5% 56.70 3.82 
AW 18.7% 57.00 4.56 
AW 24.9% 50.45 3.05 
AW 37.4% 57.31 2.30 
 
Table 3.8: Open porosity of scaffolds as measured by µCT, n=4. 
 Average 
(%) 
Standard 
deviation (%) 
AW 0% 62.92 3.58 
AW 6.2% 57.00 2.14 
AW 12.5% 56.55 3.79 
AW 18.7% 56.84 4.58 
AW 24.9% 50.02 3.02 
AW 37.4% 57.01 2.35 
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Table 3.9: Closed porosity of scaffolds as measured by µCT, n=4. 
 Average 
(%) 
Standard 
deviation (%) 
AW 0% 0.15 0.08 
AW 6.2% 0.15 0.02 
AW 12.5% 0.16 0.06 
AW 18.7% 0.16 0.04 
AW 24.9% 0.43 0.03 
AW 37.4% 0.29 0.11 
 
For all the six compositions of scaffold tested, most of the general porosity derived 
from open porosity. In fact, values in Table 3.8 were very close to values in Table 3.7, 
while less than 1% of the general porosity was due to closed porosity (Table 3.9). This 
meant that, for all the compositions under study, most of the porosity of samples 
derived from an interconnected network of pores, therefore the foam replication 
method followed in this thesis allowed the final scaffolds to preserve the structure of 
the template, without a relevant amount of obstructed pores. 
The open porosity of scaffolds is also represented in Figure 3.25, where significance 
was tested using one-way ANOVA in OriginPro 2015. 
 
 
Figure 3.25: Open porosity of strontium scaffolds (n=4), as measured from the 
post-processing of micro CT data, +p<0.001. Error bars indicate the 
standard deviation (n=4). 
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All scaffolds had an open porosity of 50 to 60 % of their total volume. Only 
compositions AW 0% and AW 24.9% were found significantly different (p<0.001). 
However, only one batch of samples per composition was tested and therefore results 
did not include inter-batch variability. Because all samples were handmade, it could be 
concluded that, on average, all samples had a porosity of about 55 % independently of 
their composition.  
 
3.3.5.2 Comparison with experimental porosity 
Porosity measurements for the scaffolds could be derived also from the experimental 
mass and volume data collected for their shrinkage measurements (Section 3.3.1) and 
their measured density (Section 3.3.2). Table 3.10 compares the general porosity 
measured by the micro CT post-analysis with the porosity calculated from the 
experimental masses, volumes and densities. 
Table 3.10: Comparison between the total porosity calculated by micro CT (µCT 
porosity, n=4) and the porosity calculated from measured mass, volume 
and density (Exp. Porosity, n=30). 
 µCT porosity (%) Exp. porosity (%) 
AW 0% 63.07 ± 3.50 60.80 ± 2.34 
AW 6.2% 57.15 ± 2.13 66.31 ± 2.97 
AW 12.5% 56.70 ± 3.82 62.92 ± 2.22 
AW 18.7% 57.00 ± 4.56 59.46 ± 3.08 
AW 24.9% 50.45 ± 3.05 61.14 ± 2.82 
AW 37.4% 57.31 ± 2.30 68.04 ± 3.54 
 
Porosities calculated from the experimental mass, volume and density of samples 
tended to be higher than those calculated computationally from the micro CT data. 
This could depend on the inter-batch variability of specimens, as scaffolds in the two 
groups were taken from different batches. Another reason for this difference could be 
the fact that, for the experimental calculations, samples were approximated as cuboids 
(a linear measure was taken for each dimension using a calliper), but their shapes 
were actually irregular as each foam was cut manually: this could have caused an 
under-estimation of their volume and, consequently, an over-estimation of their 
porosity. Because the micro CT analysis made use of ROIs all contained within the 
volume of samples, the micro CT porosity results could be considered closer to the 
actual porosity of scaffolds. 
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3.3.5.3 Effect of strontium addition to AW scaffolds on trabecular 
thickness and spacing 
CTAn also provided the overall mean trabecular thickness (Tr.Th.) and trabecular 
spacing (pore size, Tr.Sp.). These values are reported in Table 3.11. 
Table 3.11: Overall trabecular thickness (Tr.Th.) and trabecular spacing (Tr.Sp.), 
as calculated in CTAn from the micro CT data. Values are average ± 
standard deviation from 4 scaffolds per composition. 
 Tr.Th. (µm) Tr.Sp (µm) 
AW 0% 96.29 ± 4.14 250.15 ± 11.77 
AW 6.2% 123.02 ± 4.45 247.77 ± 12.92 
AW 12.5% 103.45 ± 5.18 223.38 ± 28.44 
AW 18.7% 138.09 ± 8.52 274.88 ± 26.55 
AW 24.9% 130.10 ± 5.95 244.55 ± 13.97 
AW 37.4% 126.08 ± 3.80 268.84 ± 5.15 
 
The average trabecular thickness ranged from 96.29 µm for scaffolds AW 0% to 
138.09 µm for scaffolds AW 18.7%, while the overall mean pore size, indicated as 
trabecular spacing, ranged from 223.38 µm for scaffolds AW 12.5% to 274.88 µm for 
scaffolds AW 18.7%. Although often reported as the parameters that characterise a 
scaffold, these values strongly depend on the strut thickness distribution and pore size 
distribution, respectively, so it must be taken into account that, in the present case, 
values do not present Gaussian distributions, as it will be shown in Figure 3.26. In 
addition, as mentioned previously, these results were obtained from 4 scaffolds that 
belonged to the same batch for each composition, therefore inter-batch variability was 
not taken into account. 
 
3.3.5.4 Effect of strontium addition to AW scaffolds pore size distribution 
Figure 3.26 shows the pore size distributions of scaffolds as calculated by CTAn for 
their open porosity. The CTAn software automatically outputs distributions dividing the 
pore size in fractions that are twice the pixel size: since, for the scaffolds tested here, 
the pixel size was 8.88 µm, the width of each pore size fraction of the distribution was 
17.76 µm.
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Figure 3.26: Pore size distributions of strontium scaffolds as calculated from micro CT data, n=4. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, 
(d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. Error bars indicate the standard deviation .
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For all samples, most pores were included in the range 100-400 µm, which is the 
range recommended for bone scaffolds, as it allows for cell colonisation and bone 
ingrowth (30, 260). All compositions presented a bimodal distribution, with the first 
peak at around 200 µm and the second peak between 310 µm and 380 µm; the 
second peak moved towards bigger pore sizes for samples containing a higher 
amount of strontium. While pores around 200 µm derived from the 90 PPI foam 
template used for producing the scaffolds, the second peak probably derived from 
defects created by uncomplete struts due to uneven coating of foams with the slurry 
during the preparation of samples, as also observed in micro CT images in Figure 3.24 
and SEM images in Figure 3.16. The fact that the bigger pores were larger for higher 
strontium compositions could be the consequence of the different shrinkages that 
samples underwent during their thermal treatment (Section 3.3.1): the smaller their 
shrinkage, the bigger the final pores, with the effect being more evident for larger 
diameters. All compositions also presented a smaller peak in the region 25-45 µm, 
likely deriving from the incomplete fusion of glass during sintering already observed in 
the SEM micrographs in Figure 3.17.  
 
3.3.6 Effect of strontium addition on the mechanical properties of 
porous scaffolds 
Porous scaffolds were tested for compression and biaxial flexural strength. Results are 
presented in Section 3.3.6.1 and 3.3.6.2, respectively. 
 
3.3.6.1 Effect of strontium on compressive strength and elastic modulus 
Figure 3.27 shows the average compressive strength of porous cylindrical scaffolds, 
while Figure 3.28 displays their average Young’s modulus. 
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Figure 3.27: Average compressive strength of porous scaffolds (n=8). Error bars 
represent the standard deviation. No significant difference was found 
between samples (p>0.05). 
 
 
Figure 3.28: Young’s modulus of porous scaffolds (n=8). Error bars indicate the 
standard deviation. *p<0.05, **p<0.005. 
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All samples presented an average compressive strength of about 10 MPa, which is 
within the range suggested for cancellous bone (34, 35). Data were tested for 
significance using one-way ANOVA in OriginPro 2015, but no difference could be 
found (p>0.05). High standard deviations derived from the intrinsic variability of 
scaffolds and their highly porous nature. However, all compositions seemed to 
possess a similar resistance to compression. Considering that samples contained 
different crystal phases depending on their composition (Section 3.3.3), it is possible 
that differences in compressive strength for the six materials under study were 
overcome by their porous structure. 
 
On the contrary, the Young’s modulus of samples decreased with increasing 
strontium, being about 300 MPa for samples AW 0% and about 120 MPa for samples 
AW 37.4%. Composition AW 37.4% was found significantly different from AW 0% and 
AW 6.2% (p<0.05) and AW 12.5% (p<0.005). This suggested that porous samples, 
despite being able to withstand similar stresses in compression, resisted to the 
application of load in a different way, with samples with increasing strontium 
undergoing a larger deformation before fracturing. 
 
 
3.3.6.1.1 Effect of strontium addition to AW porous scaffolds on fracture 
mechanism in compression 
Figure 3.29 and Figure 3.30 show SEM micrographs of fracture surfaces of samples 
tested for compression, at lower and higher magnification, respectively. 
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Figure 3.29: SEM micrographs, imaged from secondary electrons, of the fracture 
surfaces of samples tested for compression, low magnification. (a) AW 0%, 
(b) AW 6.2%, (c) AW 12.5 %, (d) AW 18.7%, (e) AW 24.9%, (f) AW 37.4%. 
Scale bars represent 200 µm. 
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Figure 3.30: SEM micrographs showing details, at higher magnification, of the 
fracture surfaces of the samples displayed in Figure 3.29. Samples imaged 
from secondary electrons. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, (d) AW 
18.7%, (e) AW 24.9%, (f) AW 37.4%. Scale bars represent 10 µm. 
 
Sintering necks could be identified for all samples, but fracture surfaces propagated 
through the densified material. In Figure 3.30, where surfaces are shown at a higher 
magnification, it was possible to observe smoother and rougher areas, which could 
correspond to areas of different crystalline composition or indicated the areas of 
mirror, mist and hackle typical of ceramic fracture. As expected from a ceramic 
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sample, no signs of plastic deformation were visible and cracks likely propagated 
through the crystal grains rather than at grain boundaries. 
3.3.6.2 Effect of strontium on biaxial flexural strength 
Figure 3.31 reports the average biaxial flexural strength, measured from slices 
obtained from the strontium AW porous scaffolds, 15 specimens tested per 
composition. Their Weibull distributions are then shown in Figure 3.32 and their 
Weibull characteristics summarised in Table 3.12. 
 
 
Figure 3.31: Average biaxial flexural strength of porous scaffolds. Error bars 
indicate the standard deviation (n=15). **p<0.005, ***p<0.0005. 
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Figure 3.32: Weibull distributions and fitting trendlines for porous scaffolds 
tested for biaxial flexural strength (n=15). ■ AW 0%, ● AW 6.2%, ▼ AW 
12.5%, ▲ AW 18.7%, ◄ AW 24.9%, ♦ AW 37.4%. 
Table 3.12: Weibull characteristics for porous scaffolds tested for biaxial flexural 
strength, Weibull modulus m and characteristic strength σ0. 
 m σ0 (MPa) 
AW 0% 5.3397 22.6483 
AW 6.2% 3.7692 19.5558 
AW 12.5% 5.6440 15.4532 
AW 18.7% 5.0540 18.3212 
AW 24.9% 4.4983 19.0132 
AW 37.4% 4.4561 16.1502 
 
The biaxial flexural strength for all compositions was between 14 and 21 MPa, thus 
higher than the corresponding compressive strengths. Samples AW 12.5% and AW 
37.4% had significantly lower strength than AW 0% (p<0.0005 and p<0.005, 
respectively). This could be also seen from their Weibull distributions, for which these 
two compositions had lower Weibull characteristic strength, while AW 0% had the 
highest: 22.6 MPa. On the contrary, the Weibull moduli ranged from 3.7 to 5.6, with 
samples AW 6.2% showing the lowest and samples AW 12.5% giving the highest. 
Therefore, scaffolds AW 6.2% had the highest dispersion of values for their biaxial 
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flexural strength results and scaffolds AW 12.5% were the least dispersed, but 
samples AW 0% had the lowest probability of failure at a set flexural stress. 
 
3.3.6.2.1 Effect of strontium addition to AW porous scaffolds on fracture 
mechanism in flexure 
SEM micrographs of the fracture surfaces of samples tested for biaxial flexural 
strength are shown in Figure 3.33 and Figure 3.34, at lower and higher magnification, 
respectively. 
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Figure 3.33: SEM micrographs, imaged from secondary electrons, of the fracture 
surfaces of samples tested for biaxial flexural strength, taken at low 
magnification. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, (d) AW 18.7%, (e) 
AW 24.9%, (f) AW 37.4%. Scale bars represent 200 µm. 
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Figure 3.34: SEM micrographs showing details, at higher magnification, of the 
fracture surfaces of the samples displayed in Figure 3.33. Samples imaged 
from secondary electrons. (a) AW 0%, (b) AW 6.2%, (c) AW 12.5 %, (d) AW 
18.7%, (e) AW 24.9%, (f) AW 37.4%. Scale bars represent 10 µm. 
 
Fracture surfaces of samples tested for biaxial flexural strength appeared very similar 
to those observed for samples tested in compression (Figure 3.29 and Figure 3.30 in 
Section 3.3.6.1.1). The cracks propagated through particles, where visible, or through 
the dense material. Areas of different crystalline compositions could also be seen. The 
similarity in the aspect of fracture surfaces in compression and in flexure was due to 
the combination of the intrinsic brittle nature of the materials and their highly porous 
structure. In fact, because the struts of the porous samples had random orientations, 
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forces applied in compression to the samples were transmitted as tensile and flexural 
stresses to the struts, which actually caused failure. 
 
3.3.7 Effect of strontium on the apatite-forming ability of strontium-
containing AW glass-ceramic samples 
The apatite-forming ability of the materials under study was first assessed on solid 
discs (Section 3.3.7.1) and then verified on porous scaffolds (Section 3.3.7.2). 
 
3.3.7.1 Effect of strontium on the apatite forming ability of solid discs 
3.3.7.1.1 Variation of SBF pH during soaking of discs 
pH changes were monitored throughout the experiment and Figure 3.35 summarises 
the results for the six strontium compositions tested. 
 
 
Figure 3.35: pH changes in SBF during soaking of solid discs. ■ AW 0%, ● AW 
6.2%, ▲ AW 12.5%, ▼ AW 18.7%, ♦ AW 24.9%, ◄ AW 37.4%,  SBF solution. 
Error bars indicate the standard deviation (n=3). 
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After immersing the solid discs, the pH of the SBF solution changed due to ionic 
release and exchange. Compared to its initial value of 7.40, it first increased for all 
samples, becoming 7.50 to 7.55 for all compositions after 1 day. It then increased 
further for samples AW 24.9% and AW 37.4% to 7.60 within 7 days and did not 
change at the 14 day time-point. For samples AW 0% to AW 18.7%, it decreased after 
day 1 and reached values lower than the reference in the case of samples AW 0% and 
AW 12.5%, for which it was found 7.37 and 7.38, respectively. In general, variations of 
pH were small for all samples, with values remaining in the range 7.37 to 7.62. This 
could be due to the high volume of SBF used for each sample, chosen in order to 
avoid saturation of the solution and therefore spontaneous precipitation of apatite 
crystals instead of material-led bioactivity. 
3.3.7.1.2 Surface morphology of discs during SBF soaking 
Samples were tested for 1, 3, 7 and 14 days and their surface changes were 
monitored using SEM. Micrographs taken at the different time-points are shown in 
Figure 3.36 to Figure 3.41 for compositions AW 0% to AW 37.4%, looking for 
deposited apatite. 
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Figure 3.36: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 0% solid discs upon soaking in SBF solution. (a) Disc as such, (b) 1 
day soaking, (c) 3 days soaking, (d) 7 days soaking, (e) 14 days soaking, (f) 
higher magnification of the 14 day sample surface. Error bars in (a-e) 
represent 20 µm; the error bar in (f) represents 5 µm. 
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Figure 3.37: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 6.2% solid discs upon soaking in SBF solution. (a) Disc as such, (b) 
1 day soaking, (c) 3 days soaking, (d) 7 days soaking, (e) 14 days soaking, 
(f) higher magnification of the 14 day sample surface. Error bars in (a-e) 
represent 20 µm; the error bar in (f) represents 5 µm. 
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Figure 3.38: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 12.5% solid discs upon soaking in SBF solution. (a) Disc as such, (b) 
1 day soaking, (c) 3 days soaking, (d) 7 days soaking, (e) 14 days soaking, 
(f) higher magnification of the 14 day sample surface. Error bars in (a-e) 
represent 20 µm; the error bar in (f) represents 5 µm. 
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Figure 3.39: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 18.7% solid discs upon soaking in SBF solution. (a) Disc as such, (b) 
1 day soaking, (c) 3 days soaking, (d) 7 days soaking, (e) 14 days soaking, 
(f) higher magnification of the 14 day sample surface. Error bars in (a-e) 
represent 20 µm; the error bar in (f) represents 5 µm. 
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Figure 3.40: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 24.9% solid discs upon soaking in SBF solution. (a) Disc as such, (b) 
1 day soaking, (c) 3 days soaking, (d) 7 days soaking, (e) 14 days soaking, 
(f) higher magnification of the 14 day sample surface. Error bars in (a-e) 
represent 20 µm; the error bar in (f) represents 5 µm. 
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Figure 3.41: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 37.4% solid discs upon soaking in SBF solution. (a) Disc as such, (b) 
1 day soaking, (c) 3 days soaking, (d) 7 days soaking, (e) 14 days soaking, 
(f) higher magnification of the 14 day sample surface. Error bars in (a-e) 
represent 20 µm; the error bar in (f) represents 5 µm. 
 
Changes of surface appearance suggested that only samples AW 0% and AW 18.7% 
underwent the deposition of apatite crystals after as early as 1 day of soaking in SBF 
solution. After 3 days of immersion, also composition AW 12.5% was covered in 
apatite. For these three compositions, the layer grew over the time-points becoming 
thicker. High magnification micrographs in panel (f) of Figure 3.36, Figure 3.38 and 
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Figure 3.39 showed the typical morphology of hydroxyapatite deposited on AW 0%, 
AW 12.5% and AW 18.7% discs from SBF solution, respectively, with needle and 
plate-like crystals as in the cauliflower structures often observed in apatite formation 
studies. However, crystals on samples AW 18.7% appeared smaller than those on 
samples AW 0% and AW 12.5%, suggesting that their growth could have been slower 
or, being samples AW 18.7% richer in strontium, that a different apatite was deposited. 
No deposition was observed on samples AW 6.2%, AW 24.9% and AW 37.4%, 
although a modification of their surface could be observed. In samples AW 6.2%, 
darker areas appeared with increasing soaking time, which could indicate that some 
zones with a different molecular composition were exposed over time. Changes in the 
surface appearance in samples AW 24.9% and AW 37.4% were stronger, with their 
ceramic phases becoming more evident. This could suggest that, in these samples, 
the residual glass phase was preferentially dissolved in the solution, leaving behind 
their ceramic phases. While the lack of apatite formation for samples AW 24.9% and 
AW 37.4% could be inferred from the pH readings (Figure 3.35), this was not expected 
for samples AW 6.2%, whose behaviour in SBF solution needs further investigation. 
3.3.7.1.3 Surface composition of strontium AW discs after soaking in SBF 
Data in Table 3.13 to Table 3.18 report the EDS atomic compositions (10 kV) of the 
surface of the same samples tested for apatite forming ability, which were shown in 
Figure 3.36 to Figure 3.41. 
Table 3.13: EDS atomic composition (at%) of AW 0% solid discs soaked in SBF 
solution over time. 
Atom 0 days 1 day 3 days 7 days 14 days 
Si 31.34 24.01 9.52 0.40 0.55 
Mg 4.28 4.10 2.95 2.04 2.25 
F 2.29 2.50 1.84 2.07 1.87 
Ca 46.34 48.40 54.20 55.92 55.94 
P 15.75 20.99 31.49 39.57 39.29 
Sr 0.00 0.00 0.00 0.00 0.10 
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Table 3.14: EDS atomic composition (at%) of AW 6.2% solid discs soaked in SBF 
solution over time. 
Atom 0 days 1 day 3 days 7 days 14 days 
Si 31.46 30.85 30.67 30.53 30.36 
Mg 4.35 5.31 4.97 5.35 5.08 
F 1.92 2.15 1.54 1.12 1.42 
Ca 41.22 41.46 41.57 42.30 41.81 
P 15.80 15.02 15.96 14.96 15.34 
Sr 5.25 5.21 5.29 5.74 5.99 
 
Table 3.15: EDS atomic composition (at%) of AW 12.5% solid discs soaked in 
SBF solution over time. 
Atom 0 days 1 day 3 days 7 days 14 days 
Si 30.78 26.29 16.84 0.41 0.81 
Mg 5.19 4.31 2.85 1.94 1.97 
F 2.63 2.97 3.54 2.03 1.65 
Ca 35.85 37.93 42.12 56.55 54.69 
P 14.83 13.07 23.12 39.05 40.67 
Sr 10.72 15.43 11.53 0.02 0.21 
 
Table 3.16: EDS atomic composition (at%) of AW 18.7% solid discs soaked in 
SBF solution over time. 
Atom 0 days 1 day 3 days 7 days 14 days 
Si 31.43 25.71 15.19 2.42 0.31 
Mg 4.90 5.06 2.55 2.26 1.94 
F 1.82 1.79 3.61 3.19 2.37 
Ca 31.66 33.29 36.10 47.96 52.18 
P 14.12 19.08 19.37 38.14 39.91 
Sr 16.07 15.07 23.18 6.03 3.29 
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Table 3.17: EDS atomic composition (at%) of AW 24.9% solid discs soaked in 
SBF solution over time. 
Atom 0 days 1 day 3 days 7 days 14 days 
Si 33.18 23.98 20.95 25.38 18.55 
Mg 5.64 4.35 3.33 5.14 3.55 
F 1.84 3.51 3.98 1.62 4.10 
Ca 23.71 26.12 27.20 26.01 27.30 
P 14.04 14.55 16.04 22.28 18.09 
Sr 21.59 27.49 28.50 19.57 28.41 
 
Table 3.18: EDS atomic composition (at%) of AW 37.4% solid discs soaked in 
SBF solution over time. 
Atom 0 days 1 day 3 days 7 days 14 days 
Si 30.73 24.64 23.40 19.69 14.92 
Mg 4.72 6.46 5.47 5.06 4.26 
F 2.05 1.93 1.70 1.14 1.71 
Ca 12.55 15.86 17.12 20.60 22.84 
P 16.82 21.00 22.90 26.07 30.16 
Sr 33.13 30.11 29.41 27.44 26.11 
 
Variations in surface composition reflected what observed with SEM micrographs: 
samples AW 0%, AW 12.5% and AW 18.7% changed their composition as the apatite 
layer grew, increasing in calcium and phosphorus and reducing the amount of silicon, 
magnesium and strontium. No relevant changes could be seen for samples AW 6.2%, 
which maintained their composition throughout the two weeks of testing. An increase 
in calcium and phosphorus, along with a decrease in silicon, magnesium and strontium 
could also be observed for samples AW 24.9% and AW 37.4%, suggesting that a 
bioactive ionic exchange took place for these compositions as well, although it was 
slower and not strong enough to see the formation of the apatite layer during imaging 
(Figure 3.40 and Figure 3.41, respectively). The stoichiometric 1.67 
calcium:phosphorus ratio of hydroxyapatite could not be found for any of the samples; 
however, samples AW 0% reached the value of 1.72, 1.41 and 1.42 after 3, 7 and 14 
days respectively, while for samples AW 12.5% it was found 1.82, 1.45 and 1.34 after 
3, 7 and 14 days respectively. It is therefore possible that the deposited apatite was 
actually a calcium-deficient hydroxyapatite, or that the variation from the expected 
value was due to instrumental error. In samples AW 18.7%, a small amount (3.29 at%) 
of strontium was still detected after 14 days of soaking, while it was 0.21 at% for AW 
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12.5%. This could mean that the deposited layer was a strontium-hydroxyapatite for 
composition AW 18.7%, which could also be the reason for the crystal morphology 
looking slightly different in Figure 3.39. 
3.3.7.1.4 Ionic release from strontium AW discs during soaking in SBF 
The ion release from solid discs was measured from the SBF solution, collected after 
soaking at each time-point, using ICP-OES and results are summarised in Figure 3.42. 
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Figure 3.42: ICP-OES ion release measured from solid discs soaked in SBF 
solution for up to 2 weeks. (a) Calcium, (b) phosphorus, (c) strontium, (d) 
silicon, (e) magnesium. ■ AW 0%, ● AW 6.2%, ▲ AW 12.5%, ▼ AW 18.7%, ♦ 
AW 24.9%, ◄ AW 37.4%. Error bars indicate the standard deviation (n=3). 
 
For all five ions tested (calcium, phosphorus, strontium, silicon and magnesium), little 
variations could be found in their concentration for compositions AW 0%, AW 6.2% 
and AW 12.5% compared to SBF as such (values at the 0 day time-point on the 
graphs). In particular, calcium and phosphorus slightly decreased from the baseline, 
no release of strontium could be detected and silicon and magnesium remained at 
similar concentrations compared to the initial SBF. For composition AW 18.7%, 
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calcium remained unvaried, phosphorus decreased the most, by 0.4 mM, strontium 
and silicon were progressively released with time up to 0.2 and 0.6 mM, respectively, 
while magnesium also remained unvaried. Samples AW 24.9% and AW 37.4% 
induced the highest release for all the tested ions: calcium, strontium, silicon and 
magnesium all increased, while phosphorus decreased by about 0.3 mM for both 
samples. In general, the concentration of strontium followed the expected trend, 
increasing with time and with the amount of strontium oxide in the samples. The fact 
that compositions AW 24.9% and AW 37.4% gave the highest release corresponded 
with the SEM and EDS results presented in Figure 3.40, Figure 3.41, Table 3.17 and 
Table 3.18, from which it was hypothesised a prolonged dissolution of the material 
allowed by the delayed formation of the apatite layer. The decrease in phosphorus 
concentration in the solution indicated that this ion was consumed by the soaked 
samples for their bioactivity process. The lack of detected release for samples AW 0% 
and AW 12.5% could be due to the formation of the apatite layer slowing down further 
ion release. Although samples AW 6.2% behaved similarly to AW 0% and AW 12.5% 
in terms of ion release, they did not show any sign of apatite forming during SEM 
imaging nor EDS compositional analysis, therefore further investigations would be 
required for this disc composition. 
 
3.3.7.2 Effect of strontium on the apatite forming ability of porous 
scaffolds 
3.3.7.2.1 Variation of SBF pH during soaking of porous scaffolds 
Bioactivity was also tested on porous scaffolds, with soaking times of 1 day, 7 days 
and 14 days. Figure 3.43 shows the pH variation of the SBF solution during testing. 
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Figure 3.43: pH changes in SBF during soaking of porous scaffolds. ■ AW 0%, ● 
AW 6.2%, ▲ AW 12.5%, ▼ AW 18.7%, ♦ AW 24.9%, ◄ AW 37.4%,  SBF 
solution. Error bars indicate the standard deviation (n=3). 
 
The pH did not vary significantly for compositions AW 0%, AW 6.2% and AW 12.5%, 
which maintained a physiological pH around 7.43 throughout the whole experiment. 
On the contrary, the pH of samples AW 18.7%, AW 24.9% and AW 37.4% increased 
with time, with compositions containing more strontium leading to a higher increase in 
pH. For samples AW 18.7%, the pH was 7.46 after 1 day of soaking, 7.53 after 7 days 
and 7.57 after 14 days; for samples AW 24.9% it was 7.47 after 1 day, 7.60 after 7 
days and 7.66 after 14 days, while for samples AW 37.4% it was 7.49 after 1 day, 7.62 
after 7 days and 7.71 after 14 days. This was different from what observed with flat 
solid discs (Figure 3.35), where pH either decreased or maintained the value reached 
at 7 days. These results for the porous scaffolds suggested that the three lower 
strontium compositions maintained an ionic equilibrium in the solution, while the three 
higher compositions kept dissolving and releasing ions over time. It must be noted that 
the pH measurements presented here described the general variations in the whole 
volume of SBF (30 mL), while bioactivity phenomena happen locally near the surface 
of the soaked sample. As it will be explained with the following pictures, in the case of 
porous scaffolds the growth of the apatite layer could only be observed for inner struts, 
suggesting that the conditions for the formation of apatite were reached only in a more 
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enclosed environment. In addition, as it was the case for the solid discs, the early 
formation of apatite in the samples could have prevented the further release of ions, 
keeping the pH of the SBF solution stable, while this did not happen for samples with a 
slower bioactivity behaviour, i.e. AW 18.7%, AW 24.9% and AW 37.4%. 
3.3.7.2.2 Surface morphology of porous scaffold struts after soaking in SBF 
Pictures in Figure 3.44 to Figure 3.49 are the SEM micrographs of scaffold struts at 
the different time-points of soaking in SBF solution. As mentioned before, the struts 
shown in the pictures are inner struts, as apatite could not be detected on outer struts 
for these samples. For this reason, the EDS signal could not be recorded, which would 
have provided compositional information about the deposited layer. 
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Figure 3.44: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 0% porous scaffolds upon soaking in SBF solution. (a) Scaffold as 
such, (b) 1 day of soaking, (c) 7 days of soaking, (d) higher magnification of 
the 7 day sample surface, (e) 14 days of soaking, (f) higher magnification of 
the 14 day sample surface. Error bars in (a-c, e) represent 20 µm; error bars 
in (d, f) represent 5 µm. 
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Figure 3.45: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 6.2% porous scaffolds upon soaking in SBF solution. (a) Scaffold as 
such, (b) 1 day of soaking, (c) 7 days of soaking, (d) higher magnification of 
the 7 day sample surface, (e) 14 days of soaking, (f) higher magnification of 
the 14 day sample surface. Error bars in (a-c, e) represent 20 µm; error bars 
in (d, f) represent 5 µm. 
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Figure 3.46: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 12.5% porous scaffolds upon soaking in SBF solution. (a) Scaffold 
as such, (b) 1 day of soaking, (c) 7 days of soaking, (d) higher 
magnification of the 7 day sample surface, (e) 14 days of soaking, (f) higher 
magnification of the 14 day sample surface. Error bars in (a-c, e) represent 
20 µm; error bars in (d, f) represent 5 µm. 
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Figure 3.47: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 18.7% porous scaffolds upon soaking in SBF solution. (a) Scaffold 
as such, (b) 1 day of soaking, (c) 7 days of soaking, (d) higher 
magnification of the 7 day sample surface, (e) 14 days of soaking, (f) higher 
magnification of the 14 day sample surface. Error bars in (a-c, e) represent 
20 µm; error bars in (d, f) represent 5 µm. 
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Figure 3.48: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 24.9% porous scaffolds upon soaking in SBF solution. (a) Scaffold 
as such, (b) 1 day of soaking, (c) 7 days of soaking, (d) higher 
magnification of the 7 day sample surface, (e) 14 days of soaking, (f) higher 
magnification of the 14 day sample surface. Error bars in (a-c, e) represent 
20 µm; error bars in (d, f) represent 5 µm. 
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Figure 3.49: SEM micrographs, imaged from secondary electrons, of the surface 
of AW 37.4% porous scaffolds upon soaking in SBF solution. (a) Scaffold 
as such, (b) 1 day of soaking, (c) 7 days of soaking, (d) higher 
magnification of the 7 day sample surface, (e) 14 days of soaking, (f) higher 
magnification of the 14 day sample surface. Error bars in (a-c, e) represent 
20 µm; error bars in (d, f) represent 5 µm. 
 
All samples except AW 37.4% formed apatite on their struts within the two weeks of 
testing. As predicted from the pH results (Figure 3.43), samples AW 0%, AW 6.2% and 
AW 12.5% showed the formation of apatite after only 1 day of soaking in SBF solution. 
AW 18.7% was covered by a thick layer after 7 days, while AW 24.9% started to form 
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apatite between 7 and 14 days of soaking. As seen with the solid discs (Figure 3.41), 
in scaffolds AW 37.4% the sample surface changed over time so that crystals that 
were already present in the material became more evident, indicating that the 
remaining glass phase, being less stable compared to the crystal phases, dissolved 
preferentially. In addition, as previously observed for the flat discs as well, the 
morphology of the deposited apatite layer on samples AW 18.7% looked different than 
the morphology found on samples AW 0%, AW 6.2% and AW 12.5%: crystals looked 
thinner and smaller, giving a finer texture to the coating layer. As proposed basing on 
the results of Table 3.16, it is possible that in the case of samples AW 18.7% the 
deposited layer was actually a strontium-containing hydroxyapatite. In addition, 
observing the higher tendency to form cracks and the fact that the coating layer looked 
like it was almost detaching from the surface underneath, it could be that the addition 
of strontium in the samples caused the bioactivity process to follow a different 
mechanism, with the formation of a silica gel (more prone to cracking) that was not 
expected for the proposed original bioactivity mechanism reported for the AWGC 
material, which was described in Chapter 1. 
 
3.3.8 Effect of strontium content on the radiopacity of AW porous 
samples 
Radio density of samples was tested on 1.5 mm slices of scaffolds previously tested 
for biaxial flexural strength and on small cubic samples produced for tissue culture. 
Figure 3.50 shows the x-ray pictures used for calculating the radiopacity of the six 
compositions under study, while Table 3.19 and Table 3.20 report the average results 
for these two sets of samples, including the relative intensity compared to the no-
strontium AW 0% sample, then summarised in Figure 3.51. 
 
131 
 
 
Figure 3.50: X-ray images of porous samples used to calculate their radiopacity, 
three repeats per set (i-iii). (a) Slices previously tested for biaxial flexural 
strength, (b) cubic scaffolds. 
 
Table 3.19: Average pixel intensity (a.u.) of slices of porous scaffolds measured 
from the x-ray images in Figure 3.50a.i-iii, with relative intensity to AW 0% 
samples. 
 Average St. dev. 
Relative 
intensity 
AW 0% 15.76 2.09 1.00 
AW 6.2% 24.21 3.23 1.54 
AW 12.5% 31.10 3.03 1.97 
AW 18.7% 37.06 4.95 2.35 
AW 24.9% 44.09 4.17 2.80 
AW 37.4% 50.07 2.77 3.18 
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Table 3.20: Average pixel intensity (a.u.) of cubic porous scaffolds measured 
from the x-ray images in Figure 3.50b.i-iii, with relative intensity to AW 0% 
samples.  
 Average St. dev. 
Relative 
intensity 
AW 0% 33.50 5.07 1.00 
AW 6.2% 49.41 5.83 1.47 
AW 12.5% 62.27 7.24 1.86 
AW 18.7% 65.39 5.51 1.95 
AW 24.9% 77.88 2.32 2.32 
AW 37.4% 82.52 3.81 2.46 
 
 
Figure 3.51: Radiopacity of porous scaffold slices and cubic porous scaffolds, 
as measured from the average pixel intensity of sample radiographs. Error 
bars indicate the standard deviation (n=3). Fitting trendlines are shown 
with corresponding equations and R-square values. 
 
The increase in radiopacity with the increase in strontium in the samples was evident 
by eye from the pictures taken and then proven by the intensity measurements. 
Because the cubic samples pictured in Figure 3.50b.i-iii were thicker than the slices in 
Figure 3.50a.i-iii, their intensities reported in Table 3.20 and plotted in Figure 3.51 
were higher than those of the thin slices of Table 3.19. However, the pixel intensity 
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relative to the no-strontium composition AW 0% was higher for the thin slices in all the 
strontium samples, meaning that the contrast between AW 0% and AW 37.4% was 
higher in the case of the thin slices than the cubic scaffolds. In the case of the cubic 
porous scaffolds, in some of the samples it was also possible to identify the presence 
of defects, visible as areas darker than the rest of the sample, indicating an imperfect 
coating of the original struts of the foam with the slurry during the foam replication 
process. The increase in radiopacity was found linear for both series of samples, with 
a better fitting of the trendline in the case of the scaffold slices (R2=0.97) compared to 
the cubic scaffolds (R2=0.86). 
3.4 Discussion 
This chapter described and presented the production and the characterisation of 
porous 3D scaffolds for bone regeneration, made using the AWGC material modified 
with strontium. The technique chosen for this work was the foam (or sponge) 
replication method, first used with hydroxyapatite by Tian and Tian in 2001 (79) and 
then transferred to glass-ceramics in 2006 (80, 81), but never applied to strontium-
containing apatite-wollastonite before. The parent glasses used for producing the 
scaffolds were described in Chapter 2. 
The foam replication method combines the use of a template that presents an 
interconnected porosity with the sintering and crystallisation of the glass particles used 
and it has been widely described in the literature since 2006. Different authors used 
Bioglass 45S5 in combination with the foam replication method, such as Boccaccini et 
al. (261), Bretcanu et al. (83), Baino et al. (258) and Li et al., who then coated the 
scaffolds with a vancomycin-containing polymer (262). Vitale-Brovarone et al. 
prepared foam-replicated scaffolds using a bioactive glass belonging to the SiO2-P2O5-
CaO-MgO-Na2O-K2O system named CEL2 (98), comparing CEL2 with ICEL2, which 
had inverted silica and phosphorus oxide molar amounts (257), or with SCNA (263), a 
glass-ceramic in the system SiO2-CaO-Na2O-Al2O3 used to create a porous coating on 
dense alumina. Fu et al. applied the foam replication method to the 13-93 glass of 
composition 53SiO2-6Na2O-12K2O-5MgO-CaO-4P2O5 wt% (95), while Erol at al. and 
Fu et al. applied it to a boron-containing and a borate glass, respectively (264, 265). 
After the first sponge replication by Tian and Tian in 2001 (79), also Tripathi and Basu 
used hydroxyapatite for the preparation of porous bone-like scaffolds (82), while Vitale 
Brovarone et al. used a fluorapatite-containing glass-ceramic with nominal composition 
50SiO2-18CaO-9CaF2-7Na2O-7K2O-6P2O5-3MgO mol%, then modified with silver to 
impart antibacterial properties to the constructs (266). Some authors proposed the use 
of marine natural sponges instead of the polyurethane foams generally utilised. For 
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example, Boccardi et al. used natural foams in combination with 45S5 Bioglass (267), 
while Wang et al. used natural sponges to create hierarchically porous scaffolds 
containing macro and mesopores through the combination of the foam replication 
method with the sol-gel production of glasses (268). Also other authors described 
scaffolds with a hierarchical porosity, either produced by coating foams with the early-
stage solution of sol-gel glasses such as Li et al. (269), or using an electrophoretic 
deposition approach like Fiorilli et al., in order to deposit mesoporous glass particles 
on macroporous scaffolds (270). More related to the apatite-wollastonite material used 
in the present thesis, Jun et al. described the production of hydroxyapatite sponge-
replicated scaffolds coated with apatite-wollastonite in a multi-step foam replication 
procedure (84), whereas Serna optimised the composition of the slurry for the 
production of apatite-wollastonite porous scaffolds (121). In addition, Ni et al. produced 
macroporous wollastonite scaffolds and compared them with β-TCP scaffolds using 25 
PPI foams (271), while Kunjalukkal Padmanabhan et al. prepared 
hydroxyapatite/wollastonite composite porous scaffolds starting from ceramic powders 
of the two components mixed in the slurry, then using 25 PPI sponges as templates 
and sintering their samples at 1300 °C (272). However, no author described the use of 
strontium-containing apatite-wollastonite for 3D porous, foam-replicated scaffolds.  
 
3.4.1 Strontium content in AW glass-ceramic scaffolds influences 
shrinkage and sintering 
The addition of strontium to the starting apatite-wollastonite material caused its 
shrinkage to linearly decrease during thermal treatment with the increase of strontium, 
when all sample compositions were treated at 1050 °C for 2 h. This could be due to a 
reduction in the degree of sintering for the glass particles. In fact, as observed in the 
SEM micrographs in Section 3.3.4, the original particles constituting the material were 
still partially visible for compositions with higher strontium. Massera and Hupa (273) 
and Kapoor et al. (274) observed a reduction in the sintering temperature with 
increasing strontium or strontium and zinc substitution in silica-based glasses, 
respectively. The sintering temperature is usually obtained by testing the samples with 
hot stage microscopy (HSM) and it is defined as the temperature at which the height of 
the sample is reduced to 95% of its starting height during heating (273). Bellucci et al. 
did not observed any change in volume shrinkage of their CaO-rich silicate bioactive 
glass when substituting 10 mol% of CaO with SrO and/or MgO; however, they treated 
each sample at their specific sintering temperature found using HSM (275). In another 
study, the same research group doped a tricalcium phosphate (TCP) cement with 
strontium and/or magnesium: the authors did not find differences in the sintering 
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behaviour of samples depending on their composition, although they observed an 
increase in the residual porosity when samples were fired at a higher temperature 
(276). As explained also by other authors, this could happen because the onset of 
crystallisation could hinder further sintering, especially at low (below 700 °C) 
temperatures (277, 278). This observation corresponds with the results found for the 
materials under study in the present thesis during the DSC testing reported in Chapter 
2. In fact, it was found that the onset of the first crystallisation, indicating the formation 
of the apatite phase, decreased with increasing strontium; therefore, the earlier onset 
of apatite could have hindered the sintering of the glass particles. This suggested that 
a composition-specific thermal treatment might be required for the materials under 
study, in order to adjust the volumetric shrinkage of samples and improve the sintering 
of glass particles. A sintering step could also be required, consisting of holding the 
temperature at a specific temperature determined through HSM, before further heating 
could be applied for a controlled crystallisation. As displayed in the SEM micrographs, 
in samples with a higher amount of strontium (AW 24.9% and AW 37.4%) the original 
glass particles were still visible, although smoothened and connected with wide 
sintering necks in both solid discs (Figure 3.14) and porous scaffolds (Figure 3.17). 
For the porous scaffolds, this also led to the formation of struts that looked incomplete 
or hollow, while this phenomenon was less important in lower strontium compositions. 
The formation of hollow struts during foam replication has been widely described in the 
literature, not only for Bioglass 45S5 (80, 258, 279), but also for other ceramic and 
glass-ceramic materials such as mullite (280), titania (281), a biphasic calcium 
phosphate (hydroxyapatite and β-TCP) (282) and a complex glass-ceramic derived 
from glass wastes (283). Although these defects are expected to cause a reduction in 
the mechanical properties of the constructs, this effect was not observed for the 
samples tested in this work, as it will be further discussed in Section 3.4.5. On the 
contrary, an effect on the different degree of shrinkage and sintering of samples could 
be observed on the porosity of scaffolds: as shown in Figure 3.26, the second peak in 
the pore size distributions calculated from micro CT data moved towards bigger 
diameters with the increase of strontium content, from 310 to 380 µm, as differences in 
volume were likely more easily detected on larger pores. 
 
3.4.2 Strontium addition increases the density of AW glass-
ceramics 
The density of the ground glass ceramic scaffolds increased with increasing strontium, 
as it was already observed for the glass samples before the thermal treatment, 
reported in Chapter 2. A linear trend was found again, with densities after the 
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treatment being slightly higher than in the respective parent glasses for compositions 
AW 0% to AW 18.7%, while they were slightly lower for compositions AW 24.9% and 
AW 37.4%. This similarity could indicate that the atomic rearrangement due to heating 
was balanced by the formation of the crystal phases, which either had similar densities 
to the starting glass or balanced each other in the whole final glass-ceramic sample. In 
fact, a crystal phase might have a significantly higher or lower density than the starting 
glass, to the point that density could be used to measure the degree of crystallisation 
of a glass-ceramic (284), because the generated phase could move the density of the 
final glass-ceramic towards higher or lower values. In the case of the apatite-
wollastonite material under study, Kokubo reported a density of 3.078 g/cm3 for the 
AW 0% composition (103), which is slightly higher to what found in this study (3.002 
g/cm3) and could be due to the slower heating rate they used during crystallisation: 5 
°C/min instead of the 10 °C/min applied to the samples in this thesis. The density of 
the individual phases, apatite and wollastonite, could be found in the literature: while 
the density of apatite is higher than the measured density of the final AW 0% sample, 
3.156 g/cm3 (285), the density of wollastonite is lower, 2.92 g/cm3 (284). Hence, in the 
case of the AW 0% material under study, one crystal phase was denser than the 
starting glass and the other was less dense, thus balancing each other and giving, 
along with the remaining glass phase, only a little difference from the density of the 
starting glass. It can therefore be assumed that the same happened for the other 
compositions. For samples AW 24.9% and AW 37.4%, they contained higher strontium 
than the other compositions and their final densities were slightly lower than those 
found for their glasses. This could be due to the fact that strontium causes an 
enlargement of the atomic network, as seen with the parent glasses in Chapter 2; 
apatite preferentially picks up strontium, compared to the silicate phase, which likely 
reduces its density and hence the overall density also decreases. 
 
3.4.3 The addition of strontium to AW affects the crystal phases 
formed during thermal treatment 
XRD results of the AW 0% samples confirmed that they contained apatite and 
wollastonite. In particular, the matching phases that were found with X’Pert Highscore 
Plus were hydroxyapatite (ICDD 00-064-0738) and wollastonite 2M (ICDD 00-066-
0271). This is in slight contrast with what Vickers found for the same composition, 
which was fluorapatite (ICDD 04-009-4021), instead of hydroxyapatite (186). However, 
it is in closer agreement with the description of the same material by Kokubo et al., 
who found that the precipitated phases were oxy- or fluorapatite (Ca10(PO4)6(O, F2)) 
and β-wollastonite (CaSiO3) (85). In fact, because of the very small amount of CaF2 
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contained in the parent glass (0.4 mol%), it is not possible that all the apatite phase 
that formed was fluorapatite, although the small amount that formed proved to be 
enough to be detected by x-ray diffraction. β-wollastonite is another name for 
wollastonite 2M and is the low temperature form of wollastonite. In fact, wollastonite 
undergoes a phase transformation, β to α (also called pseudowollastonite), when 
heated above 1200 °C (271, 286, 287). The two phases have different XRD patterns, 
as shown in Figure 3.52, and are both biodegradable. Ni et al. compared wollastonite 
to β-TCP and showed that wollastonite was bioactive, that α-wollastonite degraded 
more quickly than β-TCP, that bone-like cells attached better to β-wollastonite than α-
wollastonite and better to α-wollastonite than β-TCP. Although the authors suggested 
that this could be due to the difference in surface roughness of the samples, they 
concluded that both types of wollastonite could be good candidates for bone implants, 
as long as the degradation rate would be kept under control (271, 287).  
 
 
Figure 3.52: Comparison between the ICDD reference patterns for wollastonite 
2M (β-wollastonite, top) and pseudowollastonite (α-wollastonite, bottom). 
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The modification of the initial AW 0% composition by the addition of strontium caused 
a progressive change in the XRD patterns recorded from the samples. In particular, it 
appeared that strontium interacted mainly with the apatite phase, starting from sample 
AW 6.2%, while a strontium-containing silicate could be found only for samples AW 
24.9% and AW 37.4%. In fact, the wollastonite phase detected was wollastonite 2M (β-
wollastonite, ICDD 00-066-0271) for samples AW 0% and AW 6.2%, it then shifted to 
diopside (calcium magnesium silicate, CaMgSi2O6, ICDD 04-011-6810) for sample AW 
12.5%, it became pseudowollastonite (α-wollastonite, ICDD 04-012-1764) for sample 
AW 18.7% and eventually turned into calcium magnesium strontium silicate (ICDD 01-
083-5061, (CaSr)Mg(Si2O7)) for samples AW 24.9% and AW 37.4%. On the other side, 
the apatite phase became a strontium apatite (Ca7.7Sr2.3)(PO4)6(OH)2 (ICDD 01-089-
5632) with sample AW 6.2% and then moved to a strontium apatite with a higher 
content of strontium ((Ca3.6Sr6.4)(PO4)6(OH)2, ICDD 01-089-5633) from sample AW 
12.5% and higher. A change in shape and height of peaks was also observed with the 
addition of strontium, in particular with the apatite peak becoming higher and narrower 
with the increasing strontium. This effect could be explained by the fact that strontium 
was more electron dense than calcium (186), thus giving a stronger signal, as also 
found by Lotfibakhshaiesh et al. (237). Because wollastonite did not acquire strontium 
as quickly as apatite, this altered the height ratio of peaks for the two phases and the 
apatite signal became predominant in the higher strontium compositions. These 
results can be related to the findings from the DSC analyses run on the glass powders. 
In fact, DSC results presented in Chapter 2 showed that, while the formation peak of 
apatite moved to lower temperatures with higher strontium, the formation of the silicate 
phase shifted towards higher temperatures. It is therefore likely that the first crystal 
phase that formed, apatite, started consuming the bivalent cations, calcium and 
strontium, thus depleting the remaining material and therefore delaying the formation 
of the silicate phase, making it shift to different phases and incorporate magnesium. 
In the literature, it has been widely shown that strontium substitution for calcium can 
cause changes in the XRD patterns detected from glass-ceramic samples. Hill et al. 
observed that a glass in the SiO2-Al2O3-P2O5-CaO-CaF2 system gave fluorapatite and 
mullite when no or 50 mol% of CaO was substituted with SrO, but when the 
substitution was 100 mol% then the XRD shifted towards lower 2θ, without 
corresponding to neither calcium or strontium fluorapatite; this was explained by 
suggesting that a solid solution of strontium/calcium apatite formed, with about 55 
mol% of calcium apatite. Changes were attributed to the larger diameter of the 
strontium ion, also supposed to cause the shift from bulk to surface nucleation of the 
apatite phase (235). Lotfibakhshaiesh et al. reported that a SiO2-P2O5-CaO-SrO-Na2O-
K2O-MgO-ZnO glass, when treated at 900 °C, formed wollastonite if no strontium was 
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present and gave a strontium silicate (SrSiO3) when all calcium was substituted with 
strontium. The intermediate composition, with 50 mol% of strontium substituted for 
calcium, gave an XRD pattern that did not match any known crystal phase; however, it 
looked similar to the strontium silicate pattern, but shifted to higher angles, thus 
suggesting the presence of a mixed calcium strontium silicate (237). Li2O-CaO-SiO2 
glasses were studied by Salman et al. where strontium, magnesium and aluminium 
were added. They observed that the presence of strontium partially promoted the 
transition from wollastonite to pseudowollastonite (288), as also found in the present 
work in samples AW 18.7%. If magnesium was substituted for calcium, diopside was 
found, while if both strontium and magnesium were present then a strontium 
magnesium silicate and a calcium strontium silicate were detected (289). This is in 
agreement with what was found for the AW samples in the present work, having 
diopside detected for sample AW 12.5% and then a mixed silicate for scaffold 
compositions with higher strontium. The influence of strontium on the α-β transition 
was also confirmed by Wu et al.: they observed that when doping CaSiO3 with 
increasing strontium, the detected crystal phase shifted from β for 0 or 1 mol% 
strontium, to a mixed composition of α and β calcium silicate for 2.5 mol% strontium, to 
only α pseudowollastonite for 5 and 10 mol% strontium calcium silicates. This was also 
proven by a decrease of the transformation temperature with increasing strontium 
during thermal analysis (290). Hesaraki et al. studied a sol-gel CaO-SrO-SiO2-P2O5 
glass, then treated at 1000 °C; they found that both Sr-free and Sr-containing glasses 
formed hydroxyapatite, thought to partially be Sr-hydroxyapatite for the Sr-containing 
sample. The second phase was classified as α-wollastonite for the Sr-free glass, then 
thought to become a mixture of Ca2SiO4 and various calcium strontium silicates, not 
precisely identified because of the similarity in the reference patterns (181). Bellucci 
and Cannillo modified the composition of Bioglass by adding strontium and 
magnesium, obtaining a glass with an ultra-high crystallisation temperature. This result 
was believed to be possible through the combination of the effects of magnesium, 
which can inhibit devitrification, and strontium, which favours the viscous flow and the 
sintering of the melting glass due to its larger ionic radius (291). Although these 
observations did not apply directly to the AW samples describe in the present thesis, 
as they formed two crystal phases, it is possible that they were valid for the 
wollastonite phase, which was the phase that acquired magnesium and that had its 
DSC peak moving towards higher temperatures with the increasing strontium (Chapter 
2). Vickers studied the same AW compositions described in this thesis (except AW 
37.4%) and also concluded that it was likely that, for the strontium-containing 
compositions (in particular those with a high content of strontium), more than one 
calcium silicate phase formed, thus giving a mixture of magnesium silicate, 
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pseudowollastonite and strontium silicate; because peaks of the reference patterns for 
all these phases highly overlap, it was not possible to discriminate which of these 
phases were effectively present in the samples and in which proportion (186). These 
observations appeared to be likely applicable to the materials studied in the present 
thesis. 
 
3.4.4 Effect of strontium addition on the architecture of 3D porous 
scaffolds 
Micro CT analysis of the porous scaffolds showed that all samples maintained their 
internal interconnected porosity. For all the compositions, most of the porosity was 
found to be open porosity, with closed porosity contributing for less than 0.5 % of the 
volume. 
During the last decade, micro computed tomography (sometimes also referred to as 
microtomography) has become a powerful tool for assessing the microstructure of 
samples in a non-invasive way. In the field of biomaterials, it has been applied to all 
categories of materials: metals (292-294), polymers (295-297), composite cements 
(298-300) and ceramics (281, 301, 302), alongside bioactive glasses and glass-
ceramics (121, 247, 267, 301, 303-312). For scaffolds belonging to this last category, 
micro CT imaging and analysis are particularly important for assessing their porosity 
and verifying the presence of open interconnected pores, with pore sizes that can 
allow colonisation and infiltration of cells. Different compositions of glass and glass-
ceramic materials have been tested using micro CT porosity analysis. Jones et al. and 
Yue et al. tested 70S30C scaffolds prepared by sol-gel foaming: porosity was found 
between 85 and 92 % and the majority of pores were around 500 to 800 µm, 
depending on the sintering temperature (304); the analysis was then applied to in vitro 
SBF-soaked samples (247) and ex vivo samples (305) to assess their evolution over 
time. Liu et al. used micro CT analysis to compare unidirectional-frozen and foam-
replicated samples ex vivo (306). Fu et al. used the glass 6P53B (51.9SiO2-9.8 Na2O-
1.8K2O-15.0MgO-19.0CaO-2.5P2O5) to prepare porous scaffolds with different 
porosities via direct ink assembly, then imaged with micro CT (307). Micro CT analysis 
has been applied also to foam replicated scaffolds: Renghini et al. prepared CEL2 
scaffolds with 54 vol% porosity and 180 µm average pore size; they used micro CT to 
monitor sample evolution over soaking in SBF solution (308), also comparing them 
with Bioglass scaffolds (309). Baino et al. used CEL2 to prepare scaffolds from foams 
of 45, 30 and 20 pores per inch (PPI) in order to simulate healthy and osteoporotic 
bone, then they applied micro CT analysis to characterise all samples (310). Baino 
and Vitale-Brovarone found, with micro CT analysis, that foam replicated SCNA 
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scaffolds had a porosity of 56 vol% with mean pore size of 240 µm, also observing a 
bimodal pore size distribution on SEM micrographs, with macropores bigger than 100 
µm and micropores below 10-20 µm (303). Boccardi et al. compared foam-replicated 
Bioglass scaffolds prepared using polyurethane foams and two types of marine 
sponges, using micro CT analysis for imaging their internal structure and assessing 
their porosity and pore size distribution (267). Shen et al. prepared foam replicated 
borosilcate and strontium-borosilicate scaffolds, using micro CT for imaging and 
measuring their porosity, which was about 73 vol% for both compositions (311). 
Oliveira et al. produced porous hydroxyapatite scaffolds using polyurethane foams and 
imaged them using micro CT (312), while Cunningham et al. followed the foam 
replication method with hydroxyapatite utilising different types of marine sponges, then 
comparing the scaffolds so obtained with micro CT quantitative analysis (301). Serna 
studied the fabrication of apatite-wollastonite foam-replicated scaffolds and found, 
through micro CT analysis, that the final porosity and pores size distribution depended 
on the liquid:glass ratio of the slurry, the heat treatment applied and the combination of 
the two, but all samples had the majority of their pores in the range of 40 to 450 µm, 
with porosities going from 40 to 56 vol% (121). The presence of two sets of pores 
observed by Baino and Vitale-Brovarone (303) was also observed for the strontium 
scaffolds under study in this work. In fact, all compositions had a small peak for pores 
in the range 25-45 µm and then macropores were mainly found, in a bimodal 
distribution, between 100 and 400 µm. As in the mentioned paper, pores in the smaller 
range could be attributed to the presence of residual porosity after the fusion of glass 
particles during sintering and crystallisation, while the bimodal distribution of pores 
bigger than 100 µm could be assigned to pores deriving from the template structure 
(peak around 200 µm) and pores created by incomplete struts (310 to 380 µm), 
originated during preparation by coating defects, as also suggested by Serna (121). It 
must be noted that, generally, micro CT-derived structural characteristics of sponge 
replicated scaffolds differ from those of natural human trabecular bone: while the 
porosity of synthetic scaffolds, as described above, ranges from 40 to 70 vol%, that of 
human trabecular bone spans between 50 and 90 vol% (30); this is reflected also on 
the average pore size found in the samples, as it usually ranges between 200 and 400 
µm for the synthetic scaffolds, but it can be between 600 and 800 µm for natural bone 
(313-316). These differences are intrinsic to the foam replication method of producing 
scaffolds for bone applications and derive from the fact that the templates used do not 
exactly replicate the structure of bone. In fact, as explained in Chapter 1, the structure 
of trabecular bone is anisotropic and derives from the constant remodelling to which it 
is subjected in vivo (19, 317), depending on the mechanical stimuli and the 
physiological environment, and this condition cannot be simulated with an artificial 
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construct without bone cells. However, because the class of scaffolds under study is 
meant to dissolve and get remodelled once implanted, it has been demonstrated that 
bone regeneration can be achieved with implants that present more than 50 vol% 
porosity and pore size of at least 100 µm, better if bigger than 300 µm (30, 260). The 
micro CT analyses conducted on the strontium AW scaffolds showed that all 
compositions complied with these structural requirements. In addition, it must be taken 
into account that the majority of data for trabecular bone found in the literature derive 
from elderly patients who underwent surgery with osteoporosis or osteoarthritis, which 
affect the quality and structure of bone and, therefore, the results of porosity analyses. 
Osteoporosis in particular, causing bone resorption, can make the total porosity higher 
and the average pore size bigger (318), thus skewing the results towards higher 
values. 
Another aspect that must be considered when discussing and comparing micro CT 
results is the computational model used for the calculation of pore sizes, which is not 
always specified in the literature. In the case of the CTAn Bruker software and the 
present work, a sphere-fitting model was used. Briefly, the algorithm automatically 
calculated the median axis for all the porous structures, then the diameter of a sphere 
was calculated for each voxel of this medial axis so that (i) the sphere contained the 
voxel and (ii) the sphere was completely enclosed within solid surfaces (319). This 
method allows for a reduction in the bias due to 3D orientation of pores; however, in 
the case of oval pores, the longer axis will not appear in the calculated diameters. 
Although this means that long pores in the scaffolds, such as those deriving from 
incomplete coverage of the foam struts with the slurry, will be considered smaller than 
their actual size in the pore size distribution, the diameter measured by the software 
will probably be the distance that cells will see when populating the sample, bridging 
pores across. Therefore, although very big pores might not appear in the final 
structural results for the samples, the general characterisation will still be valid for 
planning in vitro and in vivo studies. 
 
3.4.5 Effect of strontium addition on the mechanical properties of 
porous AW glass-ceramic scaffolds 
All strontium AW compositions were tested for their compressive strength and biaxial 
flexural strength, from which their elastic modulus and their Weibull distributions were 
obtained, respectively. For each composition, samples tested with the two methods 
belonged to the same batch for better comparison. It must be noted that no 
international standard exists for the optimal testing of porous ceramics (35). The 
American standard ASTM F2883-11 “Characterisation of ceramic and mineral based 
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scaffolds used for tissue-engineered medical products (TEMPs) and as device for 
surgical implant applications” (320) mentions only the compression test as the method 
for assessing the mechanical properties of scaffolds. However, this standard gives 
only generic indications for sample preparation and parameters for testing, without 
setting any criteria of acceptance for samples to pass the test. In addition, it must be 
considered that ceramic materials are not usually tested in compression because of 
their brittle nature. In fact, the ISO standard BS EN ISO 6872:2015 “Dentistry – 
Ceramic materials” (251) lists two different tests for the assessment of mechanical 
properties: a bending test and the biaxial flexural strength test used in this thesis. 
However, also this standard is only partially applicable to bone scaffolds, as it 
describes tests for solid, not porous, ceramics. In the literature, most authors tested 
their porous scaffolds only in compression (82, 95, 98, 238, 245, 258, 321); Chen et al. 
and Dong et al. combined compression strength tests with three-point bending tests 
(80, 322); three-point bending strength tests were also chosen by Kokubo et al. when 
testing solid apatite-wollastonite ceramics (12) and by Vickers when testing strontium-
containing apatite-wollastonite samples (186), while Fan et al. tested sintered 
compacted hydroxyapatite samples with biaxial flexural testing (323). In the work 
presented in this thesis, it was chosen to perform two different tests for comparison: 
the most commonly used compressive strength test and the biaxial flexural strength 
test, following what was done by Serna (121). 
In the present thesis, all strontium AW scaffolds showed an average compressive 
strength around 10 MPa, which is comparable to the upper value of the range reported 
in the literature for trabecular bone: 2-12 MPa (34, 35). No significant difference was 
found between samples (p>0.05). The high standard deviations found for all the 
compositions can be ascribed to the intrinsic variability of the production method, but 
also to the difficulty in preparing samples of exactly the shape required by the test: 
regular cylinders with two perfectly parallel surfaces. This value is well below the 1060 
MPa reported by Kokubo et al. for apatite-wollastonite (85); however, that value was 
found for solid samples. On the contrary, Serna found a compressive strength 
between 2.3 and 3.6 MPa, depending on slurry composition and thermal treatment 
applied (121). Regarding foam-replicated scaffolds, different authors found different 
compressive strengths depending on the material used and their porosity. Muhamad 
Nor et al. produced foam-replicated porcelain (not bioactive) foams by varying the 
ceramic load of the initial slurry, thus obtaining compressive strengths between 3 and 
23 MPa for porosities between 30 and 70 vol% (324). Fu et al. produced porous 
scaffolds using the 13-93 bioactive glass and modifying it with boron, obtaining 11 
MPa compressive strength with 85 vol% porosity for the original composition (95) and 
6.4 MPa with 72 vol% porosity for the boron-containing glass (265). Vitale-Brovarone 
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et al. used CEL2 glass-ceramic and tested different coating methods and thermal 
treatments; they obtained porosities that ranged from 53 to 72 vol% and compressive 
strengths comprised between 1.3 and 5.4 MPa (98). Baino et al. found that the 
compressive strength of Bioglass-based scaffolds varied between 0.2 and 2.5 MPa for 
porosities included between 70 and 83 vol%, depending on the particle size chosen for 
the slurry and the thermal treatment applied (258). Chen et al. also used Bioglass for 
the production of foam-replicated glass-ceramic scaffolds, reporting 90 vol% porosity 
for samples with 0.3-0.4 MPa compressive strength (80). Yin et al. found that the 
compressive strength of foam-replicated scaffolds made with the borate-based glass 
13-93B2 slightly increased from 10 to 12 MPa, when the strontium content was 
increased from 0 to 9 mol% (214). Therefore, the results reported in the present thesis 
are comparable to the stronger samples described in the literature and, being closer to 
the upper limit of cancellous bone, are thus more promising for load-bearing 
applications. 
Kokubo et al. showed how the precipitation of wollastonite in addition to apatite from 
the apatite-wollastonite parent glass caused an increase in bending strength and 
Young’s modulus of the material, as the wollastonite crystals could deflect cracks, thus 
increasing the fracture surface energy and the toughness of the material (12, 106). 
The same effect was also observed for the compressive strength by Kunjalukkal 
Padmanabhan et al. in wollastonite/hydroxyapatite composite scaffolds, for 
compositions with up to 50 wt% wollastonite (272). 
Conversely to compressive strength, the Young’s modulus measured for the strontium 
AW scaffolds depended on the strontium content. In particular, it decreased with 
increasing strontium: it was found to be about 300 MPa for AW 0% and then it 
decreased to about 120 MPa for AW 37%, this being significantly lower than AW 0% 
(p<0.005) and AW 6.2% and AW 12.5% (p<0.05). Despite the variation, these values 
are all comparable with those found for cancellous bone, for which the reported elastic 
modulus is comprised between 50 and 500 MPa (32, 33), increasing linearly with 
increasing compression strength (22). The dependence of the Young’s modulus on the 
strontium content for a glass-ceramic has not been reported in the literature before, 
where most porous scaffolds are described only in terms of compression strength. 
Barbieri et al. used Vickers indentation to measure the elastic modulus of strontium-
containing feldspars and found that it depended on the porosity of samples, but not on 
their composition (325). Jallot studied the interface between an hydroxyapatite implant 
and bone in vivo and observed that, after implantation, an increase in strontium 
content corresponded with an increase of the Young’s modulus measured with non-
destructive, cyclic compression of explanted samples (326). Meixner and Cutler tested 
strontium-doped perovskites, where strontium was substituted for calcium, and found 
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that a high content of strontium corresponded with lower Young’s modulus and lower 
fracture strength (327). Poh et al. produced composite scaffolds using Bioglass or 
strontium-doped Bioglass particles in polycaprolactone and observed that the Young’s 
modulus increased with the presence of the dispersed glass, with the strontium 
Bioglass giving the highest elastic modulus (328). As suggested by Meixner and 
Cutler, the Young’s modulus of a material depends on its atomic bonds (327), while 
the compressive strength depends more on the architecture of the tested samples. 
Therefore, the behaviour observed for the strontium AW scaffolds might be due to the 
distortion of the glass network caused by the bigger diameter of strontium compared to 
calcium. 
As mentioned above, only few authors described the mechanical properties of their 
ceramic scaffolds also in terms of biaxial flexural strength. Despite it being a more 
suitable method for measuring the mechanical behaviour of ceramics, it requires 
sample machining and slicing, thus making the method more complicated when 
samples are highly porous and fragile (35). Meganck et al. tested solid samples of 
hydroxyapatite, biphasic calcium phosphate and β-TCP, finding that their biaxial 
flexural strengths were 130, 24 and 23 MPa, respectively, Weibull modulus 12, 13 and 
9, respectively, and Weibull characteristic strength 135, 24 and 24 MPa, respectively 
(329). Fan et al. studied the behaviour of porous hydroxyapatite (porosity around 60 
vol%) with the sintering temperature; the maximum mean fracture strength they found 
was 5 MPa for the highest sintering temperature, the Weibull characteristic strength 
increased from 1 to 5 MPa with increasing temperature, while the Weibull modulus 
varied between 6.6 and 15.5 independently from temperature (330). Zocca et al. 3D 
printed wollastonite, obtaining scaffolds with 64 vol% porosity, 6 MPa biaxial flexural 
strength, 6.6 Weibull modulus and 5.9 MPa Weibull characteristic strength (331). 
Vickers used the 3-point bending test for measuring the flexural strength of strontium 
AW scaffolds; he found that composition AW 24.9% had the highest flexural strength, 
46 MPa, while composition AW 18.7% had the lowest, 23 MPa. He suggested that the 
different outcomes were due to the lack of liquid phase sintering for compositions AW 
0%, AW 6.2% and AW 12.5%, along with the reduction in crystal volume percentage 
(186). Other authors compared the biaxial flexural strength with the bending strength 
of porous bioceramics or glass-ceramics. Chung et al. showed that there is a good 
correlations between 3-point bending strength and biaxial flexural strength for dental 
composite materials (332), while Xu et al. observed that, for dental Y-TZP (yttria-
stabilised tetragonal zirconia polycrystal), the measured flexural strength was always 
higher for biaxial flexure than 3-point bending, which was higher than in 4-point 
bending (333).  
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It is evident from the literature reported above that the mechanical properties of 
scaffolds strongly depend on their porosity. Fu et al. showed in their review paper how 
compressive, flexural and tensile strengths all depend on the porosity of the scaffolds 
tested (35), with Liu (334) and Barralet et al. (335, 336) finding an exponential relation 
between compressive strength and porosity for hydroxyapatite and calcium phosphate 
cements, respectively. Similar trends were found also by Chen et al. when fitting 
experimental data of compressive and tensile strength from different scaffold materials 
to computational models (337). This could explain why, in the present study, no clear 
trend was found for the strontium AW scaffolds, despite them containing different 
crystal phases: it is possible that the effect of their porosity overcame that of their 
crystal composition. Fan et al. studied the relation between Weibull modulus of 
hydroxyapatite and its porosity and found that, for porosities between 10 and 55 vol%, 
the Weibull modulus remained in a narrow band from 4 to 11 (323). Scaffolds tested in 
the present study fell around the upper limit of this porosity and showed Weibull moduli 
between 4 and 5, thus agreeing with the authors’ results. Therefore, despite the biaxial 
flexural strength being strongly dependent on porosity, the dispersion of its values was 
not influenced by it. 
As already mentioned in this thesis, it is important that the mechanical properties of 
scaffolds match those of bone, in order to guarantee a full integration with the 
surrounding tissue, trabecular bone in this case, after implantation. Fu et al. reported a 
range of 2-12 MPa compressive strength, 10-20 MPa for flexural/bending strength and 
1-5 MPa for tensile strength of cancellous bone (35). Therefore, values found in the 
present work are within the trabecular bone range and close to its upper limit. Currey 
compared the Young’s modulus of human cancellous bone reported by different 
authors in the literature, measured following different methods in dry and wet 
conditions. Values ranged from 4 to 20 GPa (22), thus one or two orders of magnitude 
higher than what found for the samples tested here. It must be noted that bone is an 
anisotropic material, so its mechanical properties highly depend on the direction of the 
applied force during the test, as well as the method and conditions of testing, the 
harvesting of samples and their preservation before testing. In addition, bone tissue 
can be considered a composite material, with collagen imparting elastic and toughness 
characteristics that cannot be replicated with an only-ceramic (or glass-ceramic) 
material. Therefore, it would be advisable that scaffolds for bone regeneration would 
be also checked for toughness and fatigue resistance, along with static compressive, 
flexural and tensile strength. Furthermore, Liu et al. showed how 13-93 porous 
scaffolds moved from a brittle mechanical response before implantation to an elasto-
plastic response in vivo after 12 and 24 weeks of implantation (96, 306). Therefore, it 
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is important that all mechanical properties are also monitored in vivo, especially for 
samples that degrade once implanted. 
 
3.4.6 Strontium content affects the in vitro apatite forming ability of 
AW glass-ceramics 
Both solid discs and porous scaffolds were tested for their ability to form apatite once 
immersed in SBF solution. This test was optimised by Kokubo et al. (255) and is 
described in the ISO standard 23317-2014 (254). For the solid discs, apatite was 
found on samples AW 0% and AW 18.7% after 1 day and on samples AW 12.5% after 
3 days of soaking. For the porous scaffolds, compositions AW 0%, AW 6.2% and AW 
12.5% formed apatite within 1 day, AW 18.7% within 7 days (3-day time-point was not 
tested) and AW 24.9% had some small deposited crystals at the 14 day time-point. 
Since bioactivity is a surface-driven mechanism, it is possible that these differences 
derived from the much higher exposed surface area of porous scaffolds compared to 
solid discs. 
It has been shown in the literature that also the atomic structure of a bioactive glass 
has a strong influence on its bioactivity (62, 65). The network connectivity (NC), as 
explained in Chapter 1, is a parameter that describes the average number of bridging 
oxygens per [SiO4] tetrahedron and, consequently, the solubility of a glass in solution. 
Its formula depends on the number of network formers and, for the glasses under 
study in the present thesis, on the atomic concentration of oxygen, phosphorus and 
silicon as the network former (62-64). For all the strontium AW compositions under 
study, NC was calculated as 1.98 (Hollings, personal communication). This is in line 
with the network connectivity of most bioactive glasses, being it below or close to 2.00, 
according to Hill (65) and Watts et al. (66). Fredholm et al. studied strontium 
substitution in a different bioactive glass and they also observed, through 29Si Nuclear 
Magnetic Resonance (NMR), that it did not impact the NC of the glass (63). In a 
following publication, the same authors studied the bioactivity behaviour of the same 
glasses and observed that strontium was released linearly according to its initial 
amount, when the glass powder was soaked in SBF. They also concluded that 
strontium substitution enhanced bioactivity; however, XRD and FTIR (Fourier-
Transform Infrared spectroscopy) showed the presence of calcium and strontium 
carbonates after soaking in SBF and only traces of apatite (230). Conversely, other 
authors observed that strontium could slow down the bioactivity of glasses. Hesaraki 
et al. observed a delay in the formation of apatite, after 7 days in SBF, when strontium 
was added to a calcium silicophosphate glass, concluding that strontium limited the 
growth of the apatite layer by preventing the formation of the intermediate phase 
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octacalcium phosphate (181, 338). Wu et al. prepared mesoporous 3D scaffolds with 
different mol% of strontium substitution and observed that the highest Sr composition 
(10 mol%) formed apatite after 3 days of soaking, while lower and no Sr compositions 
had an apatite layer after only 1 day (191). Kargozar et al. modified a multi-component 
bioactive glass by adding strontium and/or cobalt (6 mol% Sr, 0.5 mol% Co) and they 
showed that the formation of the apatite layer was delayed in compositions that 
contained the doping ions (216). They also observed that the formed apatite did not 
contain strontium in its lattice, while Pan et al. found that the calcium-deficient apatite 
layer that formed on strontium borate glasses in DMEM (Dulbecco’s Modified Eagle’s 
Medium) incorporated strontium and magnesium (339). Various authors observed an 
increase in dissolution for the strontium-containing compositions (177, 189, 191, 214), 
explained by the expansion of the glass network caused by strontium and discussed in 
Chapter 2. This is in contrast with what was found by Lao et al., who observed a 
reduction in dissolution for strontium glasses soaked in DMEM (215), and Wu et al., 
who studied strontium-CaSiO3 ceramics and also observed a reduced dissolution rate 
in SBF for the doped compositions (290). Vickers, who studied the same glass-
ceramic compositions presented in this thesis (except AW 37.4%), found that only AW 
0% and W 6.2% formed an apatite layer after 1 day of soaking, giving a confluent layer 
after 7 days; AW 12.5% did not change its surface morphology, while AW 18.7% and 
AW 24.9% presented an increased size of their original apatite domains over the test 
period (186). This is partially in contrast with what was found in this work. However, 
samples were prepared in a different way: Vickers compacted 45-90 µm powders in 
carbon moulds, subsequently sintered, while in this thesis discs and porous scaffolds 
were made from a slurry, dried and then heat-treated. This caused differences in the 
resulting surface morphology, which has also been shown to have a strong influence 
on glass reactivity. This is particularly evident with mesoporous bioactive glasses, 
which can have NC close to 4 and still be bioactive, as shown by Arcos et al. (340). In 
this class of glasses, bioactivity highly depends on porosity (341), to the point that 
even porous silica can induce apatite precipitation in SBF (342). 
The mechanism of bioactivity for AWGC was described by Kokubo and was presented 
in Chapter 1. Briefly, ion dissolution leads to the formation of silanol groups (Si-O-H) 
on the surface, which provide nucleation sites for the precipitation of apatite without 
the formation of the silica gel characteristic of 45S5 Bioglass (105, 109). The apatite 
that forms is a carbonated hydroxyapatite (Ca/P ratio 1.46), which contains small 
amounts of magnesium and silicon and is composed of needle-like nano-crystals, 
randomly oriented (105, 106). Here, differences between strontium AW compositions 
and between discs and porous scaffolds could have been caused by a combination of 
factors: the much higher exposed surface area for porous scaffolds could explain the 
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formation of HAp on sample AW 24.9% only for its porous form and not the disc form; 
the different morphology observed for the apatite found on samples AW 18.7%, with 
smaller crystals and big cracks in the layer, could suggest the formation of a silica gel 
for this composition, which could have delayed the re-precipitation of ionic species and 
was more prone to cracking when drying; the rapid formation of the HAp layer within 
24 hours for some of the strontium AW compositions could have masked the pH 
changes and prevented further ionic release, to the point that the absence of pH 
variations could be used as a predictor for the formation of the bioactive apatite layer; 
the fact that HAp was found only on inner struts of the porous scaffolds highlighted 
how bioactivity is a local phenomenon; the change in surface morphology, with the 
apatite phase of the material becoming more prominent as described by Kokubo (109), 
could also be observed for samples AW 24.9% (discs) and 37.4% (discs and 
scaffolds); the absence of HAp for the AW 6.2% discs could be due to a substantial 
difference in surface morphology, for instance a much lower residual microporosity, or, 
if a silica gel formed, it caused the bond between the deposited layer and the sample 
to became too weak and the newly formed HAp was washed away during rinsing of 
the sample at collection.  
O’Donnell and Hill and Maçon et al. illustrated how the SBF bioactivity test actually 
presents many flaws: it can be difficult to calculate the required amount of solution 
when samples are porous or in powder form; the solution contains no organic 
molecule, so it is not a true representation of biological fluids; it can give false positives 
or false negatives; the test is static and does not reproduce the movement of fluids in 
vivo (343, 344). Therefore, although bioactivity in SBF solution is a powerful tool for 
the initial evaluation of a new biomaterial, it does not always reproduce how a material 
will actually behave once in vivo and so care must be taken when interpreting the 
results. 
 
3.4.7 The addition of strontium determines an increase in 
radiopacity of porous AW scaffolds 
Section 3.3.8 showed x-ray pictures of the porous strontium AW samples, presenting a 
clear linear increase in radiopacity for increasing strontium content. The fact that 
strontium can impart radiopacity to a material is a known effect, often utilised in dental 
materials for their radiological assessment after implantation. For example, Watts 
showed that dental composites can achieve a higher radiopacity than enamel when 
the glass filler contains about 40 wt% of SrO, with a linear relationship between 
strontium content and equivalent mm of aluminium (345), as it has been observed in 
the present study. A linear correlation between radiopacity and strontium content was 
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also found by Shahid et al., who compared different strontium-containing glass 
compositions of glass ionomer cements (259). Lachowski et al. compared 28 
commercial dental cements and resins and observed an enhancement in radiopacity 
for those containing strontium, compared to the respective standard compositions; the 
authors noticed that the radiopacity of the final material depended on the atomic 
number of the doping element, but also on the concentration of the radiopaque agent 
in the material (346).  
The use of radiopaque cements is of great importance also in other orthopaedic 
specialisations. For instance, Romieu et al. investigated a strontium-containing 
calcium phosphate cement for spinal applications and found that its radiopacity was 
about three times higher than that of cortical bone and twice as higher as that of the 
no-strontium cement (347). A study closer to the final application of the strontium AW 
scaffolds studied in the present thesis was presented by Mohan et al., who prepared 
strontium calcium phosphate porous scaffolds through gel casting and monitored their 
radiopacity in vivo in a rabbit bone defect model; they found that the strontium-
containing samples displayed a higher radiopacity compared to the hydroxyapatite 
controls, facilitating the follow-up assessment of the surgical site, of the callus 
formation and of the osseointegration of the implant (348). This showed how this 
intrinsic feature of strontium, when used for bone-repairing materials, could provide 
additional value to the design of a new material. In the case of the compositions 
studied in this thesis, radiopacity increased with the increase in strontium, however 
comparison with trabecular and cortical bone, as well as an in vivo assessment, would 
be necessary for the selection of the optimal composition.
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Chapter 4  
Microbiological testing of strontium and strontium glasses 
4.1 Introduction 
As described in Chapter 1, strontium has been a chemical element of interest for many 
years thanks to its therapeutic properties for bone regeneration (15, 150, 152). More 
recently, attention in the literature has increased on whether strontium could also 
present antibacterial properties for preventing and treating infections, either in 
combination with fluoride in glass ionomer cements (17, 195), or as a doping element 
in bioactive glass compositions (18, 197, 198). The incidence of infections in 
orthopaedics varies in the literature from 1 % to 20 % for primary joint replacements 
(129, 349-353), going up to 30 % in the case of traumatic fractures (131), with a huge 
economic burden for hospitals and health systems. In addition, resistance of bacteria 
to standard antibiotics is constantly increasing, therefore finding alternative treatments 
for post-operative infections is becoming of primary importance. Modifying the 
composition of bioactive glasses and glass-ceramics so that they can elute active ions 
once implanted is one of the explored solutions. The relevant bacterial species for in 
vitro tests depend on the applications of the material, for example oral bacteria are 
considered for materials designed for dental applications (17, 18), or species 
commonly found in peri-prosthetic infections are used when studying a new implant 
material (198, 201, 202), such as the scaffolds described in the present thesis.  
The scope of this chapter is therefore to explore the potential antimicrobial features of 
the strontium AW glasses described in Chapter 2, with the ultimate aim of finding, if 
possible, a composition that could prevent or treat infections while enhancing new 
bone tissue formation at the same time. While the bone regenerative potential will be 
explored in Chapter 5, the present Chapter will focus on the antimicrobial testing of the 
base materials. Four bacterial species were chosen to study the effects of strontium, 
which are the four species most frequently detected in post-operative infections, 
including orthopaedic infections (130, 141, 354). Bacteria were first characterised for 
their growth profiles and antibiotic resistance. Strontium salts were then used to 
assess their susceptibility to this element, before the AW glass powders described in 
Chapter 2 were tested. 
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4.2 Materials and methods 
4.2.1 Bacterial strain characterisation 
Four species were chosen for the antimicrobial testing of strontium and the strontium 
AW glasses, which correspond to the four species most commonly found in 
nosocomial and post-operative infections (130, 141, 354): Staphylococcus aureus, 
Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa. Their 
NCTC (National Collection of Type Cultures) strain and Gram-staining characteristic 
are summarised in Table 4.1. 
Table 4.1: Summary of the four bacterial species used in this work. 
Species NCTC number Gram 
Staphylococcus aureus 8532 Positive 
Staphylococcus epidermidis 11047 Positive 
Escherichia coli 11954 Negative 
Pseudomonas aeruginosa 10332 Negative 
 
During every test, Gram-staining was systematically used to confirm the species in 
culture and the absence of contaminations, along with colony morphology on agar 
plates. Examples of Gram-stain appearance of the four species are shown in Figure 
4.1. First, a small amount of bacterial cells was spread on a microscope glass slide 
with a droplet of water that was fixed using a Bunsen flame. The glass slide was then 
covered with crystal violet solution (Pro-Lab Diagnostics) for 1 min, rinsed with tap 
water, and the stain fixed using iodine solution (Pro-Lab Diagnostics). The slide was 
rinsed again under tap water, washed with ethanol and then covered in safranin 
solution (Pro-Lab Diagnostics) for counter-stain for 1 min. The slide was rinsed again 
under tap water, blotted, let dry and then observed under optical microscope (Motic 
B1-220A) using immersion oil and a 100x magnifying lens. 
 
Each species was characterised for its growth curve, optical density standard curve 
and antibiotic susceptibility to gentamicin, as described in the following Sections. 
 
All culture media was from Oxoid and prepared following the manufacturer 
instructions, culture plates were from Corning and Petri dishes from Scientific 
Laboratory Supplies Ltd. Brain Heart Infusion (BHI) was used for broth cultures of S. 
aureus, S. epidermidis and E. coli, while LB (Lysogeny Broth) was used for P. 
aeruginosa. Mueller-Hinton (MH) agar was used for culturing all the four species. 
Living cultures were maintained by streaking new plates at least once a week. 
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Incubation was performed in a Thermo Scientific Forma Direct Heat CO2 Incubator, 
kept at 37 °C and 10 % CO2. Because of its tendency to aggregate, planktonic cultures 
of P. aeruginosa were always incubated in a shaking incubator (MaxQ Mini 4450, 
Thermo Scientific) and aliquots withdrawn using cut-end pipette tips, as described in 
Schleheck et al. (355). 10-fold dilutions in 900 µL of phosphate buffered saline (PBS, 
Lonza) were carried out for CFU enumeration. 
Statistical analysis was carried out using one-way ANOVA. 
 
 
Figure 4.1: Microscope pictures of the four bacteria studied after Gram-staining, 
100x lens, 4x camera. (a) S. aureus, Gram-positive, (b) S. epidermidis, 
Gram-positive, (c) E. coli, Gram-negative, (d) P. aeruginosa, Gram-negative. 
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4.2.1.1 Determination of the growth curves of bacterial cultures 
The growth characteristics for the four bacterial species were investigated, in order to 
determine the time required to get a log-phase culture from inoculation of the broth. A 
schematic of the experimental procedure is displayed in Figure 4.2. 
 
 
Figure 4.2: Diagram representing the experimental procedure for the 
determination of growth curves. 
 
On the first day, 250 mL of BHI media was prepared in a 500 mL bottle and autoclaved 
for S. aureus, S. epidermidis and E. coli and LB for P. aeruginosa. Fresh agar cultures 
were started by streaking MH agar plates and incubating them overnight.  
On the second day, 60 mL of stock media were inoculated with a small bacterial 
colony, taken from the fresh culture prepared the day before. This was also incubated 
overnight to reach a steady culture. 
On day 3, the monitored growth was initiated: 25 mL of the overnight broth were 
poured into the 250 mL of pre-warmed media prepared on day 1, shaken and then 2 
mL were taken for the 0 time-point optical density (OD) measurements at 600 nm 
using a Jenway 6305 spectrophotometer. The bottles were kept in the incubator 
between time points, P. aeruginosa cultures were kept in the shaking incubator set at 
37 °C and 200 rpm (revolutions per minute). At each time-point, two samples of 1 mL 
were taken from the cultures, their OD600 measured and the two measures averaged. 
Measures were taken regularly until the steady phase was reached. OD600 
measurements were zeroed using plain media saved before inoculation. 
For each species, the test was repeated three times and average and standard 
deviation of results calculated.  
 
 
Day 1
- Media preparation
- Fresh cultures streaked on plates
Day 2
- Overnight inoculum preparation
Day 3
- Inoculation of growth media
- OD600 monitoring
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4.2.1.2 Determination of the standard curves for calculating the bacterial 
cell concentration from optical density measurements 
Standard curves were prepared in order to combine the optical density of a broth 
culture with its concentration of viable bacterial cells. The procedure is summarised in 
Figure 4.3. 
 
 
Figure 4.3: Diagram representing the experimental procedure for the 
determination of optical density (OD) standard curves. 
 
First, new media was prepared and an agar plate streaked for fresh cells, incubated 
overnight. 10 mL of warm media were inoculated with a small colony from the streaked 
plate and the planktonic culture was also incubated overnight. 1 mL of this overnight 
culture was then transferred into 9 mL of warm new media and a timer started 
according to the results of the growth curve (Section 4.3.1.1) in order to get a late log-
phase culture. The sample was then 2-fold diluted down to 1/64 of the initial log-phase, 
the OD600 of each dilution measured twice, the log-phase sample diluted down to 10-8 
and plated on MH agar in duplicate. Plates were incubated overnight and the morning 
after colonies were counted from the dilutions that held 20-200 colony-forming units 
(CFUs). This was repeated three times for each species. Data from the three repeats 
were pooled together and linearly interpolated to obtain a simple equation that related 
measured ODs to CFU concentrations. 
 
 
Day 1
- Media preparation
- Fresh cultures streaked on plates
Day 2
- Overnight inoculum preparation
Day 3
- Inoculation of media and growth to log-phase
- Broth dilutions and OD600 measurements
- Log-phase broth dilution and plating
Day 4
- CFU count
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4.2.1.3 Determination of antibiotic concentrations to use as test positive 
controls 
The antibiotic gentamicin sulphate (Sigma, potency ≥ 590 µg/mg) was chosen as the 
positive control for all the strontium tests presented in this Chapter. Sections 4.2.1.3.1 
to 4.2.1.3.3 describe how the concentration of gentamicin required for each test and 
for each species was obtained. The EUCAST protocol (by Matuschek et al. (356)) was 
used as a reference for the disc diffusion tests described in Sections 4.2.1.3.1 and 
4.2.1.3.2. 
4.2.1.3.1 Determination of the concentration of gentamicin required for positive 
controls in zone of inhibition assays with paper discs 
Paper discs were used for the testing of strontium salts, as described in Section 4.2.2. 
This test was carried out to find the gentamicin concentration needed for the positive 
controls. Three plates were prepared for each species. The procedure is schematically 
represented in Figure 4.4. 
 
 
Figure 4.4: Diagram representing the experimental procedure for the 
determination of the effective concentrations of gentamicin in paper discs, 
to be used as positive controls in tests with strontium salts. 
 
Day 1
- Media preparation
- Fresh cultures streaked on plates
- Paper discs preparation
Day 2
- Overnight inoculum preparation
- Paper discs impregnated with antibiotic solution
Day 3
- Inoculation of media and growth to log-phase
- 108 CFU/mL swabbed on agar plates, incubated 
for 15 min
- Discs placed on plates, incubated for 18 h
Day 4
- Zones of inhibition measured
- CFU count for inoculum
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Before starting the test, new cultures were streaked on MH agar plates and cultured 
overnight, fresh media was prepared and paper discs (diameter 6.5 mm) were cut from 
Whatman Qualitative 1 filter paper, labelled and autoclaved.  
40 mL of pre-warmed media were then inoculated with a small colony taken from the 
agar culture and also incubated overnight. Sterile gentamicin sulphate dilutions were 
prepared in distilled water in three concentrations: 35, 70 and 140 µg/mL. The filter 
paper discs were then placed in empty sterile Petri dishes and 20 µL of the 
corresponding antibiotic concentration dropped on each disc, as described by Walter 
et al. (357). PBS was used as the negative control. Discs were let dry at 37 °C before 
using them. 
On the third day, log-phase cultures were started by inoculating 1 mL of the overnight 
broth into 9 mL of warm new media and cultured according to the results of the growth 
curves (Section 4.3.1.1). Cultures were then checked for their OD600 to ensure they 
had reached their log-phase of growth, their CFU concentration was calculated 
according to the standard curve reported in Section 4.3.1.2 and consequently diluted 
in new media to reach a concentration of 108 CFU/mL. This suspension was used to 
swab pre-labelled MH agar plates, which were then incubated for 15 minutes before 
the dried paper discs were placed on them using sterile tweezers. Each plate was 
divided in quarters as shown in Figure 4.5. The 108 suspension was then diluted and 
plated to verify the exact CFU concentration used. All plates were cultured for 18 h 
before inhibition zones were measured and the required gentamicin concentration 
found. 
 
 
Figure 4.5: Partition of agar plates used for testing the required concentration of 
gentamicin sulphate in paper discs for disc diffusion assays. 
 
140 µg/mL 70 µg/mL
35 µg/mLPBS
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4.2.1.3.2 Determination of the concentration of gentamicin required for positive 
controls in zone of inhibition assays with glass agar discs 
This test was carried out to find the gentamicin concentration needed for the agar disc 
diffusion, described in Section 4.2.3 and adapted from the work published by 
Fernandes et al. (198). Three plates were tested for each species; a diagram for the 
test is represented in Figure 4.6. 
Before starting the test, fresh media was prepared and MH agar plates were streaked 
for fresh colonies and incubated overnight. 
For each species, a volume of 40 mL of media was then inoculated with a small 
bacterial colony and also incubated overnight. 2.4 % w/v technical agar was prepared 
using distilled water. Five gentamicin concentrations in agar were prepared: 17.5, 35, 
70, 140 and 280 µg/mL; pure agar was used as the negative control. Gentamicin was 
dissolved in water and stock dilutions prepared so that the desired concentrations 
could be obtained by adding 1 mL of the stock solution to 100 mL of agar. For each 
gentamicin concentration, four plates were prepared by pouring 15 mL of the antibiotic 
agar in 90 mm Petri dishes. 
Log-phase cultures were then started by inoculating 1 mL of the overnight culture into 
9 mL of warm fresh media and incubating them according to their growth curve 
(Section 4.3.1.1). Three concentrations of gentamicin were tested for each species, 
depending on the results of the paper disc diffusion presented in Section 4.3.1.3.1, 
and are reported in Table 4.2. 
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Figure 4.6: Diagram representing the experimental procedure for the 
determination of the effective concentrations of gentamicin in agar, to be 
used as positive controls in tests with glass agar discs. 
 
Table 4.2: Concentrations of gentamicin sulphate tested in technical agar. 
Species 
Concentrations tested 
(µg/mL) 
S. aureus 17.5, 35, 70 
S. epidermidis 17.5, 35, 70 
E. coli 35, 70, 140 
P. aeruginosa 70, 140, 280 
 
Once cultures had reached their log-phase, their CFU concentration was calculated 
according to their standard curve reported in Section 4.3.1.2 and dilutions were made 
to obtain 108 CFU/mL suspensions. For each species, three MH agar plates were 
swabbed and then incubated for 15 min. Small gentamicin agar discs were prepared 
by punching them off the plates prepared as described above, using a sterile size 4 
puncher (disc diameter 7.5 mm, 3 mm thickness). These discs were then positioned 
using sterile tweezers on the swabbed plates, which were incubated for 18 h before 
measuring the zones of inhibition. Test plates were partitioned in quarters again, 
similarly to what shown in Figure 4.5 for the paper disc test. The 108 CFU/mL 
suspension was diluted and plated for verifying the actual amount of cells used. 
Day 1
- Media preparation
- Fresh cultures streaked on plates
Day 2
- Overnight inoculum preparation
- Gentamicin agar plates preparation
Day 3
- Inoculation of media and growth to log-phase
- 108 CFU/mL swabbed on agar plates, incubated for 15 min
- Agar discs placed on plates, incubated for 18 h
- 108 CFU/mL broth diluted and plated
Day 4
- Zones of inhibition measured
- CFU count for inoculum
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4.2.1.3.3 Determination of the concentration of gentamicin required for positive 
controls in planktonic cultures 
Positive controls for planktonic cultures were required for the broth dilution tests 
presented in Section 4.2.4. Gentamicin sulphate was selected as the antimicrobial 
agent for all the four bacteria under testing, consistently with the other tests presented 
in this Chapter. The minimum inhibitory concentration (MIC) and the minimum 
bactericidal concentration (MBC) were determined, where the MIC was defined as the 
minimum concentration of the antimicrobial agent that prevented further growth of the 
initial inoculum, while the MBC was the minimum concentration that could kill the initial 
inoculum. 
The procedure for the testing is schematically shown in Figure 4.7. 
First, new media and fresh cultures on agar plates were prepared, then overnight 
cultures were started. 
Log-phase stage was reached by 10-fold diluting the overnight broth and incubating it 
accordingly to the growth curves shown in Section 4.3.1.1. In the meantime, well-
plates were prepared: 48-well plates and a stock solution of 17.9 mg/mL of gentamicin 
sulphate in media were used, carrying out 2-fold dilutions in 1 mL of the stock and thus 
leaving 500 µL of gentamicin solution in each well. Once the bacterial suspension had 
reached its log-phase, its OD600 was measured and an inoculum prepared with a 
bacterial concentration of 2x106 CFU/mL, basing on the standard curves displayed in 
Section 4.3.1.2. A volume of 500 µL of this inoculum was then added to the well-plate, 
thus bringing the final volume of each well to 1 mL. The final concentrations tested 
ranged from 8.95 mg/mL to 0.5 µg/mL, as shown in Figure 4.8. The used 2x106 
inoculum was diluted and plated to ensure that the correct CFU/mL concentration was 
prepared. 
The inoculated well-plates were incubated for 24 h, after which they were collected 
and the MIC chosen as the lowest antibiotic concentration that did not show any 
growth in the corresponding well, i.e. that left clear media in the well. 10 µL of this 
concentration and of the three concentrations above were then plated: the MBC was 
chosen as the concentration that did not bring any growth on MH agar after 24 h 
incubation. 
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Figure 4.7: Diagram representing the experimental procedure for the 
determination of gentamicin MIC and MBC, to be used as positive controls 
in broth dilution tests. 
 
 
 
Figure 4.8: Gentamicin sulphate dilutions tested for MIC/MBC of the four 
bacteria under study. 
 
Day 1
- Media preparation
- Fresh cultures streaked on plates
Day 2
- Overnight inoculum preparation
Day 3
- Inoculation of media and growth to log-phase
- Serial dilutions of gentamicin sulphate in 48 
well-plate
- Preparation of 2x106 CFU/mL inoculum
- Inoculation of well-plate, incubated for 24 h
- 2x106 CFU/mL inoculum diluted and plated
Day 4
- MIC determination
- Plating for MBC assessment
- CFU count for inoculum
Day 5
- MBC determination
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4.2.2 Zone of inhibition tests using strontium salt solutions on 
paper discs 
In order to test the potential antimicrobial effect of strontium ions, without the presence 
of the glass material, strontium chloride anhydrous (Fisher Scientific Ltd) and strontium 
nitrate (Sigma) were chosen to run the zone of inhibition tests described in Sections 
4.2.2.1 and 4.2.2.2. Sodium chloride (Sigma) was used as a control for the effect of 
chlorine, PBS was used as the negative control. The procedure described in the 
EUCAST protocol (356) was followed. 
 
4.2.2.1 Testing of the antibacterial effect of strontium using two 
strontium salts in zone of inhibition assays 
A diagram describing the testing procedure is shown in Figure 4.9. 
New MH agar plates were streaked and incubated overnight and fresh media was 
prepared. Paper discs were cut from Whatman Qualitative 1 filter paper, diameter 6.5 
mm, labelled and autoclaved.  
 
 
Figure 4.9: Diagram representing the zone of inhibition testing of strontium salts 
using paper discs. 
 
The antibiotic stock was prepared according to the concentration found in Section 
4.2.1.3.1. The stock solutions for strontium chloride and strontium nitrate were 
prepared at 4 mM concentration, while the sodium chloride solution was 8 mM to 
Day 1
- Media preparation
- Fresh cultures streaked on plates
- Paper discs preparation
Day 2
- Overnight inoculum preparation
- Paper discs impregnated with salt and antibiotic stock solutions
Day 3
- Inoculation of media and growth to log-phase
- 108 CFU/mL swabbed on agar plates, incubated for 15 min
- Discs placed on plates, incubated for 18 h
Day 4
- Zones of inhibition measured
- CFU count for inoculum
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match the chlorine concentration. Following the procedure described by Walter et al. 
(357), 20 µL of each solution were dropped on the corresponding paper disc, three 
repeats per bacterial species, and left in the incubator for drying. 40 mL of media were 
inoculated with a small colony from the fresh culture and incubated overnight.  
On the following day, the CFU concentration was calculated at log-phase and a 
bacterial suspension of 108 CFU/mL was prepared. This was swabbed on MH agar 
plates, which were incubated for 15 minutes before the paper discs were placed on 
them using sterile tweezers. Plates were organised as shown in Figure 4.10. The 108 
CFU/mL inoculum was diluted and plated to verify that the correct concentration was 
used. Zone of inhibitions were checked and measured after 18 h incubation. 
 
 
Figure 4.10: Partition of agar plates for the zone of inhibition assay using 
strontium salts. Gent: gentamicin positive control. 
 
4.2.2.2 Comparison of strontium salts with silver and zinc salts in a zone 
of inhibition assay 
The salts used in the test described in the previous Section 4.2.2.1 were compared 
also with zinc chloride and silver nitrate (both from Sigma), as zinc and silver are 
known for their antimicrobial activity (200, 358, 359). This test was done as a proof-of-
concept experiment, using other elements that are established antimicrobial agents in 
the case it will be decided, in future work, that the composition of the glasses under 
study should be modified to strengthen their antibacterial properties. 
The test was repeated as described in Section 4.2.2.1, preparing additional 4 mM zinc 
chloride and silver nitrate solutions for the discs. MH agar plates were divided as 
shown in Figure 4.11. 
 
NaCl
SrCl2
Sr(NO3)2PBS
Gent
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Figure 4.11: Partition of agar plates for the zone of inhibition assay, run to 
compare strontium salts with silver and zinc salts. Gent: gentamicin 
positive control. 
 
4.2.3 Zone of inhibition tests using strontium glass powders 
embedded in agar 
It has been described in the literature that some bioactive glass compositions can 
exert antimicrobial properties (17, 18, 197), even some that do not contain any 
antimicrobial agent (94, 204, 210). Therefore, after testing strontium alone, another 
zone of inhibition test that could include glass particles was carried out, so that the 
effect of the six strontium AW glasses could be assessed. This test was adapted from 
the work published by Fernandes et al. (198). Small agar discs containing 72 mg/mL of 
glass powder were produced and used on MH agar plates as samples for the zone of 
inhibition tests. The diagram for the test is shown in Figure 4.12. 
 
NaCl
SrCl2PBS
ZnCl2
Sr(NO3)2GentAgNO3
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Figure 4.12: Diagram representing the zone of inhibition testing of agar discs 
containing strontium glasses. 
 
New cultures were streaked on MH agar plates and cultured overnight, while fresh 
media was prepared. 
40 mL of warm media were inoculated with a small fresh colony and incubated 
overnight. Glass-containing agar discs were prepared using 2.4 % w/v technical agar 
in distilled water. To obtain the glass concentration of  72 mg/mL, the main bottle of 
technical agar was kept at 50 °C, 1.44 g of autoclaved glass powder were poured in a 
sterile vial and 20 mL of agar added. The vial was vortexed in order to ensure a 
homogenous suspension of the glass particles, 15 mL were transferred into a sterile 
Petri dish and allowed to solidify at room temperature. This was repeated for all the 
strontium AW compositions and an agar-only plate was prepared as the negative 
control. Positive controls containing gentamicin were produced as described in Section 
4.2.1.3.2. Small discs were obtained using a sterile size 4 puncher, 7.5 mm diameter.  
The morning after, log-phase cultures were prepared as already described above, their 
CFU concentration was calculated measuring their OD600 according to their standard 
curves (Section 4.3.1.2) and a 108 CFU/mL concentration was prepared. This was 
swabbed on MH agar plates, then incubated for 15 min before the small agar discs 
were placed on their surface using sterile tweezers. Plates were organised as shown 
in Figure 4.13 and incubated for 18 h. The 108 CFU/mL bacterial suspensions were 
diluted and plated so that the actual bacterial concentration utilised could be verified. 
The following day, zones of inhibition were checked and measured. 
 
Day 1
- Media preparation
- Fresh cultures streaked on plates
Day 2
- Overnight inoculum preparation
- Glass agar plates preparation
Day 3
- Inoculation of media and growth to log-phase
- 108 CFU/mL swabbed on agar plates, incubated for 15 min
- Agar discs placed on plates, incubated for 18 h
- 108 CFU/mL broth diluted and plated
Day 4
- Zones of inhibition measurement
- CFU count for inoculum
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Figure 4.13: Partition of agar plates used for the zone of inhibition assay with 
glass agar discs. Gent: gentamicin positive control. 
 
4.2.4 Broth dilution testing of strontium glass powders suspended 
in culture media 
A different experiment was set up, so that previous results (presented in Sections 
4.3.2 and 4.3.3) could be verified and the strontium glasses could be tested with a 
different approach. The test was based on the broth dilution method described by 
Fernandes et al. (198), where bacteria were tested in direct contact with the glass 
particles, rather than with ions leached from salts on paper or from glass powders 
embedded in agar. In this test, glass powders were suspended in media for either 24 h 
or 7 days, then a bacterial inoculum was added and incubated for 24 h before the 
concentration of CFUs was measured using serial dilutions and viable counts. 
All four species were tested after the glass powders were soaked in media for 24 h 
(Section 4.2.4.1), Pseudomonas aeruginosa was tested also with glass powders 
soaked for a week (Section 4.2.4.2). 
 
4.2.4.1 Determination of the antibacterial effect of strontium glass 
powders suspended in media for 24 hours 
The method is visually summarised in Figure 4.14. 
 
AW 0%Agar
Gent
AW 37.4%
AW 24.9% AW 18.7%
AW 12.5%
AW 6.2%
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Figure 4.14: Diagram representing the broth dilution testing of strontium glass 
powders, suspended for 24 h. 
 
432 mg of each composition of strontium glass powder <45 µm were weighed and 
autoclaved. Fresh media and new cultures on MH agar were prepared. The antibiotic 
stock was prepared in culture media (BHI for S. aureus, S. epidermidis and E. coli, LB 
for P. aeruginosa), so that the final concentration after the addition of the inoculum 
was the one found with the MIC/MBC test described in Section 4.2.1.3.3.  
On the following day, the sterile glass powders were suspended in 3 mL of media, 
then 0.5 mL were transferred in 3 bijou vials as repeats. Three 0.5 mL vials were 
prepared with media only as the negative controls. Three 0.5 mL of the antibiotic 
dilutions were prepared as the positive controls. Vials were left in the shaking 
incubator set at 37 °C and 200 rpm for 24 h. 40 mL of warm media were inoculated 
with a small colony and cultured overnight. 
Log-phase cultures were prepared and then diluted to 2 x 106 CFU/mL according to 
their standard curves. 0.5 mL of this bacterial dilution were added to all the vials, 
making their final volume 1 mL, and left in the shaking incubator for another 24 h. The 
inoculum used was diluted and plated to verify its actual bacterial concentration. 
After 24 h incubation, all suspensions were diluted, plated on MH agar and incubated 
so that colonies could be counted.  
Day 1
- Media preparation
- Fresh cultures streaked on plates
- Glass powder sterilised
Day 2
- Sterile powders suspended in media for 24 h
- Overnight inoculum preparation
Day 3
- Inoculation of media and growth to log-phase
- Glass powders inoculated with 2 x 106 CFU/mL and 
incubated for 24 h
- 2 x 106 CFU/mL broth diluted and plated
Day 4
- Glass suspensions diluted and plated
Day 5
- CFU quantitation
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Because P. aeruginosa showed some susceptibility for the strontium AW glasses 
(results shown in Section 4.3.4.1), this test was repeated three times for this species 
and also tested with a longer soaking time of the glass powders, as detailed in the next 
Section 4.2.4.2.  
 
4.2.4.2 Determination of the antibacterial effect of strontium glass 
powders suspended in media for 7 days 
The same test described in the previous Section 4.2.4.1 was repeated again for 
Pseudomonas aeruginosa, soaking the strontium AW glass powders for 7 days 
instead of 24 h (Day 2 in Figure 4.14) before the vials were inoculated, cultured for a 
further 24 h and then diluted and plated for measuring their CFU concentration.  
4.3 Results 
4.3.1 Growth characteristics and gentamicin susceptibility of 
Staphylococcus aureus, Staphylococcus epidermidis, 
Escherichia coli and Pseudomonas aeruginosa 
4.3.1.1 Bacterial growth characteristics 
Growth curve measurements were prepared for the four species under study, so that 
information on the time required to reach log-phase cultures could be obtained. 
Figure 4.15 shows the traces of the growth curves found for S. aureus, S. epidermidis, 
E. coli and P. aeruginosa. 
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Figure 4.15: Growth curves for the four selected bacterial species. Error bars 
indicate the standard deviation (n=3). 
 
The four bacteria reached their log-phase, the phase of fast growth characterised by a 
steep increase in optical density, at different times. E. coli was the fastest growing 
species, reaching the mid log-phase in about 1 h. S. aureus took about 2 h, while S. 
epidermidis took 3 h. P. aeruginosa took the longest, about 5 h; its optical densities 
were lower because of its high tendency to form agglomerates, which prevented 
accurate spectrophotometric measurements and caused the different trend of its 
growth curve, more similar to a line than a sigmoid curve. However, this test was used 
to have an indication of the time required by a culture to reach its log-phase for the 
next experiments described in this Chapter, therefore the information provided was 
considered acceptable. 
Some degree of variability, represented by the standard deviation bars in the graphs of 
Figure 4.15, was probably due to differences in the concentration of alive bacterial 
cells present in the inoculum used to initiate the growth study. 
The results of this test were used every time a planktonic culture was to be brought to 
its log-phase, as specified in the tests and assays previously described in Section 4.2. 
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4.3.1.2 Relation between bacterial cell concentration and optical density 
of cultures: Standard curves 
Standard curves were obtained from optical density measurements and CFU counting 
and are shown in Figure 4.16. For each species tested, the equation for calculating the 
CFU concentration in a broth culture sample from its OD600 was derived and is 
reported in Equation 4.1 to Equation 4.4. 
 
 
Figure 4.16: Standard curves, obtained from trendlines, that relate the measured 
optical density to the corresponding CFU concentration. (a) S. aureus, (b) 
S. epidermidis, (c) E. coli, (d) P. aeruginosa. 
 
A linear relationship was chosen for interpolating all the data obtained from three 
repeats. P. aeruginosa showed the highest variability, leading to the lowest R2 value of 
0.77. The R2 value found for the other fitting lines was 0.96 for S. aureus and 0.99 for 
S. epidermidis and E. coli. The formulas derived from the data are specified in 
Equation 4.1 for S. aureus, Equation 4.2 for S. epidermidis, Equation 4.3 for E. coli 
and Equation 4.4 for P. aeruginosa. These results were used every time an inoculum 
of a known CFU concentration was needed from a log-phase culture, as specified in 
the methods presented in Section 4.2. 
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𝐶𝐹𝑈𝑆.𝑎. = 5.1 ∙ 10
8𝑥 𝑂𝐷600 
Equation 4.1: Formula for the calculation of S. aureus CFU concentration from 
the measured optical density OD600. 
 
𝐶𝐹𝑈𝑆.𝑒. = 8.2 ∙ 10
8𝑥 𝑂𝐷600 
Equation 4.2: Formula for the calculation of S. epidermidis CFU concentration 
from the measured optical density OD600. 
 
𝐶𝐹𝑈𝐸.𝑐. = 5.8 ∙ 10
8𝑥 𝑂𝐷600 
Equation 4.3: Formula for the calculation of E. coli CFU concentration from the 
measured optical density OD600. 
 
𝐶𝐹𝑈𝑃.𝑎. = 5.9 ∙ 10
8𝑥 𝑂𝐷600 
Equation 4.4: Formula for the calculation of P. aeruginosa CFU concentration 
from the measured optical density OD600. 
 
4.3.1.3 Gentamicin susceptibility of Staphylococcus aureus, 
Staphylococcus epidermidis, Escherichia coli and Pseudomonas 
aeruginosa 
Results reported in this section summarise the gentamicin sulphate concentrations 
needed as positive controls in the tests run with strontium salts and strontium AW 
glass powders, with glass agar discs and with loose glass powders in planktonic 
cultures. 
4.3.1.3.1 Concentration of gentamicin required for positive controls in zone of 
inhibition assays with paper discs 
Different gentamicin sulphate concentrations were tested to find the one required for 
the assays that used paper discs with strontium salts (Section 4.2.2.1) and with 
strontium, silver and zinc salts (Section 4.2.2.2). Three plates were tested for each 
species; Figure 4.17 shows one representative plate each. The required 
concentrations were chosen as the lowest concentrations that gave visible zones of 
inhibition on the plates. 
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Figure 4.17: Gentamicin sulphate concentration testing from paper discs. (a) S. 
aureus, (b) S. epidermidis, (c) E. coli, (d) P. aeruginosa. Concentrations 
tested from top right and clockwise on each plate: 35 µg/mL, 70 µg/mL, 140 
µg/mL of gentamicin sulphate, PBS (negative control). Scale bars represent 
20 mm. 
 
The four species tested led to different concentrations of gentamicin sulphate required 
for giving inhibition of growth. 35 µg/mL was enough to prevent the growth of S. 
aureus around the sample. For S. epidermidis, since the zone of inhibition observed 
for the lowest concentration tested, 35 µg/mL, gave a large area of growth prevention, 
half this concentration was chosen as the required concentration for positive controls 
with this species. On E. coli plates, both reduction and inhibition of growth were 
observed, so the lowest concentration that gave both was chosen. P. aeruginosa 
showed inhibition only with the highest concentration of gentamicin sulphate. 
The required gentamicin sulphate concentrations found are summarised in Table 4.3. 
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Table 4.3: Gentamicin sulphate concentration required for the positive controls 
in the zone of inhibition assays run with paper discs and strontium salts. 
Species 
Gentamicin 
concentration (µg/mL) 
S. aureus 35.0 
S. epidermidis 17.5 
E. coli 70.0 
P. aeruginosa 140.0 
 
4.3.1.3.2 Concentration of gentamicin required for positive controls in zone of 
inhibition assays with glass agar discs 
As the agar disc diffusion assay required the use of small agar discs loaded with the 
strontium glass powder, equivalent agar discs were prepared containing different 
amounts of gentamicin sulphate. For each species, the lowest concentration that gave 
inhibition was chosen as the one to be used in positive controls for the test. Figure 
4.18 shows a representative plate out of the three tested for each species. 
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Figure 4.18: Gentamicin sulphate concentration testing from agar discs. (a) S. 
aureus, (b) S. epidermidis, (c) E. coli, (d) P. aeruginosa. Gentamicin 
concentrations increasing from top right and clockwise on each plate, 
amounts reported in Table 4.4. Top left sector of each plate: negative 
control (technical agar only). Scale bars represent 20 mm. 
 
Like in the previous test with paper discs in Section 4.3.1.3.1, the required 
concentrations were different for each bacterial species and are summarised in Table 
4.4.  
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Table 4.4: Gentamicin sulphate concentration required for the positive controls 
in the zone of inhibition assay using glass agar discs. 
Species 
Gentamicin 
concentration (µg/mL) 
S. aureus 70.0 
S. epidermidis 17.5 
E. coli 35.0 
P. aeruginosa 70.0 
 
The same or lower concentrations were found compared to the paper discs test (Table 
4.3), with the exception of S. aureus that in this case gave inhibition for a higher 
concentration (70 µg/mL). 
4.3.1.3.3 Concentration of gentamicin required for positive controls in 
planktonic cultures for broth dilution tests 
MIC and MBC were tested for the positive controls of the broth dilution tests described 
in Section 4.2.4, when planktonic cultures were grown in the presence of strontium AW 
glass particles. 
As shown in Table 4.5, MIC for gentamicin sulphate against S. aureus was the same 
concentration found in the agar discs. MICs for the other three species were lower 
than those found in agar discs. S. aureus and E. coli had their MBC remaining at the 
same value of their MIC, while MBC for S. epidermidis and P. aeruginosa were higher 
than their MIC, but still lower than their agar disc concentrations. 
Table 4.5: MIC and MBC values for gentamicin sulphate, to be used as the 
positive controls in the broth dilution tests. 
Species MIC (µg/mL) MBC (µg/mL) 
S. aureus 70.0 70.0 
S. epidermidis 4.4 8.7 
E. coli 17.5 17.5 
P. aeruginosa 8.7 17.5 
 
4.3.2 Susceptibility of selected bacteria to strontium salts in zone 
of inhibition assays 
Salts were used as a simplified model of the strontium-containing glasses under study: 
since it was hypothesised in this work that the chemical element strontium could 
impart antimicrobial properties to the glasses, salts were used in zone of inhibition 
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tests to assess the effect of strontium ions alone on the selected bacterial strains. 
First, strontium chloride and strontium nitrate were utilised (Section 4.3.2.1). Then, 
silver nitrate and zinc chloride were also tested for a comparison with known 
antimicrobial elements (Section 4.3.2.2). 
 
4.3.2.1 Susceptibility of selected bacteria to strontium salts: Strontium 
chloride and strontium nitrate 
The effect of strontium, the doping agent chosen for the AW glasses described in this 
work, was studied by using two different strontium salts: strontium chloride and 
strontium nitrate. Sodium chloride was used as a control to take into account the 
potential effect of chlorine in strontium chloride, while PBS was used as the negative 
control. Figure 4.19 shows the results of the test, one representative plate per bacterial 
species (three were tested). 
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Figure 4.19: Plates showing the results of the zone of inhibition testing of 
strontium salts from paper discs. (a) S. aureus, (b) S. epidermidis, (c) E. 
coli, (d) P. aeruginosa. Samples from top right and clockwise on each 
plate: strontium nitrate, strontium chloride, sodium chloride, positive 
control (gentamicin), negative control (PBS). Scale bars represent 20 mm. 
 
None of the tested salts induced inhibition of the growth of the four bacterial species. It 
was not possible to determine if this was due to a lack of antimicrobial action of the 
salts or if the concentration used was not high enough to highlight it. 4 mM was the 
highest concentration that could be tested before the stock solution precipitated, as 
strontium can react with sulphate, carbonate and phosphate ions contained in media 
(360). Although higher concentrations have been used in the literature (195), this 
highly depends on the media chosen; however, 4 mM is usually the concentration 
used in both bacterial (18) and cell studies (361). 
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4.3.2.2 Susceptibility of selected bacteria to strontium salts: Comparison 
with silver and zinc salts 
Since the strontium salts showed no antibacterial effect in the test in Section 4.3.2.1, 
with no induced inhibition of growth, a silver and a zinc salt were also tested to check 
the response of the four chosen species to the same concentration of these known 
antibacterial elements. Three plates were produced for each bacterial species; one 
representative plate for each species is shown in Figure 4.20. 
 
 
Figure 4.20: Plates showing the results of zone of inhibition testing using paper 
discs, comparing strontium salts with zinc chloride, silver nitrate and 
controls. (a) S. aureus, (b) S. epidermidis, (c) E. coli, (d) P. aeruginosa. 
Samples from top right and clockwise on each plate: strontium chloride, 
strontium nitrate, sodium chloride, zinc chloride, silver nitrate, negative 
control (PBS); centre sample: positive control (gentamicin). Scale bars 
represent 20 mm. 
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The strontium salts and sodium chloride did not induce any inhibition, as seen with the 
previous test, thus confirming results shown in Section 4.3.2.1. Zinc chloride also had 
no inhibitory effect on bacterial growth, suggesting that the 4 mM concentration used 
might be perhaps not high enough. However, a clear zone of inhibition was found 
around the silver disc for all the four species tested, average diameters of the halo are 
reported in Table 4.6. These results proved the much stronger antimicrobial action of 
silver, suggesting that this element could be taken into consideration as a second 
doping element for the strontium AW glasses under study, if stronger antibacterial 
properties were required. For S. aureus and S. epidermidis, the zone of inhibition 
produced by silver was comparable to the one induced by the antibiotic positive 
control. For E. coli and P. aeruginosa, the effect of silver was stronger than the 
antibiotic; for P. aeruginosa, the halo produced by the positive control was small, 
probably due to variations in the gentamicin sulphate stock solution prepared. 
Table 4.6: Average diameter of the inhibition halo induced by silver nitrate, 
compared to the zone measured for the gentamicin sulphate positive 
controls. For E. coli, both diameter of inhibition and diameter of reduction 
of growth (in brackets) are reported. 
Species 
Silver 
Diameter (mm) 
Gentamicin 
Diameter (mm) 
S. aureus 9.17 9.07 
S. epidermidis 10.57 11.73 
E. coli 8.07 7.57 (11.77) 
P. aeruginosa 9.90 7.13 
 
4.3.3 Susceptibility of selected bacteria to strontium glass powders 
embedded in agar 
The antimicrobial effect of the six strontium AW glasses was also investigated, so that 
the properties of the material for the final porous scaffolds could be characterised. In 
this Section, technical agar containing glass powder was used to produce cylindrical 
samples that were tested in a zone of inhibition type of assay. Figure 4.21 shows the 
results of this test with a representative plate for each species tested (three plates 
were made for each species).  
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Figure 4.21: Plates showing the results of zone of inhibition testing using 
strontium AW glass powders mixed in agar discs. (a) S. aureus, (b) S. 
epidermidis, (c) E. coli, (d) P. aeruginosa. Samples from top right and 
clockwise on each plate: AW 0%, AW 6.2%, AW 12.5%, AW 18.7%, AW 
24.9%, AW 37.4%, positive control (gentamicin) and negative control (PBS). 
Scale bars represent 20 mm. 
 
None of the glass compositions produced a zone of inhibition for any of the four 
bacterial species tested, while halos were visible only for the positive controls. It is 
possible that the six strontium AW glasses did not allow enough ions to leak and 
diffuse through the agar, or that the concentration of glass powder used in the agar 
was not high enough; higher concentrations and ion release should be assessed in 
future work for better tuning of this experiment. 
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Because of the inconclusive results of this and the previous tests, it was chosen to 
investigate the antimicrobial properties of the six glasses under study with a different 
test rather than testing different concentrations for the glass agar discs; results are 
reported in the following Section 4.3.4. 
 
4.3.4 Susceptibility of selected bacteria to strontium glass powders 
in broth dilution tests 
Strontium AW glass powders were tested after soaking for 24 h against all the four 
bacterial species (Section 4.3.4.1), or after soaking for 7 days against P. aeruginosa 
(Section 4.3.4.2).  
 
4.3.4.1 Susceptibility to strontium glass powders suspended in culture 
media for 24 hours 
Figure 4.22 shows the results of the broth dilution test against the four bacterial 
species chosen in this work. The positive control was gentamicin sulphate at the four 
concentrations found in Section 4.3.1.3.3, negative control was culture media without 
any glass powder. In this case, the strontium AW glass powders were soaked and 
mixed in a shaking incubator for 24 h before inoculation. The test with P. aeruginosa 
was repeated three times with comparable results; the graph in Figure 4.22d shows 
the results of one of the three repeats. 
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Figure 4.22: CFU count after 24 h incubation with the strontium AW glass 
powders pre-soaked for 24 h. The red line represents the bacterial 
concentration of the initial inoculum, positive control is gentamicin 
sulphate, negative control is culture media with no glass powder. (a) S. 
aureus, (b) S. epidermidis, (c) E. coli, (d) P. aeruginosa. Error bars indicate 
the standard deviation (n=3); * indicates significant difference with p0.05. 
 
None of the strontium AW glass powders induced any reduction in bacterial growth for 
S. aureus, S. epidermidis and E. coli compared to the negative control. The positive 
control killed all the CFUs in the S. aureus and P. aeruginosa samples, while some live 
cells could still be detected for the positive controls of S. epidermidis and E. coli, 
possibly due to variations in the actual concentration of the diluted gentamicin stock. 
The large error bar of the positive control for S. epidermidis was due to the fact that 
the three plates gave very different CFU counts. 
For P. aeruginosa, AW 37.4 % induced a reduction in CFU count compared to the 
other samples and the negative control, with a statistically significant difference to 
sample AW 6.2 % (p<0.05). The CFU concentration in sample AW 37.4 % was found 
lower than the 106 CFU/mL inoculum used, indicating that the sample was at least 
bacteriostatic, but also potentially had an antibacterial effect on this species. 
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4.3.4.2 Susceptibility to strontium glass powders suspended in culture 
media for 7 days 
Since, with P. aeruginosa, sample AW 37.4 % showed some growth inhibition (Section 
4.3.4.1), which indicated some possible susceptibility of this species to strontium-
containing glasses, the test was repeated by soaking all the six AW glass powders for 
7 days before inoculation. Only one repeat of the experiment was performed, with 
triplicates for each sample. Results are shown in the graph in Figure 4.23. 
 
 
Figure 4.23: CFU count after 24 h incubation with the strontium AW glass 
powders, pre-soaked for 7 days. The red line represents the initial 
inoculum, positive control is gentamicin sulphate, negative control is 
culture media with no glass powder. Error bars indicate the standard 
deviation (n=3); no standard deviation could be calculated for the positive 
control. • indicates compositions that showed significant difference from 
the other compositions, but not from one another. P values are displayed 
in Table 4.7. 
 
When the glass powders were soaked and mixed for 7 days before inoculation, three 
compositions showed reduction in the final CFU count of P. aeruginosa compared to 
the negative control (broth with no glass): AW 0%, AW 24.9 % and AW 37.4 %. These 
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were significantly different from the other samples, but not from one another, and the 
p-values are reported in Table 4.7. The positive control had no error bar because only 
one plate could be counted. Sample AW 24.9 % had a large error bar because of the 
difference in CFU count found for the three plates. Only AW 37.4 % gave a CFU count 
lower than the initial inoculum, confirming its bacteriostatic or bactericidal action seen 
in the previous Section 4.3.4.1.  
Table 4.7: One way ANOVA p-value results with Bonferroni test for the 
compositions that showed significant differences when the strontium AW 
glass powders were soaked for 7 days and then incubated in the presence 
of P. aeruginosa for 24 h. 
Compared compositions 
Mean difference 
(CFU/mL) p-value 
AW 0%  AW 6.2% -7.90x109 5x10-5 
AW 0%  AW 12.5% -5.10x109 5x10-3 
AW 0%  AW 18.7% -6.84x109 5x10-4 
AW 0%  Negative control  -7.50x109 5x10-5 
AW 24.9%  AW 6.2% -7.91x109 5x10-5 
AW 24.9%  AW 12.5% -5.11x109 5x10-3 
AW 24.9%  AW 18.7% -6.85x109 5x10-4 
AW 24.9%  Negative control  -7.51x109 5x10-5 
AW 37.4%  AW 6.2% -7.93x109 5x10-5 
AW 37.4%  AW 12.5% -5.13x109 5x10-3 
AW 37.4%  AW 18.7% -6.87x109 5x10-4 
AW 37.4%  Negative control -7.53x109 5x10-5 
 
The reduction in CFUs found for the three compositions was strongly significantly 
different compared to the other samples. The p-values found with the Bonferroni test 
were 0.005 when glasses were compared to sample AW 12.5 % and lower for the 
other compositions, being 5x10-4 when the three glasses were tested against 
composition AW 18.7% and 5x10-5 when compared to glass AW 6.2% and to the 
negative control (absence of glass powder in the sample) 
4.4 Discussion 
As presented in Chapter 1, there is evidence in the literature that strontium-containing 
bioactive glasses can exert some antibacterial properties (17, 18). Therefore, this 
Chapter investigated strontium as a possible antimicrobial agent, both as a free 
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element through the use of strontium salts and as a dopant in bioactive glass powders 
intended for bone scaffolds. In the work described in this thesis, antibacterial 
characterisation only for the material used for the scaffolds was described, while 
testing of the final scaffolds will be part of the future work (Chapter 8) for a full 
assessment of the constructs. 
 
4.4.1 Selection of bacterial strains 
Four species were chosen for this work as the most representative of post-operative 
infections (130, 141), two Gram-positive and two Gram-negative: Staphylococcus 
aureus, Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa. 
These were characterised for their growth profiles and antibiotic resistance to 
gentamicin sulphate. Gentamicin sulphate was chosen as the antibiotic control 
because all the four species under testing proved to have some degree of 
susceptibility to it, also confirmed by the literature (362-365). Although it might not be 
the antibiotic of choice for each of the four species, and in fact some live cells were 
found in the broth dilution tests (Section 4.3.4.1 and 4.3.4.2), it was not the scope of 
this work to find a specific antibiotic for each of them, but simply to have a positive 
control that proved that the strain responded to known antimicrobial agents. 
 
4.4.2 Investigation of strontium antibacterial effect using salt 
solutions 
First, strontium salts were tested for an initial investigation of the antibacterial 
properties of strontium. Two salts were chosen for comparison, strontium nitrate and 
strontium chloride, so that the possible effect of chlorine, a known antimicrobial agent 
(366), in strontium chloride could be ruled out. 4 mM was the highest concentration of 
strontium tested, as it is the highest concentration usually found in the literature for 
both antibacterial testing (18) and cell culture testing (361). In addition, 4 mM was 
found to be the maximum concentration that could be prepared in culture media 
without the formation of precipitates. It has been observed in fact that, although highly 
soluble in deionised water, strontium can easily react with sulphate, carbonate and 
phosphate ions present in a solution to give precipitates (360). 
None of the two strontium salts nor sodium chloride induced growth inhibition in the 
four species tested. 20 µL of each solution were used, according to literature (357), on 
each paper disc, corresponding to about 7 µg/disc of strontium. Because no such test 
has been described in the literature using strontium salts, there is no comparison that 
could indicate if the concentration used was high enough and strontium had no effect, 
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or if the concentration was not high enough to see any effect. Looking at the literature, 
it is still uncertain whether strontium could impart antimicrobial properties to bioactive 
glasses. Guida et al. tested strontium-containing glass ionomer cements with the agar 
disc diffusion test against two species involved in dental caries: Streptococcus mutans 
and Actinomyces viscosus; they observed that the cement samples showed stronger 
antibacterial properties for strontium-containing compositions, with S. mutans being 
more susceptible than A. viscosus, and suggested a synergistic effect of fluorine and 
strontium (17). Liu et al. studied the effect of strontium-containing bioactive glasses 
against Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis using 
the AlamarBlue viability assay; they found that the presence of strontium enhanced the 
antibacterial activity of the material, although the no-strontium glass also showed 
antimicrobial properties. The authors also used strontium chloride to assess the effect 
of strontium itself, and they found a dose-dependent effect on the inhibition of bacterial 
growth with strontium, which was stronger against P. gingivalis than A. 
actinomycetemcomitans (18). Brauer et al. tested composite cements for spinal 
applications that contained strontium glasses; they found that the cell count of 
Streptococcus faecalis and Staphylococcus aureus was reduced in the presence of 
strontium, although the reduction was not enhanced for increasing strontium and also 
the composite cement containing the strontium-free glass induced a decrease in cell 
count after 6 days of culture (197). Dabsie et al. tested different strains implicated in 
carious or periodontal pathologies by exposing them to culture broth containing 
strontium chloride for 5 min, maximum concentration 1.11 M; they observed about 1 
log reduction in cell count only for the highest strontium concentration (195). Fielding 
et al. produced silver and strontium containing plasma-sprayed hydroxyapatite 
coatings and tested their antimicrobial properties against P. aeruginosa; they found 
that the presence of strontium could offset the cytotoxic effect of silver, but only 
compositions containing silver showed antimicrobial properties (200). Geng et al. 
tested hydroxyapatite coatings, produced via hydrothermal treatment and doped with 
silver and strontium, against E. coli and S. aureus; all the silver-containing samples 
showed antimicrobial properties and the addition of strontium reduced the cytotoxicity 
of strontium in MG63 cells, but strontium-only samples did not show any antibacterial 
activity (201, 202). These last publications are in agreement with what was found in 
this work in the test that included silver and zinc: only silver proved to be a strong 
bactericidal agent, giving zones of inhibition for all the four species tested. Zinc is also 
a known antibacterial element, however, its effect is less strong than that of silver 
(358, 359) and in fact it did not show any inhibition in the test carried out here. This 
test with silver and zinc was carried out as a proof-of-concept, comparing the element 
under investigation, strontium, to other known antibacterial elements. Results 
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suggested that, for an AW-based scaffold material with enhanced antimicrobial 
properties against pathogens commonly found in orthopaedic peri-prosthetic 
infections, silver could be the element of choice, while strontium could be added for 
improving the cytocompatibility.  
 
4.4.3 Effect of strontium on the antibacterial activity of AW glass 
powders 
Testing of strontium AW glass powders was based on the work of Fernandes et al., 
who tested the same four bacterial species chosen for this work (198). Two types of 
test were performed: disc diffusion, using glass-loaded agar samples, and broth 
dilution, suspending the glass powders in media before inoculation. 
For the agar disc diffusion, Fernandes et al. loaded agar discs (diameter 9.5 mm) with 
72 mg of glass powder, while here, for simplicity reasons, technical agar was loaded 
with 72 mg/mL of glass powder and then small discs (diameter 7.5 mm) were cut out. 
The authors observed inhibition only for P. aeruginosa, which they therefore selected 
for the broth dilution testing. However, no inhibition could be observed from the 
strontium AW samples for any of the four species tested in this work. This difference in 
the results could be due mainly to three factors: differences in preparation of the test 
samples, the difference in the bacterial strains used (American Type Culture Collection 
(ATCC) or Coleccíon Española de Cultivos Tipo (CECT), for Fernandes et al. (198), 
NCTC in the present work) and the difference in the composition of the tested glasses. 
Differences in preparation of the test samples could have determined a difference in 
the final glass concentration, or a difference in the amount of glass powder in direct 
contact with the bacterial surface. Different bacterial strains could have generated 
different responses to antimicrobial agents. Different glass compositions could have 
induced different effects in bacteria. It is likely that the absence of response observed 
with the strontium AW glasses was caused by a combination of these three factors. 
In the present work, broth dilution was carried out for all the four chosen species, using 
the highest concentration of glass powder in media that was used in the reference 
paper: 72 mg/mL. In this case, results agreed with the findings of Fernandes et al., as 
only P. aeruginosa appeared to be susceptible to the strontium glass powder of 
sample AW 37.4%. However, Fernandes et al. used different concentrations of the 
same glass to assess the dependence of P. aeruginosa susceptibility to strontium and 
they found that, with 1 day of glass incubation, 9 mg/mL of glass powder gave a 
bacteriostatic effect, while 18, 36 and 72 mg/mL eradicated the bacteria. The 
composition of their glass was 5Na2O-35SrO-20B2O3-40SiO2 mol% (198), so close to 
AW 37.4% in terms of strontium content. In the present work, in order to reduce the 
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number of samples tested, only one concentration of glass in media was used and 
dependence to strontium was assessed through the six strontium AW compositions; 
with 1 day of glass dissolution and 1 day of incubation after inoculation, only AW 
37.4% showed a bacteriostatic effect against P. aeruginosa, with about 1 log reduction 
of CFU from the inoculum. Because of these results, the strontium AW glass powders 
were tested again only against P. aeruginosa with 7 days of powder dissolution at 37 
°C before inoculation. AW 37.4% confirmed its bacteriostatic nature, while AW 0% and 
AW 24.9% showed a reduction in CFUs compared to the negative control, but the final 
count was still higher than the inoculum, indicating that the growth was slowed down, 
but not prevented. While the effect of AW 24.9% could be expected as the second 
highest strontium-containing composition, the response to AW 0% was not predicted. 
However, other bioactive glass compositions have been described in the literature that 
showed antimicrobial properties without containing any specific antimicrobial agent. 
The best example, in this sense, is the case of the S53P4 glass, composition 53SiO2-
23Na2O-20CaO-4P2O5, commercially available under the brand BonAlive as 
antibacterial granules indicated in the treatment of chronic osteomyelitis. For this 
glass, it is thought that its antibacterial properties derive from the increase in pH and 
osmolarity induced by the release of alkaline ions into the surrounding environment, 
which causes bacterial cell shrinkage and damage to the bacterial cell membrane (94, 
205-208). In addition, Brauer et al. observed that their no-strontium composition of 
cement showed some antimicrobial properties, which were ascribed to a combined 
effect of fluorine (11.04 mol% CaF2) and of the cement matrix (197). Moya et al. 
observed that soda-lime glass compositions containing more than 15 wt% CaO 
reduced the CFU count by more than 4 log for E. coli, Micrococcus luteus and Candida 
krusei (a yeast). They concluded that the antibacterial properties of this class of 
glasses were due to the depolarisation of the bacterial cell membrane caused by the 
very high concentration of Ca2+ at the glass-membrane interface, enhanced by the 
local low pH (< 2) induced by the proton pumping activity of bacteria (211). Cabal et al. 
showed that the same high-calcium compositions preserved their antibacterial 
properties when the material was turned into a glass-ceramic, proving its efficacy 
against five biofilm-forming bacterial species (210). Allan et al. (203) and Hu et al. 
(204) studied the behaviour of Bioglass 45S5 against different species and both 
publications found that the particulates or powders of this glass could induce a strong 
bactericidal effect, explained by the increase in pH that was induced by the material 
interacting with the culture media, along with the formation of needle-like debris that 
caused damage to the cell walls. On the contrary, Gorriti et al. tested Bioglass and 
boron-containing Bioglass glass-ceramic scaffolds against different strains of S. 
aureus, but did not observe any inhibition of bacterial growth (367). Two publications 
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compared the effect of different bioactive glass compositions on 29 aerobic species 
(208) and 17 anaerobic species (209); both found that all compositions induced 
moderate to strong antimicrobial effects, which were ascribed to the increase in pH 
and osmolarity induced by the glasses in solution, as well as the high concentration of 
Ca2+ perturbing the bacterial membrane potential. 
In conclusion, many factors can influence the outcome of bacterial tests for bioactive 
glasses and methods can vary considerably between publications. Many species have 
been tested in the literature, using many different strains for each species. Outcome of 
testing of bioactive glasses and glass-ceramics can depend strongly on glass 
composition, form of the material (particles, paste, solid, porous solid, coating), particle 
size, crystallinity, concentration and reactivity of the glass. Different tests have been 
described depending on the proposed research question. When the antibacterial 
properties of a new glass are investigated, simple tests are typically carried out that 
can assess whether the material presents any antimicrobial feature, usually disc 
diffusion tests (also called agar diffusion test, or zone of inhibition test, or Kirby-Bauer 
test) (17, 198, 201, 202) or broth dilution tests (94, 197, 198, 203, 204, 206-211, 367). 
Only Liu et al. described the use of the AlamarBlue viability assay for assessing the 
antibacterial properties of strontium-containing glasses (18). Only once a glass had 
shown antimicrobial properties, additional tests can be carried out to investigate, for 
example, its effect on biofilms (200, 202, 205, 207, 210), the effect on cell morphology 
through imaging (201, 202, 204-206, 208, 211) or the mechanisms of action of the 
specific composition under study (203, 211). In the case of the glass compositions 
described in this thesis, only the first level of testing was carried out and results 
suggested that composition AW 37.4%, tested as <45 µm glass powder, 72 mg/mL in 
LB, exhibited bacteriostatic action against P. aeruginosa, strain NCTC 10332. A mild 
bacteriostatic effect was also observed for compositions AW 0% and AW 24.9% under 
the same testing conditions, but with a longer dissolution time. Therefore strontium AW 
glasses could induce only minor antimicrobial effects and thus did not indicate to be 
promising antibacterial materials for the prevention and treatment of post-operative 
bone infections.
190 
 
 
 
191 
 
 
Chapter 5  
Effect of strontium AW scaffolds on the growth and 
osteogenesis of bone-forming cells 
Although the mechanism of action of strontium on bone-forming cells is still unclear, its 
positive effect on bone formation and regeneration has long been studied. In fact, as 
described in Chapter 1, this element is known for its dual ability of inducing osteogenic 
differentiation in bone marrow mesenchymal stromal cells (MSCs) and bone 
extracellular matrix deposition in osteoblasts, as well as reducing bone resorption by 
osteoclasts (15, 150). In clinical applications, a strontium salt, strontium ranelate, is 
currently used for treating severe osteoporosis (16, 163, 165). However, as potential 
systemic side effects have been associated with this drug (173, 176), localised 
delivery of small doses of strontium would be preferable. Various compositions of 
bioactive glasses have been proposed for the fabrication of strontium-containing bone 
scaffolds in the literature (151, 156, 177, 181, 368). However, this is the first time that 
this element has been added to the AW glass-ceramic material for the production of 
foam-replicated scaffolds. This chapter will explore the effects of the strontium AW 
porous scaffolds, produced as described in Chapter 3, on bone-forming cells in vitro. 
Tests were initially carried out using G292 cells, an osteosarcoma cell line commonly 
used as a model for MSCs (369-371), before samples were tested on human bone 
marrow-derived MSCs (hBM-MSCs).  
5.1 Materials and methods 
The six compositions of strontium AW porous scaffolds were prepared as described in 
Chapter 3. Samples were first tested using the G292 cell line to screen for any 
osteogenic or proliferative effect. Some of the strontium AW compositions were then 
further tested using primary human bone marrow-derived mesenchymal stromal cells 
(hBM-MSCs). General cell culture methods, seeding and analysis techniques are 
described in Sections 5.1.1, 5.1.2 and 5.1.3, respectively. Details on the tests 
conducted on the G292 cell line are reported in Section 5.1.4 and tests carried out on 
the hBM-MSCs are described in Section 5.1.5. 
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5.1.1 General cell culture 
5.1.1.1 General cell culture materials 
Alpha-modified minimum essential media (α-MEM) and 1x phosphate buffered saline 
(PBS) were purchased from Lonza; foetal bovine serum (FBS), penicillin-streptomycin 
(PS), L-glutamine, trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA) solution and 
dimethyl sulphoxyde (DMSO) were from Sigma; all plasticware was from Corning, 
unless otherwise stated. 
 
5.1.1.2 In vitro cell culture and expansion 
20 mL of media were used for T75 culture flasks, 30 mL for T175 flasks. Plain media 
was prepared as α-MEM with 1 % PS (resulting in 100 units/mL of penicillin and 0.1 
mg/mL of streptomycin in the final media) and 2 mM L-glutamine. G292 culture media 
was prepared by adding 10 % FBS to plain media, while culture media for hBM-MSCs 
was prepared by adding 15 % FBS to plain media. Cells were harvested by rinsing the 
flask twice with PBS and then incubating them with trypsin-EDTA for 5-10 min. 
Detachment was confirmed under a microscope and the cell suspension was diluted 
with FBS-containing media and collected in a Falcon tube; the centrifugation protocol 
will be specified, depending on the cell type, in the relevant Section 5.1.4 for G292 and 
5.1.5 for hBM-MSCs. The cell pellet was then re-suspended in different media 
according to the experimental design and the cell number was counted using a 
haemocytometer. 
 
5.1.1.3 Cryopreservation of cells 
Cells were detached, counted and pelleted down as described previously. Freezing 
media was prepared by adding 30 % FBS and 10 % DMSO to α-MEM. Each cell pellet 
was re-suspended with 1 mL of freezing media, transferred to a cryogenic storage vial 
and placed in a Mr. Frosty (Thermo Scientific) box containing isopropanol, which was 
placed in a -80 C freezer overnight. The day after the vials were moved to a storage 
box and kept at -80 C until use. 
 
5.1.2 Seeding of cells on 3D porous scaffolds 
100 mm3 porous scaffolds, prepared from 5 mm-side foams as described in Chapter 3, 
were sterilised by autoclaving and handled using sterile tweezers. 
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Scaffolds were pre-treated with plain media containing 20 % FBS overnight at 4 °C, in 
order to modify their surface chemistry and facilitate cell attachment. Treated scaffolds 
were then rinsed in plain media before cells were seeded. The effect of performing this 
treatment was verified with G292 cells against samples treated with plain (no FBS) 
media, as described in Section 5.1.4.1. 
Cells were counted as described in Section 5.1.1.2 and suspensions were prepared in 
plain media so that 1 x 105 cells were seeded on each scaffold in a 50 µL drop. Cells 
were allowed to attach for 3 h in incubator at 37 °C, then scaffolds were rinsed in plain 
media to remove all the non-attached cells and cultured in 48 well-plates using the 
designated culture media (500 µL per well). 
Media was changed twice a week, with a rinsing step with plain media, until the 
required time-point. 
 
5.1.3 General characterisation of seeded scaffold 
5.1.3.1 Fluorescent labelling for visualising cell attachment 
The staining solution was prepared by adding 5 µL of calcein AM (from the Invitrogen 
live/dead kit: 4 mM calcein AM) to 10 mL of plain media and the solution well mixed 
before use. 
Samples were incubated in 500 µL of the staining solution, covered in foil, for 30 min 
at 37 °C, then rinsed in plain media; the calcein AM signal (495/515 
excitation/emission) was observed under inverted fluorescence microscope (Zeiss 
Axio Vert A1). Images were taken using the Zeiss imaging software, with live cells 
represented in green. 
 
5.1.3.2 Live/dead staining and confocal imaging 
Confocal microscopy was used to observe the 3D distribution of cells in the porous 
scaffolds. 
The staining solution was prepared using the Invitrogen live/dead kit, following the 
manufacturer’s instructions: 20 µL of 2 mM ethidium homodimer-1 (dead cell stain) 
and 5 µL of 4 mM calcein AM (live dead stain) were added to 10 mL of plain media. 
Scaffolds were rinsed in plain media before they were incubated in 500 µL of staining 
solution, covered in foil, for 30 min at 37 °C. Samples were then rinsed again in plain 
media and kept in 500 µL of plain media if observed immediately with the confocal 
microscope, or preserved in 500 µL of 10 % formalin (Sigma) at 4 °C overnight and 
observed the day after.  
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During imaging, samples were moved to PBS and observed using immersion lenses 
under a Leica SP8 confocal microscope. 488 nm and 552 nm lasers were activated 
and filters adjusted to minimise cross-talking of the channels. Stacks of planar images 
were taken, 5 µm apart, then combined for a 3D projection of maximum signal. Live 
cells were represented as green, dead cells as red, scaffolds in greyscale. 
After confocal imaging, samples were kept in 10 % formalin at 4 °C until SEM imaging 
was carried out. 
 
5.1.3.3 Cell morphology with cold-stage scanning electron microscopy 
Samples kept in 10 % formalin were first rinsed in distilled water. A Daben cold-stage, 
connected to the Hitachi S-3400N scanning electron microscope (SEM), was pre-
cooled to 0 °C, then samples were placed on the stage and moisture removed with 
absorbent paper. Temperature was gradually brought to -20 °C while pressure in the 
SEM chamber was reduced to 70 Pa. Pictures were acquired in backscattered 
electrons (BSE) mode for better contrast between cells and scaffold. 
 
5.1.3.4 Alkaline phosphatase staining 
Alkaline phosphatase (ALP) is an early marker of osteogenic differentiation in MSCs, 
which indicates the commitment of the stromal cell to the osteoblast lineage (372). 
To qualitatively assess the presence and the amount of this enzyme, samples were 
rinsed in PBS and fixed using 98 % ethanol at 4 °C for 20 min. Then samples were 
rinsed again in PBS and let air dry. 
10 mL of ALP staining solution were prepared by mixing 9.6 mL distilled water with 0.4 
mL Naphthol AS-MX phosphate (Sigma) and 4.2 mg Fast Violet B salt (Sigma). 500 µL 
of this staining solution were added to the samples, then covered in foil and incubated 
at 37 °C for up to 60 min, until stain was visible. The staining solution was then 
removed, samples air dried and pictured using a Leica M205C stereomicroscope, 
coupled with Leica KL1500 LCD illumination and Schott KL1500 light system. 
 
5.1.3.5 PrestoBlue metabolic activity quantification 
PrestoBlue is a resazurin-based reagent that can measure the viability of cells. It 
contains a blue, non-fluorescent, cell-permeant compound (resazurin) that gets 
reduced within the cell cytoplasm by cell respiration; when reduced, it turns into red, 
fluorescent resorufin. The conversion is proportional to the number of metabolically 
active cells and it can be measured as fluorescence or absorbance. The compound 
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does not interfere with cell metabolism, so the same cells can be monitored over time 
or collected for DNA and ALP activity quantification (373, 374), as done in the present 
thesis (Sections 5.1.3.6 and 5.1.3.7). 
In the case of cells cultured on the strontium AW scaffolds, samples were rinsed and 
then placed in 500 µL of plain media in a 48 well-plate. Negative controls consisted of 
plain media only. 50 µL of Invitrogen PrestoBlue Cell Viability Reagent were added to 
each well as per manufacturer’s instructions. The plate was covered in foil and 
incubated at 37 °C until a significant change in colour could be observed. 100 µL 
aliquots were then taken from each well and transferred to a 96-well plate. The 
fluorescence signal was measured using a Thermo Fisher Varioskan Flash plate 
reader, set at 560 nm for excitation and 590 nm for emission. The average signal from 
the negative controls was subtracted from the measured signals. 
Samples were then transferred back to plain media for 1 h, in preparation for DNA and 
ALP quantification (Section 5.1.3.6 and 5.1.3.7, respectively). 
 
5.1.3.6 PicoGreen DNA quantification 
The lysing solution of 0.1 % Triton-X in carbonate buffer was prepared by dissolving 
4.2 g of sodium carbonate (Na2CO3, Thermo Fisher) in 200 mL of distilled water and 
1.7 g of sodium hydrogencarbonate (NaHCO3, Thermo Fisher) in 100 mL of distilled 
water. The two solutions were then mixed together and the pH adjusted to 10.2 using 
1 M hydrochloric acid. Triton-X (Fisons) was then diluted to 0.1 vol% in the so-
prepared carbonate buffer.  
The DNA standard and the testing solution were prepared using the Invitrogen Quant-
iT PicoGreen dsDNA assay kit. First, the provided 20x TE buffer was diluted to 1x in 
distilled water. The standard sample was prepared by adding 10 µL of the dsDNA to 
490 µL 1x TE buffer. The PicoGreen testing solution was prepared by adding 10 µL of 
the PicoGreen stock to 1990 µL of 1x TE buffer. 
Scaffolds were rinsed in PBS, moved to new wells and 500 µL of lysing solution were 
added. Well-plates were sealed with Parafilm, then frozen at -80 °C and thawed 3 
times, before samples and solution were transferred to 1.5 mL Eppendorf vials and 
sonicated for 5 min in an ultrasonic water bath (Advantage-Lab AL04-01). 
The calibration curve was set up by serially diluting the DNA standard in 1x TE buffer. 
5 µL of sample lysing solution were added to 95 µL of 1x TE buffer in a 96 well-plate. 
100 µL of the PicoGreen solution were added to each well, then the plate was 
incubated, covered in foil, at room temperature for 5 min and fluorescence 
measurements were taken with the Thermo Fisher Varioskan Flash plate reader set at 
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480 nm excitation and 520 nm emission. Linear interpolation of data from the standard 
curve was used to calculate the DNA concentration in the samples. 
Results were used to normalise cell viability (PrestoBlue assay, Section 5.1.3.5) and 
ALP activity (Section 5.1.3.7) measurements. 
 
5.1.3.7 Alkaline phosphatase activity quantification 
The ALP standard and the testing solution were prepared using the Alkaline 
Phosphatase Diethanolamine Activity kit (Sigma-Aldrich). The ALP standard was 
diluted to 1 U/mL in the provided reaction buffer, while a 0.67 M dilution of the p-
nitrophenyl phosphate (pNPP) substrate was prepared in ultrapure water. 
10 to 50 µL of each sample, depending on how strong the signal was expected, were 
diluted in the reaction buffer in a 96 well-plate, so that the total volume in each well 
was 98 µL. The standard curve was set up by serially diluting the ALP standard, 
obtaining a final volume of 98 µL in each well. 2 µL of the pNPP substrate solution 
were added to each well and the plate incubated at 37 °C, covered in foil, for up to 60 
min until a change in colour was clearly visible. The reaction was then stopped by 
adding 100 µL of 1 M sodium hydroxide to each well, before the absorbance was read 
at 405 nm with the Thermo Fisher Varioskan Flash plate reader. 
 
5.1.3.8 Picroserius Red staining of extracellular deposited collagen 
The Picroserius Red Stain kit (Polysciences, Inc.) was used to qualitatively investigate 
the presence of deposited collagen on seeded scaffolds. It contains: 
- Solution A: Phosphomolybdic Acid; 
- Solution B: Picrosirius Red F3BA Stain; 
- Solution C: 0.1 N Hydrochloric Acid. 
After fixing in 10 % formalin, the seeded scaffolds were first rinsed in distilled water 
and then moved to a new 48 well-plate. 500 µL of solution A were added to each 
sample and incubated at room temperature for 2 min. Samples were then rinsed in 
distilled water, before 500 µL of solution B were added and scaffolds incubated at 
room temperature for 1 h, after which they were moved to solution C for 2 minutes. 
Scaffolds were then thoroughly rinsed in distilled water and let dry, before being 
imaged under the Leica M205C stereomicroscope. 
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5.1.3.9 Statistical analysis 
In the quantitative assays, statistical differences in the average results between 
compositions at each time-point were confirmed with one-way analysis of variance 
(ANOVA) tests. Results were displayed as mean ± standard deviation. P values over 
0.05 were considered as not significant.  
 
 
5.1.4 Culture of G292 cells on strontium AW porous scaffolds 
G292 cells, clone A141B1, were purchased from Sigma. G292 cultures were started 
from frozen stocks of previously expanded cells. Cryovials were first quickly thawed at 
37 °C in a water bath, the content transferred to a Falcon tube, re-suspended in plain 
media and centrifuged at 1100 rpm (Eppendorf 5804 R centrifuge) for 5 min. The 
supernatant was discarded, the pellet re-suspended again in plain media, cells 
counted and a known amount seeded in culture flasks containing culture media with 
10 % FBS. Media was changed twice a week. Cells were passaged when at least 70 
% confluency was reached. 
 
5.1.4.1 Effect of serum pre-treatment on G292 cell attachment on 
scaffolds 
Only AW 0% scaffolds were used to verify whether the pre-treatment of scaffolds in 
FBS-rich media was necessary to guarantee good cell attachment. Two scaffolds were 
pre-treated overnight with FBS-rich media (20 % FBS), while two were treated in plain 
media. For this test, cells (monolayer) were labelled directly in the flask using calcein 
AM, before being harvested. After moving the scaffolds to new sterile vials, 1 mL of the 
prepared cell suspension (3 x 105 cells/mL) was added onto the scaffolds; after 3 h of 
incubation, the seeded scaffolds were rinsed in plain media to remove the unattached 
cells before being observed under the fluorescence microscope. Pictures were taken 
while scaffolds were kept in plain media.  
 
5.1.4.2 G292 cell growth in basal vs osteogenic media 
This study compared the use of basal culture media, prepared as described in Section 
5.1.1, with osteogenic media (StemMACS OsteoDiff Media). 
Only compositions AW 0%, AW 12.5% and AW 24.9% were tested. All scaffolds were 
pre-treated in 20 % FBS media overnight, then 25 samples per composition were 
seeded as described in Section 5.1.2, but left in plain media for 24 h before being 
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moved to basal or osteogenic media. As shown in the diagram in Figure 5.1, three 
samples per composition were stained for live cells and imaged under fluorescence 
microscope at 3 h and 24 h after seeding, for monitoring the cell attachment and 
spreading on the scaffolds. 5 samples per composition were then collected for the 1 
day time-point testing, so the 1 day samples included only the plain media condition. 
The remaining cell-scaffold constructs were moved to either basal or osteogenic media 
and cultured for 7 and 14 days.  
At each time-point, 5 samples per condition were tested as follows:  
- 1 scaffold per composition was stained for live/dead cells and imaged under 
confocal microscope, before being fixed in 10 % formalin and then imaged with 
SEM; 
- 1 sample per composition was fixed in 98 % ethanol for ALP staining; 
- 3 scaffolds per composition were tested for metabolic activity, before being 
collected and frozen for DNA and ALP activity quantitative assays. 
For this experiment, the confocal microscope used for live/dead imaging was a Leica 
TCS SP2.  
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Figure 5.1: Schematic representation of the test carried out to compare the 
culture of G292 cells in basal and osteogenic media. Compositions AW 0%, 
AW 12.5% and AW 24.9% were tested. For each yellow box, 5 samples per 
composition were tested. *Cell attachment was checked with fluorescence 
microscopy at 3 h and 24 h. 
 
5.1.4.3 Assessment of the effect of strontium content in AW porous 
scaffolds on the growth and osteogenesis of G292 cells 
All the six strontium AW porous scaffold compositions were tested. Scaffolds were 
seeded as described in Section 5.1.2 and then cultured in basal media for 3 h, 1 day, 3 
days and 7 days after seeding. 
At each time-point, 10 scaffolds per composition were collected and tested as follows: 
- 1 scaffold per composition was stained for live/dead cells and checked under the 
fluorescence microscope, before being fixed in 10 % formalin for confocal 
microscopy and SEM imaging; 
- 3 scaffolds per composition were stained for ALP; 
- 6 scaffolds per composition were tested for metabolic activity, then cells were lysed 
and frozen before DNA and ALP activity quantitative assays were run. 
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5.1.5 Culture of human mesenchymal stromal cells on strontium 
AW porous scaffolds 
Human mesenchymal stromal cells were obtained from bone marrow mononuclear 
cells (hBM-MSCs), purchased from Lonza. The Certificate of Analysis provided 
informed that cells were cryopreserved on 12th November 2007 and that the donor was 
a 41 year-old African-American man. 
Cell cultures were started following the manufacturer’s instructions. The as-bought 
cryovial was quickly thawed at 37 °C, its content transferred to a 50 mL Falcon tube, 
the cryovial rinsed with 1 mL of plain media containing 10 % FBS and 20 U/mL of 
DNase I (Sigma) and then the rinse was slowly added to the Falcon tube. The volume 
of the cell suspension was slowly brought to 50 mL by adding the same DNase-
containing media dropwise and then centrifuged at 200 G for 15 min (Eppendorf 5804 
R centrifuge). The supernatant was then gently removed, leaving 2 mL of media in 
which the pellet was re-suspended. Cells were then transferred to a 15 mL Falcon 
tube, rinsing the 50 mL tube with plain media containing 10 % FBS and transferring 
the wash to the second tube. The volume was slowly brought to 15 mL, the tube 
centrifuged again at 200 G for 15 min, the supernatant removed and the pellet re-
suspended in 2 mL of media. Cells were counted, then rested in incubator for 1 h 
before being counted again and transferred to culture flasks with plain media 
containing 15 % FBS. From the mononuclear population, it is expected that only MSCs 
would attach to the culture flasks (375-377); cells were cultured for 3 days before the 
first media change was carried out, thus eliminating all the non-adherent cells. 
Cells were cultured in the 15 % FBS media described in Section 5.1.1 and media was 
changed twice a week. Cultures were passaged when at least 70 % confluent. When 
harvested, cell suspensions were centrifuged at 200 G for 15 min, as per 
manufacturer’s instructions. Cells were used after passage 3, to ensure that the 
population contained only stromal cells. 
 
5.1.5.1 Assessment of the effect of basal and osteogenic media on the 
osteogenic differentiation of hBM-MSCs 
Only compositions AW 0%, AW 6.2%, AW 18.7% and AW 37.4% were tested to 
assess the effect of the culture media on the osteogenic differentiation of hBM-MSCs. 
After pre-treating in 20 % FBS, 6 scaffolds per composition were seeded with cells at 
passage 4 as described in Section 5.1.2 and cultured for 2 weeks. 3 samples per 
composition were cultured in basal media, while 3 samples per composition were 
cultured in osteogenic media (StemMACS OsteoDiff Media). 
201 
 
 
At 3 h, one scaffold per composition was labelled with the live cell marker and cell 
attachment was verified under fluorescence microscope, as described in Section 
5.1.3.1. After 2 weeks of culture, all samples were stained for ALP as described in 
Section 5.1.3.4. 
 
5.1.5.2 hBM-MSCs proliferation and differentiation on AW 0%, AW 6.2% 
and AW 12.5% porous scaffolds 
16 scaffolds for each of the three compositions AW 0%, AW 6.2% and AW 12.5% 
were seeded with hBM-MSCs, as described in Section 5.1.2, and cultured in 
osteogenic media. All cells were at passage 5. 
At both time-points of 7 and 14 days, 8 samples per composition were collected for the 
following tests: 
- 1 scaffold per composition was stained for live/dead cells and checked under the 
fluorescence microscope, before being fixed in 10 % formalin for confocal 
microscopy and SEM imaging; 
- 3 scaffolds per composition were stained for ALP; 
- 4 scaffolds per composition were tested for metabolic activity, before being 
collected and frozen for DNA and ALP activity quantitative assays. 
 
5.1.5.3 hBM-MSCs collagen deposition on strontium AW scaffolds 
hBM-MSCs s at passage 5 were seeded on strontium AW scaffolds of composition 
AW 0%, AW 6.2% and AW 12.5%, as described in Section 5.1.2, and cultured in 
osteogenic media for 4 weeks. For each of the 3 compositions, 3 scaffolds were 
seeded, while one scaffold per composition was kept in culture media without cells (as 
control for the staining). 
On the day of collection, scaffolds were rinsed in PBS and fixed in 10 % formalin. They 
were then rinsed in distilled water before being stained with Picroserius Red as 
described in Section 5.1.3.8. After staining, each sample was pictured under the 
stereomicroscope; bare scaffolds stained as pink, while the deposited collagen stained 
as orange. 
5.2 Results 
5.2.1 Effect of strontium AW porous scaffolds on G292 cells 
G292 cells were initially chosen as a model for bone MSCs, in the preliminary study of 
strontium-doped AW scaffolds. After assessing the effect of the scaffold pre-treatment 
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in FBS-rich media in Section 5.2.1.1, a pilot study was carried out to compare the use 
of basal and osteogenic media, shown in Section 5.2.1.2. Then all six strontium AW 
compositions were tested in basal media for cell proliferation and ALP activity (Section 
5.1.4.3). 
 
5.2.1.1 Effect of serum pre-treatment of strontium AW porous scaffolds 
on G292 cell attachment  
This experiment was carried out using AW 0% scaffolds to investigate whether a pre-
treatment step in FBS-rich media was necessary to ensure effective cell attachment. 
Fluorescence microscope pictures were taken for two samples per condition and are 
shown in Figure 5.2, with cells represented in green when positively stained with 
calcein-AM. 
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Figure 5.2: Fluorescence micrographs of G292 cells 3 h after seeding on AW 0% 
scaffolds, comparing overnight pre-treatment in 20 % FBS media with 
treatment in plain media. Live cells display in green. Scale bars represent 
100 µm. 
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Scaffolds pre-treated with 20 % FBS media showed a higher number of attached cells, 
which were starting to spread after 3 h of incubation. On the contrary, scaffolds pre-
treated in plain media had fewer and still round cells.  
It was concluded that a pre-treatment step in 20 % FBS media was required to 
guarantee effective cell attachment and it was therefore applied to all the following 
tests, with both G292 cells and hBM-MSCs. 
 
5.2.1.2 Effect of basal and osteogenic media on G292 cells cultured on 
strontium AW porous scaffolds 
Before the effect of basal and osteogenic media was assessed, the attachment and 
spreading of cells to scaffolds was verified. Figure 5.3 shows the attachment and 
spreading of G292 cells on the strontium AW scaffolds 3 h and 24 h after seeding, 
where the green colour indicates staining with the fluorescent dye calcein-AM. 
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Figure 5.3: Staining of live G292 cells on scaffolds AW 0%, AW 12.5% and AW 
24.9%, observed under fluorescence microscope. Cells were kept in plain 
media and observed 3 h and 24 h after seeding. Live cells display in green. 
Scale bars represent 200 µm. 
 
All three compositions of scaffolds were highly populated 3 h after seeding on 
preconditioned scaffolds, with cells that had already started to spread. After 24 h, 
fewer round cells were visible and most cells were well spread on the scaffold struts. 
Fewer cells appeared visible on the scaffolds at 24 h than at 3 h incubation and 
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therefore a 3 h incubation step was considered sufficient to ensure cell attachment. No 
clear difference could be observed between scaffold compositions. 
5.2.1.2.1 Effect of culture media on G292 cell proliferation 
After 24 h in plain media, the seeded scaffolds were moved to either basal media or 
osteogenic media and cultured for up to 14 days. At each time-point (1, 7 and 14 days, 
where day 1 represents the scaffolds as-seeded), samples were stained with live/dead 
fluorescent markers and the cell viability was observed under the confocal microscope 
(Figure 5.4). Signal from the scaffolds could not be collected for technical reasons. 
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Figure 5.4: Confocal microscopy pictures of AW 0%, AW 12.5% and AW 24.9% 
scaffolds seeded with G292 cells and observed 1 day, 7 days and 14 days 
after seeding. 1 day samples were kept in plain media and are considered 
as-seeded. Samples collected 7 days and 14 days after seeding were 
cultured in either basal media or osteogenic media. Live cells are labelled 
as green, dead cells are labelled as red. Images taken with Leica TCS SP2. 
Scale bars represent 200 µm. 
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Individual cells could be observed on the as-seeded (1 day) samples, although already 
covering most of the scaffold struts of their top surface. 
After 7 days of culture in basal media, cells had formed sheets that bridged across the 
borders of the pores of the scaffold structure. More pore coverage was found for 
compositions AW 12.5% and AW 24.9% than AW 0%. A higher number of red dots, 
indicating dead cells, could be observed for composition AW 24.9%. When scaffolds 
were cultured in osteogenic media, cell sheets appeared denser than on the 
corresponding compositions cultured in basal media. Sample AW 12.5% presented the 
strongest live signal from the 7 day samples and only few dead cells could be found on 
the compositions cultured in osteogenic media. 
After 14 days of culture in basal media, more occluded or nearly occluded pores could 
be seen, which indicated that a higher number of cells were bridging across the 
scaffold struts. The cell number appeared to be increasing from AW 0% to AW 12.5% 
and then further to AW 24.9%. No dead cell signal could be detected. For samples 
cultured in osteogenic media, cells were organised in dense sheets for all the three 
scaffold compositions, while very few dead cells could be observed only on sample 
AW 0%. 
In general, progressive proliferation could be observed for both culture media tested. 
However, the use of osteogenic media appeared to induce stronger proliferation of the 
G292 cells for all three strontium AW compositions. In basal media, a higher number 
of cells could be found on scaffolds AW 12.5% and AW 24.9% compared to AW 0% at 
both 7 and 14 days, with the densest cell sheet being on sample AW 24.9% at 14 
days. Cells appeared to have reached confluency on all three compositions after 14 
days in osteogenic media.  
 
The same scaffolds were then pictured under SEM. Micrographs for all the 
compositions and conditions tested are summarised in Figure 5.5 and, at higher 
magnification, in Figure 5.6. 
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Figure 5.5: Scanning electron micrographs showing the overall coverage of AW 
0%, AW 12.5% and AW 24.9% scaffolds with G292 cells, acquired in 
backscattered mode at 1 day, 7 days and 14 days after seeding. 1 day 
samples were kept in plain media and are considered as-seeded. Samples 
collected 7 days and 14 days after seeding were cultured in either basal 
media or osteogenic media. Cells appear as dark grey on lighter grey 
scaffolds; some agglomerates and sheets are pointed by white arrows. 
Scale bars represent 1 mm. 
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Results from the SEM imaging confirmed what observed with the confocal microscope.  
24 h after seeding, individual cells could be observed on the surface of scaffolds, 
accumulating in concavities. 
After 7 days of culture in basal media, the number of cells covering the surface of 
samples had significantly increased, with cell sheets being visible across some of the 
pores for composition AW 12.5% and covering most of the pores for composition AW 
24.9%. Cell number was evidently higher on all the three samples cultured in 
osteogenic media for 7 days, with wider cell sheets covering sample AW 6.2% and 
thicker sheets on sample AW 24.9%. 
After 14 days of culture in basal media, no clear further proliferation could be 
observed. On sample AW 12.5%, cell aggregates appeared sparse and sheets looked 
thin; on sample AW 24.9%, cells were visible only on a portion of the scaffold, in thick 
layers partially detached from the scaffold struts, which is in contrast with what 
observed for the same sample under the confocal microscope in Figure 5.4. It is 
possible that this sample was damaged between the confocal imaging and the SEM 
imaging, or while decreasing temperature and pressure in the SEM chamber. Samples 
cultured in osteogenic media for 14 days showed very dense cell layers on their 
surface, bridging pores for all the three compositions; most of the surface of sample 
AW 24.9% appeared covered with cells. 
In general, cells appeared to populate mainly the upper surface of all samples, which 
could be a consequence of the seeding method (the upper surface was the seeded 
surface) and of the fact that nutrients and oxygen were more easily available on the 
outer surface of scaffolds when in static culture. Osteogenic media induced faster 
proliferation on all the three compositions tested, with scaffolds AW 24.% showing 
most of their pores bridged across by cell sheets at 7 and 14 days. 
 
Details from the same samples are shown in Figure 5.6. 
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Figure 5.6: Scanning electron micrographs, at higher magnification, of the AW 
0%, AW 12.5% and AW 24.9% scaffolds seeded with G292 cells shown in 
Figure 5.5, acquired in backscattered mode 1 day, 7 days and 14 days after 
seeding. 1 day samples were kept in plain media and are considered as-
seeded. Samples collected 7 days and 14 days after seeding were cultured 
in either basal media or osteogenic media. Cells appear as dark grey on 
lighter grey scaffolds; agglomerates and sheets are pointed by white 
arrows. Scale bars represent 1 mm. 
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When samples were observed at a higher magnification, it was possible to better 
discern the morphology of cells and cell constructs. 
Individual cells were clearly visible on the as seeded samples, which were kept in plain 
media for 24 h before the two culture media were used. Cells appeared elongated on 
sample AW 0% and more rounded on sample AW 24.9%. On sample AW 12.5%, cells 
had already formed small aggregates, which extended across small pores. 
Cell sheets starting to bridge the scaffold pores could be found on scaffolds AW 0% 
and AW 12.5% cultured in basal media for 7 days, where cells grew circularly around 
the pores and progressively extending towards the centre. Fully bridged pores were 
observed on the corresponding sample AW 24.9%, with thin cell sheets still presenting 
small gaps. When cultured in osteogenic media for 7 days, all samples presented 
covered pores, with cells extending from the borders of pores or from asperities in the 
struts, with the thickness of the cell sheet increasing from AW 0% to AW 12.5% and 
then further to AW 24.9%. 
After 14 days in basal media, pores of sample AW 0% looked mainly covered by 
sheets where individual cells could still be identified. Small aggregates could be 
observed on the surface of the struts of scaffold AW 12.5% with more elongated cells, 
while partial thin cell sheets could be found on sample AW 24.9%, which again could 
indicate that the two samples were damaged prior to or during the SEM analysis. 
Thicker cell sheets could be observed on samples cultured in osteogenic media for 14 
days. Pores were covered by a layer of cells on sample AW 0% and, by a denser 
layer, on sample AW 24.9%. Cell structures appeared to stretch from the pore borders 
and strut asperities across larger gaps on sample AW 12.5%.  
In general, it was confirmed that osteogenic media induced a more rapid formation of 
denser cell layers compared to samples cultured in basal media. Enhanced 
proliferation, signified by thicker cell sheets, was observed for strontium-containing 
samples. 
5.2.1.2.2 Effect of culture media on ALP staining of G292 cells 
One scaffold per composition and per condition, at each time-point, was stained for 
ALP activity. Pictures of the samples are shown in Figure 5.7. 
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Figure 5.7: Stereomicroscopic pictures of AW 0%, AW 12.5% and AW 24.9% 
scaffolds, seeded with G292 cells and stained for ALP activity 1 day, 7 days 
and 14 days after seeding. 1 day samples were kept in plain media and are 
considered as-seeded. Samples collected 7 days and 14 days after seeding 
were cultured in either basal media or osteogenic media. ALP-positive 
areas appear as pink. Scale bars represent 1 mm. 
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While all three scaffolds that were collected 24 h after seeding appeared poorly 
stained, ALP staining became stronger after 7 and 14 days of culture.  
Sample AW 0% cultured in basal media for 7 days showed very low staining, while the 
other two compositions showed a stronger staining, particularly sample AW 12.5%. 
When cultured in osteogenic media for 7 days, samples AW 0% and AW 24.9% gave 
a very strong staining, while sample AW 12.5% showed only clusters of stained cells. 
When cultured in basal media for 14 days, all three scaffolds presented areas with 
very poor staining, probably indicating that issues occurred during the staining 
process. However, sample AW 12.5% clearly showed the strongest staining compared 
to the other two compositions. When cultured in osteogenic media for 14 days, all 
three compositions gave a very strong staining, comparable across compositions. 
In general, the use of osteogenic media during culture seemed to induced faster 
proliferation. It must be noted that G292 cells, being osteosarcoma-derived cells, 
normally express ALP. Therefore, for these samples, stronger stain corresponded also 
to the presence of more numerous cells and not only to a higher expression of 
markers related to osteogenic differentiation. 
5.2.1.2.3 Effect of culture media on DNA concentration, ALP activity and 
metabolic activity of G292 cells 
Results of quantitative assays for DNA concentration, ALP activity and metabolic 
activity are summarised in the graphs in Figure 5.8. In this case, 3 samples per 
composition and per condition were measured at each time-point and averaged. The 
same 1 day results are shown in the graphs for both basal and osteogenic media, as 
they correspond to the as-seeded samples collected before scaffolds were moved to 
their assigned culture media for the other time-points. 
 
213 
 
 
Basal media Osteogenic media 
 
 
Figure 5.8: Quantification, for G292 cells cultured on AW 0%, AW 12.5% and AW 
24.9% scaffolds in basal and in osteogenic media, of (a & b) DNA 
concentration, (c & d) ALP activity normalised to DNA and (e & f) metabolic 
activity normalised to DNA. 1 day data are the same for basal and 
osteogenic media graphs, as they represent samples as-seeded before 
they were moved to their assigned culture media. Error bars indicate the 
standard deviation of data (n=3), * indicates significant difference between 
compositions (p0.05). 
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As expected from the previous qualitative results, the amount of DNA increased with 
increasing incubation time for all the three compositions in both basal and osteogenic 
media. No significant difference could be found between the two culture media tested, 
apart from sample AW 24.9% that, at 7 days, had about twice the amount of DNA in 
osteogenic media than in basal media. Significant difference (p<0.05, Bonferroni test 
for mean comparison) was observed for samples AW 0% and AW 12.5% at 1 day 
(samples as seeded), though this could derive from uneven seeding. 
ALP activity increased at 14 days for samples in osteogenic media, while it was 
comparable for basal and osteogenic media at 7 days. Although no significant 
difference could be found, the relative ALP activity appeared to progressively increase 
from sample AW 0% to AW 12.5% and further to AW 24.9% when cultured in basal 
media. Comparable ALP activity was found for the three compositions when cultured 
in osteogenic media for 7 days, while it was higher at 14 days. 
Metabolic activity, normalised to DNA quantity, was similar between the two culturing 
conditions; only at 14 days and in samples cultured in osteogenic media, the metabolic 
activity of cells on AW 0% scaffolds was significantly higher than on AW 24.9% 
(p<0.05, Bonferroni test), with composition AW 12.5% falling in between. 
Very high standard deviations were found for some of the samples, possibly due to 
variability in the seeding efficacy. No significant difference was found between 
compositions. However, proliferation appeared to be enhanced by composition AW 0% 
in basal media (7 days) and AW 24.9% in osteogenic media (7 and 14 days). ALP 
production was higher for composition AW 24.9% in basal media at 7 days and 
strongly enhanced at 14 days in osteogenic media for all three compositions. 
Therefore it was concluded that the use of osteogenic media could mask the effect of 
strontium on G292 cells by strongly enhancing their ALP production, as observed at 
the 14 day time-point with both this quantification assay and the ALP stain (Figure 
5.7). Hence, only basal media was used when testing all the six compositions of 
strontium AW scaffolds with G292 cells, results are reported in the next Section 
5.2.1.3. 
 
5.2.1.3 Effect of strontium content in AW porous scaffolds on G292 cells 
The proliferation and ALP production of G292 cells were tested by culturing all the six 
strontium AW compositions of scaffolds in basal media for up to 7 days. 
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5.2.1.3.1 Effect of strontium content on G292 cell attachment and proliferation 
For all compositions, cell attachment (3 h), spreading (1 day) and proliferation (3 and 7 
days) were first checked under the fluorescence microscope; images are shown in 
Figure 5.9. 
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Figure 5.9: Live stain of G292 cells cultured in basal media on AW 0%, AW 6.2%, 
AW 12.5%, AW 18.7%, AW 24.9% and AW 37.4% porous scaffolds, viewed 
under fluorescence microscope. Samples were observed for cell 
attachment (3h in plain media after seeding) and proliferation at 1 day, 3 
days and 7 days of culture in basal media after seeding. Live cells display 
as green. Scale bars represent 200 µm. 
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3 h after seeding, all six compositions of scaffolds appeared covered in a high number 
of cells that were already starting to spread on the scaffold struts. This confirmed the 
results of Section 5.2.1.1 that 3 h were enough to guarantee good cell attachment and 
to observe initial spreading of G292 cells. 
At 24 h after seeding, cells were well spread on all the compositions and had already 
started to proliferate. 
After 3 days of culture in basal media, scaffold struts were completely covered in what 
appeared to be a single layer of cells; single cells could still be identified within the 
layers. 
At 7 days of culture, the cell layer covering the scaffold struts had become denser, with 
cells forming a continuous sheet on all the six strontium AW compositions.  
Very similar results were found for all the compositions, with no evident difference 
between them. 
 
The same samples, stained with fluorescent live/dead markers, were then observed 
under the confocal microscope. Results are summarised in Figure 5.10. 
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Figure 5.10: Confocal microscopy pictures of the AW 0%, AW 6.2%, AW 12.5%, 
AW 18.7%, AW 24.9% and AW 37.4% scaffolds seeded with G292 cells. 
Samples were observed for cell attachment (3h in plain media after 
seeding) and proliferation after 1 day, 3 days and 7 days of culture in basal 
media. Live cells are represented as green, dead cells are represented as 
red and scaffolds are shown in greyscale. Scale bars represent 100 µm. 
219 
 
 
3 h after seeding, it was confirmed that G292 cells had attached to all samples, with 
some cells appearing elongated, thus showing they had started to spread, especially 
on the five strontium-containing compositions. 
At 24 h culture after seeding, well spread cells could be observed forming 
agglomerates in correspondence with scaffold concavities. These were denser for 
compositions AW 18.7% and AW 24.9%. Very few dead cells could be seen on all the 
compositions. 
At 3 days, cells were covering most of the scaffold struts and had started to bridge 
pores around their borders. Again very few dead cells could be found on all the 
scaffolds. 
After 7 days of culture, all scaffolds still appeared fully covered with live cells growing 
on the surface and ingrowing along pores. On compositions AW 0% and AW 6.2% 
they appeared to form dense elongated agglomerates that stretched across pores, 
while for the other compositions they were more uniformly distributed on the struts. 
Clusters of dead cells were found on compositions AW 12.5% to AW 24.9%, while 
sparse dead cells could be observed on sample AW 37.4% and, fewer, on AW 0% and 
AW 6.2%. 
In general, no distinct differences could be found between compositions. 
 
The same samples were then observed with SEM, in BSE mode; results are shown in 
Figure 5.11, and, at higher magnification, in Figure 5.12. 
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Figure 5.11: Scanning electron micrographs showing the overall coverage of AW 
0%, AW 6.2%, AW 12.5%, AW 18.7%, AW 24.9% and AW 37.4% scaffolds 
seeded with G292 cells, acquired in backscattered mode. Samples were 
observed for cell attachment (3h in plain media after seeding) and 
proliferation at 1 day, 3 days and 7 days of culture in basal media after 
seeding. Cells appear as dark grey on lighter grey scaffolds; white arrows 
point to cell aggregates. Scale bars represent 1 mm. 
 
SEM imaging allowed to observe the whole surface of scaffolds. Since images were 
taken in BSE mode, cells appeared as darker spots on the brighter background of the 
scaffold material.  
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3 h after seeding, small sparse individual cells could be seen on the surface of all 
strontium AW samples. 
At 1 day culture after seeding, a significantly higher number of cells could be observed 
on all samples. Cells appeared more elongated on the strontium-containing samples 
than on sample AW 0%. 
After 3 days of culture in basal media, most surface of the scaffolds was covered in 
cells for all the six compositions. No differences could be observed between 
compositions. 
At 7 days, dense cell agglomerates could be found in concavities and around the 
pores of samples of composition AW 0% and AW 6.2%. For samples AW 12.5%, AW 
18.7% and AW 24.9%, cells appeared elongated and more evenly distributed on the 
surface of the scaffolds, with smaller agglomerates found in concavities, while on 
sample AW 37.4% cells were uniformly scattered on the surface. 
Clear proliferation could be observed for all the samples. At day 7, cells appeared to 
concentrate in concavities for compositions AW 0% and AW 6.2%. Some of the 
samples fractured during imaging, probably due to thermal shock while decreasing 
temperature and pressure in the SEM chamber. 
 
Details, at higher magnification, of the same samples are shown in Figure 5.12. 
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Figure 5.12: Scanning electron micrographs, at higher magnification, of the AW 
0%, AW 6.2%, AW 12.5%, AW 18.7%, AW 24.9% and AW 37.4% scaffolds 
seeded with G292 cells shown in Figure 5.11, acquired in backscattered 
mode. Samples were observed for cell attachment (3h in plain media after 
seeding) and proliferation at 1 day, 3 days and 7 days of culture in basal 
media after seeding. Cells appear as dark grey on lighter grey scaffolds; 
white arrows point to cells and agglomerates. Scale bars represent 200 µm. 
 
Individual cells could be seen on the strut surface of all samples after 3 h and 1 day of 
culture in basal media, with an increased number of cells and some initial cell-to-cell 
contact at 1 day. Cells also appeared more elongated after 1 day than after 3 h, 
indicating further spreading after the initial attachment. 
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By day 3, all scaffolds were covered by cells, with individual cells still clearly visible, 
but forming small aggregates where few cells were in contact. Aggregates stretching 
along the scaffold struts could be seen on scaffolds AW 6.2%, AW 12.5% and AW 
18.7%. 
At day 7, no individual cells could be distinguished on samples AW 0% and AW 6.2%, 
where cells appeared to have moved to concavities and formed agglomerates that 
stretched across pores. Cell agglomerates forming in the scaffold concavities could 
also be observed on scaffolds AW 12.5%, AW 18.7% and AW 24.9%, although single 
cells could still be seen. Mainly individual cells covered the struts of scaffold AW 
37.4%. 
In general, proliferation from 3 h to 7 days of culture was confirmed. Only compositions 
AW 0% and AW 6.2% appeared to induce the early formation of cell structures that 
partially covered the scaffold pores at 7 days after seeding. 
 
5.2.1.3.2 Effect of strontium content on G292 cell ALP staining 
Three samples per composition per time-point were stained for ALP and pictured using 
a stereomicroscope. One sample per composition per time-point was chosen as 
representative of the group and they are shown in Figure 5.13. 
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Figure 5.13: Stereomicroscopic images of the AW 0%, AW 6.2%, AW 12.5%, AW 
18.7%, AW 24.9% and AW 37.4% scaffolds seeded with G292 cells and 
stained for ALP activity. Samples were collected after 3h in plain media (as 
seeded) and at 1 day, 3 days and 7 days of culture in basal media after 
seeding. ALP-positive areas appear as pink. Scale bars represent 1 mm. 
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As expected, no staining could be observed for samples collected 3 h after seeding, as 
cells had only just adhered to their surface and no significant proliferation could have 
taken place. 
A pale staining could be observed for samples cultured for 24 h, indicating mild 
proliferation of cells. The staining appeared mildly stronger for scaffolds AW 12.5% 
and AW 18.7%.  
By day 3, all compositions produced clear staining of their surface, which appeared 
slightly stronger for samples AW 0%, AW 6.2%, AW 12.5% and, only on certain areas 
of the surface, sample AW 18.7%. Sample AW 24.9% appeared uniformly stained, but 
did not present areas of more intense staining as seen for lower strontium-containing 
compositions, while the staining for sample AW 37.4% appeared clearly less intense. 
Very strong staining was found for samples AW 0%, AW 6.2% and AW 12.5% after 7 
days of culture in basal media. Scaffolds AW 18.7% and AW 24.9% also presented 
uniform, but less strong staining, while sample AW 37.4% showed again a less intense 
staining compared to the other compositions. 
In general, ALP activity followed the observed proliferation: as G292 cells naturally 
express ALP, an increase in their cell number also generates a stronger staining on 
the sample. Compositions AW 6.2% and AW 12.5%, along with the starting 
composition AW 0%, induced a mildly stronger total expression of the enzyme. 
5.2.1.3.3 Effect of strontium content on DNA concentration, ALP activity and 
metabolic activity in G292 cells 
In order to quantify these results, the ALP activity was measured, along with metabolic 
activity, and normalised to the DNA concentration from 6 samples per composition and 
per time-point. Results are shown in Figure 5.14. 
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Figure 5.14: Quantification for G292 cells cultured in basal media on AW 0%, AW 
6.2%, AW 12.5, AW 18.7%, AW 24.9% and AW 37.4% scaffolds of (a) DNA 
concentration, (b) ALP specific activity, normalised to DNA content and (c) 
metabolic activity, normalised to DNA content. Error bars indicate the 
standard deviation of data (n=6).  
 
The DNA quantification showed that G292 cells proliferated on all the six compositions 
of scaffold tested, as already observed with the imaging techniques. Only composition 
AW 37.4% appeared to cause a reduced proliferation compared to the other samples, 
although the difference was found not statistically significant (p>0.05).  
The ALP activity increased from the as-seeded samples to the 3-day time-point, then it 
maintained the same level at 7 days. Compositions AW 6.2% and AW 12.5% had a 
higher average normalised ALP activity at 3 days compared to the other samples, 
while the ALP activity for sample AW 0% was higher at 24 h than 3 days. At 7 days, 
samples AW 24.9% and AW 37.4% had lower ALP activity than the other compositions 
at the same time-point and compared to their previous time-points. 
Normalised metabolic activity was higher at day 1 and day 3, while it decreased at day 
7 for all the six compositions under study. The decrease in metabolic activity at day 7 
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could be due to the rapid proliferation of cells on the samples, which could have 
caused a faster consumption of nutrients from the media. Further tests would be 
needed to confirm this. No significant difference was found between compositions at 
any time-point. 
In conclusion, the high variability of results meant that no significant difference 
(p>0.05) could be observed between compositions for any of the three parameters 
measured at any time-point. However, results suggested that compositions AW 6.2% 
and AW 12.5% could have supported a mild increase in ALP activity. 
 
5.2.2 Effect of strontium AW porous scaffolds on human bone 
marrow-derived mesenchymal stromal cells 
Since the aim of this chapter was to assess whether strontium-doped AW scaffolds 
could better stimulate bone regeneration than no-strontium AW, further tests were 
carried out to study the osteogenic differentiation of human bone marrow-derived 
mesenchymal stromal cells (hBM-MSCs). First, the use of osteogenic culture media 
was tested against basal media (Section 5.2.2.1). Then three of the compositions were 
studied for cell proliferation and ALP activity (Sections 5.2.2.2.1 to 5.2.2.2.3) and for 
extracellular matrix production through collagen staining (Section 5.2.2.2.4). 
 
5.2.2.1 Effect of basal and osteogenic media on ALP staining of hBM-
MSCs cultured on strontium AW porous scaffolds 
Three strontium compositions (AW 6.2%, AW 18.7% and AW 37.4%) were compared 
to the no-strontium composition AW 0% in both basal and osteogenic media, in order 
to evaluate whether osteogenic media was required to induce osteogenic 
differentiation in the chosen hBM-MSC population. hBM-MSCs were at passage 4 for 
this test. 
 
First, before samples were divided between basal and osteogenic media, cell 
attachment was verified by fluorescence microscopy 3h after seeding. Pictures at 
different magnifications are shown in Figure 5.15.  
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Figure 5.15: Live stain of primary hBM-MSCs (passage 4) on AW 0%, AW 6.2%, 
AW 18.7% and AW 37.4% porous scaffolds, observed under fluorescence 
microscope 3 h after seeding and before being moved to culture media. (a-
d) cell attachment on scaffolds observed at lower magnification, (e-h) initial 
spreading of cells observed at higher magnification. Live cells are labelled 
as green. Scale bars in images (a-d) represent 200 µm, in images (e-h) 
represent 100 µm. 
 
3 h after seeding, all the tested scaffold compositions were well populated with 
attached cells. As shown in detail in the higher magnification micrographs (Figure 
5.15e-h), round cells were observed on compositions AW 18.7% and 37.4%, while 
some cells had already started to spread on the scaffold struts of compositions AW 0% 
and AW 6.2%. 
 
After being observed under the fluorescent microscope, scaffolds were put back into 
culture in the assigned culture media and collected after two weeks. Three samples 
per condition and per composition were cultured and only ALP activity staining was 
carried out. Results are shown in Figure 5.16. 
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Figure 5.16: Stereomicroscopic images of AW 0%, AW 6.2%, AW 18.7% and AW 
37.4% scaffolds seeded with hBM-MSCs at passage 4, cultured in either 
basal or osteogenic media and stained for ALP activity. ALP-positive areas 
appear as pink. Scale bars represent 1 mm. 
 
All samples cultured in basal media presented very little staining after 2 weeks of 
culture, with no difference between compositions. 
When cultured in osteogenic media, all scaffold compositions showed some clear 
staining. Sample AW 6.2% was covered in cells expressing a high amount of ALP, as 
all its surface was stained. Scaffolds AW 0% and AW 18.7% presented a large patch 
of stained cells approximately in the centre of their upper surface, while scaffold AW 
37.4% had smaller stained areas. 
From this pilot study, it was evident that osteogenic media was necessary to induce 
any osteogenic differentiation in the chosen hBM-MSC population. Amongst the four 
compositions tested, AW 6.2% appeared to be the sample that could better enhance 
osteogenic differentiation. Therefore, basing on these results, scaffolds AW 6.2% were 
compared, in the following study, only with AW 0% as the no-strontium control and AW 
12.5% as the next-higher strontium composition. 
 
5.2.2.2 Effect of strontium content in AW porous scaffolds on hBM-MSCs 
Three strontium AW compositions were tested: AW 0% as the no-strontium control, 
AW 6.2% and AW 12.5%. Only 2 time-points were considered, culturing in osteogenic 
media: 7 days and 14 days. Proliferation and ALP activity were tested and results are 
presented in Sections 5.2.2.2.1 to 5.2.2.2.3; samples cultured for 4 weeks were tested 
for extracellular collagen deposition and results are shown in Section 5.2.2.2.4. 
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5.2.2.2.1 Effect of strontium content on hBM-MSCs proliferation 
At first, the presence of cells and their distribution on the scaffold surface was verified 
under fluorescence microscope; images are displayed in Figure 5.17. 
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Figure 5.17: Live stain of hBM-MSCs (passage 5) grown on AW 0%, AW 6.2% and 
AW 12.5% porous scaffolds, observed under fluorescence microscope. 
Samples were cultured in osteogenic media for 7 and 14 days. Live cells 
are labelled as green. Scale bars represent 200 µm. 
 
After 7 days of culture in osteogenic media, all three compositions presented a high 
number of live cells distributed on their surface. On scaffold AW 0% cells appeared to 
grow in patches, stretching across pores. 
At 14 days, scaffolds AW 6.2% and AW 12.5% appeared covered by a dense layer of 
cells, while sample AW 0% still presented cells growing in separate patches.  
 
The same samples were then observed under confocal microscope, to assess the 
distribution of live and dead cells within the scaffolds, and under SEM, to observe the 
overall cell distribution and morphology on the sample surface. Pictures are shown in 
Figure 5.18 to Figure 5.20. 
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Figure 5.18: Confocal microscopy pictures of the AW 0%, AW 6.2% and AW 
12.5% scaffolds seeded with hBM-MSCs at passage 5. Samples were 
cultured in osteogenic media for 7 and 14 days. Live cells are represented 
as green, dead cells are represented as red and scaffolds are shown in 
greyscale. Scale bars represent 100 µm. 
 
After 7 days of culture in osteogenic media, hBM-MSCs grown on samples AW 6.2% 
and AW 12.5% appeared to form a layer that uniformly covered the struts of the 
scaffolds. On scaffold AW 0%, the presence of patches of cells scattered on the 
surface of the scaffold was confirmed. A few red dots, indicating the presence of dead 
cells, were observed on all the three scaffolds. 
At 14 days, the layer of cells on samples AW 6.2% and AW 12.5% had become 
denser, with cells growing around pores and bridging them, showing evidence of cell 
proliferation. Patches on sample AW 0% appeared denser and larger, indicating that 
cell proliferation occurred also for this composition. Very few dead cells could be seen 
on the three samples. 
No obvious difference could be found between composition AW 6.2% and AW 12.5% 
at any of the two time-points. 
 
The same samples were observed under cold-stage SEM, and micrographs at lower 
and higher magnification are shown in Figure 5.19 and Figure 5.20, respectively. 
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Figure 5.19: Scanning electron micrographs showing the overall coverage of AW 
0%, AW 6.2% and AW 12.5% scaffolds seeded with hBM-MSCs (passage 5), 
acquired in backscattered mode. Samples were observed for cell 
proliferation after 7 days and 14 days of culture in osteogenic media. Cells 
appear as dark grey on lighter grey scaffolds; white arrows point to cell 
sheets. Scale bars represent 1 mm. 
 
SEM micrographs allowed for the visualisation of the whole scaffold surface. 
At 7 days of culture in osteogenic media, it was confirmed that, on sample AW 0%, 
hBM-MSCs tended to grow in patches that appeared to bridge over pores of the 
scaffold structure. Cells were more scattered and evenly distributed on the surface of 
scaffolds AW 6.2% and AW 12.5%, covering some of the pores or bridging across 
them.  
At 14 days, proliferation was evident for samples AW 6.2% and AW 12.5%, where 
most of the surface was covered by a dense layer of cells that occluded the scaffold 
pores and bridged over to form a continuous sheet. For scaffold AW 0%, part of its 
bare surface was still visible as cells did not cover all of it, but remained in separate 
patches as observed at the earlier time-point and in Figure 5.17 and Figure 5.18.  
In general, proliferation and cell distribution across the scaffold surface were higher for 
scaffolds AW 6.2% and AW 12.5% than scaffolds AW 0%, but no definite difference 
could be found between the two strontium compositions.  
 
Details of the same samples are represented, at higher magnification, in Figure 5.20. 
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Figure 5.20: Scanning electron micrographs of the AW 0%, AW 6.2% and AW 
12.5% scaffolds seeded with hBM-MSCs (passage 5) shown in Figure 5.19, 
acquired in backscattered mode at higher magnification. Samples were 
observed for cell proliferation after 7 days and 14 days of culture in 
osteogenic media. Cells appear as dark grey on lighter grey scaffolds; 
white arrows point to cell sheets. Scale bars represent 200 µm. 
 
Cell sheets bridging across the samples could be observed on all scaffolds and at both 
time-points.  
At 7 days, the cell sheet on sample AW 0% appeared denser than those on samples 
AW 6.2% and AW 12.5%, which still presented large gaps over the scaffold pores. 
At 14 days, scaffold AW 12.5% presented very thick layers of cells occluding the 
scaffold pores and bridging over struts. The cell layer covering samples AW 0% and 
AW 6.2% still presented small gaps, with cells growing directionally around the border 
of pores and along struts.  
5.2.2.2.2 Effect of strontium content on ALP staining of hBM-MSCs  
Differences in ALP activity at the two time-points for the three compositions tested 
were qualitatively assessed by staining 3 samples per composition and per time-point, 
pictured under the stereomicroscope. One representative sample for each composition 
and condition is shown in Figure 5.21. 
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Figure 5.21: Stereomicroscopic images of ALP staining of AW 0%, AW 6.2% and 
AW 12.5% scaffolds, seeded with hBM-MSCs at passage 5 and cultured in 
osteogenic media for 7 and 14 days. ALP-positive areas appear as pink. 
Scale bars represent 1 mm. 
 
The ALP staining of hBM-MSCs at 7 days of culture in osteogenic media showed 
stronger staining for composition AW 6.2%, followed by AW 12.5%; a less strong 
staining was observed for the no-strontium control AW 0%. 
The difference between sample AW 6.2% and AW 12.5% was less evident at 14 days 
of culture, when both compositions gave very strong staining, thus indicating 
enhanced osteogenic differentiation of cells grown on these scaffolds. A lighter 
staining was found again for scaffold AW 0%, thus qualitatively confirming that an 
increase in ALP activity was induced when cells were cultured on strontium-containing 
porous scaffolds. 
5.2.2.2.3 Effect of strontium content on DNA concentration, ALP activity and 
metabolic activity in hBM-MSCs 
In order to confirm the qualitative results, quantitative measurements of DNA 
concentration, ALP activity and metabolic activity were carried out and are 
summarised in the graphs in Figure 5.22. Four samples per composition and per time-
point were measured and averaged. 
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Figure 5.22: Quantification of total DNA concentration (a), ALP specific activity 
normalised to DNA content (b) and metabolic activity normalised to DNA 
content (c) for hBM-MSCs grown on AW 0%, AW 6.2% and AW 12.5% 
scaffolds. Cells were seeded at passage 5 and cultured in osteogenic 
media for 7 and 14 days. Error bars indicate the standard deviation of data 
(n=4); significant difference was represented as *p0.05, **p0.005, 
++p0.0001. 
 
The DNA quantification of hBM-MSCs seeded at passage 5 and cultured in osteogenic 
media confirmed the increase in cell number with time, from 7 days to 14 days of 
culture, for all the three compositions tested. At 7 days, the amount of DNA measured 
from scaffolds AW 0% was found to be significantly lower (p  0.05) than that of 
scaffolds AW 12.5%. 
ALP activity, normalised to DNA content, of samples AW 6.2% was found the highest 
at both time-points, thus agreeing with what observed with the qualitative staining in 
Figure 5.21. At 7 days, it differed significantly from both AW 0% (p  0.0001) and AW 
12.5% (p 0.05); the ALP activity of samples AW 12.5% was also found significantly 
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higher (p 0.005) than that of AW 0% at 7 days. Although significance was not found 
at 14 days due to the high variability of results, the same trend could be observed for 
the average values. An increase in ALP activity from day 7 to day 14 was observed for 
all the three compositions. 
Trends similar to those of the ALP activity were also observed for the metabolic 
activity, normalised to DNA, of cells grown on the scaffolds, but no significant 
difference was found. Comparable levels of metabolic activity were observed between 
7 and 14 days for all three compositions. 
Overall, quantitative results suggested that the presence of strontium in the scaffolds 
enhanced hBM-MSCs proliferation and they seemed to point to scaffolds AW 6.2% as 
the composition inducing the strongest ALP activity, hence the best for enhancing 
stromal cell osteogenic differentiation in constructs designed for bone repair. However, 
due to the high variability in results, further tests are needed to confirm this. 
5.2.2.2.4 Effect of strontium content on extracellular collagen deposition  
In order to assess the deposition of extracellular matrix on the cultured scaffolds, 
collagen deposition was checked using Picroserius Red staining after 4 weeks of 
culture in osteogenic media. Three samples were tested for each composition (AW 
0%, AW 6.2% and AW 12.5%) and unseeded scaffolds were used as the negative 
controls. Pictures of the stained samples are shown in Figure 5.23. 
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Figure 5.23: Picroserius red staining of extracellular collagen deposited by 
primary hBM-MSCs at passage 5 on AW 0%, AW 6.2% and AW 12.5% 
scaffolds, cultured for 4 weeks in osteogenic media. Three repeats per 
composition were compared to unseeded (blank) scaffolds. Bare scaffolds 
stained as pink, collagen stained as orange. Scale bars represent 1 mm. 
 
During staining, the glass-ceramic scaffolds stained as pink, while the deposited 
collagen stained as orange. 
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Samples AW 0% had the weakest stain for collagen, confirming the qualitative and 
quantitative results reported in the previous Sections, which showed the two strontium-
containing compositions better enhanced proliferation and differentiation of hBM-
MSCs. 
For both compositions AW 6.2% and AW 12.5%, most of their surface appeared 
covered in a thick layer of cells that stained orange, thus indicating a high deposition of 
extracellular matrix. No clear difference could be seen between these two 
compositions, suggesting that both induced similar proliferation in the long term, along 
with the formation of new bone tissue.  
5.3 Discussion 
As described in Chapter 1, strontium is a chemical element well-known for its ability to 
enhance bone formation and regeneration, capable of stimulating osteogenic 
differentiation and bone deposition and simultaneously inhibiting bone resorption (15, 
150). The drug strontium ranelate, an organic salt containing strontium, is currently 
used in clinic, administered orally, to treat severe osteoporosis (163, 165). Because 
vascular and cardiac side effects have been recently associated with its use (173, 
176), a local delivery of small amounts of strontium would be ideal for a targeted 
treatment of certain bone diseases such as osteoporosis and osteoarthritis or repair of 
bone loss. 
Numerous alternative materials that contain strontium, in particular bioactive glasses 
and glass-ceramics, have been described in the literature for the use in bone 
substitutes (151, 177, 182, 185). However, the optimal amount of strontium necessary 
for improving bone regeneration is still not known and highly depends on the initial 
composition and final form of the material. This chapter explored the effects of 
strontium-containing apatite-wollastonite glass-ceramic (AWGC) porous scaffolds on 
the proliferation and differentiation of bone-forming cells. Preliminary studies were 
carried out by Vickers on the substitution of strontium in AWGC scaffolds obtained 
from compressed powders (186). Here porous samples were first tested using the 
osteosarcoma cell line G292 and then with human bone marrow-derived MSCs (hBM-
MSCs), in order to identify the composition that would represent the best option for 
bone implants. 
 
5.3.1 Effect of strontium content on G292 cells 
Osteosarcoma-derived cell lines are often used as models for osteoblasts, due to their 
reproducibility and ability to proliferate continuously without losing their characteristics. 
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Examples of bone-forming cell lines used in the literature include mouse-derived 
MC3T3-E1 (190), rat-derived ROS17/2.8 (183) or human-derived SaOS-2 (186, 378) 
or MG-63 (370). 
For the work presented in this thesis, the human osteoblast-like G292 cell line was 
used. This is a well established line that has been used in the literature for preliminary 
testing of different materials for bone tissue engineering, from ceramics (379, 380), 
metals (381) and silk (382) to composites (383) and nanocomposites (384-386). It is 
widely available, responds consistently and is robust, as it is routinely used for 
cytotoxicity studies (385-387); it is also responsive to osteogenic stimuli, usually 
measured in terms of increase in ALP activity (381, 384, 385, 387). In addition, 
examples in the literature exist on the use of G292 cells for bioactive materials that 
contain strontium (369, 370, 388). 
 
In the present thesis, as a preliminary step to all the subsequent tests, the need for 
scaffold preconditioning in serum-rich media was evaluated. Pre-treating scaffolds in 
media before seeding them is a step that has been described in the literature for 
polymeric (389), composite (390-392) and glass-ceramic (151, 186, 393-395) 
scaffolds. It has been shown, in fact, that pre-treating scaffolds prevents the initial 
burst of ionic release from causing an increase in pH that could induce cytotoxicity 
(390, 396), while, at the same time, does not affect dissolution and apatite formation 
kinetics (397). In the present work, porous scaffolds were preconditioned in 20 % FBS 
media overnight, before seeding; qualitative results informed that the pre-treatment 
enhanced the initial attachment of G292 cells. As these cells were used as a model for 
MSCs, the same preconditioning was also applied to scaffolds to be seeded with hBM-
MSCs. Methods for performing this treatment vary across the literature, as some 
authors use serum-free culture media (151, 390, 392-394), while others described the 
use of 10 % FBS media (186, 395) or 20 % FBS media (389, 391); some authors treat 
their scaffolds for 2 or 3 h (389, 391), others for 24 h (390, 395) and others for 3 days 
(151, 392-394).  
Culture conditions were also tested to verify whether basal (10 % FBS) or osteogenic 
media was best for culturing G292 cells, once seeded on the strontium AW scaffolds. 
Because G292 cells normally express ALP (398), its activity can always be detected in 
the presence of viable cells and only variations in its production can be assessed. In 
the present work, samples cultured in osteogenic media showed increased cell 
proliferation and, in particular, stronger ALP activity with no difference between 
material compositions. It is possible that the osteogenic media was masking the 
effects of strontium, hence, in order to avoid this, it was concluded that basal media 
would have been a better choice for testing G292 cells with the strontium AW 
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scaffolds. In addition, this was in line with the methods described in the literature, 
where strontium-containing materials, when tested with the same G292 cell line, are 
usually cultured in basal media containing either 10 % (369, 388) or 5 % FBS (370). 
  
The effect of strontium content on the G292 cells was therefore tested in basal media 
for all the six compositions. Although differences were not significant, composition AW 
37.4% appeared to support a lower rate of cell proliferation, while compositions AW 
6.2% and AW 12.5% showed a mild increase in ALP activity, compared to the no-
strontium control and the other strontium compositions. This corresponds well with the 
literature more generally, which has found that strontium doped glasses support G292 
growth and can raise ALP activity. Pouria et al. used G292 cells to study strontium-
doped gypsum and observed that low-strontium compositions induced significantly 
higher proliferation at 7 days and higher ALP activity at 3 days, compared to the no-
strontium control (369). Sharifianjazi et al. showed that glasses containing different 
amounts of silver and a fixed 5 mol% of strontium oxide could sustain G292 cell 
proliferation and ALP activity, even when the content of silver oxide increased to 5 
mol%, suggesting that Sr may also aid cell survival (388). Taherkhani and 
Moztarzadeh tested SiO2-CaO-SrO-P2O5 sol-gel derived glasses with 0-100 mol% 
strontium substituted for calcium: they used glass-conditioned media (culture media in 
which the glass powder had been soaked for 4 h, then filtered out and the resulting 
media used for growing cells) and they found that all compositions were biocompatible 
with G292 cells (370). 
Similar results were also reported in publications that made use of other osteoblast-
like and osteosarcoma cell lines for the study of strontium-modified materials. 
Taherkhani and Moztarzadeh tested the same sol-gel glasses described above for 
ALP activity with MG-63 cells and found that it increased for up to 25 mol% Sr 
substitution (corresponding to 9 mol% SrO in the glass), while it then decreased for 
higher strontium amounts (370). Qiu et al. tested porous strontium-calcium-
polyphosphate scaffolds with rat osteosarcoma cells ROS17/2.8 and they observed an 
increase in cell viability for compositions up to 10 mol% strontium substitution, while 
ALP activity and proliferation at 7 days were the highest for the composition with 1 % 
strontium substitution (183). The MG-63 human osteosarcoma cell line was also 
utilised by Thakur et al. to assess the cytotoxicity of strontium-substituted sol-gel 
glasses, showing that low concentrations of strontium improved the viability of cells 
exposed to high amounts of glass powder (399). Bellucci et al. used mouse pre-
osteoblast cells MC3T3-E1 to show that ALP activity could be enhanced by adding 
strontium to bioactive glass-TCP composites, although they also found that 
proliferation and collagen production were similar for all the scaffolds tested (276). 
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More recently, the same group used an osteocyte-like cell line, MLO-Y4, to test 
strontium and magnesium-modified glasses, proving the biocompatibility of the 
materials and showing enhanced proliferation and metabolic activity in comparison 
with the original glass and Bioglass 45S5 (275). Human osteosarcoma cells SaOS-2 
were chosen by O’Donnell et al. (177), Kargozar et al. (368) and Gentleman et al. 
(151). O’Donnell et al. observed higher viability and spreading of cells when cultured in 
10 mol%-substituted glass conditioned media (177). Kargozar et al. substituted 6 
mol% of strontium oxide and 0.5 mol% of cobalt oxide for calcium oxide in a 
multicomponent glass and observed that culture in glass-conditioned media increased 
the expression of osteogenesis-related genes, with the higher expression found for Co 
and Co-Sr containing samples (368). These studies have generally found that a 
relatively low substitution of Sr into the materials prompted the optimum response from 
the cells. However, only Gentleman et al. found that high-strontium compositions of 
solid discs (50 and 100 mol% substitution for CaO in their SiO2-P2O5-Na2O-CaO 
bioactive glass) gave the best proliferation and ALP activity compared to the no-
strontium control samples (151). These were close, in terms of mol% of contained 
strontium oxide, to compositions AW 12.5% and AW 24.9% described in the present 
thesis, respectively. It is important to note that the composition of a glass, in particular 
its ratio between network formers and modifiers described by the network connectivity 
(discussed in Chapter 3), can strongly influence its solubility, therefore the ionic 
concentrations encountered by cells cultured either in direct contact with the glass or 
in its conditioned media. Consequently, comparison between different glasses might 
not be straight-forward, even if their strontium oxide content is the same.  
 
Since osteoblasts are not the only cell type that can be affected by strontium and 
strontium-containing glasses and glass-ceramics, some authors explored its effects on 
cell lines of different cell types. For example, Farag et al. verified that the proliferation 
of primate kidney-derived Vero fibroblast cells was not affected by a gamma irradiation 
treatment of a strontium-containing glass (400). More interestingly, as strontium is 
known for also inhibiting osteoclast activity (15), the rat-derived macrophage cell line 
RAW264.7 has been utilised as a model for osteoclasts: Gentleman et al. observed a 
correlation between strontium content in the glass and reduced osteoclast activity 
(151), while Weng et al. studied copper and strontium co-doped glasses and observed 
that only strontium-containing samples inhibited osteoclast activity (401). Although this 
aspect was not investigated in the present work, it is certainly of interest for future 
work. 
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5.3.2 Effect of strontium content on human bone marrow-derived 
mesenchymal stromal cells 
It is important to consider that immortalised cells can represent normally functioning 
cells only in preliminary studies, where mainly cytotoxicity and trends in proliferation 
are investigated. For example, Maleki-Ghaleh et al. worked with both G292 cells (the 
same used in part of this work and discussed above) and rat bone marrow MSCs while 
studying a ceramic coating for titanium alloy samples; they used G292 cells for 
assessing the biocompatibility of the coating, but primary MSCs for studying the 
morphology and distribution of cells grown on the samples (371). As shown by Pautke 
et al. when comparing three cell lines with normal human osteoblasts, each cell line 
exhibited a different immunocytochemical profile, all of which differed significantly from 
osteoblasts and lacked both contact inhibition and dependence of morphology on cell 
density (402). Clover and Gowen compared human osteosarcoma cells MG-63 and 
HOS TE85 with cells harvested from human trabecular bone and concluded that these 
cell lines were not suitable for modelling proliferation and ALP activity of osteoblasts 
(403). Lauvrak et al. compared 22 cell lines as osteosarcoma models and found that 
G292 cells presented medium-high colony forming ability and had low migratory 
potential and proliferation capacity when compared to the other cell lines tested (404); 
however, comparison with normal osteoblasts was not presented in this publication.  
 
In the literature, different sources of mesenchymal stromal cells (MSCs) are described: 
animal-derived cells (usually mouse or rat), or human-derived cells harvested from 
different possible tissues, from bone marrow or adipose tissue to the umbilical cord. In 
the study presented in this thesis, human bone marrow-derived MSCs (hBM-MSCs) 
were used that were obtained from bone marrow-derived mononuclear cells; hBM-
MSCs were isolated following the standard procedure of sub-culturing only cells that 
adhered to tissue culture plastic, expanded to at least passage 3 to ensure that the 
majority of cells consisted of hBM-MSCs (375-377). 
Initial tests were carried out to verify whether osteogenic media was necessary to 
induce osteogenic differentiation or if basal media could have been enough in the 
presence of strontium. No ALP staining was found after two weeks in basal media, 
while clear staining could be observed on samples cultured in osteogenic media. This 
corresponds with what observed by Schumacher et al., who tested strontium-doped 
calcium phosphate cements and did not find any osteogenic response when hBM-
MSCs were cultured in basal media, while ALP activity and expression of bone 
sialoprotein II (a late marker of osteogenic differentiation) increased for all strontium-
containing compositions when cultured in osteogenic media, with best results found for 
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the composition containing 8.5 wt% SrO (405). Similarly, Yang et al. compared the 
osteogenic differentiation of MSCs isolated from human umbilical cord in basal media, 
osteogenic media and osteogenic media containing 2 mM Sr2+ and found very low ALP 
activity in the basal group, while the presence of strontium further enhanced the 
expression of ALP, collagen I, osteopontin and the formation of mineralised nodules, 
compared to the osteogenic media-only group (406). It is also in partial agreement with 
the findings of Birgani et al.: they tested hBM-MSCs from two donors on tissue culture 
plastic and modified calcium phosphate coatings in both basal and osteogenic media 
and found that strontium enhanced the ALP activity and bone sialoprotein expression 
in osteogenic media; however, the two donors presented opposite responses in basal 
and osteogenic media when cultured on the strontium-containing coatings (407). 
Santocildes-Romero et al. measured the metabolic activity of rat bone marrow MSCs 
cultured in the presence of strontium-substituted 45S5 Bioglass in basal media, but 
compared the expression of osteogenic genes in basal and osteogenic media; they 
found that cells cultured in indirect contact with the strontium glass powder showed 
increased metabolic activity, compared to the no-strontium glass, and the up-
regulation of ALP, bone morphogenetic protein 2 (Bmp2) and Runt-related 
transcription factor 2 (Runx2) was stronger when cells were cultured in osteogenic 
media (156). Only Hesaraki et al. (181) and Lin et al. (408) carried out their cell culture 
tests exclusively in basal media. Findings from Hesaraki et al. were in line with the 
general literature and with the results reported here, as rat foetal calvaria osteoblastic 
cells grown on a sol-gel silicophosphate glass containing about 8 wt% SrO induced 
higher proliferation and increased ALP activity at 5 days, compared to the no-strontium 
composition and the control (181). Lin et al. studied the effects of strontium-calcium 
silicate scaffolds (10 mol% substitution) on MSCs harvested from osteoporotic rats 
and also observed enhanced viability, ALP activity and gene expression when 
compared to the no-strontium samples (408). 
 
According to the conclusion that osteogenic media was required for observing 
osteogenic differentiation in the samples presented in this thesis, scaffold 
compositions AW 0%, AW 6.2% and AW 12.5% were compared for proliferation, ALP 
activity and extracellular collagen deposition. The two strontium-containing 
compositions induced higher proliferation, ALP activity and collagen deposition, 
compared to the no-strontium control, with AW 6.2% giving the highest ALP activity. 
The fact that low-strontium compositions of bioactive materials appeared to give the 
best osteogenic response was already observed in the preliminary study with G292 
cells and has been discussed previously. Here results were therefore confirmed by the 
testing of hBM-MSCs, which represent a more accurate model for the in vivo 
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behaviour of the material. These results are also supported by numerous examples in 
the literature. Isaac et al. compared strontium-modified SiO2-CaO sol-gel glasses with 
their parent glass using mouse calvaria osteoblastic cells and they found that the glass 
containing 5 wt% SrO showed higher ALP activity at day 6 of culture; at day 12, the 
expression of genes involved in osteoblast differentiation, as well as the production of 
osteocalcin, was significantly higher for samples SrO 5 wt% than for SrO 1 wt% and 
the control (180). Montesi et al. tested hydroxyapatite bone cements containing 2 or 5 
mol% SrO: mouse MSCs showed higher expression of ALP and Runx2 when cultured 
on the 2 % SrO cement; in addition, the cell line MC3T3-E1 was used as a model for 
osteoblasts and presented increased viability with increasing strontium, while 
osteoclast gene expression decreased with time in RAW264.7 cells in the presence of 
the strontium samples, compared to the no-strontium control (409). Strobel et al., 
when culturing hBM-MSCs in the presence of strontium-containing bioactive glass 
nanoparticles, did not observe any difference in proliferation, but found a significant 
increase in the expression of osteocalcin, collagen type 1, VEGF (vascular endothelial 
growth factor) and Runx2 compared to the no-strontium nanoparticles (217). Sila-Asna 
added different amounts of strontium ranelate in osteogenic media, from 0.2107 to 
210.7 µg/mL, and observed the effects on hBM-MSCs: no effect of strontium was 
observed on proliferation, but the ALP activity was significantly higher in the strontium 
groups, compared to the media as such; early detection of osteogenesis-related genes 
was found with Reverse transcriptase-Polymerase chain reaction (RT-PCR) in the 
strontium-treated samples, although bone sialoprotein inhibition was observed for the 
highest strontium concentration; therefore the culture media containing 21.07 µg/mL 
strontium ranelate appeared to be the most promising (410). Weng et al., with their 
Cu- and Sr-doped bioactive glass fibres, found that the conditioned media from 
strontium-containing fibres enhanced the proliferation, ALP activity and mineralisation 
of adipose-derived stem cells (ADSCs) compared to the no-strontium compositions 
(401).  
Regarding the specific composition of scaffolds studied in the present thesis, tests of 
hBM-MSCs on AW (with no strontium) porous scaffolds have been described by 
Dyson et al., who observed increased osteogenic gene expression in cells cultured on 
AW scaffolds, compared to culture plastic, in both basal and osteogenic media, along 
with higher ALP activity compared to cells cultured on a commercial calcium 
phosphate control (120). Serna tested human ADSCs on foam replicated AW 0% 
scaffolds and confirmed that the samples could support cell attachment and 
proliferation (121). Vickers studied the effect of strontium addition to AW microporous 
samples with hBM-MSCs derived from three different donors and observed an 
increase in ALP activity for composition AW 6.2% compared to the other compositions 
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(186). Therefore, the finding that the porous AW scaffolds with low strontium content 
provide the optimum osteogenic response are in keeping with work done previously on 
this material. 
 
In general, even though some variability in the conclusions can be observed in the 
literature, the majority of publications support the findings of the present work that a 
small amount of strontium added to bioactive glass and glass-ceramic materials can 
promote the osteogenic differentiation of stromal cells. As mentioned previously, 
differences in the observations drawn when using strontium to treat mesenchymal 
cells are highly dependent on the form and composition of the material tested.  
Another key point in the research around the use of strontium in bone regeneration is 
the fact that the mechanisms through which this ion acts in vivo are still not fully 
understood, despite the widespread use of strontium ranelate as an anti-osteoporosis 
drug and the number of publications on its use and delivery (15, 16, 161, 162, 164, 
167). A recent article by Xie et al. showed how strontium could promote cell function in 
osteoblasts only in the presence of a calcium-rich environment (411). This is 
consistent with the findings of the present work and many published articles reported 
above, where strontium oxide is substituted for calcium oxide and only low-strontium 
(corresponding to high-calcium) compositions enhanced osteogenic differentiation in 
MSCs. This hypothesis would also explain the results of Wornham et al. that Sr salts 
inhibit mineralisation in in vitro osteoblast cultures (412) and the results of Aimaiti et al. 
that high doses of strontium induce ADSCs apoptosis in in vitro cultures (413), along 
with the results of Li et al. that new bone formation is improved in vivo when Sr and Ca 
are co-administered (414). Arepalli et al. found that substituting strontium oxide for 
silica instead of calcium oxide, thus preserving the quantity of calcium while reducing 
the network connectivity of the material, significantly improved the biological properties 
of their bioactive glass when tested on human osteosarcoma U2-OS cells (415). Wu et 
al. also substituted strontium oxide for silica in their mesoporous scaffolds and 
observed a significant increase in ALP activity and osteogenesis-related gene 
expression with increasing strontium, although their highest composition contained 
only 10 mol% SrO (191). Therefore, further research is required to understand the 
therapeutic mechanisms of strontium on bone and its potential interaction with 
calcium. 
In addition, other factors can play a relevant role in cell response when new materials 
and constructs, such as the glass-ceramic scaffolds described in this work, are tested. 
For example, Dalby et al. showed how the nanotopography of a substrate can direct 
the differentiation of hBM-MSCs without the need of osteogenic supplements (416, 
417). This was also found by Hu et al., who observed improved osteogenic 
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differentiation of bone marrow MSCs on nanostructured coatings, further enhanced by 
the addition of strontium that also inhibited osteoclastogenesis (418). Another 
important aspect is then represented by the elastic modulus of the material used for 
producing the scaffolds, as the Young’s modulus of the substrate can dictate the 
phenotype to which MSCs commit for their differentiation, as shown by Engler et al. 
(419, 420).  
 
Finally, numerous considerations are required when working with MSCs, as reviewed 
by Dawson et al. (421), and these should all be taken into account when designing 
experiments or comparing results with the literature. One of them is the level of 
expansion of the initial cell population, which is measured in terms of its passage 
number. In the present work, hBM-MSCs were tested at passages 4 and 5; Bonab et 
al. observed that the differentiation potential of hBM-MSCs dropped from passage 6 
(422). Other aspects that need considering include cell selection and characterisation, 
choice of source for the primary population, concentration of MSCs in the initial sample 
and their expansion, how their differentiation is controlled and the choice of the 
substrate for a tissue engineered construct (421, 423). All these additional aspects will 
have to be considered in future work, including testing cells obtained from different 
donors, so that a deeper understanding of the effects of strontium AW scaffolds on 
bone cells can be achieved.
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Chapter 6  
General discussion 
6.1 Rationale of the project 
The repair of bone defects, in particular large bone defects and especially defects in 
load bearing bones, still represents a clinical challenge, with bone currently being the 
second most transplanted tissue after blood (6, 7). Autografts are the current gold 
standard as they allow for bone regeneration without causing any immune response. 
However, only a limited volume can be available for each patient, they cause donor 
site morbidity and prolong the duration of surgery, which increases the risk of 
infections (47-49). The use of synthetic alternatives would be the ideal solution, but it 
is strictly necessary that they comply with numerous requirements to be as effective as 
the autologous grafts. These include supporting and stimulating new bone formation, 
presenting mechanical properties comparable to those of the host tissue, being cost-
effective to produce and being easy to use in the operating theatre (9, 34, 58). 
Bone infections subsequent to trauma or surgical intervention represent another 
important clinical challenge to the life of patients at high risk and presents very high 
costs of treatment: it is estimated that 1-20 % of primary joint replacements (128, 129, 
349-353) and up to 30 % of open traumatic fractures result in infections (131), with 
associated costs up to 4 times higher than those of the initial procedure (132). 
The apatite wollastonite glass-ceramic (AWGC) material, first developed by Kokubo 
and co-workers (85), presents superior mechanical properties and excellent apatite-
forming and bone-bonding ability compared to other bioactive glasses and glass-
ceramics (12, 101, 102). Its commercial form, Cerabone®, was used as granules and 
porous and solid spacers to successfully treat more than 60,000 patients in Japan 
between 1990 and 2000 (115). 
The chemical element strontium is known for its dual effect on bone cells; it can in fact 
stimulate bone deposition and, at the same time, decrease bone resorption (14, 15, 
150, 151). Strontium ranelate was approved in Europe in 2004 as a treatment for 
severe osteoporosis, after numerous studies on its efficacy (162-167). However, 
concerns were raised from 2012 on its systemic cardiovascular side effects (169-171); 
as a result, stricter recommendations for its use are now in place, set by the European 
Medicines Agency (172-175). At the same time, studies are still ongoing to verify 
whether this element could present antimicrobial features, since a synergistic effect 
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has been observed in combination with fluoride in glass ionomer cements (17, 195) or 
when added as doping agent in bioactive glasses (18, 197, 198). Therefore, a local 
delivery of smaller doses of strontium would be preferable to stimulate bone 
regeneration and, potentially, prevent bone infections, while avoiding undesired side 
effects.  
 
In the work presented in this thesis, the AWGC material was modified with different 
amounts of strontium; preliminary work by Vickers on the substitution of strontium in 
AWGC (186) was combined with Serna’s investigations on the production of AWGC 
porous scaffolds following the foam replication method (121). Here, the effects of 
strontium substitutions on the physicochemical, antibacterial and biological properties 
of porous foam-replicated scaffolds were investigated. 
6.2 Effect of strontium on the properties of the AW material 
In order to investigate the effects of strontium substitution for calcium in AWGC, six 
compositions were designed with increasing strontium content, from AW 0% (the 
original AWGC described by Kokubo (85), which represents the no-strontium control) 
to AW 37.4%, which corresponds to 75 mol% of calcium oxide being substituted with 
strontium oxide. The changes in the parent glasses were studied, before the thermal 
treatment for the controlled crystallisation and sintering was applied. 
The substitution of up to 75 mol% strontium oxide for calcium oxide (composition AW 
37.4%) was proven feasible and the composition of the glass powders was confirmed 
with EDS analysis. Along with Vicker’s results, who showed substitution of up to 50 
mol% in the same AW system (186), similar modifications have been widely described 
in the literature for different systems of bioactive glasses. Strontium addition to 
Bioglass 45S5 has been described for up to 100 % of calcium substitution with 
strontium (177, 178); calcium oxide in sol-gel glasses was substituted for up to 5 wt% 
(215) and up to 9 mol% in the borate-based glass 13-93B2 (214). Successful 
substitutions in glass-ceramics have been described for calcium silicates (182), 
calcium phosphates (183) and hydroxyapatite (184, 185). 
 
The thermal properties of the six systems produced in this thesis were investigated for 
glass powders <45 µm. It was found that the glass transition temperature and the 
formation of the first crystal phase (apatite) moved towards lower temperatures with 
increasing strontium, while the formation of the second crystal phase (calcium silicate) 
highly depended on the strontium content, moving to higher temperatures with the 
increase in strontium. A similar effect on the glass transition temperature has been 
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reported in the literature for other bioactive glass compositions upon addition of 
strontium (177, 214, 230), as well as in the presence of other modifying ions such as 
magnesium (66, 231) or zinc (232). O’Donnell developed a mathematical model 
(Equation 6.1), based on iterative least-square fitting of experimental data that could 
predict the glass transition temperature of some bioactive glasses starting from their 
molar composition (424):  
 
𝑇𝑔 (°𝐶) = 𝐴 + 𝐵[𝑆𝑖𝑂2] + 𝐶[𝑁𝑎2𝑂] + 𝐷[𝐶𝑎𝑂] + 𝐸[𝑃2𝑂5] + 𝐹[𝑆𝑟𝑂] + 𝐺[𝑀𝑔𝑂] + 𝐻[𝐾2𝑂]
+ 𝐼[𝐵2𝑂3] + 𝐽[𝐶𝑎𝐹2] 
Equation 6.1: Mathematical model proposed by O’Donnell for predicting the 
glass transition temperature of a bioactive glass from the molar 
concentration of its constituents (424). 
 
However, the range of compositions included in O’Donnell’s study did not cover the 
apatite-wollastonite parent glass. In fact, all the glasses used for the study were 
divided into two sets based on their composition, for which different parameters were 
calculated, but these did not include glasses with lower SiO2, higher CaO or SrO and 
no Na2O, as it would be the case for the glasses studied in this thesis. In addition, Hill 
and Brauer showed how this model failed in taking into consideration structural effects 
of compositional changes such as phase separation, local structural effects and the 
role of intermediate oxides within the glass network, along with the fact that the model 
is not applicable to glasses outside the considered compositions (425). 
 
The formation of the crystal phases in AW 0%, at 887 °C for apatite and 944 °C for 
wollastonite, was close to what reported by Kokubo and co-workers when they first 
described the material: 870 °C for apatite and 900 °C for wollastonite (85, 104). The 
temperature for the nucleation and growth of the two crystal phases in the strontium-
containing compositions varied with the amount of strontium, with trends that were 
observed also by Vickers when he tested compositions up to AW 24.9% (186). One 
possible reason for these variations is the expansion of the glass network caused by 
the presence of the larger ion. This was confirmed by the XRD measurements taken 
from the six parent glasses, which showed the amorphous hump characteristic of 
silicate-based glasses moving towards lower angles with the increase in strontium. 
This is an effect commonly observed in the literature for various glass compositions 
when modified with strontium (63, 236, 237) and further confirmed by Hollings 
(personal communication) for the six glasses under study here, through neutron 
diffraction and Raman spectroscopy analyses. In addition, it was shown that different 
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strontium AW compositions formed different crystal phases, each of which likely 
presented different activation energies for initiating their phase transformation. In fact, 
XRD analysis of ground porous scaffolds for the six glass-ceramic compositions 
revealed that early incorporation of strontium occurred in the apatite phase from 
composition AW 6.2%, while no strontium was detected in the silicate phase until 
composition AW 24.9%; this, in turn, was found to contain magnesium in compositions 
AW 12.5% and above. The earlier glass transition in strontium samples could have 
facilitated the migration of divalent cations towards the nucleation sites of apatite, thus 
allowing for an earlier formation of this phase; at the same time, the facilitated 
formation of apatite could have consumed most of the available calcium and strontium 
ions, thus delaying the formation of the silicate phase. A more in-depth study of the 
crystal phases formed, using for example a Rietveld refinement approach for the XRD 
patterns, would inform on the weight ratios of the crystal phases present in the final 
samples, thus confirming whether more apatite formed in higher strontium samples. 
Hill et al. also suggested that the substitution of strontium for calcium in fluorapatite 
glasses caused the apatite phase to turn from a bulk to a surface nucleation 
mechanism (235); however, this effect was not detected in the present study and 
further investigations would be required to confirm it in the case of strontium AW 
glasses. In fact, the amount and ratio of crystal phases, their composition and 
morphology, their distribution within the material and their formation temperatures can 
all influence the degree of sintering, mechanical properties, reactivity and bioactivity of 
3D porous structures obtained upon the application of a thermal treatment. These 
factors all play a major role in the outcomes obtained from biological and 
microbiological tests of the final samples, as they can affect the substrate and the 
chemical environment encountered by cells and bacteria.  
 
The presence of strontium caused the density of the parent glasses and of the glass-
ceramic porous scaffolds to increase, as expected from the substitution of a heavier 
ion for a lighter ion. Similar trends were observed before and after the thermal 
treatment, with densities linearly increasing with the amount of strontium in both cases. 
Values presented in Chapter 2 and Chapter 3 for the glasses and the glass-ceramics, 
respectively, are here compared in Table 6.1. 
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Table 6.1: Comparison between the density measurements of the strontium 
glasses before the thermal treatment (full data presented and discussed in 
Chapter 2) and of the glass-ceramic samples, after the treatment (full data 
reported in Chapter 3). 
 
Density glass 
(g/cm3) 
Density 
glass-ceramic 
(g/cm3) 
AW 0% 2.9372 3.00157 
AW 6.2% 3.0915 3.10460 
AW 12.5% 3.1925 3.23409 
AW 18.7% 3.2849 3.29850 
AW 24.9% 3.3538 3.32916 
AW 37.4% 3.5796 3.47934 
 
In general, similar values were obtained before and after the thermal treatment, with 
densities after the treatment being slightly higher than before the treatment for 
compositions AW 0% to AW 18.7%, while they were slightly lower for compositions 
AW 24.9% and AW 37.4%. This similarity could indicate that the atomic rearrangement 
due to heating was balanced by the formation of the crystal phases, which either had 
similar densities to the starting glass or balanced each other in the whole final glass-
ceramic sample. The second case was confirmed by the literature, where a density of 
3.156 g/cm3 was reported for apatite (103), thus higher than the average density of the 
AW 0% glass-ceramic sample, and 2.92 g/cm3 was reported for wollastonite (283), so 
lower than the average and the starting glass. This effect of opposite contributions can 
be explained using Equation 6.2, which was adapted for the AW system from Shelby 
(60) and shows that the final density of a glass-ceramic derives from the weighted 
average of densities of the phases it contains: 
 
𝜌𝐴𝑊 = 𝜌𝐴𝑉𝐴 + 𝜌𝑊𝑉𝑊 + 𝜌𝐺𝑉𝐺 
Equation 6.2: Formula for the final density of the AW glass-ceramic, deriving 
from the contributions of apatite (A), wollastonite (W) and the remaining 
glass phase (G). Adapted from (60). 
 
For compositions AW 24.9% and AW 37.4%, lower densities were obtained for the 
final glass-ceramics than for their parent glasses. This was likely due to the high 
amount of strontium substituting for calcium that induced an expansion not only in the 
glass network, but also in the atomic lattice of the formed crystal phases, in particular 
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apatite, which was the denser term in the equation for the other strontium AW 
compositions. 
The increase in density was also observed when samples were pictured for 
radiopacity: a linear increase in the overall intensity of the sample image was 
measured from the radiographs of sliced and cubic scaffolds with the increase in 
strontium. This was an expected effect basing on what has been described in the 
literature (259, 345-347), where promising results have also been reported of porous 
scaffolds implanted in an animal model: strontium-containing samples resulted in more 
easily visible follow-up radiographs of the operated limb (348), thus showing that the 
use of strontium in glass-ceramic materials could facilitate the monitoring of the 
operated site over time. 
6.3 Effect of strontium on the structure and architecture of 
porous AW scaffolds 
All six of the strontium compositions under study were utilised in the production of 3D 
porous scaffolds following the foam replication method. 
The same thermal treatment (1050 °C for 2 h, 10 °C/min) was applied to all samples 
and shrinkage of the cubic scaffolds was measured by comparing their volume before 
and after the treatment. It was observed that it linearly depended on the amount of 
strontium contained in the samples, with shrinkage decreasing with increasing 
strontium. From the SEM assessment of the topography of samples, it was deduced 
that different degrees of sintering were obtained for the different compositions. This 
was considered the main reason for the observed differences in volumetric shrinkage 
and it could be a consequence of the differences in thermal behaviour that were found 
for the six compositions: in fact, it has been reported in the literature that the earlier 
onset of a crystal phase can hinder further sintering of the glass particles, especially at 
temperatures below 700 °C (277, 278). As also shown in Table 6.2 where results from 
Chapter 2 are summarised, the sintering window, defined as the range of temperature 
between the glass transition temperature and the onset of the first crystallisation (237, 
321), became wider from composition AW 0% to AW 12.5%, but then decreased for 
samples AW 18.7% to AW 37.4%.  
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Table 6.2: Width of the sintering window for the six strontium AW glasses, 
derived from the glass transition temperature Tg and the onset of the 
apatite formation Ton1 obtained from the DSC measurements in Chapter 2. 
All data in °C. 
 Tg Ton1 Sint. window 
AW 0% 754.8 ± 9.3 854.0 ± 3.8 99.2 
AW 6.2% 748.9 ± 3.3 867.1 ± 4.2 118.2 
AW 12.5% 743.7 ± 1.8 863.7± 3.7 120.0 
AW 18.7% 747.5 ± 4.8 859.2 ± 0.9 111.7 
AW 24.9% 741.3 ± 3.1 853.9 ± 5.8 112.6 
AW 37.4% 744.7 ± 9.3 838.3 ± 2.7 93.6 
 
As a consequence, composition-specific thermal treatments might be needed to 
achieve similar shrinkages across the six compositions of glasses, with a step at a 
specific temperature that could be selected using hot stage microscopy (HSM). In fact, 
this would allow for a more similar topography across compositions and, potentially, 
mechanical properties of the final scaffolds, thus eliminating one variability factor for 
the biological tests. 
 
For all scaffold compositions, their porosity was found to be mostly open porosity, thus 
confirming the presence of interconnected pores that would allow for cell ingrowth. All 
compositions presented an average porosity around 55 vol%, which is comparable to 
values presented in the literature, for example by Baino and Vitale-Brovarone (303), 
Renghini et al. (308) and Cunningham et al. (301). All samples produced distributions 
with two main peaks, around 200 µm and between 310 and 380 µm. The second peak 
at larger pore sizes, from a qualitative assessment of the distributions, appeared to 
vary between compositions and moving from lower to larger values with the increase 
of strontium. It was assumed that these larger pores derived from structural defects 
such as incomplete struts, which were observed for all compositions through SEM and 
micro CT imaging. It was hypothesised that this increase of the larger pore sizes with 
strontium could be a consequence of the different degrees of shrinkage obtained for 
the different compositions described above, as the lower volume reduction for high-
strontium samples would be more evident on larger pore diameters. However, despite 
these minor differences, the structural characteristics of all tested samples fell within 
the general requirements of at least 50 vol% open porosity and pore size larger than 
100 µm, possibly 300 µm (30, 260). Strontium AW scaffolds were also found 
structurally comparable with many other foam-replicated bioactive scaffolds, as is 
summarised in Table 6.3. The same table includes examples of structural 
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characteristics of trabecular bone obtained from micro CT data; in general, bone 
presents higher porosity and larger pores than synthetic scaffolds produced via the 
foam replication method. These differences are intrinsic to this scaffold production 
method, which cannot replicate the structural anisotropy of bone tissue nor its 
response to mechanical stimuli. In addition, data on human bone usually derives from 
samples harvested from elderly subjects during surgery, therefore often presenting 
osteoporosis or osteoarthritis, which can alter the structure of bone (318). 
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Table 6.3: Comparison of average porosity, strut thickness (Tr.Th.) and pore size (Tr.Sp.) between the strontium scaffolds produced in 
this study, other bioactive glasses and bone, as measured by micro CT data analysis. Values are reported as average ± standard 
deviation, when available. N.D. indicates that the information was not provided in the referenced study. 
Material Foam/Site Porosity (%) Tr.Th. (µm) Tr.Sp. (µm) Ref. 
AW 0% PU 90 PPI 63.07 ± 3.50 96.29 ± 4.14 250.15 ± 11.77 Present work 
 PU 90 PPI 41.4 ± 0.6 171 ± 2 118 ± 2 Serna (121) 
AW 6.2% PU 90 PPI 57.15 ± 2.13 123.02 ± 4.45 247.77 ± 12.92 Present work 
AW 12.5% PU 90 PPI 56.70 ± 3.82 103.45 ± 5.18 223.38 ± 28.44 Present work 
AW 18.7% PU 90 PPI 57.00 ± 4.56 138.09 ± 8.52 274.88 ± 26.55 Present work 
AW 24.9% PU 90 PPI 50.45 ± 3.05 130.10 ± 5.95 244.55 ± 13.97 Present work 
AW 37.4% PU 90 PPI 57.31 ± 2.30 126.08 ± 3.80 268.84 ± 5.15 Present work 
CEL2 PU 54.0 ± 0.9 60.4 ± 2.4 183.6 ± 9.1 Renghini (308) 
 PU 40.2 N.D. N.D. Renghini (309) 
 PU 45 PPI 66.2 95 229 Baino (310) 
 PU 30 PPI 75.8 96 433 Baino (310) 
 PU 20 PPI 82.0 115 952 Baino (310) 
SCNA PU 56 ± 6 N.D. 240 Baino (303) 
Bioglass PU 63.1 N.D. N.D. Renghini (309) 
 PU 45 PPI 93.00 ± 0.25 N.D. 670 ± 70 Boccardi (267) 
 Spongia lamella 76 ± 2 N.D. 265 ± 20 Boccardi (267) 
 Spongia agaricina 68.0 ± 0.2 N.D. 215 ± 2.7 Boccardi (267) 
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Table 6.3 (Continued). 
Material Foam/Site Porosity (%) Tr.Th. (µm) Tr.Sp. (µm) Ref. 
TiO2 PU 45 PPI 85.6 ± 0.6 33.8 ± 5.7 530.5 ± 30.9 Fostad (281) 
HA PU 67.8 ± 5.0 N.D. N.D.  Oliveira (312) 
 Spongia officinalis 65.6 ± 5.4 1132 ± 448 843 ± 316 Cunningham (301) 
 Spongia zimocca 62.9 ± 2.2 508 ± 215 444 ± 269 Cunningham (301) 
 Spongia agaricina 55.6 ± 3.1 257 ± 95 349 ± 82 Cunningham (301) 
Borosilicate PU 50 PPI 73.3 ± 2.8 N.D. N.D. Shen (311) 
Sr borosilicate PU 50 PPI 73.2 ± 3.5 N.D. N.D. Shen (311) 
Trabecular  
bone 
Iliac crest 84.4 ± 5.4 151 ± 27 747 ± 150 Hildebrand (313) 
2nd lumbar vertebra 91.7 ± 2.4 122 ± 19 792 ± 135 Hildebrand (313) 
 Femoral head 73.9 ± 7.8 194 ± 33 638 ± 114 Hildebrand (313) 
 Calcaneal core 88.0 ± 3.5 129 ± 18 679 ± 107 Hildebrand (313) 
 Femoral head 69.71 192 ± 69 427 ± 193 Chen (314) 
 Maxilla 85.41 ± 7.68 100 ± 20 630 ± 180 Kim (315) 
 Mandible 72.72 ± 10.19 90 ± 20 420 ± 180 Kim (315) 
 Proximal femur 72.129 ± 3.735 224 ± 31 746 ± 65 Hambli (316) 
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Scaffolds were mechanically tested for compression strength and biaxial flexural 
strength. No statistically significant differences (p>0.05) were found between 
compositions for their compressive strength, which was around 10 MPa for all 
samples. This value is within the range and near the upper limit of 2-12 MPa reported 
for trabecular bone (34, 35) and is also comparable to values reported in the literature 
for bioactive scaffolds (95, 214, 265). However, the elastic modulus was found to 
decrease with the increase in strontium, from about 300 MPa for composition AW 0% 
to 120 MPa for AW 37.4%. Although these values are all within the range of 50-500 
MPa described in the literature for cancellous bone (32, 33), no other examples could 
be found on the dependence of the Young’s modulus on the strontium content. As 
explained by Meixner and Cutler (327), while the elastic modulus of a material derives 
from the atomic bonds between its atoms, the compressive strength depends more on 
the overall architecture of the samples; since similar porosities were found for the 
samples tested, this could explain the similar compressive strengths measured. 
The same samples were then tested for biaxial flexural strength, which is considered a 
more valid test for brittle materials, at least in their solid form (251). In this case, the 
strength of samples AW 12.5% was found significantly lower (p<0.0005) than that of 
scaffolds AW 0%, which were also significantly stronger than AW 37.4% (p<0.005). 
However, it must be noted that results derived from a single batch of samples and 
therefore inter-batch variability was not taken into account. The Weibull distributions 
showed a similar dispersion of data for the six compositions, with the modulus of the 
distribution ranging from 3.77 for samples AW 6.2% to 5.64 for scaffolds AW 12.5%. 
No comparison with trabecular bone is available in the literature in this case, but again 
results were comparable or superior to other glass-ceramic scaffolds described in 
published work (329-331). 
Some authors compared test results for samples tested in both compression and 
flexure, which is represented in Figure 6.1 for the strontium AW scaffolds under study.  
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Figure 6.1: Comparison between compressive strength and biaxial flexural 
strength for the strontium AW porous scaffolds; data were reported 
individually in Chapter 3. Error bars indicate the standard deviation (n=8 
for compressive strength, n=15 for biaxial flexural strength). 
 
It can be observed that results from the two methods, presented and discussed 
individually in Chapter 3, generally followed the same trend, with flexural strength 
being always higher than the relative compressive strength for each composition. 
Chen et al. found that, for the same porosity, the 3-point bending strength was higher 
than the compressive strength and they concluded that the struts buckling led to the 
formation of shear stresses during the compression test, which caused an 
underestimation of both strength and elastic modulus (80). Magdeski also ascribed the 
high dispersion of results in the compression test to a damage accumulation process, 
observing a strong dependence on porosity when testing alumina samples with both 
methods (426). Sabree et al. produced porous wollastonite and pseudowollastonite 
scaffolds: they found that the 4-point bending strength of the bulk material was 6.2 
MPa, while porous samples tested in compression showed a strength of 12 to 24 MPa, 
depending on porosity (427). Also Dong et al. observed a higher compressive strength 
(17.4 MPa) than 3-point bending strength (7.2 MPa) for porous hydroxyapatite 
scaffolds (322). However, Serna tested foam-replicated AW scaffolds prepared with 
different slurry compositions and sintering regimes and he found that the biaxial 
flexure test gave higher strength values (2 to 10 MPa) than the compression test for 
each scaffold type (2 to 4 MPa) (121).  
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In general, it could be concluded that strontium mainly influenced the elastic modulus 
of the samples tested, causing it to decrease with the increase of strontium in the 
scaffolds. Conversely, the general compressive strength did not show major variations 
between compositions and was likely dominated by the overall porosity deriving from 
the template, thus masking trends within the tested compositions. The biaxial flexural 
strength of scaffolds AW 12.5% and AW 37.4% was found significantly lower than that 
of scaffolds AW 0%, but this would need to be confirmed by testing other batches of 
samples. 
 
The apatite-forming ability of the glass-ceramic samples under study was tested on the 
porous scaffolds, as well as solid discs as a simplified model for which ion release and 
elemental composition analysis of the deposited layer could be carried out. The 
bioactivity of samples was tested through soaking them in Simulated Body Fluid (SBF) 
solution, as described by Kokubo et al. (255) and in the ISO standard 23317-2014 
(254). A decrease in apatite-forming ability was observed with the increase in 
strontium, with samples AW 0%, AW 6.2% and AW 12.5% forming apatite within 1 
day, AW 18.7% within 7 days and AW 24.9% giving small deposits at the 14 day time-
point, while AW 37.4% did not show any evidence of deposited crystals up to the latest 
time-point. These results were confirmed by monitoring the pH for both discs and 
scaffolds and by the ionic release and EDS elemental analysis from discs. For the pH 
measurements, it was observed that only samples that did not develop apatite, or that 
developed it at later time-points, increased the pH of the soaking solution, while it 
remained constant or it slightly decreased for samples with faster bioactivity. This 
demonstrated that sustained ionic dissolution continued only for less bioactive 
compositions. The ion release from discs also confirmed that only the higher strontium 
compositions, which formed apatite at later time-points or did not form it, presented a 
sustained ion release, with the concentration of calcium, silicon and magnesium 
increasing and with the concentration of phosphorus decreasing over time. The 
concentration of strontium in the soaking solution was also higher for increased 
strontium amounts in the soaked sample, but this was obviously due to the starting 
composition of the samples. The EDS elemental analysis showed a decrease in the 
percentage of detected strontium and silicon, along with an increase in phosphorus, 
for samples that formed an apatite layer within the tested time-points, with clear 
differences from the pre-soaking compositions already at the 3 day time-point. 
Scaffolds AW 18.7% showed a slower precipitation of apatite and this was reflected in 
their elemental analysis as well, with clear differences from the 7 day time-point and 
with a higher amount of detected strontium at the last time point. These 
measurements, along with the observation of the different morphology of the deposited 
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layer with smaller and thinner crystals, suggested that a different apatite might have 
been deposited on these samples. It is also possible that this layer evolved from the 
formation of a silica gel layer, as the SEM micrographs of the cracked surface 
suggested. However, these results will need confirming. 
The reduction in bioactivity with the substitution of strontium has been reported in the 
literature (181, 191, 215, 216, 290, 339), although examples also exist of enhanced 
bioactivity with increasing strontium (230). It must be noted that different glass 
compositions can present different dissolution rates and reactivity, along with different 
bioactivity mechanisms, which would explain the differences in results reported in the 
literature. The network connectivity (NC) has been proposed as a parameter that can 
predict the bioactivity of a glass based on its atomic structure (62-64). For all the six 
strontium AW compositions under study, the NC was calculated as 1.98 (Hollings, 
personal communication); however, differences in their bioactivity were found that 
could be ascribed to limitations in the model, such as that it does not take into account 
which network modifiers are present in the glass nor the role of phosphate in the 
bioactivity mechanism (62, 66). In conclusion, the bioactivity of porous strontium AW 
scaffolds was found to decrease with the increase in strontium, with the layer formed 
on samples AW 18.7% potentially containing strontium and deriving from an initial 
silica gel layer. Further studies are therefore required to clarify the apatite-forming 
mechanisms for the six compositions under study and the nature of the deposited 
crystals. 
6.4 Antimicrobial effect of strontium 
The potential antimicrobial effect of strontium, as a free ion and when added to a 
bioactive glass, is still under discussion. On the one hand, observations were made 
that a synergistic antibacterial effect of strontium and fluoride was obtained when 
these two elements were combined in glass ionomer cements (17, 195), as well as in 
a bioactive glass for a composite cement (197), in silicate and borate bioactive glasses 
(18, 198) or in hydroxyapatite nanoparticles (199). On the other hand, it has been 
reported that no enhancement of the antibacterial properties was found in silver-
containing glasses and ceramics when strontium was added, although cytotoxicity of 
the materials was reduced (200-202). 
For this reason, antimicrobial investigations were divided in two parts in the present 
thesis. At first, the antibacterial effect of elemental strontium was tested using 
strontium salts in a zone of inhibition assay. Then, the effect of the six strontium AW 
glasses on bacteria was also tested using an adapted zone of inhibition assay and 
broth dilutions assays, basing on the methods described by Fernandes et al. (198). 
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Four bacterial species were tested: Staphylococcus aureus, Staphylococcus 
epidermidis, Escherichia coli and Pseudomonas aeruginosa, as representative of the 
most commonly detected species responsible for peri-prosthetic infections (133, 140, 
141). 
 
The investigation on the effect of elemental strontium was carried out using strontium 
nitrate and strontium chloride at 4 mM concentration in water, dispensed on paper 
discs for a zone of inhibition type of testing. All tests were run following the EUCAST 
indications of using a bacterial suspension of 108 colony forming units (CFU) per mL of 
media and incubating the plates for 18 h before assessing the zones of inhibition 
(356). No inhibition was found that could indicate an antibacterial effect from the salt 
solutions. The test was therefore repeated adding silver and zinc salt solutions at the 
same molar concentration, to compare the results with known antimicrobial elements. 
This was the first time that this test was carried out with strontium salts, therefore no 
means of comparison could be used to assess the results. It is possible that the 
concentration of 4 mM used for the salt solution was not strong enough to induce any 
growth inhibition. However, the concentration was chosen basing on literature 
concentrations of strontium chloride used for testing cell and bacterial cultures (18, 
361); in addition, 4 mM was the highest concentration that could be obtained without 
observing the formation of precipitates, due to the fact that strontium is likely to react 
with sulphate, carbonate and phosphate ions in a solution (360). 
The additional tests run using silver and zinc salts were carried out as a proof-of-
concept, to validate the test against elements with known antibacterial properties. Only 
silver inhibited the growth of all four species tested, but no inhibition was observed 
from the zinc samples. While it is known that the microbial susceptibility to zinc is 
lower than that of silver (358, 359), these results suggested that, if definite 
antimicrobial properties will have to be imparted to strontium AW scaffolds in future 
work, silver would be the element of choice. 
 
Further tests were carried out using the six strontium AW parent glasses, in powder 
form and in their <45 µm fraction. At first, small cylinders of agar containing a 
suspension of the glass powders were used in a zone of inhibition type of testing. No 
inhibition was observed, which could either indicate that the glass powders under 
study did not possess antibacterial properties, or that the agar was not the optimal 
medium for ensuring ionic diffusion from the glass particles to the inoculated surface of 
the culture plate. It was therefore decided to test the susceptibility of the chosen 
bacterial species when grown in direct contact with the glass powders in broth dilution 
tests. Initially, all powders were kept suspended in media for 24 h before being 
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inoculated with a known concentration of bacteria. Only the highest strontium 
composition AW 37.4% prevented bacterial proliferation with a final bacterial count that 
was about 1 log lower than the inoculum, but only against P. aeruginosa, indicating a 
possible mild antibacterial effect of strontium-containing AW glasses. The test was 
then repeated with only P. aeruginosa and maintaining the glass powders in 
suspension for a week, before inoculating the samples. In this case, composition AW 
37.4% confirmed its bacteriostatic effect by producing a final CFU count lower than the 
initial inoculum; in addition, compositions AW 0% and AW 24.9% gave a lower count 
than the negative (no glass powder) control and the other compositions. While the 
effect of sample AW 24.9% could be predicted, as the second highest strontium 
composition dissolved for a longer time compared to the previous test, AW 0% results 
were not anticipated. A possible explanation could be the fact that different glass 
compositions might present different ion release profiles; these could influence the 
final concentration of ionic species and the final pH of the media used to culture the 
bacteria, which, in turn, affect the survival and proliferation of bacterial cells. 
Therefore, further studies will be necessary in future work to better understand the 
antibacterial effects of these glasses and their relative glass-ceramic compositions, 
starting from an investigation on the ionic release in culture media.  
6.5 Effect of strontium content in AW scaffolds on the 
proliferation and osteogenic differentiation of bone cells 
Strontium can be sensed by bone cells through the calcium-sensing receptor (CaSR) 
and it is considered an uncoupling agent (14, 15). In osteoblast precursors, it 
stimulates proliferation and the production of osteoblastic markers, thus inducing bone 
deposition (153-156); in osteoclasts, it interferes with the actin network in their 
cytoplasm, it reduces differentiation and induces apoptosis (159, 160). 
The drug strontium ranelate is used to treat severe osteoporosis and to prevent 
osteoporotic fractures (162-167). However, cardiovascular side effects have been 
recently associated with its use (168-176), therefore a local delivery of low doses of 
strontium would be preferable to locally induce bone regeneration. In the present 
thesis, the effect of the addition of strontium to AW glass-ceramic porous scaffolds 
was studied in vitro on bone-forming cells. 
 
First, osteosarcoma-derived G292 cells were used to investigate proliferation and ALP 
activity when cultured on the six scaffold compositions in basal media (α-MEM 
containing 1 % penicillin-streptomycin, 2 mM L-glutamine and 10% serum). A high 
variability in the results was found, therefore no definite conclusion could be drawn. 
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However, results seemed to suggest that all compositions except AW 37.4% could 
support proliferation and that low-strontium compositions AW 6.2% and AW 12.5% 
could induce higher ALP activity, as observed in the literature for both G292 cells and 
other cell lines (183, 276, 369, 370, 388). 
 
Scaffolds were then tested using primary human bone marrow-derived mesenchymal 
stromal cells (hBM-MSCs). No ALP activity was detected through staining when 
samples were cultured in basal media (α-MEM containing 1 % penicillin-streptomycin, 
2 mM L-glutamine and 15% serum), while sample AW 6.2%, when cultured in 
osteogenic media, gave the strongest staining compared to compositions AW 0%, AW 
18.7% and AW 37.4% (other compositions not tested). These results indicated that 
osteogenic media was necessary to induce osteogenic differentiation in the selected 
cell population and suggested that low strontium compositions could give the highest 
bone formation. Scaffolds AW 0%, AW 6.2% and AW 12.5% were therefore further 
tested in osteogenic media. Results confirmed that strontium-containing samples 
increased cell proliferation, as observed with the G292 cell line and the ALP staining 
tests, and also enhanced extracellular collagen deposition; in addition, results showed 
that cells cultured on AW 6.2% samples induced the highest ALP activity after 7 and 
14 days of culture. Therefore, composition AW 6.2% appeared to be the most suitable 
for the fabrication of foam-replicated AW scaffolds modified with strontium. These 
results were comparable to most published work, where partial substitution of 
strontium oxide for calcium oxide in bioactive glasses or glass-ceramics is shown to 
induce the strongest osteogenic differentiation of MSCs towards an osteoblastic 
phenotype (180, 186, 409, 410). However, in the present work the role of topography 
induced by the different degrees of sintering observed in Chapter 3 was not taken into 
account; it would be preferable to optimise the thermal treatment for each composition 
and then repeat these tests. In addition, only one donor was considered in the present 
study; therefore, it would be preferable to confirm these results with cells harvested 
from other donors, so that the optimal composition could be selected for a bone 
substitute that could enhance bone regeneration. 
 
In conclusion, sample compositions containing a low amount of strontium showed 
greater potential as scaffolds for bone repair than higher strontium compositions: they 
presented similar architecture, degree of sintering, topography, mechanical properties 
and apatite-forming ability to the original composition AW 0%, as well as improved 
radiopacity and promising sustained proliferation and osteogenic differentiation of 
hBM-MSCs. However, antimicrobial properties could only be observed in one of the 
four bacterial species tested, P. aeruginosa, and only for the highest strontium 
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composition AW 37.4%, thus suggesting that a high content of strontium would be 
required to impart antibacterial properties to the glass-ceramic scaffolds under study.
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Chapter 7  
Conclusions 
The work presented in this thesis described the production and characterisation of 
strontium-doped apatite-wollastonite glass-ceramic (AWGC) porous scaffolds, 
intended as novel bone grafts for enhanced bone repair. Six compositions, containing 
from 0 to 37.4 mol% strontium oxide substituted for calcium oxide, were evaluated. 
Thermal behaviour, crystallisation, morphology, mechanical properties, apatite-forming 
ability, antimicrobial effect and osteogenic properties were taken into account. The aim 
of the present work was to investigate the effects of strontium substitution in the 
AWGC material when used for foam-replicated scaffolds. Results from this work would 
help identifying the composition that could ensure a good mechanical match and 
bonding ability to cancellous bone tissue, that could provide antimicrobial features for 
preventing post-operative infections and that could stimulate bone regeneration for 
improved tissue repair. 
The findings of the present thesis can be summarised as follows: 
- Six compositions of strontium-containing AWGC parent glasses could be 
successfully produced via the melt-quenching route. All compositions were 
amorphous and their density linearly increased with the molar amount of strontium. 
All glasses were ground and sieved <45 µm. The same bimodal particle size 
distribution was found for all six glass powders, with one peak around 250 nm 
indicating the presence of a significant fraction of small particles; the second peak 
was centred around 25 µm, with a hump at about 6 µm. 
- Thermal analysis of < 45 µm glass powder fractions showed that all six 
compositions underwent two main exothermal events, corresponding to the 
nucleation and growth of two crystal phases. Characteristic temperatures depended 
on the strontium amount. Glass transition temperature and the temperature of the 
first exothermic peak linearly decreased with increasing strontium, with 10 °C and 
30 °C difference between the no-strontium composition and the highest strontium 
composition, respectively. The temperature of the second exothermic peak linearly 
increased with increasing strontium content, with an 80 °C shift between the no-
strontium sample and the highest strontium glass. The melting temperature 
followed a second order equation, with the composition containing 24.9 mol% 
strontium (50 % substitution) representing a possible eutectic composition. 
- 3D porous scaffolds could be produced via foam replication method with all the six 
compositions tested. Shrinkage linearly decreased during sintering with increasing 
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content of strontium, being about 58 % for the no-strontium control composition and 
about 48 % for the 37.4 mol% strontium (75 mol% substitution) composition. 
- After crystallisation and sintering, the density of the glass-ceramic material obtained 
from the six compositions of glass linearly increased with the amount of strontium. 
- X-ray diffraction (XRD) analysis showed that strontium preferentially substituted in 
the apatite phase. Magnesium substitution was found for wollastonite in 
compositions containing 12.5 mol% strontium and above; pseudowollastonite was 
identified for the composition containing 18.7 mol% strontium (37.5 mol% 
substitution). A calcium-magnesium-strontium silicate phase was identified in 
compositions containing 24.9 mol% and 37.4 mol% strontium oxide, which 
correspond to 50 mol% and 75 mol% substitution, respectively. 
- Scanning electron microscopy confirmed the formation of the porous network for all 
the six compositions investigated. The degree of sintering decreased with the 
increase in strontium, as the original glass particles, though rounded and fused, 
could still be identified in scaffolds containing 24.9 mol% and 37.4 mol% strontium 
oxide. Crystals presenting different morphologies could be observed in samples 
containing 12.5 mol% strontium oxide and above; large smooth crystals were 
identified as the calcium silicate phase, while small round crystals were identified as 
the apatite. Energy dispersive x-ray spectroscopy showed an even distribution of 
the crystal phases in the no-strontium control and the composition containing 6.2 
mol% strontium oxide, while, for compositions containing 12.5 mol% of strontium 
and above, a magnesium-rich crystal phase could be detected, which was identified 
as magnesium-containing wollastonite, thus confirming the results of the XRD 
analysis. 
- Micro computed tomography imaging and post-analysis showed that all six 
strontium compositions formed interconnected open pores. All compositions 
presented about 55 vol% porosity, with most pore sizes being between 100 and 400 
µm. Pore sizes presented bimodal distributions for all six compositions, with the first 
peak being around 200 µm for all samples and the second peak moving from 310 
µm to 380 µm with increasing strontium.  
- The compressive strength of porous scaffolds was found around 10 MPa for all six 
compositions. However, their Young’s modulus decreased with increasing strontium 
content, going from about 300 MPa for the no-strontium controls to about 120 MPa 
for scaffolds containing AW 37.4 mol% strontium oxide. 
- The biaxial flexural strength of samples varied between 14 MPa for the composition 
containing 12.5 mol% strontium oxide to 21 MPa for the no-strontium composition. 
Weibull analysis showed that the Weibull characteristic strength of samples was 
between 15 MPa for the composition containing 12.5 mol% strontium oxide and 23 
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MPa for the no-strontium composition. The Weibull modulus ranged from 3.7 for 
samples containing 6.2 mol% strontium to 5.6 for samples containing 12.5 mol% 
strontium, thus showing a quite high dispersion of the biaxial flexural strength 
values for all compositions. 
- The apatite-forming ability was tested by soaking samples in simulated body fluid 
solution. Discs induced the fast formation of an apatite layer for the no-strontium 
control and for compositions containing 12.5 mol% and 18.7 mol% strontium oxide. 
Formation of apatite on the porous scaffolds could be observed only on the inner 
struts of samples and the presence of strontium induced a delay in apatite 
formation. Scaffolds containing no strontium, 6.2 mol% and 12.5 mol% strontium 
oxide induced the precipitation of apatite within 24 h of soaking; scaffolds 
containing 18.7 mol% strontium oxide showed apatite formation after 7 days of 
soaking, while small apatite crystals could be observed on scaffolds containing 24.9 
mol% strontium when soaked for 14 days. 
- The substitution of strontium oxide for calcium oxide caused a linear increase in 
radiopacity with increasing strontium. 
- Testing of strontium-containing salts against Staphylococcus aureus, 
Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa in a 
zone of inhibition test showed no antimicrobial action for the 4 mM strontium 
concentration chosen. 
- 4 mM silver nitrate showed an antibacterial effect against Staphylococcus aureus, 
Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa in the 
same zone of inhibition type of test. No inhibition was induced by a 4 mM zinc 
chloride solution. 
- No inhibition of the growth of Staphylococcus aureus, Staphylococcus epidermidis, 
Escherichia coli and Pseudomonas aeruginosa could be observed when the 
strontium AW glass powders were mixed with technical agar to produce small discs 
that were used in a zone of inhibition assay. 
- Strontium-containing <45 µm glass powders were tested in a broth dilution test 
against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and 
Pseudomonas aeruginosa. The glass containing 37.4 mol% strontium oxide 
induced a reduction in bacteria viable count of Pseudomonas aeruginosa when the 
powder was soaked for 24 h before inoculation. When soaked for 7 days before 
inoculation, compositions containing no strontium, 24.9 mol% and 37.4 mol% 
strontium oxide induced a reduction in viable counts of Pseudomonas aeruginosa, 
compared to the no-glass control. Only the glass containing 37.4 mol% strontium 
gave viable counts lower than the initial inoculum. 
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- In tests using human osteoblast-like cells, the overnight pre-treatment of scaffolds 
in serum-rich media was found to enhance cell adhesion after seeding. 
- A mild increase in alkaline phosphatase activity was observed in human 
osteosarcoma G292 cells for compositions containing 6.2 mol% and 12.5 mol% 
strontium oxide when cultured in basal media. However, results were not 
conclusive. 
- The presence of strontium in AWGC scaffolds enhanced the proliferation of human 
bone marrow-derived mesenchymal stromal cells (hBM-MSCs). Scaffolds 
containing 6.2 mol% strontium oxide gave the highest alkaline phosphatase activity, 
compared to compositions containing no strontium or 12.5 mol% strontium oxide, 
when cultured in osteogenic media for up to 2 weeks. 
- The deposition of extracellular matrix was enhanced in scaffolds containing 6.2 
mol% and 12.5 mol% strontium oxide compared to the no-strontium control when 
primary human bone marrow-derived mesenchymal stromal cells were cultured in 
osteogenic media for 4 weeks, as shown by Picroserius Red staining. 
 
In conclusion, porous strontium-containing scaffolds could be produced via the foam 
replication method that gave samples with mechanical properties comparable to those 
of cancellous bone. The amount of strontium influenced the thermal properties, degree 
of sintering, crystal phases formed and apatite-forming ability of samples. Only the 
glass powder containing the highest amount of strontium oxide showed antimicrobial 
properties after soaking for 7 days, while the composition containing 6.2 mol% 
strontium oxide induced the highest alkaline phosphatase activity in hBM-MSCs. 
Therefore, no composition could be identified that could present antimicrobial 
properties and, at the same time, enhance the osteogenic differentiation of bone cells: 
low amounts of strontium were found optimal for an increase in bone regenerative 
properties of the material, but high strontium concentrations were required to obtain a 
clear antibacterial effect.
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Chapter 8  
Future work 
The work presented in this thesis described, for the first time, the addition of strontium 
to the apatite-wollastonite glass-ceramic material (AWGC) used for producing porous 
bone scaffolds following to the foam replication method. Sample properties were 
investigated in three main fields, for a preliminary broad characterisation of the 
potential bone scaffolds: materials science, microbiology and cell biology. Future work 
is now required in each of these three areas, in order to better understand the material 
and scaffold properties and to optimise the scaffolds into the ideal construct that could 
guide bone regeneration.  
 
Most characterisation took place in the materials science field. The thermal behaviour 
of the six materials under study was evaluated and the same heating regime was 
applied to all samples. Investigation on the morphology of the final scaffolds showed 
differences in sintering and shrinkage, as well as in crystal morphology, between the 
compositions considered. A study of the thermal properties of the six glasses at 
different heating rates, along with the determination of the optimal sintering 
temperature with a hot stage microscope, could allow for the design of tailored thermal 
treatments that could be applied to each composition for the production of well 
sintered scaffolds. This would also ensure a better control on the formation of crystal 
phases and would reduce the formation of sintering defects, thus improving the 
mechanical properties of samples and leading to more reproducible results, as well as 
reducing the effect of topography in the biological tests. 
Further studies would be required to fully determine all the crystal phases that form in 
each composition upon heating, which depend on the thermal treatment applied. Two 
crystal phases were identified for all compositions, however the apatite:silicate:glass 
ratio was not evaluated, even though it could influence the mechanical properties of 
the final materials and of the porous scaffolds. In addition, the possibility of the 
presence of more than two crystal phases in some of the compositions, for example 
pseudowollastonite along with a magnesium calcium silicate or calcium silicates 
containing different amounts of strontium, was not fully explored. Since wollastonite, or 
the calcium silicate phase, is considered to be responsible for the outstanding 
mechanical properties of AWGC compared to other bioactive systems, it would be 
ideal to control the nucleation of crystal phases in the material and their final crystal 
size. 
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Micro computed tomography, scanning electron microscopy and radiopacity imaging of 
samples highlighted the presence of incomplete struts and defects within the scaffold 
structure. To overcome this, the scaffold coating process during foam replication could 
be improved. The process as described in the present thesis was fully manual, so 
some steps could be automated to ensure better repeatability, for example foam 
preparation, the timing of the soaking and squeezing steps and the initial drying step of 
the coated foams. In addition, the viscosity of the slurry was not evaluated, although it 
could affect the quality of the sponge coating during the soaking phase of the foam 
replication process: variations of viscosity with glass composition should be evaluated 
and the content of glass and the polymeric binder in each slurry optimised, if 
necessary. Only 90 pore-per-inch sponges were used in the present work. However, it 
is known that scaffold porosity can affect cell and bone ingrowth. Foams with larger 
pores could be considered, although this would hinder their mechanical properties, 
which therefore would have to be re-tested once the coating and sintering process has 
been optimised. 
Regarding the mechanical properties, scaffolds were tested for compressive strength 
and biaxial flexural strength, which allowed for an initial evaluation of the mechanical 
performance of samples. However bones, especially load bearing bones, are 
constantly subjected to cyclic stresses, along with impacts and tensile stresses 
exerted by muscles. Therefore, fatigue strength, tensile strength and toughness should 
also be considered for a thorough characterisation of the mechanical behaviour of the 
novel bone-substituting implants. Only one batch of samples per composition was 
tested in the present thesis; however, inter-batch variability should be verified in order 
to ensure repeatability of the obtained mechanical properties. 
Apatite formation was observed in in vitro simulated body fluid (SBF) tests only on the 
inner struts of scaffolds and low variations in ion concentration were found when discs 
were tested with inductively coupled plasma – optical emission spectroscopy (ICP-
OES). SBF collected from porous scaffolds should therefore be tested for ion 
concentration, optimising the volume of solution used for soaking the samples. In 
addition, more time-points could be considered to better understand the short-term 
bioactive kinetics of apatite precipitation, as well as long-term studies in either SBF, 
phosphate buffered saline (PBS), tris(hydroxymethyl)aminomethane (TRIS) solution or 
cell culture media to evaluate the dissolution kinetics of the scaffolds. 
Finally, samples were generally tested relatively shortly after being produced. 
Therefore, no data was gathered on the stability of the final scaffolds in terms of 
further precipitation and crystal growth of their crystal phases, when kept at room 
temperature for months or years. This information would give an indication on whether 
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controlled storage would be necessary for finished scaffolds and for how long scaffolds 
could be used before their properties significantly change. 
 
Microbiological tests were designed to investigate the possibility that strontium could 
be considered an antimicrobial agent. For this reason, preliminary studies were carried 
out using strontium salts and the six parent glass powders instead of the final glass-
ceramic porous scaffolds.  
No bacterial growth inhibition could be observed in the strontium salt tests, which 
made the results not conclusive. It would be therefore necessary to perform further 
testing, either modifying the test protocol, for example reducing the concentration of 
the inoculum and considering shorter incubation times, or exploring whether 
alternative tests could be considered. 
The glass powder of the sample containing 37.4 mol% strontium oxide induced a 
reduction in the proliferation of Pseudomonas aeruginosa, with a density of colony 
forming units (CFUs) below the concentration of the inoculum used, when the powder 
was dissolved in media for 1 and for 7 days. CFU reduction was also observed for 
glass compositions containing no strontium and 24.9 mol% strontium, when samples 
had their glass powders suspended in media for 7 days before inoculation. This 
suggested that the materials under study could present a mild antimicrobial activity 
and that this activity depended on the dissolution time. However, further studies would 
be necessary to confirm this. The ion release in microbiological culture media should 
be evaluated over time, which would give a better insight on the concentration of 
strontium and other relevant ions reached during these tests. Results would also 
provide reference concentrations for the salt tests.  
Porous scaffolds would need to be tested, as they represent the model for the final 
material and approximate structure that will be in contact with bone tissue. Broth 
dilution assays, which would consider different dissolution time-points, could be carried 
out with the porous scaffolds, as well as biofilm formation tests where bacteria would 
be let adhere to the samples and would be cultured for a few days before being 
collected and evaluated. 
Four bacterial species were used in the work described in the present thesis, as 
representative of the species most commonly detected in bone peri-prosthetic 
infections. However, future studies could take into consideration the use of other 
bacterial species and also of different strains for the species chosen. 
In order to prove the efficacy of the scaffolds produced, an animal study would be 
required, where an infection model would be used to compare the infection rate 
against controls with no samples and with no-strontium scaffolds. 
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Finally, silver and zinc salts were tested to compare strontium with known antibacterial 
elements. Since silver showed inhibition of growth for all the four species tested, this 
would be the element of choice if antibacterial scaffolds were to be designed, provided 
that cytotoxicity could be avoided and that the beneficial effects of strontium on the 
proliferation and osteogenic differentiation of bone cells could be preserved. 
 
Cell studies were carried out using the G292 cell line and human bone marrow-derived 
mesenchymal stromal cells (hBM-MSCs). In general, data presented in this work 
showed a high variability in the results. Because scaffolds were prepared manually, 
making their production process more repeatable and automated, as described above, 
could reduce their variability in shape, volume and porosity, which, in turn, would 
reduce the variability derived from the scaffolds themselves.  
Different seeding methods could be tested, for example using different cell 
concentrations or dynamic seeding, which would ensure a more uniform distribution of 
cells around the scaffolds. With a dynamic method of culture, which maintains an even 
distribution of nutrients and oxygen within the media and around the samples, cell 
ingrowth within the scaffolds could also be assessed by sectioning the samples and 
staining them. 
Cells from the G292 line were cultured for a week and results were not conclusive. 
Basal media was chosen in order to avoid the effect of osteogenic media overcoming 
the differences induced by the presence of strontium, in particular for alkaline 
phosphatase (ALP) activity. Considering the high proliferation rate of these cells, a 
lower number of cells could be seeded and then osteogenic media could be tested 
again, repeating the quantitative assays in particular. Alternatively, different 
osteoblast-like cell lines could be used and results compared. 
The hBM-MSCs tested in the present work derived from a single donor. Testing of 
cells deriving from more donors would be preferable to confirm the optimal 
composition in terms of bone-regenerating potential.  
Due to the reduced number of hBM-MSCs available, only two time-points could be 
tested: 7 and 14 days. Testing of more time-points would be required to assess the 
effect of the strontium scaffolds in the short and the longer term. In addition, only 
proliferation and ALP activity were analysed in the present work. However, a more 
comprehensive gene expression analysis would allow for the monitoring of other 
markers of osteogenic differentiation, such as osteonectin, osteocalcin, osteopontin or 
collagen, thus giving a more complete picture of the effect of strontium addition to AW 
porous scaffolds. 
As with the cell line, in order to enhance cell attachment, scaffolds were pre-treated in 
serum-rich media overnight before seeding. However, this meant that the initial burst 
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ion release was not taken into account in the biological studies and therefore further 
testing would be required to assess whether the release from scaffolds of different 
compositions could affect the initial attachment and the subsequent proliferation. 
Finally, the use of a bioreactor that could apply mechanical loading to the samples in 
culture would allow to study the seeded scaffolds under more physiological conditions, 
as well as in the presence of a better circulation of the culture media. In vivo work will 
then be required to assess bone integration and regeneration over time after 
implantation. 
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